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Introduction: Guidelines for the use of flow cytometry in immunology 
The marriage between immunology and cytometry is one of the most stable and productive in the 
recent history of science. A rapid search in PubMed shows that, as of March 2017, using “flow 
cytometry immunology” as a search term yields more than 60,000 articles, the first of which, 
interestingly, is not about lymphocytes. 
It might be stated that, after a short engagement, the exchange of the wedding rings between 
immunology and cytometry officially occurred when the idea to link fluorochromes to monoclonal 
antibodies came about. After this, recognizing different types of cells became relatively easy and 
feasible not only by using a simple fluorescence microscope, but also by a complex and sometimes 
esoteric instrument, the flow cytometer that is able to count hundreds of cells in a single second, and 
can provide repetitive results in a tireless manner. Given this, the possibility to analyse immune 
phenotypes in a variety of clinical conditions has changed the use of the flow cytometer, which was 
incidentally invented in the late ‘60s to measure cellular DNA by using intercalating dyes, such as 
ethidium bromide. 
The epidemics of HIV/AIDS in the ‘80s then gave a dramatic impulse to the technology of counting 
specific cells, since it became clear that the quantification of the number of peripheral blood CD4+ T 
cells was crucial to follow the course of the infection, and eventually for monitoring the therapy. As a 
consequence, the development of flow cytometers that had to be easy-to-use in all clinical laboratories 
helped to widely disseminate this technology. Nowadays it is rare to find an immunological paper or 
read a conference abstract in which the authors did not use flow cytometry  as the main tool to dissect 
the immune system and identify its fine and complex functions. Of note, recent developments have 
created the sophisticated technology of mass cytometry, which is able to simultaneously identify 
dozens of molecules at the single cell level and allows us to better understand the complexity and 
beauty of the immune system. 
However, the moon has a dark side. The main strengths of this technology, i.e., the fact that it is 
relatively easy to use and that often only a brief training is sufficient to use a flow cytometer and start 
producing data, is also its main weakness. Indeed, in several (too many) papers, the eye of a well-
trained cytometrist can identify aspects that would need, to be polite, a “little” improvement. Not to 
mention the cases in which technical mistakes are performed, involving, among others, the use of 
(in)adequate controls, the (lack of appropriate) compensation, sorting strategies or even the 
description of the methods used. 
For this reason, the editorial team of the European Journal of Immunology feels it is worthwhile to offer 
our community guidelines for the correct use of cytometric techniques in the field of immunology. 
Thus, starting at the European Congress of Immunology (ECI 2015) in Vienna (Austria) and under the 
guidance of Professor Andreas Radbruch, we asked  colleagues and friends, all renowned in this field, 
to contribute by sharing their knowledge in their particular areas of expertise, in order to present a 
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collection of protocols of great interest. Such information includes, among others, suggestions and 
tricks regarding how to study cell phenotypes, the type or amount of molecules produced or secreted 
after stimulation by a cell population of interest, signalling processes, differentiation, proliferation or 
cell death, cytotoxic activities, cell-cell interactions, activity of intracellular organelles such as 
mitochondria, different types of response induced against tumours or by anticancer or 
immunosuppressive drugs, transcription factor activity, the quantification of soluble molecules, drug 
uptake, and rare events.  
Today’s challenges also involve the choice of reagents, the preparation and eventual storage of the 
cells under analysis, the overall experimental plan and, last but not least, data analyses. We are no 
longer limited by complex instrumentation, but by our creativity to ask the critical questions.  
These “Guidelines for the use of flow cytometry and cell sorting in immunological studies” thus 
represent a community effort to collect the currently accepted best methods for monitoring most of the 
variation of the major players of immune system (along with their organelles and functionality) and 
include standards for data interpretation, as well as cautions about technical issues. One aspect of the 
guidelines concerns data reproducibility, a topic that has recently attracted considerable attention. 
Therefore, the guidelines are meant to help researchers avoid potential pitfalls that could drastically 
alter the interpretation of their data. 
While preparing the guidelines feedback was received that we feel should be highlighted in this 
Introduction. Firstly, “FACS” (fluorescence activated cell sorting) should only be used for BD 
technologies as it is a BD trademark (FACSTM); the more general term “flow cytometry cell sorting” 
should be used to be company agnostic. Secondly, CD mAbs and not anti-CD mAbs (in other words 
CD1 mAb and not anti-CD1 mAb, for example) should be used. This is because the CD nomenclature 
is primarily a system to cluster/characterise mAbs and it was only later accepted to use this system to 
also describe the respective CD molecules. Thirdly, although the guidelines are as comprehensive as 
possible, there are naturally limitations e.g. only a subset of antibodies and antigens are shown and, at 
times, only certain reagents/companies are used as examples. 
It is our opinion that all efforts must be improved– this is how science works! Thus, we would be glad 
to receive from readers of the European Journal of Immunology critical comments, new ideas and 
even suggestions for new chapters for possible future updates of the Guidelines. 
 
Andrea Cossarizza 
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Section 1 – Fluidic System of a Flow Cytometer 
 
1.1 Purposes of the fluidic system of a flow cytometer 
To accurately measure optical properties of cells with a flow cytometer, cells have to pass 
through the uniformly bright center of focused laser beams.  Light collection optics is focused on 
the intersection point of cells with the laser beams to pick up fluorescence and scattered light 
from cells. This is the sensing zone of a flow cytometer, here the measurements of cell 
parameters are taken. In a stream in air cell sorters the sensing zone is located around 0.3mm 
under the nozzle tip in other cytometers it is located inside a cuvette. 
One purpose of the fluidic system is to move the cells one by one precisely through the sensing 
region in a liquid stream in such a way that each cell is illuminated by the same amount of light 
from the lasers. 
In cytometers with sort capabilities or cell sorters the fluidic system has to establish a stable 
break off of the liquid stream in small uniform droplets. Droplets containing the cells of interest 
can be charged and deflected in an electric field for sorting.  
This kind of cell sorting technique was invented by Mack J. Fulwyler in 1965 at Los Alamos 
National Laboratory [1]. Mack Fulwyler needed a machine for testing the performance of Coulter 
counters, so the first particle separator was used for sorting of particles with different Coulter 
volumes.  Len Herzenberg was interested in a machine that can sort living cells on the basis of 
fluorescence, he got the design plans of the particle separator from Mack Fulwyler and found a 
little group at Stanford University to build the first fluorescence activated cell sorter  in the late 
1960s [13] [17]. 
 
1.2 Hydrodynamic Focusing 
For precise positioning of cells in a liquid jet the hydrodynamic focusing technique is used in 
most cytometers and cell counters. 
The cells in suspension are injected by a thin tubing in a laminar flow of a sheath fluid that enters 
from a wide tubing into a narrow tubing or small orifice. The sheath flow is sped up when it 
enters the narrow tubing and the diameter of sheath and sample flow (sample core) is 
decreased (Fig. 1). Crosland-Taylor described this technique first in Nature 1953 [2] and used it 
in a device for counting small particles suspended in a fluid. Some years before in 1947 F.T. 
Gucker used a similar technique for detecting bacteria in a laminar sheath stream of air [3]. 
The hydrodynamic focusing takes place in the so called flow chamber or flow cell of a cytometer. 
A detailed description of an optimized flow chamber for a stream in air cell sorter can be found in 
the patent applications from Gerrit van den Engh [4,5] and a flow chamber of a cuvette system is 
found in another patent application from Becton Dickinson [6]. 
In addition to flow chambers for laser based cytometers, flow chambers with hydrodynamic 
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focusing for cytometers with an arc-lamp light source were developed. These early cytometers 
are based on a standard fluorescence microscope with epi-fluorescence setup. Here the same 
microscope lens is used to bring excitation light to the cells and take fluorescence emission from 
the cells. Excitation and emission light is separated by a dichroic mirror and special filters. With 
an immersion microscope lens of high numerical aperture, a stabilized arc lamp and optimized 
staining  protocol, DNA histograms with CVs lower than 1 % (0.50-0.7 %) were achieved [7,8]. 
With the hydrodynamic focusing technique, cells can be aligned to a precision of one 
micrometer. With high sample flow rates the sample core is increased, however, and cells in the 
sample core can move out of center of the laser focus. Thus not all cells get the same amount of 
laser illumination. This means that the accuracy of measurements is lost. 
To avoid loss of measurement precision when the sample core increases and to maintain laser 
intensity, cytometers use elliptical laser focus spots. Typical sizes of focus spot are 60-150 
micrometers horizontally and 5-20 micrometers vertically. Recently beam shaping optics for flat 
top focused laser beams were introduced in flow cytometers by the manufacturer. The intensity 
profile of a gaussian laser beam with 60,100 and 150 micrometer focus diameters is shown in 
Fig. 2.  
An approximation of the sample core diameter d in micrometers is given in [14]: 
𝑑 = 1.13 ∗ 1000 ∗ √𝑢/𝑛𝑣
2
    with  u= particle measurement rate in particle per second  n= particle 
concentration in particle/ ml  and v = jet velocity in m/sec. 
An approximation of the jet velocity is given by: 
𝑣 = 3,7 ∗ √𝑑𝑒𝑙𝑡𝑎 𝑃
2
    with v in m/sec  and  delta P the sheath pressure drop at the nozzle in psi  
(in practise  around the pressure on the sheath container minus 1 to 3 psi pressure drop on 
tubings and sterile filter). 
The approximation of the sample core diameter calculation shows that for a ten times lower 
sample concentration a more than 3 times bigger sample core diameter is necessary to keep the 
particle measurement rate. 
For the sheath fluid PBS (phosphate buffered saline) filtered through a 0.22 or 0.1 micrometer 
filter is often used. The sheath fluid should be compatible with cells or species that have to be 
sorted. 
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1.3 Acoustic Focusing of particles in a liquid stream 
An Acoustic Focusing technology was developed by Gregory Kaduchak and co-workers at the 
Los Alamos National Laboratory in  2001 and introduced to flow cytometry [9,10]. Recently the 
acoustic focusing technique was implemented into a flow cytometer to support hydrodynamic 
focusing. This techniques help to increase measurement precision in particular if wide sample 
cores are used. The fundamentals of acoustic cytometry are given in [11]. 
 
1.4 Droplet generation of a cell sorter 
Based on the invention from Richard Sweet [12] droplet formation of the liquid jet of a cell sorter 
is stabilized by vibrations of an ultrasonic transducer.  
Little disturbances on the surface of the liquid jet at the exit of the nozzle orifice are generated by 
the transducer. The disturbances grow exponentially and lead to break up of the jet in little 
droplets [13,14]. A cell of interest that should be sorted is measured at the sensing zone and 
moves down the stream to the breakoff point. During the separation of the droplet with the cell in 
it from the liquid jet a voltage pulse is given to the liquid jet. So electrons are caught with the cell 
in a droplet and cannot go back when the droplet is separated from the liquid stream and the 
voltage pulse is shut off. The droplet with the cell is charged and can be deflected in a static 
electric field of two deflection plates for sorting (Fig. 3). 
It is important for the sorting process that the cell of interest is at the right place when a voltage 
pulse is given to the liquid jet to charge a droplet.  The delay from the measurements of cell 
parameters to the charging pulse is determined by the cell sorter operator or by the cell sorter 
electronics. This is done with the help of fluorescence beads   and a laser beam under the 
deflection plates. The laser beam illuminates the streams of deflected and un-deflected droplets. 
The fluorescence beads are sorted all in one direction and with a camera the fluorescence in the 
droplet streams is observed on a monitor. During observation of the fluorescence spots the drop 
delay is changed so that the brightness of the fluorescence spot of the deflected droplet stream 
is maximized and the brightness of the fluorescence spot of the un-deflected droplet stream is 
minimized. The distance from the sensing zone to the break off point is controlled by a 
microscope and held constant. 
The delay setting is fixed during sorting and in general the break off distance is kept constant by 
the operator.  If the velocity of the liquid jet is constant during sorting the sorting works fine, but 
in practice this is not always the case. Small changes of sheath pressure for example due to 
partial clogging of the sheath filter can alter jet velocity during sorting. Timothy Petersen and 
Gerrit van den Engh have examined the problem and showed how little variations of sheath 
pressure can disturb the sorting process and how the operator can handle it [15]. Toralf Kaiser 
examined how temperature changes of sheath fluid alters sorting performance and gives a 
solution for stabilizing sheath fluid temperature [16].  
A schematic of a typical fluid system of a cell stream in air sorter is shown in Fig. 4 
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Figure Legend 
Figure 1: Sample core after hydrodynamic focussing by laminar sheath flow in a flow  
chamber  
Figure 2: Intensity profile of a  focus spot of a gaussian laser beam. Note if a cell is out of 
the center of the laser focus by 10µm  (20µm sample core), laser intensity goes down about  5%  
with a 60 µm diameter laser focus. 
Figure 3: Liquid stream of a jet in air sensing cell sorter. Depending of abort settings of the 
cell sorter, cells that are too close together are aborted from sorting 
Figure 4: Schematics of fluidics of a jet in air sensing cell sorter 
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Section 2 - Optics and Electronics 
2.1 Introduction 
From a technical point of view a flow cytometer is a light detection device capable of detecting 
photons of different wavelengths over a high dynamic range. In order to achieve a high dynamic 
range, the optics, signal detection and processing units must be carefully designed. 
2.2 Optics 
2.2.1 Lenses 
In flow cytometers lenses are used to collect light emitted from the cell of interest, i.e. due to 
their spatial resolution they collect light only from the point of interest. Furthermore, they are 
used to make the collected light parallel in order to direct it through the optical bench to the 
detectors. A flow cytometer employs collection and collimation lenses. Collection lenses (convex 
lenses) are used to focus the light from the interrogation point either to the end of an optical fiber 
or directly to a collimation lens (e.g. aspheric condenser lenses). Some instruments use optical 
fibers to route the detected light to detectors which are installed in an octagon. In this case a 
collimation lens is installed at the other end of the fiber to ensure that all light is routed parallel 
through the octagon. Inside the octagon another collimation lens is placed in front of each 
detector to focus the parallel light onto the photocathode. In instruments without fiber optics the 
parallel light is routed through the optical bench and then focused onto the photocathode by a 
collimation lens.  
2.2.2 Optical Filter 
The photodetectors used in flow cytometers are spectrally broadband and therefore unable to 
generate a signal exclusively from specific wavelengths and thus specific markers. To add 
specificity optical filters and dichroic mirrors are used in a well defined manner to route the light 
to the detectors.   
Optical filters are designed as band pass (BP), long pass (LP), or short pass (SP) filters and are 
mostly installed in front of the light detectors. The common property of the filters is that they 
transmit light only within a spectral range. A BP filter transmits light in a certain range. For 
example, if the BP is named as 660/20 this means that light between 650 nm and 670 nm will 
pass through the filter. SP and LP filters transmit light above or below a certain wavelength. For 
example, a SP of 660 nm will transmit all light above 660 nm. Due to aging, quality of coating 
and contamination the actual parameter of an optical filter can differ from the technical 
description. Therefore, it is recommended to check the transmission spectra of new filters 
provided by the manufacturer and always keep filters dust-free.      
Sometimes mirrors (usually silver mirrors) are used in the optical bench of a flow cytometer in 
order to deflect light for geometrical or constructive reasons. These filters are >99% reflective 
over a wide range of wavelengths. In contrast, a dichroic mirror deflect light of a certain 
wavelength while the rest pass-through. The effect of the dichroic is dependent on the operating 
angle. In some instruments dichroics employed which have a working angle of 45° whereas 
others have a working angle of 12.5°.      
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2.2.3 Dispersing Elements 
Recently, commercial cytometers have become available which use spatially dispersing 
elements instead of or in combination with optical filters in order to deflect light wavelength 
specific to a detector array. The rationale behind this is the measurement of the entire emission 
spectra of a cell (see chapter I Section 3 – Flow cytometry including flow cytometry cell sorting). 
A dispersing element can be a dispersive prism or a grating. Prisms have a higher light 
efficiency over gratings and they are not sensitive for polarized light. This is maybe the reason 
why they are employed in the spectral flow cytometer from Sony.  
A dispersing element is installed between the interrogation point and a detector array.  
2.2.4 Laser 
Lasers employed for flow cytometers are mainly solid-state, continuous wave (CW) lasers. Such 
lasers have a small footprint and a typical output power range from 20 mW to 100 mW. Lasers 
are coherent light sources which allow a high photon density at the illumination point, and 
therefore an efficient energy transfer to the fluorochrome. Modern cytometers are equipped with 
up to seven different lasers in a typical laser line range from 355 nm to 650 nm. This gives high 
flexibility in choosing the fluorophores.     
2.3 Electronics 
As a flow cytometer measures the biological information of a particle (e.g. a cells) via photons, 
this light needs to be converted to electrons and processed by an amplifier, filter, analog to 
digital converter (ADC), and baseline restorer in order to visualize and store the biological 
information of the cells or other particles. In this section the main components of cytometer 
electronics are briefly described.   
2.3.1 Detectors 
From a technical point of view the detection of cell related light is difficult due to i) the low light 
level ii) the high analysis rate and iii) the high dynamic range of the light level. Photomultiplier 
tubes (PMTs) meet these requirements and are therefore employed in almost all flow 
cytometers. PMTs are vacuum tubes containing a photocathode, electron focusing electrodes 
and a series of dynodes for electron multiplication. The photocathode converts photons to 
photoelectrons which are then multiplied by a series of dynodes driven by a high voltage (Fig.1). 
Photocathodes of PMTs employed in flow cytometers are made from bialkali material which 
determines the spectral quantum efficiency η of the PMT, which is the ratio of emitted electrons 
to incident photons. The quantum efficiency of the photocathode is always 0< η <1 and is a 
function of the light quantum energy (h*f). A typical PMT (R9220, Hamamatsu) of a cytometer 
has a quantum efficiency η=0.2 at 500 nm and η=0.09 at 700 nm which is a reduction in 
sensitivity of about 7 dB. This means that the detection of PE-Cy7 is always less sensitive as the 
detection of FITC, for example. In many applications PMTs are increasingly being replaced, e.g. 
by avalanche photodiodes (APD) due to their higher quantum efficiency. However, in flow 
cytometry only one commercial instrument (CytoFlex, Beckman Coulter) employs APDs in order 
to improve the sensitivity for wavelengths > 700 nm [1].         
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter I: Cytometry equipment 
Section 2 – Optics and Electronics 
 
26 
 
2.3.2 Amplifier and Signal processing 
Amplifiers in a flow cytometer can be grouped as pre and main amplifiers. Pre-amplifiers are 
either voltage (VA) or transimpedance (TIA) amplifiers which are used to amplify the voltage 
amplitude of a PMT (VA) or to convert a signal current of a photodiode to a voltage (TIA). 
Furthermore, pre-amplifiers perform operations, such as: 
- impedance matching 
- filtering and pulse shaping 
- bandwidth limiting 
All amplifiers in a cytometer are analogue hardware devices which must be very well designed 
for optimal signal to noise ratios (SNRs). In a typical cytometer such amplifiers have an SNR of 
>86 dB. Once the signals are processed by the pre-amplifiers the main amplifier moves the 
signal level to a suitable range for the ADC (Fig.1).  
In modern cytometers the conversion of the continuous analog voltage signal into discrete digital 
values is done by ADCs which are defined by their sampling frequency and sample resolution. 
The required dynamic detection range (DNR) of a flow cytometer can be defined as the intensity 
range of stained and unstained cells, for example. A stained cell can be 10,000 times brighter 
than an unstained cell which gives a DNR of 4 log or 80 dB (DNR[dB]=20log(104)). The DNR of 
an ideal ADC is given by: 
DNR = 6.02*N+1.76dB [2] 
This means that in theory an ADC with N=14 bit will have a DNR of 86.04 dB. In practice the 
effective number of bits (ENOBs) of an ADC is, due to noise and distortion of the circuit, some 
decibels below the theoretical value (e.g. the ADC AD9240AS of the BD Diva electronic has 78.5 
dB [3]). This limits the dynamic range to <4 decades and, more importantly, shrinks the 
resolution of dim signals.  
The sampling frequency of the AD9240AS is 10 MHz which results in 30 samples per measured 
pulse of a high speed cell sorter (pulse length = 3µs). This results in a peak detection error of 1-
2% [4]. Modern ADCs have a resolution of 16 bit and a sampling frequency of 250 MHz  which 
allows the design of flow cytometers with dynamic range of >4 decades and a peak detection 
error of <0.1%. 
In the digital domain the signals are processed by filters, baseline restorer, pulse height, pulse 
width algorithms, and trigger (see chapter I Section 3 – Flow cytometry, includingflow cytometry 
cell sorting). Filtering is done to smooth the raw PMT signal in order to improve the signal to 
noise ratio (SNR). The resulting signal consists of an unwanted DC part due to laser scatter light 
and electronic noise (among others) and a specific AC part. Hence, the DC part is subtracted by 
baseline restorers to increase the SNR and the DNR of the cytometer. The baseline restorer 
attempts to keep the baseline at zero. In practise however, baseline restoring is not perfect and 
can lead to negative values on the histogram axis or introduce a slight distortion of low signals 
and therefore to a increased CV of dim signals. After baseline restoring the pulse parameters 
(height, width, and area) is extracted and converted in a *.fcs file. 
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Taken together, the analogue and digital components of a flow cytometer in combination with the 
baseline and pulse shaping algorithms needs to be well adjusted in order to maximise SNR and 
DNR.  
 
Figures: 
Figure1: Typical electronic signal processing of a flow cytometer. The signal coming from a 
PMT or photo diode is amplified by a preamp and a main amp. The analogue signals are then 
digitized by an ADC board. A PC is used for further data processing and HV controlling.   
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Section 3 - Flow cytometry, including flow cytometry cell sorting 
 
3.1 Convention, or fluorescence-activated flow cytometry and sorting  
 
Since the first prototype of a Fluorescence Activated Cell Sorter in 1968 at Stanford, the 
technology has become a powerful tool to analyze and sort individual cells based on their 
functional status. Moreover, flow cytometry provides a robust statistic of thousands of individual 
cells and can detect rare events at a frequency below 10-4 cells. The sample uptake by the 
instrument can be done from tubes or multi-well plates at an acquisition rate of thousands of 
cells per second. In a typical cytometer the sensitivity decreases with increasing flow rate due to 
the increasing diameter of the cell stream within the flow cell. Alternatively, the AttuneNXT 
(Thermo Fisher) uses acoustic-assisted hydrodynamic focusing which helps keeping the core 
stream tight and therefore gives accurate results even at a much higher sample throughput. 
Furthermore, the serial acquisition of multiple cell samples can be automated by using high-
throughput platforms (HyperCyt®).  
Today, instruments are available designed to detect up to 27 different bio-markers on an 
individual cell. Typically these markers are fluorescently tagged antibodies, molecular sensors, 
as well as genetically encoded reporters. For instance, the FACSymphony™ (Becton Dickinson) 
is technically capable of detecting up to 50 parameters of an individual cell. In practice, this high 
number of parameters is not achievable because at the moment the range of appropriate 
fluorescent dyes is limited.  
Technical limitations regarding the maximum number of detectable markers are also given by 
the overlap of the emission spectra of the different fluorescent tags, since each fluorescence 
detection channel is correlated to a biological marker. To overcome this, fluorescent tags 
became available which have different excitation wavelengths. Currently, up to seven lasers with 
emission wavelengths from 325 nm to 650 nm are used in order to achieve a high flexibility in 
the choice of the fluorescent tags. Furthermore, tunable lasers are used for special applications 
like fluorescent life time measurements (FLIMs). 
Flow cytometers use either photomultipliers (PMTs) or Avalanche diodes to convert the emitted 
or scattered light into amplified electrical pulses which are processed by appropriate electronics 
to extract information like pulse height, area, length and time. The electronics of the cytometer 
consist basically of a preamp circuit, baseline restoration circuit and an Analog to Digital 
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Converter (ADC). In most modern cytometers the data post-processing (i.e. pulse integration, 
compensation, log-transformation) and data analysis is done in a computer by software. All 
components together must have a low noise level (i.e. a high SNR (Signal-to-Noise Ratio)) to 
achieve high instrument sensitivity (Q) and low background (B) detection.  
Avalanche diodes have better detection efficiency in long wavelengths and thus a better signal 
to noise ratio in that range over PMTs. Furthermore, they open new possibilities for the 
application of fluorescent tags with long-wave emission spectra. Avalanche diodes are 
implemented in the CytoFLEX (Beckman Coulter) cytometer. Within this instrument the emitted 
fluorescence light is divided by a Wavelength Division Multiplexer (WDM) through a series of 
band pass filters and integrated optics, onto an array of avalanche diodes which enables a high 
sensitivity in the detection of e.g. PE-Cy7.  
Avalanche Diodes or PMTs itself are light detectors which are unsuitable for wavelength 
detection, hence the fluorescent light needs to be filtered by optical filters and mirrors. These 
filters must be carefully chosen because a multiparameter experiment, i.e. an experiment in 
which multiple parameters (markers) are analyzed, requires that multiple fluorophores are used 
simultaneously; a consequence of this is spectral overlap or spillover (see chapter III, section 1: 
compensation).  
Conventional flow cytometers circumvent this problem by compensation (see chapter III, section 
1: compensation) in order to accurately correlate the physical light properties with the biological 
properties of the cell. Following this, the data are analyzed in a multivariate fashion in 
combination with a hierarchical gating strategy (see chapter  VI, section 1 Data analysis – an 
overview and section 2 Data analysis – automated analysis: automated flow cytometry cell 
population identification and visualization).  
It is essential to adapt the combination of fluorescent tags to the given optical, laser and 
electronic setup of the instrument to minimize spillover, increase detection sensitivity (Q), and 
lower the background (B) signals. For instance, by choosing the right concentration of a certain 
reagent (see chapter IV, section 2 Titration – determining optimal reagent concentration) the 
fluorochrome related B can be optimized such that it contributes ideally nothing to the B given by 
the instrument. This can help to increase the separation (the distance between the means) 
between a blank and a fluorescent population which is a function of Q and B. Thus, it requires 
the characterization of Q and B of the used instrument.  
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Mostly polystyrene particles (beads) are used for this purpose in combination with software 
based protocols implemented in the instruments e.g. MACSQuant, Fortessa, Yeti, Cytoflex to 
name just a few. Beads are small particles and so to say ‘cell dummies’ of well defined 
fluorescent intensity and sizes which also can be used for PMT voltage optimization, 
compensation setup, cell counting, scale calibration and so on.  
Scale calibration is an especially useful approach to measure absolute values (e.g. number of 
binding antibodies, amount of fluorescent molecules or photoelectrons) instead of relative Mean 
Fluorescent Intensities (MFIs) which leads to quantitative flow cytometry (see Section VII, 
Cytometric parameters). Beside beads, scale calibration can also be achieved by using LED 
light pulses. Recently, the quantiFlash™ (APE) tool has become available which provides ultra 
stable LED light pulses. Furthermore, by using this tool, instruments can be compared within or 
between labs regarding their Q and B values. 
Up to this point, analytical cytometers have been described but cells can, in addition,be sorted 
based on specific marker expression for downstream analysis (molecular biology, sequencing, 
etc.) or cell culture (seeChapter II, cell sorting).   
 
3.2 Spectral flow cytometry: principles and evolution 
For spectral flow cytometry the ‘one detector, one marker’ paradigm is changed. After excitation 
(A in fig.1), the complete emitted light of a marker (B in fig.1) is spectrally dispersed either by 
refraction within a prism or by diffraction within a grating (C in fig.1) over a highly sensitive photo 
detector array (D in fig.1). Gratings are susceptible for polarized light. As polarization occurs 
frequently in flow cytometry [1] the total efficiency of a grating may be reduced. In fact, prisms 
are better suited for spectral light dispersion because they have a better light transmission and 
are also stable for polarized light. Unfortunately, the dispersion of a prism is not linear with 
regard to the wavelength, which makes it difficult to use linear detector arrays such as 
multianode PMTs [2].  
As mentioned above, multianode PMTs or charge-coupled Devices (CCDs) can be used as 
detector arrays. CCDs have a high quantum efficiency of 80-90% in the visible range (500-800 
nm) and a relative long readout time which limits the acquisition rate. On the other hand, this in 
combination with high spectral resolution allows the spectral detection of Raman scattering 
which is a characteristic spectrum of molecular vibrations, much narrower than fluorescence 
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spectra. This allows the application of new biological markers, such as surface enhanced 
Raman scattering (SERS) tags or near infrared (NIR) fluorescent dyes [3,4].  
Spectral flow cytometry was introduced in 1979 [5], when the cytometric measurement of FITC- 
and PI-labelled mouse cells was demonstrated using a video camera tube as a detector. More 
recently, Goddard et al. [6] employed a grating spectrograph attached to an intensified CCD for 
measuring microspheres and cells. This spectrograph was implemented in the optical pathway 
of a conventional flow cytometer and was able to take spectra of single cells and microspheres 
as well as to discriminate free versus bound propidium iodide. Gregori et al. [7] investigated a 
spectral flow cytometer based on a 32-channel PMT array detector using a holographic grating 
and demonstrated the detection and analysis of labelled lymphocytes and microspheres.  
The first commercially available spectral flow cytometer, the SP6800, was developed by Sony 
[8]. This instrument employs a prism array to disperse the collected light over a 32-channel 
multianode PMT. Moreover, the instrument is equipped with 3 lasers (405 nm, 488 nm, 638 nm), 
which allows for full spectral detection of the resulting emission spectra. The measured spectra 
from single cells are subsequently unmixed by using reference spectra of all used dyes and the 
autofluorescence spectrum. Least Square Fitting algorithms are used to calculate the most 
accurate fit for all reference spectra, leading to an accurate determination of which dyes are 
present on each cell and at which intensity. Using this method, a complete fluorescence 
emission is used instead of only a small portion of emitted light entering a dedicated detector 
through a specific set of mirrors and optical filters. This is a major advantage over conventional 
flow cytometry, in which light that is lost outside of the optical filters also contaminates other 
channels with unwanted light which has to be corrected by a subtractive method (see chapter III, 
section 1: compensation). Since dyes frequently used in flow cytometry have rather broad 
emission spectra and large spectral overlaps, spectral unmixing can help mitigate this problem. 
Therefore, applications for spectral flow cytometry are similar to those performed on 
conventional flow cytometers with the additional benefit of spectral unmixing, which allows 
spectrally overlapping dyes to be measured, and auto-fluorescence subtraction to be included. 
Moreover, control of reagents (especially tandem dyes) is paramount with the increased need for 
standardization. Given that spectral flow cytometry shows full spectrum, unbiased data, quality 
control is more or less integrated. 
In this fashion, spectral flow cytometers are designed to measure the biological information 
across multiple detection channels, where the optical configuration can be fixed for all 
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experiments, giving the added benefit of instrument stability, sensitivity [9], and easier 
standardization across instruments, aided by the lack of individual PMTs and individual optical 
filters and mirrors. 
 
Figure legend   
Figure 1: Principle of a spectral flow cytometer. [A] Excitation light source (laser), [B] labeled 
cell, [C] dispersing element, [D] multichannel light detector (CCD or multichannel PMT).  
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Section 4 - Imaging flow cytometry 
4.1 Introduction 
Imaging flow cytometers combine conventional flow cytometry with the additional benefit of 
imaging each individual cell.   By utilizing the the speed and phenotyping ability of flow cytometry 
with the imagery of microscopy it allows a broad range of applications to be studied that would 
be impossible using either technique alone. Imaging flow cytometers are manufactured by Merck 
Millipore using technology originally developed by Amnis®. Peer review publications using 
Imaging flow cytometers have rapidly increased and, with the third generation of the Amnis® 
ImageStream released into the market, the use of the technology is expected to expand rapidly. 
Each generation has become faster with higher resolution, and the addition of a benchtop model 
has made imaging flow cytometry more accessible to researchers. 
 
4.2 Imaging flow cytometers 
Currently, two platforms are on the market, Amnis® FlowSight® and Amnis® ImageStream®X 
Mark II (Merck Millipore). Both capture 12 images of each cell, of which 10 can be fluorescent. 
The ImageStream®X Mark II is the larger and more powerful of the two instruments, with higher 
resolution, up to x60 magnification and seven laser options, compared with x20 magnification 
and the four lasers of the FlowSight®. 
The high throughput cell imaging of these instruments allows cellular functions, which are often 
only otherwise measurable by microscopy, to be investigated. It is very time-consuming and 
user-biased to analyze large number of cells by microscopy, and near impossible for rare cell 
types. In addition, the Amnis® instruments have been successfully used to investigate many 
important biological questions specific for immunology research. Examples of biological 
measurements achieved by the ImageStreams include spot count and co-localization features 
such as that between LC3 puncta and LysolD to measure autophagy in human peripheral blood 
mononuclear cells [1] (Fig. 1A and B); identifying and quantifying immune synapses by the 
presence of phalloidin in a mask created at the junction of a DC and T cell doublet.  [2] (Fig. 1C); 
phagocytosis of monocytes measured by quantification of the uptake of FITC-conjugated beads 
using a spot count analysis feature (Fig. 1D); and identification of the differentiation stages in 
neutrophil maturation using nuclear morphology to detect banded neutrophils through to the fully 
mature segmented neutrophils (Fig. 1E). 
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4.3 Experimental Set-up 
The antibody panel design guidelines for conventional flow cytometric analysis also apply to 
Amnis® instruments. An antibody panel appropriate for the biological question should be chosen 
and selection of the fluorochrome conjugates should take into account the expression level of 
the molecules while avoiding excessive compensation. The software on the Amnis® instruments 
(INSPIRE) and the analysis software (IDEAS) both compensate effectively; however, 
fluorochromes requiring little or no compensation should be used to detect proteins in similar 
locations (for further information see Chapter III, section 1: compensation). Web based software 
can aid in the panel design, such as BD fluorescence spectrum viewer and Biolegend 
fluorescence spectra analyzer. 
For optimal results, and as for conventional flow cytometry, antibodies should be titrated when 
used for the first time on Amnis® instruments (more detail in Chapter IV, Section 2 – Titration, 
determining optimal reagent concentration). Since the laser powers frequently differ from 
conventional flow cytometers, even antibodies, which provide optimal cell detection in 
conventional flow cytometry require titration. The imaging component helps to determine the 
appropriate concentration and ensures that the protein is detected in the expected cell 
compartment.  
As for conventional flow cytometry, correct controls (positive and negative) need to be included, 
i.e. single stained cells (or compensation beads) for compensation, and unstained cells to 
determine levels of autofluorescence (more detail found in Chapter IV, Section 1: Controls – 
determining positivity by eliminating false positives). Positive experimental controls are also vital 
to assist in the generation of the best analysis strategy. For example to investigate NFB 
translocation, untreated and LPS-treated cells are ideal negative and positive controls. LPS 
causes a translocation of NFB from the cytoplasm to the nucleus, and hence is an ideal control 
to determine and validate the analysis method. After acquisition, the machines return unused 
sample, and this could be useful when setting up a new assay allowing direct comparison of 
imaging flow cytometer data to an established technique (i.e. flow cytometry or fluorescent 
microscopy). 
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4.4 Acquisition 
The power of each laser can be adjusted on the INSPIRE software which will alter the signal 
level. Therefore when performing titration experiments, it is important to test antibodies from the 
same panel at the same laser power. For example, FITC and PE are both excited by the 488 nm 
laser and should be titrated at the same laser power. This prevents saturation of bright stains 
when they are used in combination with dim stains. Data quality is enhanced when the 
brightness levels of all probes excited off a single laser are balanced within one log scale of 
fluorescence intensity.  
Due to long acquisition times and the lack of temperature control of the machines, fixation of 
cells is recommended (for further information see Chapter IV, Section 6 – Cell Fixation and 
Permeabilization for Flow Cytometric Analyses). As cell number is also vital, it is recommended 
to run no less than 1x106 cells in 50 l/sample. On the ImageStream®X Mark II this will produce 
running speeds of 400 cells/sec on low speed, whereas the Mark II can achieve speeds of 5000 
cells/sec, and maximum acquisition speed of the FlowSight® is 4000cells/sec.  
File sizes which are generated after acquisition can be very large, for example 500 MB for a 
10,000 event file. To investigate rare cell populations several 100,000s of cells may need to be 
acquired. Here it would be beneficial to collect data only from the cells of interest. Thus, the file 
size becomes manageable and the analysis is sped up, as it needs to be remembered that the 
software is slow when handling large data files. 
 
4.5 Data analysis 
Analysis is usually performed using IDEAS, a PC based free software downloadable from 
Amnis® Millipore. FCS Express (DeNovo software) can be used as an alternative analysis 
programme .FCS files and the associated images, in .tif format, can be exported from IDEAS 
into FCS Express. The FCS files alone can also be exported into other data analysis software for 
flow cytometry, but would only provide information about fluorescence intensity and not imaging.  
Analysis of a new experiment can be very time consuming, but once optimized, for example the 
optimal mask and feature have been determined, it can be quickly applied to future experiments.  
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IDEAS has many features to aid new users with analysis, as well as user defined features for 
advanced users. The first step is compensation. Compensation files generated in INSPIRE can 
be imported or new ones created using single stained controls. IDEAS guides the user through 
the process automatically, selecting what it considers as positive events for each channel. This 
can be inaccurate, and therefore it is important to check the correct population has been 
selected by clicking on the values in the compensation matrix and if necessary adjusting the 
gating in the compensation graphs. 
The simplest way to generate a new analysis method is to use one of several built-in wizards, 
such as spot count, internalization and co-localization. These guide the user step by step 
through the analysis. If no analysis wizard exists the feature finder wizard is a useful tool to 
determine the best feature to use. If this also does not lead to a useful strategy, one can 
determine masks and features manually from the 85 features/channel and 14 function masks 
that are available and described in the IDEAS handbook. If several features are an option for the 
read-out of interest, the method that gives greatest separation between positive and negative 
controls should be chosen.  
Once an analysis method has been developed samples can be batch analysed.  One should be 
aware that each sample might require a different gating. A treatment or activation may change 
the properties of the cell e.g. shape and size. Therefore, the analysis should be checked 
ensuring the gating is still valid for each treatment and adjust if necessary. Following analysis, a 
statistics report can be then generated of the parameters of interest. 
Useful for presentation/publication is the ability to tailor the image gallery to create the most 
suitable images/composites for presentations/publication. The brightness and contrast can be 
manipulated for each channel and any background staining removed. Importantly changing the 
way the images are viewed does not alter the raw data or analysis. 
In summary, the Amnis® technology is a very powerful tool allowing the combination of imaging 
and flow cytometry. However, slow running and long complicated analysis should be taken into 
consideration when opting for this technique over conventional flow cytometry.  
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Figure legend   
 
Figure 1: Amnis® ImageStream assays on immune cells. Autophagy assay on human 
peripheral blood mononuclear cells (PBMCs) showing A) LC3 puncta in CD8+ PBMCs. B) 
Autolysosome formation by co-localisation of LC3 and LysoID from untreated cells (control), 
cells treated with an autophagy inducer (Rapamycin) or inhibitor (Chloroquin), is further 
quantified as percentage of cells with a bright detail similarity (BDS) of >1.5 or >2. BDS is a 
feature in IDEAS software that compares the bright detail image detail of two images to quantify 
co-localisation. C) Immune synapse detection between mouse CD90+ T cells and CD11b+ 
dendritic cells (DCs) cultured in vitro. An anti-mouse phalloidin-FITC antibody was used to detect 
synapse formation. D) Phagocytosis of FITC-conjugated beads in human CD14+ macrophages. 
E) Differentiation of mouse bone marrow Ly6G+ neutrophils. Cell were stained with a fixable live 
dead violet marker (L/D), anti-mouse Ly6G FITC antibody and DRAQ5 nuclear stain. Nuclear 
morphology, shown by DRAQ5 staining, indicates the neutrophil maturation state. 
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Section 5 – Mass Cytometry 
5.1 Introduction 
Since its introduction in 2009 [1], mass cytometry (or Cytometry by Time-Of-Flight technology, 
CyTOF) has pioneered a new era of high-dimensional single-cell analysis, surpassing the limits 
set by the availability of spectrally resolvable fluorochromes in conventional flow cytometry [2, 3]. 
The innovative concept of mass cytometry is the use of stable rare earth metal isotopes of very 
high isotopic purity coupled to antibodies or other target-specific probes for labeling of single cell 
suspensions. These probes are detected and characterized based on the metals’ mass/charge 
ratios by inductively-coupled plasma time of flight mass spectrometry (ICP-TOF-MS) [4]. 
Thereby, it is comparatively easy to perform single-cell cytometric experiments with currently 
approx. 40 parameters in a single measurement without the typical obstacles inherent to 
fluorescence-based cytometry, such as spectral overlap/compensation and autofluorescence. 
5.2 Mass cytometry in biological research 
Mass cytometry is ideally applied to research requiring high parametrization at single-cell 
resolution, e.g. for resolving cellular heterogeneity in complex mixtures of cells (such as blood or 
tissue cells) or complex phenotypes of isolated cell types (such as T-cell subsets according to 
intracellular cytokine expression and chemokine receptor expression) [5-7], or when a maximum 
of information is to be extracted from a given, limited sample, such as from certain cell cultures, 
fluids, tissue biopsies, childrens’ or certain patients’ blood samples [8-11]. Since lanthanide-
labeled antibodies used in mass cytometry largely resist the methanol treatment that is used for 
permeabilization of cells in order to detect phosphorylated states of intracellular signaling 
mediators, mass cytometry is a sought-after tool in cell signaling studies. Mass cytometry also 
facilitates large-scale immune monitoring and drug screening in clinical/translational research 
and systems immunology. 
To date, mass cytometry has been performed not only on leukocytes from different species 
including mouse, man, and non-human primates [12], but also on cell lines and bacteria [13]. 
Metal-containing polystyrene beads [14] are used as internal standards in mass cytometry 
measurements and could potentially be modified to work as capture beads for serological 
analysis using the CyTOF platform, similar to fluorescence-based Luminex technology. 
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5.3 The mass cytometer - cell introduction and signal detection 
The mass cytometer combines a cell introduction system with a mass spectrometer consisting of 
three basic components: the ion source, the ion analyzer, and the ion detector. Essential parts 
and steps of the measurement are summarized in Figure 1. 
During a CyTOF measurement, single cells labeled with metal-tagged probes suspended in 
water are injected at a flow rate of 45 µL / min into a nebulizer. Using argon as a carrier gas, the 
nebulizer creates an aerosol that is guided into the ion source. The nebulizer’s orifice of about 
80-150 µm diameter limits the size of cells or particles measurable by mass cytometry. 
The ion source of the CyTOF instrument is an inductively coupled argon plasma. At a plasma 
temperature of 8,000 K, injected cells are vaporized, and entirely disintegrate into their atomic, 
ionized constituents. Thus, each cell generates an ion cloud that expands by diffusion and 
enters the vacuum. From these ion clouds, uncharged materials are depleted by an electrostatic 
deflector, and low-weight ions, including those of elements abundant in organic material such as 
C, O, H, N, and Ar (atomic mass less than ~80 Da), as well as ions carrying multiple charges, 
are filtered out by a quadrupole ion guide, leaving only heavy-weight single-charged ions to pass 
on to the detector.  
The ion analyzer of the CyTOF instrument is a time-of-flight (TOF) analyzer. Ions are 
accelerated by an electric field of a known strength, resulting in ions having the same kinetic 
energy. Since the ions all have the same charge too, the ions can be separated by their mass 
difference. The velocity of lighter ions is higher and they reach the detector first, followed by 
heavier (and slower) ions, in the sequence of increasing ion mass.  
The ion cloud of a given cell is measured in small portions, termed pushes. The CyTOF 
instrument performs 76,800 measurements (pushes) per second, which means that one mass 
spectrum is captured every 13 microseconds. Since the CyTOF technology focuses on metal 
isotopes with high atomic mass, only the segment of the spectrum corresponding to atomic 
masses higher than 80 Da is taken in consideration. Typically, a single ion cloud is captured by 
approximately 20-40 spectra. An electron multiplier is used for ion detection and consists of a 
series of dynodes maintained at increasing potentials, resulting in serial amplification of the 
original signal. The output signal of the detector is further amplified and subsequently digitized 
by an analog-to-digital conversion. 
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The spectra are then analyzed by two successive integration steps, to obtain information about 
the amount of metal associated with each ion cloud corresponding to a single event. The first 
integration is an area under curve calculated over an around 19-26 nanosecond interval 
according to the region of a given mass spectrum and represents the intensity of the peak for a 
given isotope. The region used for the first integration is determined during the quality control 
procedure of the instrument termed mass calibration, using a tuning solution. The second 
integration summarizes consecutive positive peaks corresponding to a single (cell) event. By 
default, positivity is defined by a metal signal in any mass channel exceeding the background by 
three standard deviations [15]. The signal with maximum number of consecutive spectra is taken 
as reference to identify the spectra contributing to an ion cloud representing a single cell event.  
Finally, the integrated signal intensities obtained for one cell in the different mass channels are 
converted into flow cytometry standard (FCS) 3.0 format files. Thus, mass cytometric data sets 
can be viewed and analyzed manually using standard flow cytometry software packages. 
However, considering the high complexity of mass cytometric data, manual data analysis is time-
consuming, subjective and may miss much information contained in mass cytometric data. It is 
advisable to employ automated cell clustering, population identification and dimensionality 
reduction techniques (reviewed in [16-18]) for the analysis of high-content mass cytometry data 
(see also Chapter VI: Data analysis, section 1 Data analysis – an overview; and section 5: Data 
repositories – sharing your data). An important point to consider is that data analyses of a given 
study more and more often employ several algorithms organized in an analysis pipeline, very 
similar to an experimental procedure that needs to be described and annotated in appropriate 
detail [19]. 
 
5.4 Instrumentation 
Until today, Fluidigm Corp. is the only commercial provider of mass cytometry instruments and of 
almost all mass cytometry-tailored reagents. Mass cytometers can be run in a high-throughput 
manner by employing either an autosampler suitable for consecutive measurements of larger 
number of samples of limited sample size (from a 96-well plate), or an add-on device which 
permits acquisition of larger samples of any volume (Supersampler, Victorian Airship LLC), 
which is ideally used in combination with sample barcoding approaches (for more detail please 
see Chapter IV, Section 7 - Barcoding in cytometric assays). The latest mass cytometer version 
(“Helios”) can sample volumes of up to 5 ml. 
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More recently, mass cytometry has been used for imaging of tissue sections stained with metal-
conjugated antibodies, similar to those used in immunofluorescence microscopy. The stained 
section is dissected into a series of vaporized samples corresponding to µm-sized tissue section 
spots by high-resolution laser ablation; these tissue section spots are then consecutively 
analyzed on a CyTOF instrument [20]. By these means, each spot is associated with how much 
of which metal tag was bound to the spot when the tissue section was stained with metal-tagged 
antibodies. By plotting the data so that the single spot data are next to each other in the order 
they were originally sampled from the entire tissue section, highly multiplexed images of the 
tissue sections are reconstructed. Similar data can be generated using an alternative approach 
i.e. multiplexed ion beam imaging (MIBI) that, does not rely on the mass cytometry equipment 
discussed here[21].  
More recent mass cytometer versions (CyTOF version 2 and Helios) do not necessarily require 
in-depth technical knowledge of mass spectrometry, as the daily tuning and instrument 
alignment is largely performed automatically. However, it is advisable to have the instrument 
maintained and managed by an expert operator. The installation of a mass cytometry platform 
usually requires the additional set-up of air conditioning, an exhaust system, argon gas supply 
and an IT infrastructure suitable to store and manage mass cytometry data. 
 
5.5 Bottlenecks in mass cytometry 
While the advantages of mass cytometry are striking for various applications, it should be noted 
that CyTOF instruments cannot recover the original cell sample for subsequent experiments. 
Instrument sensitivity, cell throughput and recovery should be taken in consideration when 
planning a study involving mass cytometry. 
Cells labeled with metal-conjugated antibodies usually deliver signal intensities sufficient for 
gating and quantitative analyses. At least later-generation mass cytometers have a 
manufacturer-specified dynamic range of 4.5 orders of magnitude, which is comparable to 
fluorescence-based flow cytometry. The variability in sensitivity for the detection of different 
reporters is lower in mass cytometry compared with that in flow cytometry. However, mass 
cytometry currently lacks reporters which provide a specifically ‘bright’ signal such as PE in 
conventional flow cytometry [22], due to an upper limit of metal ions which can currently be 
loaded onto a probe (~140 lanthanide ions per antibody using MAXPAR labeling kits [23]). In 
addition, of any 10,000 heavy metal ions of the CyTOF detection mass range injected, only 
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about 3 - 10 are counted by the instrument [24]. Limitations in sensitivity are in part 
compensated for by the lack of inherent biological background (no ‘autofluorescence’) and the 
absence of compensation of signal spillover, which both can negatively impact fluorescent flow 
cytometry data. However, this principally does not protect from background signals due to 
unspecific binding of metal-labeled probes to cells. Significant background binding of MAXPAR-
labeled antibodies has been reported for fixed eosinophils, which could be eliminated by pre-
incubation with heparin [25]. In theory, sensitivity could be improved by hardware design, 
allowing for the detection of more of the injected target ions, and by the use of probes that carry 
more metal per specific probe, such as heavy metal nanoparticles [26-28]. 
The volume of a single-cell derived ion cloud expands by diffusion to approximately 2 mm in 
size, restricting the instrument’s throughput to ~1,000 cells per second. A lower throughput 
(<500 events per second) usually delivers data comprising fewer doublet events. Thus, in 
contrast to most fluorescence-based flow cytometers with event acquisition rates of usually up to 
10,000 events per second, acquisition times in mass cytometry are significantly longer and might 
necessitate pre-enrichment of target cells prior to mass cytometric analysis. In addition, a 
CyTOF measurement recovers data for about one third of the injected cells, while the remaining 
two thirds of the sample are lost e.g. by accumulating on the walls of the spray chamber.  
Mass cytometers need to be set up and tuned daily (procedure detailed in [29]). Although the 
tuning process is designed to confer stable instrument performance during day-to-day 
operations, slight differences in e.g. oxide formation can remain and in theory cause batch 
effects. The impact on data of such signal variability in datasets can be counteracted by data 
normalization using metal-containing beads as an internal standard spiked into cell samples [30], 
and by sample barcoding (described in greater detail in Chapter IV, Section 7, Barcoding in 
cytometric assays) [31-33], which effectively minimizes technical variability between barcoded 
and pooled samples [32]. 
 
5.6 Experimental workflow, reagents and controls 
The experimental workflow for preparing mass cytometry assays is typically very similar to that 
for conventional flow cytometry, except for the strict requirement of cell fixation and their 
resuspension in water prior to acquisition on the CyTOF instrument. Briefly, cells are subjected 
to cell surface staining and optional dead cell label incubation, fixed, (usually using PFA), 
permeabilized, stained for intracellular antigens and DNA content, and finally resuspended in 
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water (optionally supplemented with normalization beads) for  injection into the mass cytometer. 
Cell-surface and intracellular sample barcoding solutions are available and can be applied prior 
to surface staining or after permeabilization, respectively.  
Protocols are available for in-depth surface marker-based immune phenotyping [34-36], 
intracellular cytokine staining [5], tetramer-based detection of antigen-specific T cells [5, 6], cell 
signaling analyses based on the detection of phosphorylated signaling mediators [2, 9, 31], in 
vitro proliferation assays [37] and the detection of RNA in single cells [38]. Functional probes 
available for mass cytometry include 5-Iodo-2′-deoxyuridine (IdU) for assessing cell proliferation 
[37] and a tellurium-based hypoxia probe [39]. 
Mass cytometers do not measure the light scatter parameters usually employed in flow 
cytometry for detection of cell events and separation of cell aggregates. In mass cytometry, cells 
are solely detected by the metal associated with them. Nucleated cells are typically detected by 
rhodium- or iridium-based DNA intercalators [40], and probes specific to characteristic cell 
antigens can be envisaged to reveal non-nucleated cells such as erythrocytes or platelets. 
Doublet events can be minimized in mass cytometry by i) filtering cells prior to injection, ii) 
avoiding high cell densities in the injected sample, iii) excluding cell events with high DNA signal 
and/or high ‘cell length’ parameter value by gating or iv)  sample barcoding using a restricted 
barcoding scheme filtering out doublet events formed between cell of differently barcoded 
samples very efficiently [32, 33]. Finally, DNA intercalators, cisplatin [41], or metal-loaded 
DOTA-maleimide [5, 42], are used for cell viability staining. A typical gating strategy is provided 
in Figure 2.   
A central part of any mass cytometry experiment is antibody panel design, for which various 
mass tagged-antibodies and pre-designed panels are commercially available. Antibodies can be 
labeled in-house using commercial kits for lanthanides and indium isotopes or with isotopes of 
palladium [32] and platinum [23]. Moreover, metal-containing nanoparticles such as Qdots 
containing cadmium [5, 43] and silver nanoparticles [26] have been successfully employed as 
mass tags for reporting binding of specific probes to cells. The design of mass cytometry panels 
is generally easier as compared to flow cytometric panels of similar marker capacity, since signal 
spillover and sensitivity differences are comparably minor issues [3]. However, the mere number 
of parameters and the implementation of quality control for antibodies [35] both make panel 
design a significant effort. Panel design includes optimizing the pairing of specific probes with 
unique heavy metal isotopes considering instrument sensitivity for that particular isotope mass, 
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target antigen abundance, and additionally potential signal spillover. Signal spillover in mass 
cytometry can arise from isotopic and elemental impurities of mass tags, between adjacent mass 
channels at high signal abundance (M+/-1 spillover), and because of metal oxide formation 
(M+16 spillover) [15, 35]. A careful panel design, an optimally tuned instrument and highly pure 
reagents, however, can minimize these spillovers to very low levels that are orders of magnitude 
lower than fluorescent spectral overlaps. 
Isotype and fluorescence-minus-one (FMO) controls are typically used in conventional flow 
cytometry experiments to distinguish between specific and background signal (for further detail 
see Chapter IV, Section 1, Controls – determining positivity by eliminating false positives). In 
theory, isotype and FMO controls (termed in mass cytometry as Signal-minus-one or Metal-
minus-one controls, SMO and MMO, respectively) are easily applicable to the mass cytometry. 
However, the sole fact that, in mass cytometry, typical panels include approximately 40 
antibodies renders the routine and consistent realization of these controls quite complicated, and 
often unfeasible. Isotope controls require the use of an antibody with a matching isotype and the 
same amount of metal per antibody as the reagent that is to be controlled. The evaluation of the 
number of atoms linked to each antibody molecule is still a non-standardized procedure and 
metal-conjugated antibody used as isotope controls are presently not commercially available. 
SMO/MMO controls will virtually need a number of control tubes equal to the number of markers, 
multiplying the amount of specimen necessary for the experiment.  
As a result of these practical limitations, the SMO/MMO controls are either performed 
exemplarily or combined, sometimes, in a metal-minus-many (MMM) strategy, in which a few 
rather than single antibody conjugates are omitted during the staining procedure, e.g. a group of 
markers specific to a certain project on the backbone panel shared between different projects. 
However, both strategies deliver only limited control information. 
In addition, biological controls are frequently employed to verify metal conjugate-antibody 
specificity. Here, the expression of a given marker is evaluated in the same sample on different 
cell populations or comparing (ideally barcoded) samples from untreated vs. treated conditions. 
For example, the expression of CD40L by T cells needs to be induced in vitro in order to be able 
to evaluate the performance of a CD40L mAb conjugate. Contrary to the impracticability of the 
isotype and SMO/MMO controls, biological controls are particularly adapted to mass cytometry, 
since they take advantage of the high dimensional level of the data. Counterstaining for multiple 
cell lineage markers in antibody conjugate evaluation experiments enables the identification of 
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reference cell populations serving as positive and negative controls for a given antibody 
conjugate in the multitude of populations identifiable by a 40 parameter panel. 
Finally, mass cytometry data sets and their evaluation, especially by computational means, 
benefit from bundled, batch-wise sample processing and data acquisition in addition to sample 
barcoding (as opposed to processing and acquiring samples of a given study one-by-one , on 
different days over a long period of time) to achieve the highest levels of data consistency. 
Therefore, sample banking and assay automation are actively pursued research areas in the 
mass cytometry field.  
 
5.7 Conclusions 
Mass cytometry is a new hybrid technology employing principles of flow cytometry and mass 
spectrometry. The core technology is rapidly developing along with bioinformatics and reagent 
chemistry, thereby creating a largely universal and extendable next-generation platform for high-
dimensional single-cell cytometry applied in translational research, systems biology and 
biomarker development. 
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Figure legends 
Figure 1. Schematic overview of a mass cytometric measurement. 
 
Figure 2. Typical gating strategy for PBMC analyzed by mass cytometry. 
Intact cells are identified by staining of DNA. Normalization beads elicit high signals in defined 
channels such as 140Ce in the present example. Cells (unless stained with 140Ce conjugated 
antibodies) do not elicit high 140Ce signals, and beads do not elicit high iridium signals. Events 
that appear in the upper right are cell-bead doublets, which could be either physical aggregates, 
or due to timely overlapping acquisition of two ion clouds with one cloud representing a cell, and 
the other one a bead event. Events not stained in either channel (lower left) are usually debris 
associated with metal amounts sufficient to be detected by the CyTOF instrument (1st dotplot). 
Cell events are further restricted to events showing strongly correlating DNA signals according to 
their 193Ir and 191Ir staining. Both Ir isotopes almost equally contribute to the natural 
abundance iridium used in the DNA intercalator. Thus ,signals are expected to correlate. Events 
with high iridium staining intensity are excluded since the DNAhigh fraction is enriched for cell 
doublets. This procedure does not fully eliminate doublets but reliably reduces their presence 
when barcoding was not used to filter out doublets. However, backgating should be used to 
confirm that target cells are not excluded in this step (2nd dotplot). Gating according to “cell 
length” or “event length” is often employed in order to minimize the presence of doublets. The 
“length” parameters corresponds to the number of spectra which belong to a given event. Events 
labeled with large amounts of metal (and doublets) tend to show higher, and those with little 
metal tend to show lower “length” values. Upper and lower cell length boundaries are defined in 
the acquisition software. The length parameter is not indicative of cell size. Again, backgating 
should be employed to ensure that target cell are not excluded (3rd dotplot). Next, dead cells are 
excluded by gating on 103Rhlow/- cell events. High 103Rh signals result from stronger labeling of 
dead cells by 103Rh-mDOTA compared to live cells. PBMC identity is confirmed by CD45 
staining (in-house Pd104 conjugate, 4th dotplot), and CD36 and CD20 staining differentiate 
between monocytes/dendritic cells and B cells, respectively (in-house conjugates, 5th dotplot). 
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 Introduction to Cell sorting  
There is great diversity amongst biological cells. Studying the function of different cell types 
and subsets often requires the isolation of many cells of a specific population with a high 
degree of purity or the isolation of single cells for a better understanding of the heterogeneity 
of cells within a subset. 
In the following sections of this chapter “parallel” and “serial” cell sorting techniques are 
discussed, together with both their advantages and limitations.  
Parallel cell sorting (also called bulk cell sorting) is useful when either simple physical 
parameters, e.g. size or density, or a very few cell surface markers can be used to 
differentiate cell subsets. In particular, magnetic cell sorting techniques (see section 1.2 of 
this chapter) use the specificity of antibody-staining. As detailed in sections 1.3-1.5 of this 
chapter, other parallel cell sorting technologies exploit the characteristics of size, density or 
sensitivity to hypotonic shock to isolate large numbers of cells from a biological sample in 
one step, often with very simple techniques. With some methods more than 1011 cells can be 
processed in less than one hour. This approach is also useful for reducing the number of 
cells through pre-enrichment of specific cells of interest for subsequent processing with serial 
cell sorting technologies. 
Serial cell sorting technologies use rapid measurements at the single cell level. This allows 
the isolation of even very rare cells from complicated mixtures. Serial cell sorting discerns 
cell subsets by staining with (fluorescently) combinations of labeled antibodies. The data are 
processed in real time, to classify and make a decision on a cell-by-cell basis which cell to 
collect. Cells can be collected into a tube, a well in a microtiter plate, a chamber in a 
microfluidic device or droplet sorters, and additionally a single cell in a sub-nanoliter size 
droplet can be deposited in a specific spot.  Analytical methods for rapid electrostatic serial 
cell sorting have been refined to use multiple lasers and more than 18 optical parameters 
derived from the reaction of cells with fluorescently labelled affinity reagents providing 
diverse excitation and emission signatures to define very specific subsets with many 
applications in immunology (see section 2.1 of this chapter). Microfluidic technologies also 
allow single cell sorting based on immunofluorescence and morphological microscopic image 
analysis. The combination of many serial cell sorters in a microfluidic chip promises very high 
sorting rates (see section 2.2 of this chapter). Present serial cell sorters process cells at rates 
from a few cells per hour to 105 cells per second depending on the diverse range of 
applications being done and the specific cell sorter configuration being used.  
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Section 1 – Parallel cell sorting 
 
1.1 Introduction and general considersations 
Parallel or bulk cell sorting is generally used to isolate a large number of cells in a batch 
mode, often as a pre-enrichment step before a single cell sort. Parallel sorting uses 
parameters like cell size, density, magnetic, or electrical properties. Affinity binding reagents 
(e.g. antibodies)  for specific cell subsets can be used to change specific properties e.g. 
magnetism or density to achieve an antigen-specific bulk sort.   
General considerations: Bulk cell sorting from a cell mixture can be done by many 
methods, each one having different advantages and challenges. The main variable 
parameters to be considered are specificity, yield, purity, viability, functionality. Moreover, 
speed, cost and consumables for equipment must be also taken into account (Fig. 1). The 
importance of the different functional parameters will depend on the specific experimental 
goals e.g. very high purity may be essential in many cases, while yield may be less 
important, because sufficient material is available. Instrumentation features depend on the 
specific needs and the experience of the user(s). Figure 1 illustrates the various parameters 
needed in deciding on a sorting strategy or method. Not always can all parameters be set at 
optimal levels simultaneously. For cell isolations, where multi-parameter sorting is not 
needed, but where speed is of essence, e.g. because high numbers of cells must be sorted, 
bulk cell sorting is preferred. 
 
Flow cytometry cell sorting, where cells are sorted one-by-one, is the gold standard for multi-
parameter cell sorting. This procedure yields very high specificity according to one or several 
surface markers, which are made visible by fluorescence-labeled antibodies.  The limitation 
is mainly the number of cells which can be sorted during a work-day. Pre-enrichment for 
subsequent flow cytometry cell sorting is another important application of bulk sorting and 
should always be considered, especially when the wanted cells are comparatively rare. First, 
because it reduces time of the cell sort, and second because it helps to improve gating 
quality by eliminating potential fluorescence overlap between stained and unstained cells 
(Fig. 2). An overview of cell sorting technologies and applications can be found in [1]. 
Bulk cell sorting can either use any cell surface marker for distinction, or use distinct physical 
properties of cells, such as density differences (Ficoll™ isolation), size, plastic adherence, 
phagocytic capacity (macrophage enrichment), or sensitivity to hypotonicity (erythrocyte 
lysis). Keeping track of cell numbers, viability, and analyzing the sorted cells before, during 
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and after any separation is good routine in order to determine cell yield and cell purity, and to 
detect any unreasonable cell losses or damages. Cell “yield” is the fraction of wanted cells in 
the original mixture which could be recovered alive after the sorting procedure.  
To quantitatively evaluate sorting performance, several calculations can be performed. The 
purity, i.e. fraction of positive cells in the sorted fraction, can be expressed as the ratio of 
positive cells and the sum of positive and negative cells. Then, using the measured purity 
and yield, the yield for non-target particles, the so-called negYieldFraction (…Fraction = 
…Percentage/100), in the target sample after sorting can be calculated. This provides a  
helpful metric when optimizing a sorting technology. Ideally this number will be zero, when 
100% purity is achieved in the separation. The negYieldFraction, a measure for how many 
unwanted cells are found in the sorted sample, can be calculated by re-arranging the 
equation: 
PurityFraction = 
posFraction∗posYieldFraction
posFraction∗posYieldFraction+negFraction∗negYieldFraction
     to obtain 
negYieldFraction = 
posFraction∗posYieldFraction∗(1.0/PurityFraction – 1.0)
1.0−posFraction
  
Another approach for the evaluation of bulk sorting performance is described in [2], where it 
only uses fractions of cells in the original and positive fraction and does not need information 
about the yield of the positive (wanted) population. The enrichment factor Fe in [2] is the 
inverse of the negYieldFraction, if the yield of positive cells is 100%. At lower yields there are 
small differences between the two metrics. Table 1 provides an example showing that final 
purity values alone are not a good measure for sorting performance (rows 4 and 5 in Table 
1), even though it may be the important measure for biological activity. 
1.2 Antibody based bulk cell sorting  
Physical properties of cells can be changed by the reaction with specially tagged affinity 
reagents like antibody conjugates with magnetic particles. In this way specific subsets can be 
isolated with bulk sorting methods. 
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1.2.1. Magnetic beads coupled to antibodies  
This technique uses the force of magnetism to sort out cells according to specific cell surface 
markers. Several commercial systems are available, which use either inorganic 
superparamagnetic or ferromagnetic materials embedded in polystyrene beads or in a matrix 
such as dextran, or coated with graphene [3]. Beads in sizes from tens of nanometers up to 
several times the size of a typical mammalian cell are available for bulk cell sorting. The 
bead-size is not disclosed by all companies. Cells are incubated with the beads and then 
drawn to a magnet of appropriate strength either in a column, tube, or 96-well plate. 
Nanometer sized beads require high field strength and field gradients, generally achieved in 
columns or microfluidic channels with optimized ferromagnetic structures. Unwanted cells are 
poured off or eluted. In negative selection strategies, all unwanted cells are labeled, leaving 
the wanted ones untouched for downstream applications or a second round of selection by 
another surface marker. Several bead or affinity reagent chemistries allow the detachment 
from the cells if needed. The bulk sorting method hinges on the quality of the antibodies 
used, and the density of the surface markers on the cells. Very low density marker may be 
more difficult to sort. Rare cell sorting is possible, albeit it may require several rounds of 
sorting and intensive washing to remove non-magnetic cells. Bulk sorting with beads, 
especially with large beads, cannot distinguish between high and low expression of a given 
antigen on the cells. Selection of a good antibody is crucial for successful sorting, as is the 
concentration of beads in the labeling step. Non-specific binding associated with antibodies 
clustered on beads has to be addressed with some reagents and cell types. Nowadays, 
many kits for sorting a range of cell types in various species are commercially available. 
Custom-made beads may be a choice as well, and are offered by some companies. 
Conjugation of antibodies to magnetic beads in the own laboratory or the use of avidin beads 
with second-step labeling with biotinylated antibodies is another option. 
Advantages: fast, high cell numbers, specific, positive and negative selection possible 
Pit-falls: No distinction of antigen density in sorting with larger beads (some nanometer-sized 
colloidal beads show some differences in magnetic retention in some systems [4]); activation 
of cells by bead attachment is possible (must be excluded for individual down-stream 
applications). Temperature and duration for binding must be considered (in the context of 
phagocytosis, decreasing possibility of non-specific binding, capping, or efficient binding 
kinetics). Note: the sort quality must always be analyzed to detect possible cell losses and 
impurities. 
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Manufacturers: miltenyibiotec.com, Sepmag.eu, stemcell.com, thermofisher.com, 
turbobeads.com 
 
1.2.2. Non-magnetic beads coupled to antibodies 
Non-magnetic beads coupled to antibodies (pluribeads®) use strainers to fish out cells, 
attached to large polystyrene beads. The method is based on the size-enlargement of cells 
as the beads are larger than cells. Specificity is achieved by the antibodies and, again, the 
quality of the antibodies is important. As beads vary in size, several cell subsets can be 
sorted out of a mixture by using different sized beads for different antibodies. A potential 
advantage is that the size of the beads may prevent phagocytic uptake. Beads can be 
detached by a special buffer, and sequential sorting is possible.  
Advantages: fast, high cell numbers, specific, positive and negative selection possible 
Pitfalls: Generally no distinction of antigen density in sorting; activation of cells by bead 
attachment/detachment procedure is possible (must be excluded for individual down-stream 
applications); non-specific binding (the sort quality must be analyzed to detect possible cell 
losses and impurities). Temperature and duration for binding must be considered (in the 
context of phagocytosis, decreasing possibility of unspecific binding, capping, or efficient 
binding kinetics). 
Manufacturer: pluriselect.com  
 
1.3 Methods based on density differences 
Cells, organelles, parasites etc. have different densities, and their density differences can be 
used for cell separation [5,6]. 
 
1.3.1 Ficoll-Paque™, Lymphoprep™ 
Ficoll-Paque contains Ficoll™, a highly branched polysaccharide, and metrizoate. 
LymphoPrep™ replaces the latter with sodium diatrizoate. Side-by-side comparisons of the 
gradient media have been done [7]. They have low viscosity, are non-toxic and can be 
prepared for different densities. Ready-made solutions are also commercially available. 
Ficoll-Paque™ gradients are frequently used to separate peripheral blood mononuclear cells 
versus granulocytes/erythrocytes from whole blood. Efficient removal of dead cells from a 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter II: Cell sorting 
Section 1 – Parallel cell sorting 
 
 
56 
 
mixture is possible as well (note of caution: this procedure is stressful for the living cells). 
When separating blood, the upper fraction contains both lymphocytes and other 
mononuclear cells. Addition of iohexol, a nonionic X-ray contrast agent, to the gradient 
medium can remove monocytes as well [7]. Nycoprep™ and OptiPrep™ are gradient 
solutions without Ficoll™, based on a tri-iodinated derivative of benzoic acid with three 
aliphatic, highly hydrophilic side chains or on iodixanol, respectively. They thus are not based 
on a polysaccharide net [8]. From the granulocyte/erythrocyte mix, neutrophil granulocytes 
can be isolated further by dextran sedimentation [9,10], and erythrocytes lysed by hypotonic 
shock (see section 1.5 below).  
Advantage: Easy to use, little equipment needed.  
Pitfalls: density for similar cells between species can differ, (e.g. for mouse, horse and 
human lymphocytes [11]); erythrocytes and granulocytes can become captured in the upper 
layer, if the gradient is overloaded or the blood was frozen. Centrifuge must be at room 
temperature and without breaks. The step of overlayering blood on the gradient is time-
consuming and must be done with care. Various commercially available systems such as 
SepMate™ exist to aid in this, including prepared Ficoll-gradients in containers to draw 
blood. Loss of cells and recontamination when harvesting them from the gradient surface is 
possible. Cell activation can be an issue, e.g., when isolating neutrophils [9].  
Manufacturers: gelifesciences.com, http://www.stemcell.com/en/Products/Popular-Product-
Lines/SepMate.aspx 
 
1.3.2 Percoll 
A second density separation medium is Percoll, made from colloidal nanosized silica  
particles coated with polyvinylpyrrolidone (PVP) [12]. Percoll is non-toxic and has a low 
viscosity, so cells can be centrifuged at low centrifugal forces. Iso-osmotic gradients of 
densities between 1.0 to 1.3 g/ml can be formed by layering solutions of different 
percentages of Percoll in a tube. Cells of differing densities collect at the different interfaces 
and can be taken off. Colored density marker beads made of Sephadex™ are helpful to 
visualize the density borders in the gradients.  
 
Advantage: Versatile, as several cell types separate in the different layers in one tube. 
Pitfalls: see Ficoll-Paque; cell activation can be an issue and must be considered.  
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1.4. Methods based on cell size  
Size differences of cells of interest e.g. erythrocytes, platelets, leukocytes, or circulating 
tumor cells in blood, can also be used for separation.  
 
1.4.1 Filters  
Membrane filters are applied in sample de-bulking as they can separate particles or 
molecules based on size. The pore size enables larger cells to be retained on the membrane 
and smaller cells to pass through. For example, leukocytes (mean diameter 8-10µm) can be 
isolated from erythrocytes (6-8µm but disc shaped) by flowing whole blood through a 
membrane filter; back flushing will recover the captured white blood cells. However classical 
filter membranes do not have homogeneous and precisely controlled pore sizes, so the 
resolving power of this separation is limited and, due to the material of the filter, the recovery 
of white blood cells may be inefficient.  
 Another separation method based on cell size that targets red blood cells and platelets 
specifically uses microfibrated silicon chips. These feature homogeneously etched slots of a 
size to let erythrocytes to pass through under a certain pressure and that retains leukocytes 
on the top which can by recovered by elution. Early evaluation of the technology has 
demonstrated 98.6±4.4% recovery of the leukocytes without bias to subpopulations and 99% 
removal of erythrocytes. The enriched leukocytes have over 95% viability. [13].  
Mesh-sizedbased catching of cells from adipose tissue directly in culture has been 
demonstrated using various filter materials. [14]  
Advantages: easy to use and little equipment is needed 
Pitfalls: throughput of the filters is limited by surface area and overload may result in reduced 
purity and recovery of leukocytes. So far the commercial devices can only handle up to 2ml 
of whole blood which is sufficient for some cell analysis assays but not enough for blood 
transplantation and cell therapy applications. The recovery of leukocytes is sensitive to the 
pressure applied – pushing with higher pressure and higher flow rate may result in 
decreased recovery.  
Manufacturer: avivabio.com (for microchip devices) 
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1.4.2 Deterministic lateral displacement (DLD) 
A method of bulk sorting currently under development is based on cell size. There are 
several publications reporting a microfluidic device that separates particles and cells with 
high resolution [15] and is able to not only fractionate whole blood components by their sizes 
[16] but to also isolate circulating tumor cells (CTCs) from whole blood [17]. Recent work 
describes improvements for the routine use of the technology. [18]. 
The micro-fabricated silicon device consists of a matrix of obstacles, and the gap and the 
size of the obstacles are precisely calculated. When the particle mixture is introduced to the 
device, the laminar flow goes through the arrays of obstacles and the smaller particles will 
follow the streamlines and the larger particles will be “bumped” by the obstacles and 
deflected into a different flow stream. Multiple sections of an obstacle matrix with varying gap 
sizes can be built in one device so that multiple sized particles can be isolated because each 
sized particle will follow its own determined path flowing through the device. In theory, there 
should be no throughput limitation of the technology as it is a continuous flow system; 
however, some surface treatment of the device may be needed to avoid cell adhesion. The 
device has little tolerance to clogging, air bubbles or cell aggregates, as changes in the fluid 
flow profile alter the particle travel path and deflect the flow streams possibly resulting in 
decreased purity and/or recovery. 
Advantages: high resolution, continuous separation and having the potential to be high 
throughput, high resolution size-discrimination with high purity of cell populations with non-
overlapping sizes 
Pitfalls: clogging with samples with cell aggregates.  
 
1.4.3 Acoustic particle sorting 
Particles exposed to an acoustic field are known to move in response to an applied acoustic 
radiation force. Numerous researchers have investigated the effect of acoustic waves on 
cells and particles in aqueous solution. The force exerted on a particle by an acoustic field 
can be described by the following equation   
Fx ~ r3  K  sin(2 x/)  
where r is particle radius, K is a constant proportional to density of medium and particle,  is 
the acoustic contrast factor (proportional to density and compressibility) and x is the distance 
from the pressure node in the direction of the wave [19]. Thus, acoustic focusing can be used 
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to separate and position particles based on size, density and deformability. The ultrasonic 
standing wave is generated by a piezoelectric transducer and resonance vibration of the 
microfluidic device made in silicon or glass. The channel width is designed to match half a 
wave length resonance of 2MHz in order to have larger cells “focused” in the middle of the 
channel. Dykes et al [20] demonstrated the removal of platelets from PBPC (Peripheral 
Blood Progenitor Cell) product on a microfluidic device in which an acoustic standing wave is 
generated in the fluidic channel. The acoustic pressure pushes leukocytes to the pressure 
node located at the center of the channel and leaves platelets at the side stream going to a 
waste outlet. Size is a dominant parameter for acoustic cell sorting but not the only 
parameter as shown in the equation above. For example, separation of leukocytes from 
erythrocytes in whole blood is not easily done on an acoustic device as erythrocytes, though 
having a smaller diameter, move to the acoustic energy node along with leukocytes as the 
erythrocytes have a higher density.  
Advantages: continuous flow – no throughput limitation, label free 
Pitfalls: the cell moving trajectory in the flow channel is determined by both the acoustic 
pressure and the shear pressure so the flow rate and channel configuration need to be well 
controlled otherwise the separation efficiency will suffer. Due to the heterogeneous nature of 
cells in biological sample and the multi-parameter physics of acoustic separation, 
separations have to be optimized for specific samples. No commercial product is available 
yet.  
1.5. Erythrocyte lysis  
Enucleated erythrocytes are more susceptible to hypotonic shock than nucleated cells. Either 
a low isotonic Tris/NH4Cl buffer for several minutes at room temperature or 37°C, or pure 
water for several seconds will lyse erythrocytes in cell mixtures. The latter method is 
particularly useful for blood, which contains approximately 1000 times more erythrocytes 
than leukocytes. Several other cell lysis solutions are available commercially as well. [21,22] 
1.6. A historical note  
The methods described in sections 1.2-1.5 of this chapter have superseded older methods to 
specifically isolate cells, such as panning on antibody-coated plastic dishes [23], nylon-wool 
based isolation of T cells, or sheep-red blood cell rosetting followed by a Ficoll gradient 
[24,25]. The latter is still commercially available under the name RosetteSep™ for specific 
uses, in particular for the removal of unwanted cells from blood. These older methods are not 
discussed here, but they are summarized in [26]  
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Figure 1: Check-list: parameters for selecting a sorting method 
The parameters that affect cell sorting and therefore must be prioritized when choosing a 
sorting strategy are shown. Starting from the available material (amount, fragility), they range 
from the mundane cost aspect to practical and methodological concerns such as the 
available time, to the important experimental approaches regarding what yield, purity, or 
versatility is needed for down-stream applications. Optimization of one parameter may 
downgrade another parameter, e.g. a high purity may be at the expense of a high yield or 
speed, or unchanged functionality of the cells may not allow direct positive selection.  
 
Figure 2: Improvement of population discrimination after pre-enrichment. Cytometer 
histograms of  unwanted (gray lines) and wanted (solid green) populations.  A. A large 
excess of an unwanted population may create substantial overlap with the target population, 
making it impossible to achieve a good single cell sort. B. After a pre-enrichment bulk sort, 
which removes most of the unwanted population a good discrimination between the two 
populations can be achieved  
 
Table 1: Example of sort performance metrics. The values for purity, yield, and the fraction of 
positive cells in the original sample are measured and the negative logarithm of negYieldFraction, -
log(Y-) (the underlying equations are detailed in the text of this Chapter (Chapter II section 1.1) and  
the logarithm of Fe [2] are calculated.  
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Section 2 - Serial cell sorting 
2.1 - Cell Sorting by flow cytometry  
Successful flow cytometry cell sorting often requires that more attention be paid to sample 
preparation than is typically done when preparing samples for analysis only. When sorting, 
the often challenging objective is to not only separate some sample fraction in a timely 
manner such that the sorted output is a pure viable fraction, but also that the sorted cells be 
functionally capable, that they expand well in culture or perhaps be competent to perform in 
some other subsequent assay (e.g. produce cytokines or some other vital cellular function). 
Another requisite for good cell sorting is to have a proper single cell suspension, ensuring the 
best sample behavior in flow where good doublet discrimination can be done and with 
minimal conflict aborts during the sort. How to best achieve good sample behavior and 
maximize performance? 
2.1.1 Choice of buffers 
The most commonly used media/buffers for processing mammalian cells were designed to 
work at 1 atmosphere pressure either on a laboratory bench or within a CO2 incubator, yet 
inside the sample chamber of most cell sorters the pressure can often exceed 2 to 4 
atmospheres depending on the conditions and nozzle size chosen for the sort. Sample 
buffers that historically tend to perform well for sorting such as Dulbecco’s Phosphate 
Buffered Saline (DPBS) or Hank’s Balanced Saline Solution (HBSS, minus Ca++ and Mg++), 
both with 10 to 25 mM HEPES and protein (usually 1 to 2% heat inactivated serum or BSA), 
and more recently BD FACS™ Pre-Sort Buffer plus from 0.2 to 2.0% protein (application 
dependent) are recommended. Bicarbonate media buffers such as RPMI or DMEM usually 
do not make the best candidates for sample sort buffers or sort collection buffers since they i) 
are a different buffer type than the cytometer’s sheath buffer (bicarbonate vs phosphate), and 
ii) by design require 5% CO2 to maintain physiological pH and iii) usually contain divalent 
cations (Ca++ and Mg++) plus phenol (very fluorescent). If a bicarbonate media is used, one 
should be wary and use either Ca++ and Mg++ minus formulas without phenol or mitigate the 
undesirable divalent cation side effects for sorting (making the cells “sticky”) by adding ~1.0 
mM EDTA in addition to 25 mM HEPES and protein. HEPES buffered bicarbonate media has 
been reported to be light sensitive [1], and it is generally a good idea to protect any sample 
for flow cytometry cell sorting from light. 
2.1.2 Considerations for adherent cells and cells isolated from solid tissues 
In preparing adherent cell lines for sorting a common pitfall is often within the protocol to 
remove the cells from a dish using trypsin or trypsin-EDTA and subsequently inactivate the 
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trypsin by adding back culture media containing a significant amount of serum. This step is 
designed to stop the proteolytic activity of the trypsin and make the cells “sticky” to easily 
adhere to a plastic dish when passaging the cells. The opposite effect is desired for flow 
cytometry cell sorting, the sample should not be “sticky” with a tendency to adhere to plastic. 
As a result, good flow cytometry cell sorting protocols for adherent cells will typically either 
inactivate the trypsin with soybean trypsin inhibitor or use one of the many available non-
enzymatic cell disassociation buffers (e.g. Accutase™);in either case, if the cells grow in 
media with serum, the culture should be gently rinsed twice with DPBS before disassociating 
and removing the cells from their substrate. Some cell types, when disassociated with non-
enzymatic disassociation buffers that rely on chelating agents, may show decreased viability 
as compared to trypsin disassociation [2]. If there is any doubt, a few simple pilot 
experiments designed to determine the best preparation method for the specific cells in 
question is often a very good investment towards successful sorting. 
Similarly, isolating cells from any primary tissue for flow cytometry cell sorting can be very 
challenging, care should be taken to insure the chosen protocol is optimized and tested to 
not only provide the intended cells (e.g. regarding isolated dendritic cells from spleen 
different protocols can enrich for different phenotypes), but helps coerce the cells into a well 
behaved single cell suspension. The highest quality reagents should be used, especially 
when using proteolytic enzymes such as collagenase, pronase, dispase or trypsin since 
small amounts of contaminants can have serious undesirable effects resulting in poor sample 
performance. Collagenase is dependent on calcium for activation, for example, and other 
divalent cations may be activators (Zn++) or inhibitors (Mg++) [3], and care should be taken to 
ensure any additive endotoxin levels are as low as possible. 
2.1.3 Stickiness to plastic – the menace of cell sorting 
When performing bulk sorts and collecting a sorted fraction into a plastic tube, it is usually 
best to pre-coat the tube with serum leaving some at the bottom, or if desired, additionally 
seed the tube with a small volume of the sample buffer containing 2 to 10% serum. Adding 
unbuffered bicarbonate media to the collection tube and sorting on top of it runs the risk of 
high pH conditions causing undesirable salts to form while the phosphate and bicarbonate 
buffers mix with the cells present, thereby reducing cell viability. When performing single cell 
sorts into a microtiter plate, any media pre-added to the wells should be HEPES buffered and 
conditioned beforehand if possible. Additionally, when sorting onto/into small targets such as 
microtiter plate wells extra care should be taken to ensure the accuracy of the deflected 
drops during the sort by choosing an appropriate nozzle size to minimize the effects of cells 
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on drop breakoff [4] (choose a nozzle at least 5 – 6 times the cell diameter as verified under 
a microscope). 
2.1.4 Cell concentrations and sorting rates 
Once prepared, the sample should have a final cell concentration that allows the desired 
event rate to be achieved with only a modest differential pressure on the sample. Increasing 
the sample rate significantly by simply forcing more through the system is not recommended. 
The sample should be filtered just prior to being loaded onto the sorter to help ensure no 
clumps are present and further disperse any weakly adhered cells. After filtering the sample 
through a Nitex nylon monofilament mesh with an appropriate pore size (~30 to 50 µm 
depending on cell size), any samples that tend to dynamically reaggregate during a sort are 
best dealt with by installing an in-line nylon sample filter of the same pore size to help 
prevent clogs. Generally, since the theoretical sorting efficiency of a single cell preparation is 
that of a homogenous Poisson process [5], the operational efficiency of the sorter may be 
estimated by: 
𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =  𝑒
−(𝑟𝑎𝑡𝑒 × (1.0−𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛)×
𝑑𝑟𝑜𝑝 𝑝𝑎𝑐𝑘𝑒𝑡
𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 ) 
Where rate is total events/second, fraction is percent being sorted, drop packet is the number 
of drops including any additional temporal purity mask, and frequency is the drop rate in 
drops per second. Normalizing to sorter drop frequency, this means when sorting a fraction 
that is 10% of the total at an event rate of one cell to every 4 to 5 drops, it can be expected to 
sort with an efficiency of 80% to 85% when using a single drop sort.  
2.1.5 Purity and doublets 
If, after optimizing the sorter during setup, suddenly the application sorting efficiency is low 
(higher than expected conflict abort rate) it is indicative that the sample is not a 
monodisperse cell suspension, that cells are likely “sticky”, adhering to one another during 
entrainment and not arriving into the sensing zone as a homogenous Poisson process. This 
is a very common scenario with many cell preparations, especially adherent and primary 
cells, and often the sorter performance is blamed for what is a behavior intrinsic to the 
sample. Much of the time this can be significantly mitigated by reexamination of the sample 
preparation protocol to discover what might be improved to help coerce the cells into a well-
behaved single cell suspension. This often involves the addition of EDTA or DNase etc. to 
the sample sort buffer. 
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Whenever a sorted sample using a purity sort mode (where system-defined spatial-temporal 
drop zones in the stream are examined logically for potential contaminants for each sort 
event) is not as highly sorted as desired, the most common reasons are that either the 
classification scheme for single cells is not robust enough and hidden passenger cells are 
occasionally sorted, or that there are particles in the stream that are disturbing the droplet 
breakoff stability and, as a result, the wrong drops will occasionally appear in the collection 
tube, or a combination of the two. Sorters certainly cannot read the operator’s mind and will 
attempt to do exactly what they are set up to do so, if a positive selection from the sorter 
suffers from disappointing purity, one simple performance check is to sort a completely 
negative cell fraction for comparison. If that sorted negative fraction is 99% pure or higher, 
yet the positive fraction is only 80% to 95% pure, then the likely cause is undetected 
‘doublets’ due to an insufficiently constrained single cell gating strategy. In many flow 
systems doublets tend to align with the doublet figure’s major axis in-line with the partially 
developed laminar flow and the pulse width becomes a very useful parameter to help 
distinguish singlets from doublets. Other systems, such as the BD FACSAria™ family that 
use fully developed laminar flow in their fluidics design can have those same doublet figures 
rotate off axis after entrainment in flow such that Forward Scatter (FSC) pulse width alone 
will not detect enough doublets, and in such cases using both FSC and Side Scatter (SSC) 
looking at plots of Height vs Width (or Height vs Area – but that usually leaves less screen 
real estate for drawing gates) will help reveal many more doublets, boosting the purity to a 
more acceptable level with careful gating. Fig.1 (reproduced with permission from [6]) is an 
example of such a strategy where pulse geometry gates on both FSC and SSC detect an 
additional 9% of doublets that would pass through a standard scatter gate. 
Matching nozzle size to particle size is key, and the general the rule of thumb is that the 
nozzle should be 4 to 5 times that of the particles for bulk sorting and 5 to 6 times that of the 
particles for plate deposition where accuracy is more critical. Ensure that the actual cell size 
is what you expect it to be when choosing a nozzle, and whenever there is doubt it is very 
useful to quickly compare to known bead size standards by simply putting small drops of 
each on a microscope slide and checking, not only the size(s) within the sample but also the 
quality as the amount of debris should be low, the number of single cells high, and 
clumps/aggregates should be the rare exception rather than the rule. Electrostatic cell sorters 
tend to perform very well with monodisperse samples and struggle with poorly dispersed 
ones so, as with many other applications, sample preparation can be the limiting or enabling 
step.  
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The International Society for the Advancement of Cytometry (ISAC) Cell Sorter Biosafety 
Standards were published in 2014 by the ISAC Biosafety Committee [7], and related 
information is readily available and highly recommended reading before embarking on any 
series of cell sorting experiments including: 
i) The ISAC web site (http://isac-net.org) 
Resources for Cytometrists → Biosafety 
ii) CYTO University (ISAC’s on-line portal for cytometry education) 
http://cytou.peachnewmedia.com  → Course: Flow Cytometry Biosafety 
 
Figure 1: PBMC Sort. A PBMC sort on a BD FACSAria™ where by adding both FSC and 
SSC Height vs Width plots and carefully gating on singlets an additional 9% of likely doublets 
are removed (reproduced with permission from [6]). 
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2.2 - Microfluidic 
Recently, microfluidic devices have entered the arena of flow cytometry and, in particular, 
cell sorting devices [1] [2] [3] [4]. As these devices also utilize sequential sorting and similar 
fluorescence detection technologies to identify the cells of interest, best practices for 
microfluidic devices have a lot in common with those applicable to droplet sorters. This is 
especially true for considerations regarding sample preparation, such as choosing the right 
marker panel or appropriate buffer selection as discussed in the previous section (Chapter II, 
section 2.1). While sequential sorting technologies have a lot in common, there are also 
some major differences and knowing and understanding these differences is key to 
successful application.  
One of the biggest differences is that droplet sorters are typically operated in resonance [5], 
whereas many microfluidic sorters are operated purely on demand. [3] [6] [7]  
Even though the enabling principles vary, the sorting effect is mainly generated by displacing 
a certain volume [6] [8]. Given that the sort-timing is precise and correct, this volume defines 
expected purities and yields of target cells. In an ideal system, target cells and non-target 
cells are totally uncorrelated and thus follow a Poisson distribution [9]. In the case of a “yield 
sort”, where all target cell candidates are to be sorted independently of the non-target-cells 
nearby, the expected yield is 100% by definition. The expected purity can be calculated as 
follows: 
Let 𝜆𝑇 be the average number of target cells per displaced volume, then the relative number 
of sort-actuations is defined by 𝑁𝜆𝑇 = 𝑒
−𝜆𝑇. For each displaced volume, there is a chance to 
catch a non-target cell, defined by 𝜆𝑁, the average number of non-target cells per displaced 
volume. With this, the expected purity 𝑃 can be calculated to be 
𝑃 =
1
1 + 𝜆𝑁 𝑒−𝜆𝑇
 
On the other hand, in case of a “purity sort”, every time a second cell is in close proximity to 
a target cell, the potential displacement will be inhibited. Thus, the theoretical purity is 100%, 
whereas the expected yield decreases. In this case, the yield calculation is simply the 
likelihood of having a single cell within the displaced volume. 
𝑌 =  
(𝜆𝑁 + 𝜆𝑇)
1
(𝜆𝑁 + 𝜆𝑇)1!
𝑒(−𝜆𝑁−𝜆𝑇) =  𝑒(−𝜆𝑁−𝜆𝑇) 
Besides the obvious close formal relationship between the two formulas, it is worth noting 
that the expected yield in a purity sort is solely determined by the total cell frequency (𝜆𝑁 +
𝜆𝑇) and not by the target/non-target ratio, whereas the expected purity in yield sorts is 
strongly dependent on the target cell frequency.  
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In order to give a practical example, these two figures are here calculated for a virtual sorting 
device assuming that the microfluidic sorter: 
i) has a sample flow rate of 4 mL per hour and does not require a sheath to be 
operated 
ii) is able to redirect 100% of the sample stream into the target cell reservoir for 50µs 
and then instantly return the flow back to the non-sorted fraction 
iii) uses a sample with 106 total cells/mL with 0.1% target cells.  
This translates to a flow of 1.1µL per second and cell detection frequency of 1.1 ∙ 103 total 
cells per second. Since in this example 0.1% of all cells are target cells, the target cell 
frequency is 1/s; resulting in an average time of 1,000,000µs between target cells and 900µs 
between any two cells. Given that the sorting volume displacement is done in 50µs, 𝜆𝑇  and 
𝜆𝑁 can be calculated: 
𝜆𝑇 =  
50µ𝑠
1.000.000µ𝑠
= 0,00005 
𝜆𝑁 =  
50µ𝑠
900µ𝑠
= 0,056 
Thus the expected purity in a yield sort would be: 
𝑃 =
100%
1+0,056  𝑒−0,00005
= 96% 
Similarly the expected yield in a purity sort would be: 
𝑌 =   100% ∙ 𝑒(−0.05605) = 96%  
Using the same calculation for 1 ∙ 107total cells/mL and 108  total cells/mL, the following can 
be expected: 
 
The key observation here is that, even though the resulting purity in the above yield sort 
example is limited, especially when processing input material with a concentration of 1 ∙
108total cells/mL (Table 1), the enrichment from 0.1% to 18% purity is still 180-fold. This 
opens up the opportunity to utilize a sequential sorting strategy, where a fast yield sort is 
followed by a purity sort. 
When starting the experiment with the higher frequency yield sort from the above example, 
the first pass would have theoretically yielded an 18% pure target cell fraction being 
processed with a rate of roughly 100.000 cells per second. If re-suspended again in the 
original volume, the second pass is processed with a total cell count very close to the one in 
the first example and would have yielded the target cells in a greater than 99% pure fraction.  
 
The above is demonstrated with a microfluidic sorter using a MEMS sorting chip in a 
completely closed cartridge performing a CD34+ cell enrichment from an non-mobilized 
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donor. As seen in Error! Reference source not found. the staining pattern and gating 
strategy is straightforward. 
 
The target cell frequency was determined to be 0,08% and the total concentration was 
chosen so that the 109 total cells were suspended in 10mL. From there, a yield sort was 
carried out, with a flow rate of 4mL/h. The resulting cell processing rate is 110,000 total cells 
per second. With a target frequency of 0.08%, approximately 90 sorting actuations per 
second are expected. The enriched cells are then re-suspended in 10mL and processed a 
second time for purity. The results are shown in Error! Reference source not found..  As a 
result of this sequential sorting strategy, with an overall sorting time investment of only 5 
hours, a result has been achieved equaling a typical 20h single pass sort.  
 
Since microchip sorting devices are particularly powerful in sorting cells gently due to the 
absence of high shear forces or electrostatic charges, they are ideally suited to follow such a 
sequential sorting approach. The rarer the target cell population or the higher the total cell 
count, the more advantageous this method becomes.  
 
Figure 1: Staining pattern and gating strategy for a CD34+ enrichment. The cells are 
stained with CD34-Pe and CD45-APC. For analysis purposes only, PI was added for post 
analysis only. 
Figure 2: Result of a sequential sorting process. 109 total cells have been processed 
sequentially in 5 hours to a final purity greater than 99%. Overall 280.000 target cells have 
been harvested from 800.000 target cells starting material, resulting in an overall yield of  
approximately 35%. 
Table 1 Expected purities, yields and processing times for different starting cell 
concentrations 
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Section 1 - Compensation 
1.1 Introduction  
In flow cytometry, fluorescence spillover (i.e. compensation) is probably the single greatest 
source of frustration for the scientist and cause of bad data.  Correctly compensating for 
spillover is critical to accurately identify populations in multi-color flow experiments.  Errors 
in compensation for one fluorochrome can be propagated into other detectors resulting in 
erroneous “virtual” positive populations or errors in population percentages due to incorrect 
gating. Mastering fluorescence spillover is much like chess, the rules are simple, but 
becoming a skilled practitioner can take some effort.  Here the basic concepts of 
fluorescence spillover are reviewed and some simple principles to follow in order to 
maximize data quality are provided, while debunking some of the myths that surround this 
field. For further information on this subject readers are referred to the following references 
[1-4].  In addition a guide as to the Minimum Information about a Flow Cytometry 
experiment (MIFloCyt) has been develop and vetted by the International Society for the 
Advancement of Cytometry (ISAC) [5].  This includes recommendations for ways to 
document compensation of complex panels.      
 
1.2 Principle of Spillover and Compensation  
Fluorescence spillover is the amount of signal, measured in median fluorescence intensity 
(MFI), that a fluorochrome emits in a secondary detector specific for a different 
fluorochrome (Figure 1A shows the fluorochrome PerCP-Cy5.5 is spilling into the PE-Cy7 
detector [dark red]).  This is equivalent to a background in that detector.  We can calculate 
a spillover value (SOV) of PerCP-Cy5.5 into PE-Cy7 as Y/X x 100% (Figure 1B, left).  
Compensation is the mathematical process used in all flow cytometers and software in 
which these SOVs are used to determine a compensation matrix which effectively 
subtracts/corrects background due to spillover in all detectors. (Figure 1B, right).   
 
The accuracy of this correction is totally dependent upon the accuracy of the SOVs 
determined from the appropriate single-color compensation controls. In Figure 1B, the 
spillover is correct when the MFI [PE-Cy7] of the PerCP-Cy5.5 positive (+) population is 
equal to the MFI [PE-Cy7] of the PerCP-Cy5.5 negative (-) population.  With a few 
exceptions, the mathematical calculation of SOVs is the same for all cytometers and flow 
cytometry software packages.   
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1.3 Measuring SOVs / Compensation Controls 
On all cytometers SOVs should be determined using single-color compensation controls.  
Most errors in calculating SOVs are due to the use of inappropriate compensation controls.  
A compensation control should consist of a positively stained population and a negative or 
unstained population.  The positive and negative populations do not need to be run in the 
same tube.  Cytometer and software protocols will specify what combinations can be used.  It 
is never good practice to try to run two controls in the same tube, for example using FITC 
CD4 mAb and PE CD19 mAb.  This makes the assumption that there is absolutely no 
antibody bound to the “negative” cells which is typically not the case. 
 
Many software packages from flow cytometer manufactures and  third party companies have 
an “auto-compensation” feature.  While these can be very powerful, they are based on 
automated gating algorithms in which the software identifies the positive and negative 
populations. These gates may not always be appropriate.  It is recommended that for new 
controls the user confirm that the software is providing correct gates and results. 
 
In general, correct SOVs can be obtained by following four simple principles for single-color 
compensation controls. 
1) The fluorescence spectrum of the compensation control fluorochrome-conjugated 
reagent should be identical to the reagent used in the experiment.  More specifically the 
fluorochrome should be identical not similar.  For example, even though Alexa Fluor® 488 
and FITC are spectrally very similar, an Alexa Fluor® 488 compensation control cannot be 
used for a FITC reagent or vice versa.  Other examples are APC/ Alexa Fluor® 647 and 
APC-Cy7/ APC-H7. 
 
This principle is especially critical for tandem reagents (e.g. PE-Cy7, APC-Cy7) where there 
can be significant spectral differences from lot to lot, which can lead to differences in the 
SOV [6].  In such cases it is recommended that users run individual single-color, lot-specific 
compensation controls. 
 
2) The autofluoresence of the positive and negative populations must be equivalent.  
The spillover calculation assumes that any difference in the MFI of the spillover detector (e.g. 
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Y in Figure 1A, left) is due to the presence of the fluorochrome measured the primary 
detector.  If the autofluoresence differs then part of the MFI in the spillover detector will be 
due to the difference in autofluoresence and not the fluorochrome itself.  An example is 
shown in Table 1.   In measuring the SOV of FITC into PE when similarly autofluorescent 
positive and negative cells are used, the calculated SOV is 27%; however, incorrectly using 
beads for the negative population results in an SOV of 22%, a 5% error.   
 
This also applies to cell types.  Do not use cell lines and lymphocytes for the same control.  If 
you use a stained cell line as your positive population use that same unstained cell line as 
your negative population.  Similarly do not mix lymphocytes and monocytes as positives and 
negatives in a control tube.  Some software programs allow you to have a universal negative 
population (e.g. unstained lymphocytes) which is used with many positive samples.  This is 
acceptable as long as all the positive samples are all lymphocytes. 
 
Myth: The SOV depends upon the type and autofluoresence of the cells you are analyzing. 
FALSE. The SOV is only a function of the fluorochrome.  When correctly measured, the SOV 
is independent of the cell type(s) in the biological sample. 
 
3) The positive population should be as bright as possible.   
As noted earlier, the SOV is equal to the slope of the MFI of the two detectors (Figure 2, 
dashed line). The actual SOV is not a function of the brightness of the positive population but 
is the same all across the dynamic range.  A truly correct SOV will provide correct 
compensation whether it is derived from a bright or dim positive population. (Figure 2, 
Correct SOV).  When calculating a slope the most accurate measurement (i.e. SOV) is 
obtained when the two data points obtained are as far apart as possible.  This is especially 
important for low spillover values such as PE-Cy7 into PE.   
 
However, we rarely get “perfect” SOVs and the impact of any errors in the SOV are 
magnified as the MFI of the primary detector increases as shown in Figure 2.  In this 
example, if there is a 1% error under compensation error in the SOV (Figure 2; red line), it 
would have a minimal impact on a dim population.   In this example, an MFI of 103 in FL1 the 
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error would be 10 MFI in FL2, not noticeable.  However, if the FL1 MFI is 105, the MFI error 
in FL2 would be 1000 and this would incorrectly look like a new positive population.   
 
Myth: For spillover to be correct it is required that the compensation control positive 
population needs to be as bright as your sample. Partly FALSE.  
To restate the message here, you want to get the most accurate slope/SOV possible. 
Therefore as noted in the title, it is good practice to have the positive control population as 
bright as possible, preferably close to your sample MFI (static or activated). However, for 
spillover to be correct it is NOT required that the compensation control positive population 
needs to be as bright as your sample.  In some cases the positive population of 
compensation beads may not be a bright as your sample. This does not mean it is not a valid 
compensation control.  In general, if the positive population is approximately equivalent to 
CD4 you will get good results.  There is one major caveat to this statement.  For all 
measurements it is critical that the positive population is in the linear range of the detector. 
Outside of this range the corrected data will be inaccurate.  Most cytometer manufacturers 
provide linearity information for their instruments. 
 
4) Collect enough events to obtain meaningful accurate SOVs   
As a rule of thumb collect at least 5,000 events for both your negative and positive 
population.  Again this is to insure the accuracy of the measurements, especially for low 
SOVs. 
 
1.4 Compensation Controls 
Compensation controls typically fall into two categories: i) stained cells; ii) beads, these are 
seen as either a) directly fluorochrome-coated or b) anti-immunoglobulin capture beads and 
are available from a number of sources.  Each of these controls has advantages and 
disadvantages.  In a given multi-color experiment, compensation controls can be mixed and 
matched including all three types.  That is beads (positive and negative) can be used to 
compensate Fluorochrome A, and cells (positive and negative) to compensate Fluorochrome 
B.  The key is to follow the second principle and do not mix and match different control types 
within the same single color fluorescent control. 
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i) Stained Cells 
These are the best and most reliable compensation controls.  The conditions most closely 
replicate what is happening in the assay tube.  The disadvantage is that you may have to use 
precious biological material.  In particular, if you need a tandem lot-specific control for a 
specific CD marker the number of cells expressing the marker may be low requiring the use 
of even more of the biological sample. 
ii) Beads 
The advantage of beads is that no biological material is required and they are easy to 
prepare and use.  Following the manufacturer’s protocols, for many fluorochromes beads 
provide sufficiently accurate SOVs.  The disadvantage is that these beads are a surrogate for 
cells and may not in all cases provide a perfect match to cells.  This can result in discernable 
and reproducible differences in the SOVs obtained from the exact same reagent measured 
on beads versus cells.  Where different SOVs are obtained, the cells must be considered the 
biologically relevant gold standard. 
 
Compensation controls using fluorochrome-coated and anti-immunoglobulin capture beads 
are available from a variety of sources.  Some are used as stand-alone controls, some are 
integrated into software packages.  However, when used for 10-18 color instruments 
differences in SOVs can be seen in all of these beads when comparing the SOVs obtained 
with the beads to the SOVs obtained with the gold standard of cells.  These differences can 
vary from manufacturer to manufacturer.  For example, the beads from Manufacture A may 
be more accurate than the beads from Manufacture B when calculating the SOV of 
Fluorochrome X into Y, while the beads from Manufacture B may be better for calculating the 
SOV of Fluorochrome Y into Z.  SOV differences between beads and cells can be as large 
as 5-10%. 
 
Compensation beads are a powerful tool for making the process of determining SOVs fast 
and easy and should be used where appropriate.  However it is important to use them with 
reasonable caution.  The best laboratory practice to ensure accurate compensation when 
using beads is to pre-test any new reagent on both beads and cells to ensure that they are 
providing you with SOVs equivalent to your stained assay samples.  For example if you are 
using a new fluorochrome or a new lot of a tandem, run a quick test staining both cells and 
beads; calculate the SOVs from both.  If the SOVs are effectively equivalent then you can be 
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comfortable using the beads as controls for all future assays.  However if there are significant 
differences you may need to use cells as your controls or try a different bead.  Finally, in 
such a test you may want to treat the cells and beads as you would in your assay, e.g. if your 
assay includes a fix/perm step you can include this in your control staining.  Fix/Perm buffers 
can sometimes, but not always alter the SOV of your fluorochromes. 
 
1.5 What are “good” SOVs?  
This is really a question that cannot be definitively answered.  There is great deal of 
misunderstanding regarding what SOVs actually mean in terms of a multi-color flow 
cytometer and the experiments run on them.  First and foremost, SOVs are empirically 
determined mathematical values which are used by flow cytometry software to correct for the 
background due to fluorescence.  While these values are related to fluorescence spillover 
they ARE NOT direct absolute measurements of the fluorescence spillover of one 
fluorochrome into another detector.  SOVs are based upon median fluorescence 
measurements which are gain (i.e. photo multiplier [PMT] voltage) dependent.  That means 
that when you change the PMT voltage on a detector the SOVs associated with that detector 
will change.  However, the actual spillover of fluorescence from one detector into another is 
unchanged.  So you cannot ask “Why is the SOV on my instrument different than the lab next 
door?” without knowing the PMT voltages.  The single most important fact to remember is 
“Changing the PMT voltage on an instrument will change the SOVs but it has absolutely no 
impact on the actual florescence spillover and its associated spread and DOES NOT affect 
the quality of the data. 
 
1.6 What is “good enough” accuracy for SOVs?  
Using the right compensation controls under the right conditions will maximize the accuracy 
of your spillover values.  Still, no matter which controls are used it is likely that there will be 
some error in some of the SOV measurements you make.  This brings up the final question 
of what SOV accuracy is good enough to provide you quality data.  The honest answer is 
that “it depends”.  It depends upon the design of your assay, the fluorochromes used and the 
density of the antigens being analyzed.  Any error in the final data is directly proportional to 
both the error in the SOV measurement and the brightness (MFI) of the population being 
analyzed.  This is demonstrated in Figure 3.  In the assay represented in the top panels, the 
Brilliant Violet™ 510 (BV510) positive population is somewhat duller (MFI ~6,000).  In this 
situation, small (+/- 2%) errors in the BV510 into BV605 detector do not significantly affect 
the error in the MFI in the BV605 detector (~+/-100). 
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The situation in the assay shown in the bottom panels is quite different.  The BV510 positive 
population is quite bright (MFI ~68,000).  Identical errors (i.e. +/- 2%)  in the BV510BV605 
SOV results in truly BV605 negative populations appearing to be positive (BV605 MFI errors 
of +/- 1,300).  The MFI error in the spillover detector (here BV605) = the MFI of the 
population in the primary detector (BV510) X the % error in the SOV.  Therefore, an 
“acceptable” error in the SOV for one assay (e.g. the top panels) may be quite unacceptable 
for another (the bottom panels).  This is again why it is important to pre-test your 
compensation controls to better understand and manage any potential errors that can impact 
the quality of the final assay. 
 
In conclusion, with an understanding of the concepts of compensation / fluorescence 
spillover and following a simple set of principles when using compensation controls, it should 
be relatively easy to obtain and present high quality multi-color flow cytometry data. 
 
Figure 1 Spillover and Compensation – A) the emission spectra of PerCP-Cy5.5 and PE-
Cy7. B) Peripheral Blood Lymphocytes stained with PerCP-Cy5.5 CD4 mAb.  The Median 
Fluorescence Intensity (MFI) is shown for the PerCP-Cy5.5 and PE-Cy7 detectors without 
(left) and with (right) compensation 
Figure 2: Brightness of positive population  
Figure 3: Accuracy for SOV- The figure shows two different assays in which lysed whole 
blood was stained with the same fluorochromes: BD Horizon™ Brilliant Violet 510 (BV510) 
and BD Horizon™ Brilliant Violet  605 (BV605).  Both assays used the same BV605 reagent. 
In the top panels the BV510 positive population was dim will in the bottom panels the BV510 
positive population is very bright.  For each assay the SOVs were determined and the correct 
spillover was applied (Middle panels).  For the left panels the BV510BV605 SOV was 
increased by 1% (over-compensated) and compensation applied.  For the right panels the 
BV510BV605 SOV was decreased by 2% (under-compensated) and compensation 
applied. 
 
Table 1: The consequences of using positive and negative populations with differing 
autofluoresence – Lymphocytes were stained with diluted FITC CD4 mAb.  The MFI of the 
CD4+ [Cells (+), unstained [Cells (-)] cells and unstained beads [Beads (-)] were measured in 
the FITC and PE detectors. SOVs were calculated using positive and negative cells or 
positive cells and negative beads. 
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Section 2 - Maintenance 
 
2.1 Introduction 
Maintaining flow cytometric instruments is an important step in ensuring a constant quality 
level of measurement. The signals generated by flow cytometric instruments are dependent 
on many factors (i.e. optical layout (laser and laser power, optical filter), sheath fluid, room 
climate etc.). A prerequisite is thereby a deeper knowledge of the performance of the 
respective system, making it necessary to define the original status once and track it over 
time.  
This can be done at different levels and is dependent on the type of instrument (analyzer, cell 
sorter), the instrumental layout (number of lasers, High Throughput System (HTS)) and the 
type of measurement one wants to conduct on such an instrument (e.g. screening, 
diagnostic, qualitative versus quantitative or volumetric tests). Due to the high diversity of 
available flow cytometers on the market, there is no common routine of conducting 
maintenance and also the time frames and maintenance intervals may vary from instrument 
to instrument. While most of the manufacturers offer service contracts for their systems, the 
user can do several things to prevent potential damage and maintain or restore the 
instrument’s original level of performance. Be aware that for some steps during maintenance 
(e.g. laser alignment) additional precautions (e.g. wearing laser safety goggles) are 
necessary to accommodate for an altered hazardous potential (optical (high energy laser), 
biological or electrical (high voltage)) as compared with normal instrument operation. 
Why is tracking of instrument performance so important? One reason is that the data 
generated by flow cytometers have no absolute unit numbers but are relative. They are 
strictly dependent on the context of and the conditions during data acquisition. Only if one 
“knows” the capabilites of the system at a certain time point and has the appropriate controls 
or standards is one able to interpret flow data accordingly. Maintaining a flow cytometer 
means being able to retrieve information about the actual status of an instrument and 
compare it to the original (ideal) situation. If the performance check fails one needs to know 
how to bring it back to the original level (if possible). The following section describes several 
options for how to check the performance of a flow cytometric instrument and what can be 
done as a preventive procedure (summarized in Table 1).  
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2.2 Cleaning of Instruments 
2.2.1 Optical Devices 
Maintenance starts with cleaning the instrument. For example, it is necessary to remove dust 
from the ventilation systems to allow effective air-cooling of lasers and power supplies as 
well as from optical filters (Band-, Short- and Long-pass), (dichroic) mirrors and prisms of the 
optical path. Dust will impair the laser-alignment and sensitivity of fluorescence signals by 
generating additional background and loss of fluorescence signals. These parts can be 
cleaned with unsoiled pressurized air (e.g. as used for electronic parts or computers) and 
more resistant dust can be carefully removed with cotton swaps or dust free paper wipes 
(moistened with a drop of pure methanol (e.g. as for microscopy, methanol will evaporate 
without leaving residues on the optics). How often these types of preventive maintenance 
have to be performed strictly depends on the environmental conditions and are sometimes 
included in maintenance contracts of the vendors. Many flow cytometers’ lasers are directed 
via glass fibers to the detection site and, therefore, are stable over time in their alignment. 
Other machines are equipped with fixed optical benches, making repetitive laser- and filter-
alignment nearly obsolete. But in any case, it is important to check (or “know”) the instrument 
status prior to the measurement.  
The Cytometer Setup and Tracking (CS&T) module from Becton Dickinson (BD) is an 
example of how instrument performance can be monitored over time [1]. The combination of 
software and the use of standardized beads make it possible to retrieve critical parameters in 
one run. After installation through a service engineer or exchange of components (e.g. 
lasers, filters or PMTs) the status of the instrument is documented in a so-called “baseline”. A 
lot of information (not all are listed here) about the linear range of each PMT (important for 
proper measurement and compensation (see Chapter III section 1 Compensation)), 
electronic noise and background (Br, SDEN), detector efficiency (Qr) as well as sensitivity 
(Peak ratio between negative and positive population) and quality of laser alignment (%rCV) 
is stored in this file. All the introduced values are summarized in Table 2 with a very brief 
explanation and cannot discussed further here but are described in much greater detail 
elsewhere [2-10]. 
In a second step, the instrument performance can be tracked and compared to the baseline 
values by running the same lot of standard-beads at different time points. The software 
module is than reporting every observed change compared to the baseline (and has some 
more features, which are not described here). In Figure 1a a typical result of a CS&T 
performance check is shown. A wrong band-pass (bp) filter in front of the PMT-detector 
resulted in a lower signal. As a consequence the system needed a higher PMT-Voltage (ΔV) 
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to reach the defined target value for this particular channel. The change in ΔV was larger 
than the accepted range (normally between 20-50 V [1] and instrument performance failed 
with notice to the user (red cross).Note that in the linear range of many PMTs, a change of 
about 40 V results in a doubling of the mean fluorescence intensity (MFI) of a population. On 
flow cytometers without a CS&T-option, a similar result can be achieved by using nearly any 
kind of standardized particles (e.g. Rainbow Beads, 6- or 8-Peak Beads, Calibrite® or other 
fluorescent labeled beads, CS&T Beads [1], etc.). Instead of a “baseline” one has to 
generate a system-specific calibration containing all the fluorescent channels and 
parameters. At the already suggested time intervals, the beads under defined settings are 
measured and the results saved as a (instrument specific) “standard”. Future measurements 
with the same kind of beads and the same instrument settings will allow a comparison to the 
first “standard” measurement and thus monitors changes in instrument performance. In 
Figure 1b a result for the same situation as described for the CS&T-option is shown. With the 
correct bp-filter (510/50) the beads are falling inside the target values (positive peak of the 
blue curve is inside the brackets), whereas with a wrong bp-filter (610/20), the instrument 
performance fails (red curve). Having this kind of information for all parameters at various 
time-points (every day or week) will give a good overview of the stability of the system. 
Besides the target channels, the shape and width of the peaks are also of importance and 
can indicate for instance a laser misalignment. As shown in figure 2a the peak of the positive 
beads is still inside the defined target area, but the width (%CV) is twice as big as the 
corresponding measurement during the standard performance (Fig 2b). After realigning the 
laser the shape of the peak and the %CV value are again in the expected range. 
The selected examples illustrate that tracking an instrument performance is possible in 
different ways (8-Peak Beads, CS&T or fluorescent labeled beads, etc.) as long as one 
knows where to look at and to what instrument specific “standard” an actual result has to be 
compared to. As noted earlier, there are several additional parameters, which can be tracked 
(e.g. laser delay and area scaling factors), but with a correct standard setup, most of them 
can be accessed via appropriate bead measurements. 
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2.2.2 Fluidic system 
The fluidic system of most flow cytometers is assembled with parts that need to be 
maintained on a regular basis. One has to ensure that the fluidic lines and filters are free of 
air bubbles. Entrapped air compresses differently than sheath fluid and can cause unstable 
(“dancing”) fluorescence signals due to incorrect time calculation of the incoming signals. 
The more lasers a machine has, the less tolerant the system is against air bubbles or 
unstable compressed air supply. Sheath or saline filters therefore have to be vented on a 
daily basis and replaced every 6 months (the most commonly suggested time interval by 
manufacturers). In machines without an extra sheath supply (e.g. Guava EasyCyte, Partec/ 
Sysmex, Accuri etc.), air in the system will cause false values for volumetric cell counting or 
will lead to empty fcs-files without any measured event.  
Sheath tanks, especially when they are pressurized, have to be refilled and checked for 
leakiness on a frequent basis. Ball seals have to be replaced before they lose integrity. The 
consequences are similar to those described above for entrapped air bubbles. An additional 
consequence in cell sorters is an unstable droplet breakoff point, which is critically dependent 
on a constant and stable pressure (especially for nozzle sizes above 85 m).  
To ensure sterile cell sorting, one has to clean/autoclave the sheath tanks from time to time. 
This goes in line with cleaning the sample injection port (SIP) and the sample tubing (see 
Table 1). Some machines offer semi-automated start-up and shutdown protocols, as well as 
cleaning routines one can run after a defined period of time or on demand as detailed in 
reference manuals e.g. [11-15]. In general, there are at least 4 major protocols to maintain a 
fluidic system, depending on the intention of the cleaning: 
- sterilization/ decontamination 
- avoid crystallization for long-term storage (e.g. overnight) 
- unclogging 
- bleaching (get rid of cross-contaminating dyes) 
 
For long-term storage, such as an overnight shutdown or prior to maintenance through a 
service engineer, most labs run a decontamination protocol followed by a wash cycle before 
they switch off the instrument (or hand it over to a service technician). The most commonly 
used solutions to decontaminate a flow cytometer are 1% sodium hypochlorite or 70-80% 
ethanol but freshly prepared 1% hydrogen peroxide can also be used. Distilled or deionized 
water is ideal for washing out the cleaning solution. To keep a machine in a “dormant” / 
unused state for a longer period of time (weeks / month) one could dry the tanks and system 
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tubing completely after the cleaning process or leave them filled with distilled or deionized 
water.  This is to ensure that even if the SIP or tubing were to dry out, no salt crystal 
formation, which could subsequently cause clogging, would occur.  
Sticky or clumpy cells, which are either not properly filtered or used at too high a cell 
concentration, could block the orifice of an instrument. In some (mostly pump driven) 
instruments (e.g. BD Accuri, Merck/ Millipore Guava EasyCyte) one can revert the direction 
of the fluidic to push the blockade backwards out of the tubing. In other cases (e.g. 
FACSCanto II, BC Galios) running a (pre-warmed) detergent through the system for several 
minutes, followed by filtered deionized water or PBS, can help to release the blockade. In 
machines where one can easily access and remove the SIP, sonication (in clean water) of 
the tubing is also an option (e.g. Guava EasyCyte). As a last resort, the usage of thin wires to 
clean the SIP, working like a sweeper is cleaning a chimney, can be recommended. If an 
optional High Throughput Sytem (HTS) or Carousel Module is available the washing steps 
are even more important and fluidic parts and tubing should be changed as recommended by 
the vendor. The usage of fluorescent dyes such as PI, DAPI or Acridine Orange (AO), which 
are used to stain nucleic acids (e.g. live/dead, cell cycle or RNA-DNA-Ratio) makes an 
additional cleaning step necessary and, because the use of AO can cause a lot of trouble, 
there are different alternatives (e.g. lysotracker, Syto® dyes, Pyronin Y) available for many 
applications when AO is used. These dyes are often stained in excess to ensure a good 
staining profile. Due to their planar structure, they are sticky and can also adhere to the 
tubing. Therefore a high likelihood of cross-contaminating samples between different users 
exists. Running a bleaching solution (e.g. 1% sodium hypochlorite) for 5-10 minutes will 
prevent this.  
In all situations, one has to be careful with the use of aggressive/corrosive solutions and 
make sure that they are washed out/replaced by the respective sheath fluid or distilled water 
and are not left inside the flow cell for an extended period of time (e.g. overnight) [16]. This 
will damage the tubing and sealing and ends up in leakiness of the system. 
Some flow cytometers (e.g. Accuri C6, Guava easyCyte, Attune Nxt, MACSQuant, CyFlow) 
allow volumetric measurement, which enables counting and direct calculating of the cell 
number and concentration of a sample. A prerequisite for accurate cell counting is again an 
air bubble and particle free (filtered) sheath fluid and intact sample tubings. Mechanical 
stress makes it necessary to replace the tubing at constant intervals (e.g. a bi-monthly 
change of the peristaltic pump tubing is recommended for the BD Accuri C6 system [17]).  
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2.3 Computer and software  
Beside the above-described maintenance steps to ensure proper function of a flow 
cytometer, the computer and software need some attention. Defragmentation of the 
computer’s hard drive and backups of the FCS-files should be scheduled in a frequent way 
(weekly/monthly, depending on the usage). If the FCS-files are organized in databases, one 
should take care that the size of the database does not exceed recommended size limits 
(e.g. ≤ 45% of available disk space [18]) . This will impair and slow down the performance of 
the entire system at a certain time point.   
Although most flow cytometers on the market are very robust and reliable, there are still 
many things that need to be controlled. Table 1 summarizes many common steps to consider 
during instrument maintenance. As already mentioned, it depends on the instrument and 
environmental setup, as to which steps have to be done in which frequency, and the focus 
might vary from lab to lab. Therefore, this  is an overview and a suggestion of procedures, 
which should help to get the best results out of your flow data. In any case of doubt,  the 
reference guidelines should be consulted and/ or service engineers of your vendor contacted 
to prevent damage to your system and to keep it in a good condition.  
 
Figure 1: Examples for performance tracking with and without a CS&T module, 
performed according to [1]. 
a) The weekly measured performance for one parameter (out of 10) is shown. The cross in 
red indicates a failure in the performance check (a higher PMT-Voltage is needed to reach 
the target values of the beads, which corresponds to a loss of sensitivity). After checking and 
changing the band-pass filter in front of the PMT, the performance is measured again and is 
compared to the previous situation (blue dots). With the correct band-pass filter installed, the 
performance of the PMT is back to the previous level. The graph is taken from a CS&T-
Cytometer Performance Report of a BD FACSCanto II equipped with 3 lasers. b) The 
histogram of channel A of the violet 405 nm laser shows the corresponding measurement to 
the situation described above in a) and is taken from a self-defined, instrument-specific 
calibration worksheet. The blue population represents the “standard” setup (with a 510/50 
band-pass filter in front of the PMT of channel A, where the beads are reaching the 
respective target values (brackets). The red curve shows a measurement with a 610/20 nm 
band-pass filter instead. The beads are clearly outside the target values and the positive and 
negative populations are barely separated from each other. This is an example, how one can 
easily track basic instrument performance without having a separate software module 
available. 
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Figure 2: How one can detect suboptimal alignment of lasers. 
Both histograms display a negative and positive bead population in the 450/50 channel of the 
UV-Laser of a BD FACSAria SORP cell sorter. Although the positive peak in a) still falls into 
the defined target area (brackets = P2), the shape and %CV of the peak suggest a 
suboptimal alignment of the UV-Laser. After realignment the shape of the positive peak 
become narrower with only the half of the %CV. Laser-Alignment is optimal, when the lowest 
%CV values are reached. 
 
Table 1: Suggested Maintenance Intervals for different Instrument Components 
 
Table 2.: Summary of critical parameters defining the optical performance of a flow    
 cytometer 
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Section 1 – Controls – determining positivity by eliminating false positives 
1.1 Introduction 
For antibodies the desired way of binding is the specific binding of the antibody, i.e. via its 
antigen-binding site, to its antigen. However, antibodies can bind in another manner to cells, also 
deemed as "specific", by interaction with that cell's endogenous Fc receptors.  A third possible 
interaction between antibodies and antigens is "nonspecific", and occurs through ionic and 
hydrophobic interactions between the two molecules ("stickiness"). It is of critical importance to 
exclude the latter two to be able to reliably quantify antigen expression by immunofluorescence. 
Therefore proper controls are essential in flow cytometry to determine background fluorescence 
and/or background staining, to distinguish false positivity from true staining and to quantitate 
"true" positivity as such. Antibodies, the most widely used staining reagents in flow cytometry, 
can bind a cell in many different manners. 
 
1.2 Fluorescence spreading into the channel of interest – FMO controls 
The first step in establishing what a positive signal should look like is to obtain a reference for 
the natural or background levels, autofluorescence, in that particular detection channel. For this 
purpose, a sample without the staining of interest should be acquired. In the case of 
multiparameter staining, this should be the fluorescence minus one (FMO) control. In the FMO 
control, all antibody conjugates in the experiment are included except the one which is controlled 
for. The FMO control provides a measure of the spread of fluorescence from the other staining 
parameters into the channel of interest, and is required to accurately determine the threshold for 
positive staining [1]. It does not, however, provide any measure of non-specific binding.  
 
1.3 Specificity of reagent for staining target – biological controls 
There are several methods to control for the specificity of antibody-mediated immunofluorescent 
staining, each of which confers varying degree of confidence. The most reliable, but often also 
the most difficult to obtain, control is a negative control consisting of cells which do not express 
the marker of interest. The negative control should be as similar as possible to the experimental 
sample to exclude differences due to autofluorescence, size, “stickiness”, etc. Such a negative 
control could be represented by using cell lines that do not usually express the marker of 
interest, and comparing these against cell lines engineered for ectopic overexpression of the 
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marker, or by comparison to cells genetically deficient for the marker of interest, both of which 
provide excellent controls for establishing staining protocols and for testing staining specificity. 
Depending on the nature of the marker of interest, the comparison to activated versus non-
activated cells may be suitable if markers dependent on activation are analyzed, although one 
has to consider that activation may also change properties of the cell, such as its size and 
shape, which may also increase the inherent autofluorescence or unspecific staining. The use of 
internal controls, by staining additional markers to identify cells not expressing the marker of 
interest within the same sample, e.g. using CD8+ T cells as a negative control for CD4+ T cell-
specific markers, or CD19+ B cells when examining CD3+ T cell-specific markers, should also be 
considered.  
 
1.4 Specificity of reagent for staining target – blocking and isotype controls 
In cases where biological negative controls are not available or difficult to come by, blocking 
controls can also provide an excellent measure of unspecific binding. Specific binding is 
blockable, i.e. loss of staining by the fluorescently labeled antibody after the addition of either 
excess soluble antigen or unlabeled antibody, both of which block the specific interaction of the 
staining antibody with its cognate antigen. Unlabeled blocking antibody must recognize the same 
antigenic epitope with comparable affinity of the labeled antibody whose specificity has to be 
verified. Any positive signals still detected despite the use of blocking controls indicate that 
unspecific binding due to ionic and hydrophobic interactions of the antibody or the fluorochrome 
has occured. When using these controls, however, one has to be aware that blocking controls 
do not exclude cross-reactivity of the staining antibody to other antigens. Normal human serum 
(10% in PBS with an optional addition of 0.5% BSA) can be used to block the binding of labelled 
antibodies to FcR when human cells (particularly B cells or myeloid cells i.e. monocytes, 
dendritic cells macrophages) are analyzed. 
Probably the most widely used staining control, the isotype control, is of limited use in 
determining the threshold of positivity/level of background fluorescence due to unspecific 
binding. The rationale behind using isotype controls is the assumption that unspecific staining is 
due to the isotype of the antibody. As a matter of fact, positive staining with isotype controls may 
be an indication that antibodies bind via Fc receptors to the cell. In that case, Fc receptor 
blocking reagents should be used to prevent such an interaction [2]. However, isotype controls 
are by nature different reagents than the staining antibody, with a different amino acid 
composition in the variable region, different numbers of fluorochromes bound to the antibody 
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and different concentrations, and, thus, have different “unspecific” binding properties. Therefore, 
a negative staining with the isotype control does not infer that the staining one observes with the 
experimental antibody is specific. 
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Section 2 – Titration – determining optimal reagent concentration 
Before any experiment it is good practice to validate and optimize the reagents used. In flow 
cytometry these reagents are generally specific antibodies used to detect and quantify proteins 
on single cells. Using too much or too little of the staining reagent will result in increased 
unspecific staining, decreased signal-to-noise ratio, decreased sensitivity, lack of linearity 
between level of expression and staining intensity, and increased experimental costs. Thus, it 
cannot be stressed enough that determining the optimal concentration of antibodies for your 
experiment is of utmost importance. The optimal concentration or “titer” of an antibody or any 
other staining reagent has to be determined empirically for target and your staining condition (i.e. 
staining time and temperature), and for every new batch of staining reagent for that matter. Live 
cells may have a different staining optimum than fixed cells, proteins stained on the cell surface 
different than the same protein stained intracellularly. As it is very improbable that commercial 
reagents have been tested on your particular experimental conditions, they should also always 
be titrated rather than being used at the manufacturer’s recommended titer or concentration.  
To determine the optimal titer for the staining antibody it is recommended to make a serial 
dilution of the antibody. If it is not known from which concentration to start from, a generic 
starting point is 10 µg/ml of antibody, which is then serially diluted 1:2 for 6-8 dilution steps. The 
number of cells used for the titration should be orientated towards the number of cells being 
stained in the actual experiment. However, while the number of cells affects the staining quality, 
staining tends to be quite robust within quite a large density range, e.g. 105-5x106 cells. Once 
titrated, an antibody concentration generally gives comparable staining quality within a 10-50 
fold range of cell concentrations. If cell concentrations are increased by more than that, it is 
usually sufficient to increase antibody concentrations by 2-3-fold, or to make a quick 2-3 step 
titration. 
Once a titration series has been made, there are several ways to evaluate the data to determine 
the optimal titer. The simplest method is to calculate the ratio of the MFI of the positive 
population (stained by the CD4 mAb) to the MFI of the negative population, i.e. the signal-to-
noise ratio (Figure 1A and B). It should be taken into consideration that the applied gates for the 
negative and positive population will have to be adjusted for each sample in the titration series. 
The titer for the best separation will be the one with the highest signal-to-noise ratio (Figure 1B), 
i.e. in this case 0.68 µg/ml or a 1:800 dilution of the original antibody stock.  
 
One can also consider the lowest antibody concentration which gives near maximum signal. This 
will be the concentration at which staining is saturating and most robust towards changes in cell 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter IV: Before you start: reagent and sample preparation, experimental design  
Section 2 – Titration – determining optimal reagent concentration 
 
94 
 
number, staining time and temperature. Other methods to assess optimal staining by 
determining the staining index are described here [1] 
 
Additional aspects to consider are 
i. When using antibodies, it is the concentration of the antibody which is the critical 
parameter, i.e. when upscaling an experiment to stain in a bigger volume, increase the 
amount of antibody correspondingly to keep the concentration the same. 
ii. When titrating an antibody, make sure you have a population which does not express the 
antigen of interest; this helps to correctly assess background staining. If there are no 
“negative” cells in the population, consider spiking in cells. 
iii. Once an optimal titer has been determined, indicate the concentration of the staining 
antibody for optimal staining, and not the dilution factor, when it comes to publishing your 
results. 
iv. If possible, use counterstains to identify subsets of cells which coexpress or do not 
coexpress the marker you are titrating for. This will help determine/confirm the specificity 
of the titrated antibody.  
 
Figure legend: 
Figure 1. Titration of a CD4 mAb (clone GK1.5) conjugated to FITC and titrated on murine 
splenocytes. The antibody was titrated in 1:2 dilution steps starting from a 1:100 dilution (5.4 
µg/ml) up to 1:12800 (0.04 µg/ml). (A) Histograms of the stained samples are shown. (B) MFI of 
the positive and negative populations (left axis) and signal-to-noise ratio between the positive 
and negative populations (right axis) are plotted. Best separating titer for this particular antibody 
was determined to be 0.7 µg/ml (1:800 dilution). 
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Section 3 – Preparation of Single Cell Suspensions 
3.1 Introduction 
The fluidic nature of counting in flow cytometry requires single-cell suspensions. If cells from 
either solid tissue or an adherent cell culture have to be analyzed, a disintegration of the tissue 
or the cell layer into single cells is an absolute prerequisite for any flow analysis.  
Techniques for the disaggregation of tissue into single cells are very old withmost of the basic 
protocols being from the 1980s or 1990s. Since flow cytometry was first developed, it has always 
been of great importance to measure cells not only from a suspension culture but also from 
adherent cell cultures or from solid tissue. In particular, in tumor research, disaggregation of the 
tissue has to be done carefully for the application of flow cytometry. Nonetheless, despite all the 
protocols and even some automatic disaggregation systems, disaggregation  is still a process 
which has to be optimized specifically for each tissue in order to get the best possible results. A 
high degree of standardization can be maintained in the cytometric laboratory using automatic 
processing machines from industrial companies.  For non-automated protocols, companies 
provide a large variety of special enzymes and protocols for enzymatic digestion.  
The protocol for cell preparation depends strongly on the cellular properties which are under 
study. These staining targets could either be markers on the cell surface, in the cell plasma or in 
the nucleus. Alternatively, it could be DNA or RNA extracted from each cell after cell sorting.  
With similar techniques, subcellular components such as nuclei, chromosomes and mitochondria 
can be extracted either directly from the tissue or after disintegration. 
The two main principles for dissociation of a tissue or an adherent cell culture into single cells 
are mechanical or enzymatic dissociation, and as always, just as a reminder, if unknown clinical 
material is to be analyzed, biological safety regulations have to be maintained. 
 
3.2 Mechanical disintegration 
From a tissue (e.g. solid tumors) a sufficient number of cells have to be extracted by applying 
mechanical forces. The tissue is generally placed into a petri dish containing some growth 
medium and held by forceps. Using a scalpel, the tissue is then scraped and minced, as long as 
it takes until cells are released. The solution is then filtered to remove large tissue pieces and 
very gently centrifuged. The resulting pellet is resuspended in growth medium afterward. 
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3.3 Enzymatic digestion 
For enzymatic digestion, very often trypsin and collagenase Type II are used. In addition, other 
commonly used enzymes include papain, elastase, pronase, hyaluronidase  and Dispase®. If 
the degree of ploidy has to be determined, as in the case of tissue from solid tumors, DNAse I 
should be added to the cocktail to remove DNA from non-intact cells. The tissue is incubated in 
the enzyme solution, usually at 37°C for some time. This is followed by removing the enzymatic 
cocktail by centrifugation and resuspending the cells in medium.  
 
It is advised after dissociation by either mechanical or enzymatic methods to determine the 
number of cells and their viability. An easy way of determining viability is to use a dye exclusion 
test with the classical Trypan blue test in a hemocytometer by visual microscopic inspection 
being the “gold standard”. Use of either this test, or other dye exclusion tests with fluorescing 
dyes that can be assessed by flow cytometry are helpful to perform.  Further information on 
establishing/controlling for viability is covered later in this chapter, Section 5 – Frozen samples 
and cell viability. After viability has been established, the cell suspension can be used directly for 
flow cytometric analysis or stored after fixation or freezing for later measurement. 
In many published protocols, both mechanical and enzymatic methods of generating single cell 
suspensions from original material are commonly combined and modified appropriately to give 
the best results in term of cell yield, cell viability and integrity of aneuploid populations. A good 
representation of all kinds of cells in the sample after tissue dissociation is always aimed for; 
however,. it can never be taken for granted that it is 100% and that the proportion of different cell 
types in the final sample resembles exactly their proportions in the tissue. Furthermore, the 
physiological state of the generated cell suspension may be different from that in the starting 
material. 
 
3.4 Special disaggregation techniques 
Two special disaggregation techniques deserve a mentioned and these are nuclei from paraffin-
embedded tissue and nuclei and chromosome isolation. 
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3.4.1 Nuclei from paraffin-embedded tissue 
The preparation of samples from paraffin-embedded sections for flow cytometry requires a 
different protocol from those described above. In clinical research, the flow cytometric analysis of 
cells from a paraffin-embedded section can be required, especially if backward screening of 
patients needs to be performed. Preparations of cell nuclei from paraffin sections are possible. In 
principle, a section cut from the paraffin block has to be dewaxed using a solvent such as 
xylene, followed by treatment with ethanol and water for rehydration. However, this can be a 
very lengthy procedure. Thereafter, DNA staining of the isolated nuclei with intercalating dyes 
can give reasonably good DNA histograms. 
 
3.4.2 Nuclei and chromosome isolation 
Pure cell nuclei and/or micronuclei can be isolated directly from most tissues and the protocols 
used for nuclei preparation for cells in suspension can be adopted. Excellent results from 
adherent cell cultures are possible even without using trypsination. The tissue is first treated with 
salt solutions containing a detergent and RNAse. This is followed by treatment with an acidic 
sucrose solution. In this way, the cytoplasm is destroyed and nuclei are released. [1]. In a very 
similar way, whole chromosomes can be isolated from metaphase cells and their DNA content 
can be measured with high precision. Even single chromosomes can be sorted based on their 
difference in DNA content. 
 
3.5 Ensuring a single-cell suspension/Removing oversized aggregates after extraction 
 
For all disaggregation methods described it is essential to ensure a single-cell suspension and to 
remove oversized aggregates after extraction. To do so, the suspensions should be filtered 
through a simple mesh (~30 to 50 µm) or a cell strainer to remove larger aggregates, which 
otherwise can clog the flow cytometer's nozzle or channel. 
3.6 General Comments 
Once a protocol for a certain cell type and experiment has been developed, it is strongly 
recommended to always proceed in a highly standardized way. Automatic systems with high 
reproducibility provide mechanical as well as enzymatic tissue disaggregation in a more or less 
automatic process and may be advantageous in the routine cytometric laboratory. For a typical 
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solid tissue, the cell yield is about 107 cells per mg material and it should be possible to achieve 
>50% viability in the isolated cells. What should not be underestimated, however, is the 
probability of perturbing cell surface structures and epitopes or disrupting the cell, which could 
occur in solid tissue disaggregation. In some cases, cell clumping, dramatically reducing the 
cellular yield, can be a big obstacle for a productive flow analysis. 
Many protocols for tissue dissociation and cell isolation use a combination of the above 
procedures as one technique on its own may not deliver a high cell yield and cell viability. A 
successful protocol depends in general on the personal experience in the laboratory. It is also 
highly dependent on the amount of available tissue(s), the nature of the tissue and the planned 
use of the material.  
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Section 4 - Pre-enrichment of low abundant cell populations prior to 
acquisition/ cell sorting 
4.1 Introduction 
One of the major advantages of flow cytometry is the capability to measure multiple parameters 
per cell with a speed of several thousand cells per second. This allows the measurement and 
detection of rare cell populations with frequencies below one in one million cells (≤ 1/1 x106). But 
even with this relatively high number of cells analyzed per second, a lot of time is required to 
acquire a significant number of rare cells for statistical analysis. Assuming a frequency of 1 cell 
of interest per 1x106 cells in a given sample, one would need to acquire a minimum of 1x109 
cells to have at least 103 cells of interest at the end of acquisition. The average acquisition 
speed of many flow cytometeric analyzers, at which they will detect and acquire all incoming 
signals without significant loss due to coincident aborts or electronic aborts, is around 104 cells 
per second. It would therefore take more than 24 hours to acquire enough of the described 
sample in order to reach the 1000 cells of interest. 
While this time calculation is true for many available flow cytometric analyzers, for cell sorting, 
the time calculation is different.  Here additional parameters come into focus. In common flow 
cytometers which hydrodynamically focus the cells in front of the laser intersection point (point of 
fluorescence detection) the speed of the carrier stream is given by the system and only the 
volume of sample running through per time can be adjusted by the user (generally in three steps 
between approx. 10µl / min until approx.120 µl/ min). The fluidic of most cell sorters is more 
variable and allows adjustments of speed and flow-through volumes at various steps (both on 
the sample and instrument side). In most cell sorting experiments there is a demand/ necessity 
to maximize both the yield and purity of the sorted cells and minimize the time you need to run 
your cells through a machine. Yield and purity influence each other and are both dependent on 
the speed (cells running through a sorter per second) and the frequency of cells of interest (see 
Chapter V, Section 6). Unfortunately they cannot be maximized both at the same time. The less 
abundant a cell population is, the lower the speed of acquisition/sorting has to be, in order to 
ensure a high yield/ outcome with an acceptable purity (> 95%). If you speed up, (increase the 
number of cells running through the machine per time) your yield will drop significantly (up to 
50% in some cases) or alternatively, the purity is sacrificed for a higher yield obtained in a 
shorter period of time. Therefore sorting 1000 rare cells with high purity could last twice as long 
as the acquisition only (the relation between speed, frequency of cells, yield and purity are 
discussed in more detail in Chapter V, Section 6). This crude calculation only accounts for the 
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time needed for acquisition and cell sorting; not counted is the time already invested in preparing 
and staining the cells (see e.g. Chapter IV Section 3).  
Given that flow cytometry as a method allows the identification and quantification of 
single/individual cells within a given population and given that in flow cytometry cell sorting this 
decision takes even more time, thereby slowing down the process, it is obvious that 
enumeration/evaluation of every single event especially of samples with large cell numbers prior 
to sorting is not a practicable way to go about analysis of rare cell populations. How then can we 
achieve acceptable work times and make it possible to analyze those rare cell populations? 
We need to reduce the workload – in this case, meaning the amount of cells that need to be 
counted/ measured in the flow cytometer.  One way to overcome this situation is to get rid of as 
many “unwanted” cells as possible prior to acquisition, in the form of pre-enrichment. Cells can 
be separated from each other in many different ways and some methods of pre-enriching rare(r) 
cells before flow cytometric analysis are discussed in this chapter. 
 
4.2 Pre-enrichment by physical properties 
Physical properties of cells may be exploited to enrich them. For instance, monocytes, 
macrophages and dendritic cells within a mixed cellular population adhere to plastic and are in 
general adherent within the first 2 hours of being incubated on a petri dish. Cells other than 
macrophages and dendritic cells can be removed and washed off with the supernatant. After 
longer incubation periods (approx. 20 hours), dendritic cells start detaching from the plastic 
again. With this method, an enrichment of up to 70 % could be reached. This method is used in 
the process of generating and isolating dendritic cells out of monocytes and macrophages 
derived from blood or bone marrow [1,2]. 
Another simple method to eliminate unwanted cytometry events is the lysis of red blood cells 
(see also chapter II, section 1.5), which are a common “contaminating element” in tissue 
preparations. In contrast to nucleated cells, erythrocytes burst upon brief exposure (≤ 60 
seconds) to a hypotonic medium (erythrocyte lysis buffer: 155 mM NH4Cl; 10 mM KHCO3; 100 
mM EDTA) . Remember that human and mouse erythrocytes differ in size and ability to resist 
hypotonic shock over time. Various buffers and protocols are available, which differ in 
temperature and exposure time, affecting lysis outcome. It is therefore necessary to adapt the 
lysing protocol to the experimental conditions [3].   
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Peripheral blood mononuclear cells (PBMCs) can be enriched by density gradient centrifugation 
using Ficoll® . This biological inert polysaccharide allows the separation of PBMCs from plasma, 
granulocytes and erythrocytes based on their cellular density (Figure 1) (see also Chapter II, 
Section 1: Parallel cell sorting: 1.3.1 Ficoll-Paque™, Lymphoprep™” 
While many users report a lower recovery (up to 10-15%) in the absolute numbers of target cells 
after density gradient centrifugation, they profit from faster operational times in downstream 
assays and lowered costs, because fewer (staining) reagents in less buffer are needed for the 
significantly reduced total cell numbers. In functional assays, e.g. antigen presentation or 
proliferation assays and transplantation (e.g. hematopoietic stem cell transplantation to 
reconstitute bone marrow and blood formation in irradiated mice), a higher cell viability and 
reconstitution frequency is reported when Ficoll-enriched cells were used, as compared to 
preparations without pre-enrichment via density gradients.   
Elutriation [4-6] is another method of separating cells based on their size, which uses centrifugal 
forces. The technique is also called counter flow centrifugation and makes use of a modified 
elutriator rotor containing a separation chamber with which one can gently separate a large 
variety of cells from different tissues and specimens. The cells are separated in this chamber 
mainly based on their different sizes by the opposing action of the centrifugal field generated by 
the rotation of the rotor and the liquid flow inside the chamber (Figure 2; centripetal, means in 
direction to the rotor axis (counter flow)).  Because the separation is not dependent on a specific 
density gradient, this method is compatible with a wide set of media. Another big advantage is 
high viability and low activation of the cells of interest [7]. 
 
4.3 Pre-enrichment by immunological properties 
Although pre-enrichment methods based on physical properties (such as size, density etc.) are 
straightforward, they do not allow for functional or biological discrimination of sub-populations, 
e.g. discrimination between T lymphocytes and B lymphocytes. To do so, immunological 
separation methods, which make use of antibodies to reach the specificity and cell population of 
interest, could be used.  
One of the first methods established (in the early 1970s) is antibody-mediated complement lysis 
of unwanted cells. The cells (e.g. erythrocytes or T cells in a mixed lymphocyte pool) that you 
want to eliminate are detected and opsonized with specific antibodies (at the beginning serum 
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from immunized animals were used, nowadays one can use also monoclonal antibodies against 
the antigen of interest). Soluble parts from the complement C system are added to the cell 
suspension, bind to the antibody-tagged cells and lyse them [8,9].  This method is mentioned 
only to complete the overview of pre-enrichment possibilities because, in the meantime, a variety 
of easier and more efficient techniques have become available. These techniques combine the 
advantages of beads and antibodies. 
To enrich or deplete subpopulations out of a heterogeneous cell population, one can use beads 
coupled with monoclonal antibodies against antigens expressed on the cells of interest that bind 
to the antigens forming larger aggregates. These cell-bead-aggregates can now be easily 
separated from the unbound cells in the solution by passing the bead/cell-mixture over a mesh 
(Figure 3).  Cells that are bound to beads would not pass through the mesh, and are thus 
enriched on the mesh surface, whereas all other cells are smaller than the mesh-size and flow 
through. After filtration through the mesh, the antibody-coupled beads can be detached from the 
cells to allow the cells to be further analyzed. Using varying sizes of mesh and beads make 
sequential separations possible. For example, the pluriBead® technology allows cell enrichment 
as well as depletion of specific subpopulations [10]. 
The most commonly used methods for pre-enrichment of subpopulations are based on beads 
passing a magnetic field. A variety of companies offer different solutions for enrichment or 
depletion of cell populations.  One system of immunological pre-enrichment employing magnetic 
fields is the MACS® Bead-Technology [11]. As described above for mesh-filtration based 
enrichment, the concept is based on the attachment of small, inert, supra-magnetic particles to 
monoclonal antibodies specific for antigens on the target cell population. Cells labelled to these 
antibody-bead conjugates are then separated via a column containing a ferromagnetic matrix. 
By applying a magnetic field to the matrix, the beads stick to the matrix inside the column and 
the bead-carrying cells are held back from passing through. Unlabelled cells can pass through 
the matrix and are collected in the flow-through. To elute the trapped cells from the column, the 
magnetic field is simply removed. The MACS technology therefore enables different strategies 
for positive enrichment or depletion of cells. MACS® beads are very small and offer the 
advantage of not interfering with downstream assays such as fluorescence staining and cell 
sorting. In contrast to cell sorting, up-scaling the cell numbers doesn´t significantly increase 
processing times. For some cell types (e.g. CD4+ T cells or B cells), a high enough purity can be 
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achieved such that further enrichment is not necessary (of course this is dependent on the 
quality needed for the downstream assay e.g. RNA/ DNA purification) (Figures 4 and 5). 
Solutions using magnetic beads other than MACS beads are also available for cell separation 
(e.g. Dynal®-Beads [12] or BD iMagTM [13]). The beads in these kits are generally larger than the 
MACS® beads and do not require a separate matrix to retain the cells in the magnetic field. The 
disadvantage of using these systems is that, for many downstream assays, it is necessary to 
detach the beads from the cells to avoid interference with the system.  
To pre-enrich your cells you can choose a protocol from a variety of different techniques, which 
separate your cells based on their physical and/ or immunological properties. Pre-enrichment 
could be useful to cut down the processing time of your experiment, increase the quality of 
downstream assays or to reduce the amount of reagents needed. 
 
Figure 1: Schemata of density gradient centrifugation with Ficoll® as pre-enrichment 
The distribution of different cell types such as mononuclear cells, granulocytes and erythrocytes 
after the separation through the Ficoll® density gradient is shown. 
 
Figure 2 
Cells from different sources and with different sizes can be concentrated in a centrifuge 
containing an elutriation chamber. Without centrifugal force, the cells would just pass through 
(a). If you apply a centrifugal force cells of a particular size and density will start concentrating in 
the chamber. The equilibrium inside the chamber will be formed, dependent on the speed of the 
cellular flow, the amount of applied centrifugal force and the viscosity of the used medium (b). 
This is the reason why Elutriation is compatible with a wide range of cell types and carrier media. 
 
Figure 3 
Unlabelled cells will pass the mesh without any (enrichment) effect (a). If you add beads, which 
are coated with specific antibodies against your target cells (black) to the cell suspension, the 
target cells will form aggregates with the beads. These aggregates are hold back on the top of 
the mesh while the rest of the cell suspension is floating through (b). With this method one can 
either deplete or enrich for a specific cell population. Combining different mesh and bead sizes 
allow for a serial enrichment of target cells. 
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Figure 4: Examples for MACS®-enriched cell populations.  
Pooled mouse lymphocytes from the spleen and lymph nodes were positively enriched with 
CD25 MACS microbeads to isolate regulatory T cells (Tregs: CD4+CD25+FoxP3+). After the 
MACS-enrichment cells were stained for flow cytometry cell sortingand analysed on a flow 
cytometer. Compared to the non-enriched sample (upper panel), the target population of 
regulatory T cells is significantly increased in the MACS pre-enriched sample (lower panel) and 
can now be sorted on a flow cytometric cell sorter with higher sort efficiency (higher yield) in a 
shorter period of time. The gating strategy is shown in Figure 5 (a). Human peripheral blood 
lymphocytes were enriched for B cells with CD19 MACS microbeads. After the enrichment, the 
lymphocytes were stained with antibodies against CD45 and CD19 and analysed in a flow 
cytometer. In the MACS-enriched sample, the B cell population is already highly enriched (purity 
> 95%). For many downstream applications (e.g. functional assays), this purity might already be 
high enough (b). (Data kindly provided by Dr. Michael Delacher, DKFZ). 
 
Figure 5 
Lymphocytes from spleen and lymph nodes were pooled and stained for regulatory T cell 
identification (CD3, CD4, CD8, CD25 and FoxP3). One part of the sample was measured before 
(left column), the second part of the sample was analysed after a positive MACS enrichment for 
CD25 (right column). The first gate was set on FSC/ SSC to include the lymphocyte population 
(a). Based on the lymphocyte gate doublet exclusion on FSC-H vs FSC-W was done (b). From 
the single cells the dead cells were excluded (c). T cells were divided by gating on CD4 or CD8 
(d). Out of the CD4+-subpopulation the regulatory T cells (CD25+FoxP3+) were sorted (Figure 
2a).   
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Section 5 – Frozen Samples and Cell Viability 
 
5.1 Freezing Cell Samples  
The freezing of cell samples offers the advantage of being able to perform studies over large 
periods of time, or manage epidemiological studies with many patients and/or healthy donors. 
Freezing cells allow them to be stored with suspended metabolism. In this way the cells are 
protected from self-destruction by chemical reactivity. Cells are further protected against genetic 
drift of cell lines, and transformation and differentiation. 
Freezing cellular samples also facilitates the logistics of measurement, such as when only a few 
samples per day are to be analyzed. The collective samples can be stored and measured at a 
single time point, and at an instrument setting which does not need to be reproduced for several 
experimental measurements. This keeps the operating time and costs down, enabling long-term 
and large studies.  
However, even if precautions are taken, it has to be considered that frozen samples never have 
exactly the same status (immunological, viability, culturability or other) as fresh cells or tissue. 
This is one of the main obstacles which should be accounted for if frozen samples are used, in 
particular if data from these samples are to be compared against those of fresh cells. 
To keep the cells alive as much as possible, cryoprotective solutions should be added to the 
cells before freezing. Dimethyl sulfoxide (DMSO) is a commonly-used solution. A concentration 
of around 5% in an appropriate medium gives in many cases a high degree of viability after 
storage.  
One technical point to consider is that the best recovery is achieved with a gradual freezing 
process, i.e. lowering the temperature of the cells by 1° to 2°C per minute. This procedure is 
intentionally slow in order to prevent cells from being ruptured by the formation of ice crystals. A 
solution with a high concentration of DMSO (up to 10%) allows faster freezing. A 10% DMSO 
freezing solution has been tested to give more than 85% post-thaw viability, with some variability 
between different types of leukemia. Automatic freezing techniques using temperature-controlled 
setups have been developed for the routine cytometry laboratory. In these systems, the cell 
samples are slowly moved down a tank of liquid nitrogen by a motor-driven spindle. 
Commercially available cell freezers are the most suitable appliances for this process. However, 
manual methods have been widely reported to give sufficient results. 
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The thawing process is as important as the freezing one, and it has to be done very rapidly. 
Active thawing is preferential to passive one. Cell samples from different sources can behave 
variably after thawing. To give an example, Alsayed et al. [1] reported that cells from a myeloid 
leukemia sample had better recovery than cells from a lymphoid leukemia sample. In the clinical 
laboratory, immunophenotyping is an important and frequently used method in risk assessment 
and post therapy follow-up. In general, to ensure reliable results, a high degree of 
standardization is required. Post-thaw viability tests should be performed to determine the 
fraction of cells that are alive.  
 
5.2 Testing for cell viability 
The “gold standard” of viability determination is the Trypan blue staining technique, which is 
carried out with a hemocytometer under a conventional microscope by visual inspection. Using 
flow cytometry, however, to determine the viability of a cellular sample, either for fresh cells or 
cells that have been thawed from frozen storage, allows the analysis of a variety of viability 
parameters at the same time. In flow cytometry, different parameters related to cell viability can 
be evaluated, such as cell morphology and cellular fluorescence due to dye exclusion or 
retention. The influx of fluorescent dyes, which should be non-permeable to the vital cell, is a 
good indicator and comparable to the Trypan blue technique. The Trypan blue test can also be 
performed by flow cytometry, if absorption can be measured as a parameter. As an 
approximation for this, forward light scatter determination can be used. 
If the dye influx into cells is used as an indicator for cell death, intercalating DNA dyes are used, 
which bind to the DNA in the nucleus; any non-viable cell is then measured with high 
fluorescence, in contrast to the non-fluorescing, viable cells. Dyes such as ethidium bromide, 
propidium iodide or 7-aminoactinomycin D (7AAD) are typical examples of intercalating dyes 
commonly used in flow cytometry. An extensive overview of life/dead cell discrimination based 
on dye exclusion can be found in Johnson et al. [2].   
 
Alternatively, dyes with very different absorption and/or fluorescence wavelengths are available, 
which allow for the combined evaluation of the live/dead cell distinction and the determination of 
other parameters at the same time. Broadly known is the use of such dyes in combination with 
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Annexin V apoptosis measurement in order to find out the percentage of late apoptosis and 
necrosis in the cell population.  
 
Dye retention can also be used to measure viability, such as by the use of supravital dyes, which 
are nonfluorescent molecules in an extracellular state, but once permeated through the 
membrane, are transformed to a fluorescent state by esterases inside the cell.  An example of 
such a supravital dye is fluorescein-diacetate (FDA), which is enzymatically processed inside the 
living cell to the fluorescing compound fluorescein. All viable cells subsequently fluoresce green 
and can be measured by flow cytometry. 
Amino-reactive dyes can be used for identifying dead cells in samples which will be fixed later. 
These dyes stain cells irreversibly by fixation Perfetto et al.[3]. This allows the identification even 
after fixation.  
All the different protocols for viability testing can be tested against each other and, in general, 
they give comparable results.  Many of the protocols are very old and have been used for 30 or 
more years. Here the work of Combrier et al. [4] has to be mentioned, which compares the many 
different procedures and different cell types. The authors prove that there are no significant 
differences between the various staining and treatment protocols in the accuracy by which 
viability is measured.  
As an alternative, if no staining protocol for cellular viability is appropriate for the experimental 
design, the combination of forward and sideward scatter provides a tool, which although not as 
precise as the fluorescence methods or Trypan blue, still gives valuable results in many assays. 
If cells die or the membrane undergoes permeabilization, a change in their light scatter 
characteristics is observed. It results in a reduction of forward scatter signals as well as in an 
increase in side scatter signals. However, the exact shape of the scatter populations may differ 
from cytometer to cytometer depending on the optical design of each instrument. Apoptotic or 
dying cells can therefore be identified without any staining by FSC and SSC parameters only. 
Reardon et al. [5] describe extensively the application of light scatter versus fluorescence 
methods after cell freezing. 
The application of a viability test to cells may itself cause a loss in cell viability, if perhaps the 
dye used in the experiment is toxic. It may in certain situations even cause apoptosis or severe 
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damage.It is important to mention that cell viability as determined in any protocol is not a 
guarantee that the cell will survive further culture. One can think of very many conditions in 
which a cell is detected as being viable but cannot be cultured and does not grow. In particular, 
in microbiological work the fraction of viable but non-culturable bacteria can be extremely large.  
The combination of different assays can help to define the true vitality of the sample.  
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Section 6: Cell fixation and permeabilization for flow cytometric analyses 
 
6.1 Introduction 
The analysis of intracellular targets using flow cytometry (intracellular cytometry) presents a 
number of technical challenges that are not generally encountered in the measurement of cell 
surface epitopes, or in the measurement of dye uptake/processing (e.g. Calcein AM) in viable 
cells. In general, cells (in suspension) must be first “fixed” to preserve and maintain both the 
structure and location of target epitopes, then “permeabilized” to allow probe (e.g. antibodies) 
access - ideally to all cellular compartments (cytoplasm, mitochondria, ribosomes, nucleus, 
etc.). 
In general, cell fixation is accomplished by the use of either crosslinking fixatives (e.g. 
formaldehyde, glutaraldehyde), or low molecular weight alcohols (methanol, ethanol), which 
generally act to “coagulate” proteins. Formaldehyde has the advantage of generally maintaining 
the overall conformation of the native protein. However, since formaldehyde generates multiple 
reactive sites on peptides, polysaccharides, and lipids, crosslinking can hide or sequester 
epitopes such that they are not freely accessible to antibody probes after fixation. An additional 
benefit of formaldehyde fixation in the study of post-translational protein modifications (e.g., 
phosphorylation, methylation, acetylation, ubiquination, etc.) is that formaldehyde appears to 
both “fix” the modification of target amino acids (serine, threonine, tyrosine), and also inhibits 
the degradation of these targets in living cells (e.g. phosphatase removal of phosphorylations, 
demethylase removal of methylations, etc.). In contrast, alcohol fixation generally results in poor 
detection of some (phospho-, and potentially other protein) modifications. 
 
6.2 Fixation of whole blood specimens 
Studies in the field of immunology frequently utilize peripheral blood, lymph node, or bone 
marrow cells, often with a preliminary purification step (Ficoll-Hypaque, hypotonic lysis, 
ammonium chloride) to remove red blood cells. In addition, preliminary purification techniques 
can remove potential target cell populations (e.g., loss of blasts using Ficoll-Hypaque). In this 
section, we will first cover fixation and permeabilization techniques for samples containing red 
blood cells, and subsequently cover fixation and permeabilization techniques for isolated cell 
populations (tissue culture cells, isolated lymphocytes, monocytes, etc.) 
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Following fixation, cell permeabilization is performed in order to gain access to the cell interior. 
This can be accomplished using either detergents (e.g. Triton X-100, NP-40/IGEPAL CA-630) or 
saponifiers (e.g. Saponin), or with low molecular weight alcohols (methanol or ethanol). A 
complete discussion of the advantages and disadvantages of different approaches/reagents is 
beyond the scope of this guideline, but please see also Chapter VII, Section 15, Transcription 
Factors. Here, we focus on a fixation and permeabilization technique developed for use with 
clinical samples (whole blood, bone marrow) [1]. We set out to develop a technique that would 
allow the direct addition of fixative to clinical samples (to immediately “fix” phospho-epitopes and 
prevent dissociation of signaling inhibitors out of cells, which can result in rapid reversal of their 
inhibition). However, the addition of fixative directly to whole blood presented the problem of 
how to remove RBCs after fixation. We discovered that the addition of Triton X-100 at the 
appropriate concentration and time directly to the sample (still containing formaldehyde) 
achieved RBC lysis and WBC fixation without any significant loss of WBC populations. As a 
cautionary note, it is important that the incubation times are strictly followed. 
As shown in Figure 1, whole blood from a healthy human was fixed using the 
formaldehyde/Triton X-100 technique shows three major populations using FSC vs SSC (lower 
panel). Here, the location of the monocyte population (blue) is determined using CD14. The 
separation of lymphocytes from monocytes by light scatter alone is sufficient to identify both 
populations; and as shown in the figure, the use of CD14 provides a good resolution of these 
cell types. The resolution of lymphocytes from cellular debris using light scatter alone, however, 
is problematic. The lysis of RBCs generates a significant amount of debris which overlaps with 
lymphocytes in light scatter measurement. However, as shown in Figure 1 (top panel), staining 
the sample with CD45 allows clear resolution of CD45-positive/negative lymphocytes from 
CD45-positive/negative debris. The data shown here were generated after a single wash 
following the RBC lysis step. Use of additional washes at this point reduces debris significantly 
for most samples. 
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6.3 Materials 
6.3.1 Staining whole human blood 
1. Fresh human whole blood (5-10 ml) collected in anticoagulant (K2EDTA or sodium 
heparin). 
2. Formaldehyde, 10% (methanol-free). Store at room temperature in the dark. Use within 
6 months 
3. Triton X-100 detergent (e.g. Surfact-Amps™ X-100, Thermo Fisher). Prepare working 
solution by diluting 116 µl 10% aqueous Triton X-100 solution with 10 ml 1X PBS. Store 
stock and working solutions at room temperature. Working solution is stable for one 
month 
4. PBS – Phosphate Buffered Saline, calcium- and magnesium-free, pH 7.4 
5. Wash buffer – PBS/5% Bovine Serum Albumin (preferably protease-free BSA if also 
using for antibody dilutions) 
6. Methanol – 100% reagent grade, dilute to 50% or 80% with NaCl (final concentration 
0.9%), store at -20°C; use at 4°C) 
6.3.2 Procedure - Whole blood fixation and permeabilization 
1. Place anticoagulated whole blood sample into 37°C and allow temperature to equilibrate. 
2. For 100 µl whole blood sample, add 65 µl 10% formaldehyde, and  immediately vortex. 
Incubate at room temperature (~24°C) for exactly 10 minutes. 
3. After exactly 10-minutes of incubation in formaldehyde at room temperature, add 1 ml of 
room temperature Triton working solution, vortex and place in 37oC bath and set timer 
for 15 minutes. 
4. Add 1 ml of cold (4°C) wash buffer and vortex. Centrifuge at 500 X g for 4 minutes.   
5. Inspect tube for complete RBC lysis (rust red pellet, clear red supernatant – not turbid). If 
RBC lysis is incomplete, resuspend pellet in 1 ml Triton working solution at 37°C for an 
additional 15 minutes. 
6. Remove supernatant, and wash pellet 3X using cold wash buffer (centrifuge at 500 X g). 
7. For methanol treatment, slowly add 1 ml 4°C methanol solution (50% or 80% depending 
on target epitope) while vortexing pellet. Incubate in ice for 10 minutes. 
8. Centrifuge (500 X g) and wash pellet 2X using 2 ml cold wash buffer. 
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9. After final centrifugation, carefully remove as much supernatant fluid as possible. 
Resuspend pellet by vortexing. Add antibody cocktail, incubate and wash 2X with cold 
wash buffer. 
10. Resuspend cell pellet in 0.5 ml wash buffer and analyze immediately on flow cytometer. 
For intracellular epitopes that degrade, or for samples that need to be analyzed more 
than 6 hrs after resuspension, resuspend in 0.1% paraformaldehyde in PBS. Store at 
4°C in the dark until analysis.  
6.4 Effect of methanol on epitope staining 
Some intracellular or intranuclear epitopes remain poorly accessible to antibody probes after 
fixation and permeabilization using the formaldehyde–Triton technique described above. This is 
likely a limitation of all similar aldehyde-detergent (only) fixation and permeabilization 
techniques. In our experience, phospho-STAT proteins are largely undetected after this type of 
processing. However, treatment of the fixed and permeabilized cells with cold (4°C) methanol 
for 5-10 min “unmasks” these epitopes [1]. As shown in Figure 2, treatment of fixed and 
permeabilized whole blood (activated using GM-CSF) with up to 50% cold methanol has 
minimal impact on the quality of P-STAT5 staining (same signal intensity for 50% methanol or 
untreated sample, not shown). However, treatment with 80% cold methanol produces a 
significantly stronger P-STAT5 signal. The impact of treatment with methanol at both 50% (left) 
and 80% (right) concentrations on P-ERK and P-S6 staining (ribosomal S6 protein) is also 
shown in Figure 2. Here, methanol treatment has minimal effect on the P-ERK signal intensity 
and reduces the P-S6 signal by about 20%. It is therefore important, when first developing and 
optimizing fixation and permeabilization for new cytoplasmic epitopes, to determine the impact 
of methanol treatment on all target epitopes that will be measured in the assay. 
While methanol “unmasking” is important for the evaluation of some phospho-epitopes, it also 
has the effect of decreasing (or eliminating) the immunoreactivity of other important epitopes 
used to detect specific cell populations. In our experience, this is of particular importance in the 
analysis of some myeloid-monocyte markers in human blood or bone marrow (CD14, CD33, 
CD64), and of less importance for stem-cell or progenitor cell markers (CD34, CD117). Please 
see [3 and 4] for details regarding cell surface CD markers which we have tested, which are 
effected by methanol treatment. 
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In the example illustrated in Figure 3, we have compared the signal strength obtained when 
staining whole blood CD14-positive monocytes using either 50% or 80% cold methanol. In 
addition, in this study cell surface CD14 was stained either before fixation and permeabilization 
(and prior to cold methanol treatment), or after fixation, permeabilization and cold methanol 
treatment. Looking at the impact of 50% methanol treatment (upper panels), comparing the 
CD14 fluorescence intensity for monocytes labelled before or after fix-perm and methanol, the 
mean fluorescence intensities (MFIs) are very similar for cells labelled before or after fixation 
and subsequent treatment. In contrast, when considering the impact of pre-or post-fixation 
staining as shown in the lower panels, cells labelled with CD14 after fix-perm and 80% methanol 
(lower right panel) show a significant reduction in CD14 staining intensity (compared with that of 
cells stained after 50% cold methanol, top right). While cells stained with CD14 mAb before fix–
perm and 80% cold methanol treatment (bottom left) show a 4-fold higher MFI than cells stained 
after, they still show a 50-60% loss in CD14 staining intensity (relative to unfixed whole blood). 
Together, these data support the concept that the CD14 epitope detected by the antibody used 
here (BCI clone RMO52) is not affected significantly by treatment with 50% cold methanol, but 
is affected following 80% cold methanol. In addition, these data show that the antibody-
conjugate is also impacted by 80% cold methanol (MFI is lower for cells stained following fix-
perm and 80% methanol treatment). These data should reinforce the concept that all of the 
details of fixation-permeabilization and methanol treatment need to be validated for the 
complete set of antibody conjugates used for a new experiment. For more information regarding 
the use of pre- or post-staining peripheral blood in relation to intracellular and CD epitopes, see 
[2]. This technique [2] has been utilized to stain both cell surface and intracellular epitopes for 
the analysis of MAP Kinase, STAT, and ribosomal S6 signal transduction pathways in human 
bone marrow samples [3, 4]. 
6.5 Fixation and permeabilization for Non-Adherent Tissue Culture Cell preparations. 
Routine fixation and permeabilization of tissue culture cells (anchorage-independent cell lines) 
is accomplished using formaldehyde fixation followed by permeabilization of cytoplasmic and 
nuclear membranes using absolute methanol. Although we routinely stain both cell surface and 
cytoplasmic or nuclear epitopes simultaneously, it is also possible to stain cell surface epitopes 
with some antibody conjugates prior to fixation and permeabilization [2]. This approach is 
particularly useful for cell surface markers which  are altered (e.g. CD19) or destroyed (e.g. 
CD14, 15, 64,) by fixation or alcohol treatment.  
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6.5.1 Determining Optimal Formaldehyde Fixative Concentration 
Optimal detection of phospho-epitopes appears to be influenced by the formaldehyde 
concentration used to fix different types of cells. As shown in Figure 4, P-STAT5 in K562 
cells is optimally detected following treatment with 0.05 to ~0.4% formaldehyde (37°C for 10 
minutes). Since the degree of potential epitope cross-linking/fixation is proportional to the 
formaldehyde concentration, incubation time, and temperature, all three of these variables 
should be controlled and performed identically each time. As shown in Figure 4, at higher 
final formaldehyde concentrations, the P-STAT5 signal decreases, likely from over-fixation, 
and limitation of phospho-epitope accessibility by antibody conjugates [5]. As also shown in 
this figure, treatment with absolute methanol alone (no formaldehyde: first data point) results 
in a background level of signal. 
 
6.5.2 Routine fixation, permeabilization and antibody staining for non-adherent cultured cell 
preparations: 
For fixation and permeabilization of non-adherent tissue culture cells, we add the optimal 
formaldehyde concentration (section 6.5.1, above) directly to sub-confluent cells (ideally re-
fed 12-24 hours prior to harvest) in tissue culture media (routinely containing 15-20% FBS), 
and return cells to the 37°C tissue culture incubator for 10 minutes. Cells are then 
centrifuged (400 X g for 10 min), and resuspended using a vortex mixer (note – cells are 
clumped at this point and require vigorous treatment with vortex to achieve resuspension of 
all cells). While vortexing, absolute methanol (stored at minus 20°C) is added with ~ 1 ml 
absolute methanol per 107 cells being added. At this point, the cells can be stored in a well-
sealed container at minus 20°C for several weeks with no significant decrease in the 
detection of phospho-epitopes (epitopes tested thus far).  
For staining of intracellular epitopes, place 3–5 X 106 cells into each tube (we routinely 
perform staining of tissue culture cells in 1.2 ml microfuge tubes). Centrifuge tubes (for 
refrigerated microfuge, use 10,000 RPM for 12 seconds), carefully aspirate off supernatant, 
and resuspend the cell pellet in 1.0 ml cold (4°C) wash buffer (Dulbecco’s PBS/5% FCS or 
Dulbecco’s PBS/5% protease-free BSA) while vortexing. Place tube on ice for 5 min to allow 
buffer to equilibrate and remove residual alcohol. Centrifuge as above. Repeat wash twice 
with cold wash buffer. 
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Carefully remove supernatant following the last centrifugation step, and resuspend cells in 
100 µl of antibody conjugate (or antibody conjugate mixture). It is important that each 
antibody used is titrated to ensure optimal signal:noise ratio. Incubate cells with antibody (or 
antibodies) on ice (4°C) in the dark (if using photosensitive conjugates) for 30 minutes. 
Resuspend cells in 0.5 ml cold wash buffer for flow cytometry analysis (if cells are to be 
analyzed within 1-2 hours). If cells will not be analyzed within 1-2 hours, centrifuge washed 
cells, and resuspend the cell pellet in cold PBS/0.1% paraformaldehyde. Cells post-fixed in 
0.1% paraformaldehyde and stored at 4°C (dark) are stable (light scatter and phospho-
epitope detection) for at least 24 hours. It should be noted that the signal intensity of some 
phospho-epitopes start to decrease significantly within minutes of the final resuspension in 
cold wash buffer (e.g. P-S6). For these epitopes, it is strongly recommended to immediately 
place the cells in PBS/0.1% formaldehyde, which significantly decreases the rate of signal 
loss. 
 
Figure 1. Human whole blood fixed with formaldehyde and permeabilized with TX-100. White 
blood cell populations were identified using CD14-PE-Cy7 and CD45-Krome Orange. Debris 
(red) is identified using CD45 vs SS (top panel). Identification of peripheral blood monocytes 
(shown in blue in both panels) was accomplished using CD-14-PE-Cy7 (not shown). 
Figure 2. Impact of methanol concentration on P-STAT5 immunoreactivity in peripheral blood 
monocytes activated in vitro using GM-CSF. Whole blood from a normal donor was treated with 
GM-CSF for up to 20 min in vitro at 37° C. One part of the fixed and permeabilized samples was 
treated with 50% methanol (top panel) and the other with 80% methanol (bottom panel) at 4° C. 
After washing, all samples were stained with (- - -) P-STAT5, (_□_) P-ERK, and (_Δ_) P-S6. 
Figure 3. Effect of methanol treatment on CD14 staining of human peripheral blood monocytes. 
Whole blood samples from one individual were stained with CD-14-PE-Cy7 before (left panels) 
or after (right panels) fixation and permeabilization. Samples were treated with either 50% (top 
panels) or 80% (lower panels) methanol. See text for details. 
Figure 4. Effect of formaldehyde concentration on P-STAT5 immunoreactivity in K562 cells 
(from reference 5, used with permission). Cells were fixed at 37°C for 10 minutes using 
increasing final concentrations of formaldehyde, permeabilized and stained with anti-P-STAT5-
PE as described. 
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Section 7 - Barcoding in cytometric assays 
 
Sample barcoding denotes a procedure in which distinct cell samples are stained with unique 
labels, pooled, and then further processed and acquired as a mixture of samples, often referred 
to as ‘sample convolute’. After acquisition of the convolute, data of the original samples are 
recovered by resolving the label signature used for sample tagging (Figure 1). 
Barcoding allows for multiplexed analyses in flow and mass cytometry. Importantly, this 
contributes to harmonization of assay conditions, a reduction in the amount of wet work 
technical errors resulting from pipetting and staining variability in different assay tubes, and 
redcued reagent consumption, as compared with processes involved in preparing and acquiring 
multiple single samples. For example, fewer pipetting steps mean a smaller likelihood of 
erroneous pipetting, and since all samples are stained, washed, and optionally fixed and 
permeabilized in the very same sample, no sample-specific artefacts can arise from these 
procedures. This results in increased data consistency and robustness. After samples have 
been pooled, the assay is performed in a single vial, which reduces the complexity of sample 
preparation work and allows for sample acquisition with only a minimal need for manual 
interference. 
Compared to running multiple single samples, no cleaning cycles are necessary when acquiring 
one barcoded convolute, thereby reducing instrument run-time. Similarly, this practically 
excludes sample-to-sample carryover, which can occur during one-by-one sample acquisition 
by the cytometer.  
Barcoding of samples is particularly useful when high data consistency is required, e.g. when 
shifts in median signal are used as the assay readout, such as in the case of signaling 
(PhosphoFlow) assays. The reduction of unwanted noise in cytometric data by sample 
barcoding/pooling benefits the quality of results achieved with algorithmic data analyses, which 
require a high degree of technical data consistency [1].  
Cytometric sample barcoding was first developed as intracellular barcoding for phospho-flow 
applications [2], where small signal shifts needed to be compared. Barcoding was later similarly 
applied to mass cytometry [3], with two barcode staining intensity levels (on/off) for each 
channel. More recent efforts moved barcoding to earlier steps in the sample preparation 
protocol to extend the number of protocol steps that benefit from sample barcoding. Behbehani 
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et al. [4] introduced intracellular barcoding with only minimal permeabilization using 0.02% 
saponin buffer. Mei and colleagues and Lai et al. [5-7] used differently labeled CD45 Abs to 
achieve cell surface barcoding of PBMCs in mass cytometry [5-7], a concept that has been 
recently transferred to flow cytometry [8] using antibodies against murine CD4 and B220.  
While barcoding of samples has many benefits, it represents an additional step in the protocol, 
needs to be optimized on its own, and usually occupies cytometric channels which would be 
otherwise available to the measurement of target analytes. Preparation of larger barcoding 
reagent mixtures can be time-consuming and require a high degree of precision. For larger 
studies, and to avoid errors and variability in barcoding from experiment to experiment, one 
should consider automating the generation of barcode reagent mixtures, and/or to prepare them 
in batches that can be stored frozen or lyophilized. A drawback of using sample barcoding is 
that any issue associated with only one or a few samples in the convolute will not be discovered 
until deconvolution, such as the lack of cells in a sample, unexpectedly low cell number, high 
frequency of dead cells, excess presence of debris or contamination events such as 
erythrocytes in PBMCs. Additionally, any errors in barcoding will result in issues during 
deconvolution, which can lead to the loss of some or all data of the barcoded sample convolute. 
Principally, any number of samples greater than one can be processed as a convolute of 
barcoded samples. The sample accommodation capacity of a barcoding scheme is determined 
by the number of cytometric channels reserved for barcode markers and the number of different 
signal intensity levels per channel. 
Example barcoding schemes are summarized in Figure 2 The simplest approach is to label 
each sample by one unique marker (Figure 2A). Here, pooling of n samples requires n different 
markers/cytometric channels. By leveraging the capacity of some barcoding reagents to stain at 
different signal intensities when used at different dilutions in the assay [2], more samples can be 
barcoded using the same number of channels, multiplying the capacity by the number of 
intensity levels used (Figure 2B). This strategy is frequently used in flow cytometry but not 
routinely applied in mass cytometry. In combinatorial barcoding, samples are labelled by unique 
combinations of multiple markers rather than by a single marker (Figure 2C). In a scheme with 
two intensities per channel (i.e. “positive” and “negative”), the capacity of such a scheme is 2n. 
However, using the full combinatorial capacity entails certain limitations. Different barcode 
labels often compete for identical binding sites, leading to different barcode marker signal 
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intensities. For example, a sample marked by one label usually exhibits higher signal than 
another sample where that label is one of four different labels. In addition, non-homogeneous 
barcode labelling of a sample may limit or even entirely preclude the retrieval of the original 
sample cells from the barcoded convolute. Doublet events, containing differently barcoded cells 
(inter-sample doublets), can mimic cells of a third sample that carries the marker combination of 
the other two cells combined. This is especially relevant in mass cytometry, which lacks the light 
scatter parameters available in flow cytometry which are applicable for cell doublet removal. 
When occupying the full capacity of a combinatorial barcoding scheme, such issues can neither 
be reliably detected nor corrected. Mislabelled cells will be lost for analysis, and will contaminate 
another barcode/sample of the convolute. As a consequence, a restricted combinatorial scheme 
has been developed, in which only unique combinations, with equal numbers of barcode labels 
per sample are used [9]. This strategy allows for the detection of samples erroneously labelled 
by more or fewer of the fixed number of labels, thereby permitting exclusion of wrongly labelled 
cells, as well as virtually all inter-sample doublets [6, 9]. With identical numbers of barcoding 
channels, the capacity of restricted schemes is significantly lower, but this is justified by the 
removal of doublets, especially in mass cytometry. Technically, intra-sample doublets are not 
removed by barcoding. However, with increasing numbers of samples barcoded and pooled, the 
likelihood of cell doublets being inter-sample (removed in restricted barcoding schemes) 
increases relative to intra-sample doublets, and leads to indirect but significant reduction of 
intra-sample doublets [6]. The sample accommodation capacity of restricted barcoding schemes 
equals n!/(k!(n-k)!), with n being the number of barcode channels and k being the number of 
labels per sample [9]. Pascal’s triangle provides quick visual access to the sample capacity of 
restricted barcoding schemes (Figure 2D). 
The effort required to establish sample barcoding for flow or mass cytometry depends on the 
complexity of the desired scheme, and includes its development and validation. Development 
steps include the selection of the barcode scheme fitting the study’s needs, the barcoding 
reagent type (depending on sample type, aspired protocol coverage, and the available 
mass/flow cytometer in combination with available dyes or mass-tags), the titration of barcoding 
reagents and the optimization of labelling conditions, which is especially key when more than 
two signal intensity levels per cytometric channel are desired. Optimal reagent concentrations 
and labeling conditions need to be experimentally determined, using the type and number of 
target cells the barcoding is finally intended for. This is specifically important when using 
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intracellular, protein-reactive barcoding reagents, as these bind to proteins in a stoichiometric 
fashion, under commonly non-saturating conditions, so that fluctuations in cell numbers (or 
protein content and composition), buffer composition, incubation time and temperature can lead 
to differing barcode label staining intensities, which can complicate deconvolution of data. It is 
important to use protein-free media for covalent barcode labeling to avoid reaction of barcode 
reagents with buffer proteins instead of cellular proteins. 
CD45 antibody-based barcoding operates at ideally saturating conditions, which make the 
barcode staining more robust to small assay fluctuations, but leads to competition between 
CD45 conjugates for CD45 target epitopes in the case of combinatorial barcoding, causing a 
decrease in barcode staining intensity depending on how many different antibody conjugates 
are combined on the same cell sample. It is therefore essential to incubate cells with premixed 
cocktails of barcoding antibodies rather then adding barcoding reagents one by one to the cell 
suspension. Finally, cell washing conditions following the barcode labeling reaction prior to 
sample pooling have to be established. Careful washing of cells is required to minimize the 
carryover of barcode reagents into the sample pool (convolute). Remaining reagents 
can cause unwanted low-level labeling of all cells in the pool, which negatively impacts on 
cytometric resolution of barcode signals, thereby complicating deconvolution. More washing 
steps usually mean a better separation of barcode/labeled cells from unlabeled background but 
also cause greater cell loss due to removal of supernatant. In our hands, 3-5 washing cycles are 
usually sufficient to achieve a clean barcode staining pattern. As for covalent barcoding 
reagents, washing buffer should contain protein such as BSA or FCS which serves to catch 
unbound barcode reagents. The barcoding reaction typically lasts 10-15 minutes. 
Experiments such as the checkerboard test or the retrieval of sample-specific traits should be 
conducted, which address the reproducibility of results achieved by measuring the samples 
separately (without barcoding), [3, 5, 6, 9, 10] to establish and validate sample barcoding 
protocols. Analyses of unique sample characteristics, such as the known lack of a certain cell 
population within PBMCs in individual samples which are either run barcoded or separately 
must provide matching results. The checkerboard test is an extension of the above strategy 
which takes into account that many experiments involving sample barcoding are prepared in 
microtiter plates. When plotting data (e.g. cell frequencies or signal intensities) of samples with 
and without a known characteristic which have been plated in different orders, heatmap 
representations generate a characteristic checkerboard or similar pattern. It should also be 
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confirmed that barcoding does not introduce systematic error, e.g. by interfering with the binding 
of specific probes post-barcoding, or due to spill-over between barcode marker and analyte-
specific signals. Barcoded sample convolutes typically contain unusually large amounts of cells 
which mandates titration of the post-barcoding antibody staining cocktail on the same amount of 
cells. 
Original sample data can be extracted from barcoded, pooled samples by deconvolution 
through consecutive manual gating in standard flow cytometry software, by Boolean gating for 
combinatorically barcoded samples [6], or using scripts developed for that purpose. 
Debarcoding software can be developed in-house or retrieved from 
https://github.com/nolanlab/single-cell-debarcoder (accessed August 15 2016) [9]. The better 
the cytometric separation of the barcoded samples from each other, the better the recovery of 
original sample cells in the deconvolution. When different cell types in a given sample show 
heterogeneous barcoding marker staining intensity, resulting in suboptimal cytometric 
separation in the barcode channels, one should consider separating those first (e.g. by gating 
for lineage markers), and then deconvoluting the data of different cell types separately. 
Different barcoding reagents have been explored. Usually, sample barcoding is achieved by 
covalently labelling cellular proteins with dyes or mass tags via reactive thiols or primary amines 
[2, 3, 9, 11, 12], or by antibodies [5-7, 13]. In mass cytometry, lipid-reactive RuO4 and OsO4 
have also been demonstrated as applicable for barcoding [10].  
Covalent labelling is usually used for barcoding of fixed and permeabilized cells, giving the 
reagent access to the cell interior with many more binding sites than present on the cell surface. 
In principle, “fixable Live/Dead markers” should work well as intracellular sample barcoding 
labels. In flow cytometry, succinimidyl derivatives of fluorescent dyes such as PacificBlue, 
PacificOrange or Alexa dyes are frequently applied [2, 14-21]. In mass cytometry, thiol-reactive 
mDOTA loaded with lanthanide isotopes [3, 12], thiol-reactive BABE or amine-reactive 
isothiocyanobenzyl-EDTA loaded with palladium isotopes [9, 11, 22] have been used for 
intracellular barcoding. In mass cytometry, DNA intercalators (containing rhodium, iridium) are 
also candidates for intracellular barcode labels, as are cisplatins which are available in different 
formats holding isotopically-enriched platinums. Lipid-reactive RuO4 and OsO4 have also been 
suggested for intracellular as well as cell-surface barcoding [10]. For intracellular barcoding, 
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cells require fixation and at least “partial” permeabilization [11] prior to barcode labelling, which 
limits the benefits of barcoding to subsequent steps in the protocol.  
Sample barcoding by antibodies [5-7, 13] is implemented earlier in sample preparation 
protocols. Because of this, more protocol steps—including surface staining of live cells—are 
performed on the barcoded sample convolute, facilitating the staining of fixation-sensitive 
markers in barcoded samples [6]. When using antibody-based sample barcoding, choosing the 
right target is key. The selected antibody target should be stably and abundantly expressed by 
the cells of interest and should not be modified by the experimental conditions applied in the 
assay prior to sample barcoding. Since CD45 is expressed by all “normal” leukocytes, and 
particularly by lymphocytes and PBMCs at high levels, combinations of CD45-antibody 
conjugates have been used to barcode PBMCs in immune phenotyping experiments [6]. For 
other cell types, different antibodies targets might be more suitable. It should be kept in mind 
that antibody labelling of live cells can induce biological  functional response to antibody-based 
sample barcoding, barcode labelling can be applied to fixed cells, if target epitopes are fixation-
insensitive, which is the case for e.g. CD45 (Mei et al., unpublished observation).  
The decision regarding using cell-surface vs. intracellular barcoding is usually determined by the 
overall study outline and protocol. For complex immune phenotyping of live cells, cell-surface 
barcoding prior to fixation will be more suitable. Intracellular barcoding is often used in signalling 
studies in which cell activation is stopped by fixation, and therefore all cytometric stainings are 
performed post-fixation.  
Sample barcoding has been frequently applied not only to human and mouse primary 
leukocytes, PBMCs, and cell lines, but also to platelets [19] and erythrocytes [21]. The 
technique is often used in cell signaling analysis using flow and mass cytometry. Since the 
induction of phosphorylated states of intracellular signaling mediators is usually characterized 
by shifts in staining intensity/signal, which can be small and can therefore be affected by 
technical tube-to-tube variations, barcoding of sample aliquots that underwent different 
stimulation conditions and their pooling for joint acquisition and analysis is often employed to 
protect against such error and resulting misinterpretation. Fluorescent and/or mass-tag 
barcoding has been employed in B cell signaling studies [23] and various other cell signaling 
studies [16, 24], in the characterization of the effects of pharmacological inhibitors on primary 
mouse and human immune cell subsets [3, 15], in the mapping of myeloid cells in mice [22], in 
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stem cell research [25, 26] and also in clinical immune monitoring that revealed a cellular 
signature of better recovery after hip replacement surgery [27]. Mei and colleagues frequently 
employ sample barcoding in everyday mass cytometry work, such as antibody titration and 
reagent development [28], since it secures safe and unequivocal comparison 
of different experimental conditions and facilities the handling and data acquisition of large 
numbers of single assay tubes. 
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Figure legends 
 
Figure 1. Workflow of cell sample barcoding for flow and mass cytometry.  
(A) Schematic overview (B) Example of flow cytometric barcoding for a PhosphoFlow 
experiment. PBMC were stimulated in vitro with eight different stimuli or controls, fixed and 
permeabilized, and cells from each condition were barcoded using Alexa750 and/or 
PacificOrange succinimidyl esters. Following the barcoding reaction, single samples were 
washed and pooled and further stained for major lymphocyte lineage antigens such as for the 
detection of B cells, and for pSTAT1 expression, as a pooled sample. After selecting B cells by 
gating (not shown), the barcode is deconvoluted by gating in the two dimensions used for 
barcode labeling. The left plot depicts the barcode labeling of all cells in that pool. Eight major 
populations corresponding to different stimulation conditions can be discriminated (indicated by 
gating). Cells of a given single sample group together as a ‘population’ with homogeneous 
Alexa750 and PacificOrange labeling, respectively. Annotations indicate stimulation conditions 
applied prior to barcoding, as well as the frequencies of gated population. The similarity of these 
frequency values confirms that the pool contains similar amounts of cells from each barcoded 
condition. On the right side, the histogram overlay representation depicts pSTAT1 expression in 
the different stimulation conditions. pSTAT1 signal was induced in B cells treated with IFN-α and 
IFN-γ, but not or only minimally in the other conditions, which are visually indifferent in pSTAT1 
signal from the ‘unstimulated’ control. Data were made by Patty Lovelace, HIMC, Stanford.  
 
Figure 2. Barcoding schemes. (A-C) Schematic two-dimensional dot plot representations of 
(A) two samples, each barcoded by a unique single marker, (B) 12 samples barcoded by 
gradually increasing label signals (6 levels each) in 2 channels, or (C) 8 samples using a 
combinatorial barcoding scheme based on 3 intensity levels per channel. Colored 
circles/ellipses indicate different barcode-labelled samples, different colors indicate distinct 
cytometric signaling, color saturation depicts staining intensity. The open circle represents 
unstained cells, which can formally be assumed as a “label” itself, but tends strongly to 
accumulate insufficiently labelled cells of other samples and debris, and is therefore 
recommended not be to used for barcoding. (D) Pascal’s triangle can be used as a tool for the 
construction of restricted barcoding schemes. The line numbering indicates the number of 
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barcode channels, and the ordering of numbers in each line reflects the number of labels per 
sample, not counting the “1”. Different scenarios are indicated by the numbers highlighted. Four 
samples labelled by one marker each consumes four barcoding channels (red), dual barcode 
marker labelling in 6 channels (blue) can be used to barcode and pool 15 unique samples, and, 
in theory, 210 samples could be barcoded by quadruple combinations in 10 cytometric channels 
(green). 
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Section 8 - Key Concepts for the Design and Testing of Multicolor Panels 
Flow cytometers can now measure as many as 30 fluorescent parameters simultaneously, thanks 
to advances in hardware (which allow for more multiplexing, with less electronic noise) and 
reagents (including new dyes that rival or exceed the brightness of phycoerthrin and 
allophycocyanin) [1].  Still, the power of this single cell technology for revealing biological 
mechanisms will depend on the ability to build high quality, highly multiplexed antibody panels. 
 It is a common misconception that successful panel design requires limiting spectral 
overlap; this is not true.  In fact, high quality multi-color panels will usually include dyes that 
overlap.  The process of compensation subtracts this reliably - even for dyes that overlap a great 
deal such as Cy5.5-PE and Cy5-PE [2].  There is little reason, therefore, to be concerned with 
avoiding compensation in panel design; one must simply ensure that compensation controls are 
made correctly (as described as in Chapter III, Section 1 Compensation).  The success of panel 
design, instead, depends heavily on a phenomenon known as “spreading error (SE)” [2]. SE 
cannot be avoided; it is an intrinsic characteristic of flow cytometry measurements, which arises 
from the counting error associated with low photon numbers. Spreading can be summarised by the 
following key points: 
i) as the wavelength of the photon emitted increases, the flow cytometer’s ability to see it 
decreases 
ii) the photons in the far red end of the spectrum (600-800nm) have low energy and are 
not efficiently detected by the photomultiplier tube (PMT) i.e. many photons can hit the 
detector, but very few are turned into photo-electrons by the PMT meaning that more 
photons have to be counted to obtain a detectable signal 
iii) the spread associated error of measure increases as the number of photons to be 
counted for a detectable signal increases 
SE is not caused by compensation; it is instead revealed in compensated data as the effects 
of counting error are more easily observed at the low end of a log scale fluorescence plot.  When 
SE is very high in a particular channel, a dim marker cannot be resolved from background; it is 
masked by the spreading of the negative population (Figure 1).  Successful panel design involves 
managing this key consequence of SE.  As described below, SE is a unique product of the 
instrument and dyes used in an experiment; therefore, web-based panel building tools – which only 
consider spectral overlap and cannot account for SE on one’s own instrument – are of limited 
value. 
To manage SE, it is important to consider how it relates to photon detection.  This, in turn, is 
influenced by laser choice and power, dye brightness, and quality of photomultiplier tubes (PMTs).  
For example, PE and its tandems are more strongly excited by 532nm and 561nm lasers than a 
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488nm laser, resulting in greater photon emission, and lower SE into neighboring channels; higher 
power lasers often have the same effect [3].  In contrast, when photon release is relatively poor (as 
with the far-red dye Cy7-APC) there is greater counting error in neighboring channels, and 
spreading error may be high.  The brightness of a dye is influenced by many factors, including 
characteristics inherent to the fluorochrome (quantum yield) and those associated with individual 
instruments (e.g., lasers (as described above) or choice of optics).  Similarly, the performance of 
PMTs strongly influences SE.  Therefore, once laser choice and dye brightness are considered, 
panel design requires assessing performance of all PMTs by measuring sensitivity (the capability 
to detect dim signals above background noise, known as the B value), and resolution (the 
photoelectron detection efficiency, known as the Q value), as described elsewhere [4].  It is 
important to recognize that measurements of Q and B, and ultimately the success of panel design, 
is heavily dependent on proper setup and calibration of the instrument, in particular the appropriate 
choice of PMT gains. 
A simpler approach is available in FlowJo software (v9, Mac Platform).  For an existing (and 
working) multi-color panel, a spillover-spreading matrix (SSM) can be calculated from the 
Compensation Wizard window.  The SSM indicates the SE created by each dye (in rows) into each 
detector (in columns).  Where no working multi-color panels are available, antibody-capture beads 
can be singly stained with all the dyes/reagents of interest, and acquired on the cytometer.  These 
samples can be used for compensation in FlowJo and generation of the SSM  (SSM can also be 
calculated manually, by reconstructing the formulas described in [5]).  Notably, SSMs are 
normalized for marker expression; therefore, the SSM/SE information from one panel will be 
applicable to all possible panels on that instrument.  However, since PMT performance can differ 
dramatically within, and between, instruments, an SSM from one instrument is unlikely to be 
relevant for another, particularly if PMT performance has not been characterized on both 
instruments. 
The information described above—laser choice/power, dye brightness, quality of PMTs, and 
SSM—can then be integrated with information on protein expression; this allows careful, data-
driven, panel building.  First, consider markers that are difficult to measure because they are dim 
(for example, chemokine receptors (CCR2, CCR5), inhibitory molecules (LAG-3, TIM-3 or CTLA-
4), or transcription factors (Eomesodermin)), or markers that are expressed by rare populations, 
(like antigen-specific T cell receptors or proliferation markers (Ki-67) in ex vivo T cells).  These 
markers should go on channels with the highest performance: where dyes are optimally excited by 
their lasers, where fluorescence quantum yield is high, and/or where PMTs have high 
sensitivity/low background and high resolution.  A useful shortcut is to place dim markers on 
detectors with low total SE values (summed over all rows) in the SSM.  Bright markers can be 
placed on channels with lower performance – where dyes fluoresce weakly, or where B values are 
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high/Q is low.  Here, again, the SSM table provides a useful shortcut to complete characterization 
of dye and instrument performance: bright (on/off) markers can be placed on dyes that affect other 
channels minimally (as indicated by the sum of all columns for a particular row entry).  Markers that 
are never co-expressed by the same cell (e.g., CD3 and CD20) can be placed on detector/dye 
combinations in the SSM where SE values are particularly high.  Finally, in general, an SE value 
over 3–4 is dangerous for resolution of dim populations. 
As panels are designed, it is important to include a channel dedicated to the exclusion of dead 
cells; these can be identified with a variety of dyes.  For intracellular applications, live/dead fixable 
(amine-binding) dyes are particularly useful, and available with a variety of different excitation and 
emission profiles.  Dead cell exclusion is particularly critical in rare event analysis, where the non-
specific binding of antibodies to dead cells can dramatically elevate the proportion of cells positive 
for a given marker [6, 7].  Similarly, many fluorescent probes routinely used to measure the 
metabolic activity of the cell (such as those detecting ROS generation, mitochondrial membrane 
potential and others) require active metabolism, which is generally not functional in dead cells [8].  
Titration is also central to panel design.  In this procedure, the cells of interest are stained with 
two-fold serial dilutions of a reagent, under the same conditions (e.g. time and temperature) as the 
study will employ.  This approach identifies the optimal concentration for experiments, namely 
where the best signal-to-noise ratio is achieved.  Typically, this occurs at the point of saturation—
where increasing concentration of antibody no longer improves signal.  When using concentrations 
above this “saturating titer,” one runs the risk of high levels of non-specific antibody binding.  
Concentrations below the saturating titer may be used with care, provided population identification 
or quantitation is not affected.  These sub-saturating concentrations are particularly valuable for 
improving panel design, as the lower intensity signal induces less SE in other channels.  This 
strategy is most useful when the primary channel (stained at sub-saturating concentration) is bright 
and exhibits on/off expression patterns (like CD3), and when the secondary channel (receiving the 
spillover) must be used for detection of a dim antigen. 
Once the dye–marker combinations are chosen, dead cell markers are slotted in, and titration 
experiments have been performed, the panel can be tested.  Panel tests can be performed with an 
add-in approach, in which subsets of markers are stained together, analyzed and approved, and 
then additional markers are added in iteratively [9].  Alternatively, researchers may wish to try the 
entire panel at once.  When using this approach, it may be valuable to include fluorescence minus 
one (FMO) controls for any dim markers or channels with high SE. This allows accurate gating and 
panel evaluation. It is worth noting, however, that FMO controls are of limited value when 
increased background fluorescence of the negative is observed as a consequence of improper 
titration or because of the intrinsic property of the reagent, even when used at optimal 
concentration [10]. Panels should also be evaluated in the context of N-by-N plots, in which every 
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parameter is plotted against every other parameter [9].  For combinations where compensation is 
incorrect (mostly due to improper controls; see Chapter III, Section 1 Compensation), under- or 
over-compensation of those channels may be occurring.  It is worth examining the staining 
characteristics of the compensation tube to check that it is at least as bright as the test stain and 
that it is combined with the proper matched negative control with the same autofluorescence [11]. 
Should these properties not be met, compensation tubes should be modified, run again and 
compensation matrix recalculated.  For combinations of markers that do not make biological 
sense, e.g., that are co-expressed in the test stain but are known to be mutually exclusive (as an 
example, CD4 and CD8), an alternate sample should be tested.  If problems are not solved with 
these re-tests, the panels should be rearranged by assigning new dye-marker combinations. 
 
Figure Legend 
Figure 1: Spreading error and loss of detection sensitivity. (A) HL750-APC data spread into 
the APC detector. Continuous line indicates the threshold of positivity in the APC channel when 
CD8 is coexpressed, while dashed lines identify the range used to calculate spreading error in the 
same detector. This results in masking APC+ cells that are also positive for HL750-APC, while 
leaving APC+ (dim) HL750-APC– cells unaffected. (B) In the example, QD800 data do not spread 
into the QD655 detector, thus not affecting the detection of QD655+ cells in both the QD800+ and 
QD800– fractions. Such a combination is therefore useful to detect dim expression by QD655 
fluorescent signals.  
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Section 9 - Variable Lymphocyte Receptor Antibodies 
9.1 Introduction 
The recently identified variable lymphocyte receptor (VLR) antigen receptors of jawless 
vertebrates have contributed greatly to our understanding of the evolution of the adaptive 
immune system [1]. Three VLR genes (VLRA, VLRB and VLRC) have been described which are 
assembled by a gene conversion-like mechanism, and are expressed by cells reminiscent of  
T cells, B cells and  T cells respectively, with VLRB being secreted in the form of disulfide-
linked decameric complexes. Conventional antibodies utilize the immunoglobulin domain as the 
basic structural unit and are generated by recombination of the variable (V), diversity (D) and 
joining (J) gene segments for the antibody heavy chain and the V and J gene segments of the 
antibody light chain. As illustrated in Figure 1, the resulting antibody consists of an F(ab)/F(ab’)2 
domain which engages the antigen primarily via interactions mediated by residues located in the 
complementarity determining regions (CDR) 1, 2 and 3 whereas the Fc domain allows for the 
communication with various cells of the immune system to elicit biological responses. The ability 
of antibodies to recognize their antigens with a very high degree of specificity and to label these 
reagents with fluorescent dyes makes antibodies the key component of most flow cytometric 
applications. 
 
Unlike conventional antibodies, VLR antibodies utilize the leucine-rich repeat (LRR) as a basic 
structural unit [2]; the resulting gene product assumes a solenoid shape (Figure 2A), wherein 
the corresponding antigen interacts with residues located at the inner concave surface, and with 
a variable loop structure protruding from the capping C-terminal LRR unit [3, 4]. VLR antibodies 
have become a novel class of highly specific biomedical research tools, by virtue of the vast 
VLR antibody repertoire.  An established protocol harnesses the expansive repertoire to 
generate antigen-specific monoclonal VLR antibodies with ready applicability in standard 
laboratory techniques such as flow cytometry and enzyme-linked immune sorbent assays [5].  
 
Several research groups have used monoclonal VLR antibodies, either unmodified or 
engineered as Fc fusion proteins for purification using protein A/G columns and detection with a 
variety of commercially available reagents recognizing the IgG Fc domain. Alternatively, 
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purification is also readily performed using Ni-columns targeting an engineered 6xHis followed 
by detection of the VLR antibody targeting the incorporated HA-epitope tag (Figure 2B). Here 
we describe a protocol for use of VLR antibodies in multicolor flow cytometry analyses of human 
PBMCs in combination with conventional, directly labeled monoclonal antibodies. Depending on 
the type of VLR antibody used and the expression levels of the targeted antigen, a two-layer or 
three-layer staining approach can be used (see below for protocol). The use of monoclonal VLR 
antibodies with engineered epitope tags or VLR-Fc fusion proteins permit a more 2-layer 
staining approach. The use of unmodified monoclonal VLR antibodies or experiments targeting 
antigens expressed at low levels require a 3-layer staining approach since the established anti-
VLRB monoclonal antibody 4C4 cannot be readily modified with common labeling systems that 
target primary amines. Several positive and negative control reagents for VLR-based 
experiments have been described [5, 8, 9]. 
9.2 Reagents: 
 Fluorescently labeled anti-epitope tag or Fc-specific reagents are available from several 
commercial sources. 
 Monoclonal mouse anti-VLRB clone 4C4 [6]. Note that this antibody is reactive with an 
epitope in the stalk region of all VLRB molecules, and it displays impaired antigen-binding 
characteristics following modification with amine-reactive dyes. 
 Negative control monoclonal VLR4 antibody (specific for the BclA antigen of the exosporium 
of B anthracis [5]). 
 Positive control VLR32 antibody (specific for human CD5) [7] or VLRB MM3 antibody 
(specific for human CD38 on plasma cells). Suitable cell lines for testing of positive controls 
are the Jurkat T cell leukemia and the Daudi Burkitt’s lymphoma, respectively [8]. 
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9.3 Two-Layer Staining Approach 
Incubate PBMC with monoclonal VLR antibody in PBS / 0.5% BSA for 25 minutes on ice 
(v=40ul) 
Wash with PBS / 0.5% BSA 
Resuspend cells in antibody cocktail containing fluorescently labeled lineage-specific 
conventional monoclonal antibodies and fluorescently labeled anti-epitope tag antibodies (or 
anti-Fc antibodies if VLR-Fc fusion proteins are used), incubate for 15 minutes on ice 
Wash 2x with PBS / 0.5% BSA 
Resuspend in PBS / 0.5% BSA / 1 ug/ml propidium iodide and analyze by flow cytometry. 
 
9.4 Three-Layer Staining Approach 
Incubate PBMC with monoclonal VLR antibody in PBS / 0.5% BSA or 25 minutes on ice 
(v=40ul) 
Wash with PBS / 0.5% BSA 
Resuspend cells in PBS / 0.5% BSA, add anti-VLRB clone 4C4 at a concentration of 1 ug/ml 
and incubate for 15 min on ice (v=40ul) 
Wash with PBS / 0.5% BSA 
Resuspend cells in PBS / 0.5% BSA, add fluorescently labeled goat anti-mouse reagent 
(typically at a 1:300 dilution), incubate for 15 min on ice (v=40ul) 
Wash with PBS / 0.5% BSA 
Important Blocking Step: This blocking is important to prevent binding of directly labeled 
antibodies from the next incubation step to potentially unoccupied binding sites of the goat anti-
mouse reagent from the previous step. 
Resuspend cells in PBS / 0.5% BSA / 5% normal mouse serum, incubate for 10 min on ice 
Add antibody cocktail containing fluorescently labeled lineage-specific conventional monoclonal 
antibodies, continue incubation for 15 minutes on ice 
Wash 2x with PBS / 0.5% BSA 
Resuspend in PBS / 0.5% BSA / 1 mg/ml propidium iodide and analyze by flow cytometry 
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As is the case with all conventional antibodies, monoclonal VLR reagents must be titrated prior 
to use and 2 µg/ml serves well as a starting point. While background signals with the negative 
control VLR4 are not typically observed, negative control stains lacking any VLR antibody, in 
addition to negative controls for the various conventional antibodies, should be routinely 
included. 
 
Figure 1:  
Structural characteristics of immunoglobulins. Ribbon diagram of a mouse monoclonal IgG 
antibody consisting of two identical heavy and light chain proteins, respectively. Antibody heavy 
chain residues are indicated in blue and light chain residues in green. Amino acid residues 
encoding the CDR1, 2 and 3 regions are shown in red. (Image was generated using the Swiss 
PDB viewer and PDB accession number 1IGT). 
 
Figure 2. Structural characteristics of VLR antibodies. (A) Ribbon diagram of the antigen-
binding units of a monoclonal VLR antibody. Parallel -sheets lining the concave antigen-
binding surface are shown in blue and a variable loop structure involved in antigen binding is 
depicted in red. The invariant stalk region necessary for multimerization of the secreted VLR 
antibody was omitted (Model was generated using the Protein Model Portal Algorithm [9]). (B) 
Structural characteristics of VLR antibodies. Individual VLRB units consist of a signal peptide 
(SP), N-terminal LRR (LRR-NT), LRR-1, up to nine variable LRRv units, a connecting peptide, 
C-terminal capping LRR (LRR-CT) and the invariable stalk region and can be modified by 
inclusion of engineered 6xHis and HA-epitope tags or Fc-fusion sequences. 
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Section 1- Suspended sample 
In order to run a successful cell sorting experiment, a cell sorter needs to be optimized in terms 
of optics, electronics, and fluidics.  In addition, cell size, quality of cell suspension (see Chapter 
IV, section 3, Preparation of Single Cell Suspensions), and cell density are also important 
parameters, which ultimately have a high impact on sort parameters such as recovery, purity, 
and yield. 
1.1 Nozzle diameter, clogging and cell filtration  
The cell diameter should not exceed ¼ of the cell sorter nozzle diameter in order to prevent 
destabilizing effects of the cells on the break-off point [1]. This ensures stable sort conditions 
and minimizes nozzle clogging. Even if these criteria are met, it is still possible that a nozzle 
clog occurs during cell sorting due to the presence of adherent cells in the sample.  
To avoid generation of cell aggregates/clumps it is recommended to filter the samples as the 
final preparation step before sorting, by passing them through a cell filter. As a general rule, the 
filter pore size should be smaller than the orifice of the nozzle, e.g. for sorting of lymphocytes 
with a diameter of 10 µm, a filter with a 30µm pore size should be used for cell filtration. Note 
that in this example a nozzle with a diameter of 70 µm should be used.  Different filter types and 
sizes from different companies are available: 
 Sysmex, CellTrics®  
 Miltenyi, Pre-Separation Filter  
 Becton Dickinson, Falcon® 5mL Round Bottom Polystyrene Test Tube, with Cell 
Strainer Snap Cap  
Cell count and viability should be checked before and after filtration to measure inadvertent cell 
loss. Besides pre-filtering before sorting, it is also possible to use a sample line filter inside the 
cell sorter. These filters are installed at the end of the sample line. Such filters are available as a 
commercial product (Sample Inline Filter, Becton Dickinson) but can easily be made by melting 
a cropped pipette tip and attaching a piece of filter mesh to the cropped end. These line filters 
are useful to prevent nozzle clogs due to cell aggregations in the sample tube, but they cannot 
be used as a replacement for pre-filtering since the filter surface is very small and usually clog 
rapidly. Furthermore, such filters needs to be replaced between different sample tubes in order 
to avoid cross-contamination. If cells tend to aggregate repeatedly during the sort process one 
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should dilute the cell suspension or add some EDTA (up to 5mM) and 1-5% protein (BSA or 
heat-inactivated fetal calf serum).       
 
1.2 How to keep cells in suspension 
The sedimentation rate of cells in a fluid depends on their physical properties such as density, 
cell size, cell shape, viscosity of the surrounding medium, and gravity [2]. In addition, the 
effective density of a cell is also affected by its water content, and thus the sedimentation rate is 
not a constant property for an individual cell type [2,3]. 
  
1.2.1 Physical treatment of cell suspension 
Another possibility to avoid cell sedimentation is the physical treatment of the cell suspension 
before or during the cell sort. This is achieved by shaking or rotating the sample tube, or stirring 
with the sample line inside the cell sorter [6]. Rotating unidirectionally is not very effective since 
the sedimentation is delayed but not prevented. For example, the threshold rate of human 
leukocytes decreases to 80% after 30 min of cell sorting and then to 50% after an additional 
15min. Moreover, the constant rotation of the tube, especially if cells stick between the lower 
end of the sample line and the tube bottom, acts like a ‘cell crasher’. A more effective and gentle 
treatment is achieved by shaking or pipetting the cell suspension.  
Another possibility is to employ surface acoustic waves (SAW) to keep the cells in a 
homogeneous suspension. SAWs are generated on the surface of a piezoelectric crystal by 
applying a high-frequency electrical signal to specially formed pairs of electrodes deposited on 
the crystal [7]. By use of a coupling fluid (e.g. water) between the crystal and the sample tube, 
the SAWs are conducted to the sample via the tube bottom. This allows a mechanical and 
gentle resuspending of the sample by acoustic streaming. This approach is specific in that it 
uses low amplitudes and high frequencies and is therefore not detrimental for living cells and 
can be implemented in a cell sorter (e.g. BD FACSAria™) [8]. Using this approach, it could be 
shown that the amount of dead cells (human leukocytes) after 45 min cell sorting was not 
increased in comparison to unmixed cells, while the yield was 30% higher [8].  
1.2.2  Density of cell suspension 
The sedimentation of cells can be controlled by using isopycnic (i.e. equal or constant density) 
media [3]. The rationale behind this is to resuspend cells after the last wash in media of equal 
density. This can be achieved by using various reagents e.g. Percoll®, Ficoll®, HBSS, 
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Nychodenz®, Xanthan Gum [2,4,5]. For example, a 60% Percoll solution results in a media 
density of 1.07g/cm³, which is equal to the density of human lymphocytes but different from that 
of human erythrocytes (1.10 g/cm³). However, in practice the sedimentation rate of both cell 
types is decreased or stopped and therefore sedimentation is drastically minimized. In any case 
the toxicity of the final buffer should be tested by leaving cells in the buffer overnight at 4°C and 
the resultant cell viability should not be below 80%. The use of an isopycnic medium is an 
option but only necessary if sedimentation is an issue. Furthermore, the resulting density and 
viscosity of the cell suspension needs to be optimized to enable a stable cell suspension uptake 
within the cell sorter. Finally, the reagents should not change the optical properties of the 
resulting media to avoid scatter noise. 
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Section 2 – Trigger, Thresholds and live gating 
 
2.1 Trigger and threshold 
To facilitate the discrimination of particles of interest from background events it is useful to 
define a minimal signal value, the threshold value, which a particle passing the optics of a flow 
cytometer must reach to be actually recognized as an event.  
The threshold value defines the signal intensity above which the cytometer starts to recognize 
an event and therefore limits the number of events coming from background signal (Fig. 1). 
Every event showing a lower signal than the threshold defined will not be detected by the 
cytometer and will not be represented in the data file.  
Background noise coming from the instrument itself (electronic noise), microparticles in the 
buffer as well as cellular debris can overlap with the signal from the relevant events especially if 
the analysis is focused on small particles like microparticles, exosomes, or platelets. Therefore it 
is advisable to look for a leading parameter (i.e. a parameter with a clear discriminator for the 
population of interest) as the trigger parameter, and predefine a threshold value. 
 
2.2 Trigger parameters 
The default setting of the trigger parameter, i.e. the parameter used to exclude signals below a 
certain intensity, on most instruments is set to forward light scatter.  
Depending on the cells or particles of interest it is also possible - and sometimes even 
necessary - to set a threshold on a fluorescence parameter. The resolution of small particles,  
e.g. platelets, erythrocytes or extracellular vesicles, is much easier when the threshold can be 
set on a fluorescent signal (e.g. a common surface marker that clearly defines the target 
population) as background discrimination in forward and side scatter is often difficult. 
Sometimes also a combination of two triggers is used to optimize the analysis. In this case the 
event must meet the value of both thresholds to be recognized by the flow cytometer. Such a 
threshold combination is often used when the expected signal of a particle is low and therefore 
quite close to the background noise of one the trigger channel. 
It should be noted that many cytometers allow the user to collect pulse area (A) to measure the 
total amount of fluorescence by considering both, pulse height (H, fluorescence brightness) and 
pulse width (W, pulse duration) [1] and this is what is then by default depicted in dotplots and 
histograms. Threshold levels however are applied to pulse height and it is advisable to set 
threshold values while viewing pulse hight, especially if the trigger parameter might be a 
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fluorescence parameter where signal levels are low and the main contributor to area is pulse 
width (W). For many cytometers pulse height and width are not collected by default and have to 
be chosen in the instrument setting beforehand.  
 
2.3 Live gating 
Setting a threshold is often used to reduce the data file size and to facilitate data analysis with 
analysis software (see chapter VI section 1). The same effect can be achieved with the setting 
of a "live gate" on the population(s) of interest during sample acquisition. This electronic 
preselection will exclude all events not falling into the gate from being recorded into the data file 
and can be set according to multiple parameters (hierarchical gating) to enrich for a rare cell 
population. However, with computer and analysis software becoming more and more powerful 
the risk of losing relevant information by setting a "live" gate often outweights the necessity of 
reducing the data file size. Live gating should be carefully thought through before excluding data 
that might be of interest later on [2]. 
 
2.4 Threshold and cell sorting 
Events with signals lower than the threshold value will not be recognized by the flow cytometer 
and will be ignored completely by the electronics of the instrument. This fact is important to 
consider when it comes to cell sorting. Because the instrument does not detect these events, 
they are not being included in the process of the sort decision nor are they shown in the actual 
events per second going through the instrument. Consequently, sorted fractions can get 
contaminated due to the fact that these 'invisible' particles although ignored by the electronics 
are in fact still part of the sample. When the droplets are formed these particles can end up 
inside or in the neighboring drop of a target cell. Normally, this would lead to a sort abort, 
depending on the sort mask, but if the threshold is set in a way that the particle is invisible to the 
software, there can be no decision on the particle, resulting in a contamination of the sorted 
fractions. 
It is therefore recommendable to use the minimal threshold value possible for identifying the 
required population. 
 
 
Figure 1: The threshold value defines a signal intensity, in one or more parameters, above which the 
cytometer starts to recognize an event. All other events will be invisible to the instrument's electronics. 
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A particle passing the laser beam emits a certain amount of light over time. The threshold is set 
on the height of the signal that is emitted by each particle. On the left hand side a dotplot with 
the forward scatter as the trigger parameter  parameter is shown. Only particles with a signal 
higher than this threshold value are recognized by the software as an event and shown in the 
dotplot (black and orange dots). The dots in on the left side of the threshold value (grey and 
blue dots) are not included in the data file. 
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Section 3 – Rare cells – General rules 
 
3.1 Introduction 
Rare cell populations are of growing importance in several fields, from basic research to 
translational medicine and diagnostics. In several clinical settings, rare cell counts provide 
valuable information on the status and stage of the patient’s disease. Some examples are rare 
circulating tumor cells in the peripheral blood, tumor stem cells, circulating endothelial cells, 
hematopoietic progenitor cells and their subpopulations, and fetal cells in maternal circulation. 
Interesting applications of rare cell analysis include the detection of metastatic breast cancer 
cells [1] or neuroblastoma cells infiltrating the bone marrow [2], monitoring of minimal residual 
disease [3,4], detection of stem cells and rare HIV-infected cells in peripheral blood [5], antigen 
specific T cells, invariant natural killer T cells and analysis of mutation frequencies in genetic 
toxicology [6]. Moreover, polyfunctional assays, such as the Ag-induced production of different 
cytokines by T lymphocytes, are often performed, and these raise the problem of finding rare 
cells within these T-cell populations as well. In this section, the main issues of this topic will be 
discussed, including the amount of biological material required, the use of pre-enriched 
populations, the number of markers to use and cells to acquire, the importance of excluding 
doublets and the use of a DUMP channel.   
 
3.2 Optimization  
 
Studying rare cells requires attention, optimal methodologies in all phases, including collection 
of biological samples, well defined controls and adequate use of software and hardware [7]. The 
term “rare” generally refers to events with a frequency of 0.01% or less, although the record 
claimed in the literature has long stood at 1 cell in 10 million for tumor cells spiked in the 
peripheral blood [8,9]. For this, the acquisition of a large number of events (see Chapter V, 
section 3.2.3) and a high signal-to-noise ratio (see Chapter V, section 3.2.5) are the most 
relevant aspects.  
 
3.2.1 The quantity of the biological material 
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On the basis of the estimated frequency of the rare cells under investigation, it is crucial to 
calculate how much biological material is required. For example, if the endpoint of the 
experiment is to enumerate rare cell populations present in the cerebrospinal fluid (CSF), 
considering that only a few mL can be obtained from a patient, it is logical that all the CSF has 
to be all used. If blood is the biological matrix of interest, the rare cell population of interest and 
the pathology of the patient should be considered in depth. Should the endpoint of the study be 
the evaluation of cytokine production after in vitro stimulation by cells such as invariant natural 
killer T (iNKT) cells in patients with HIV infection, some pre-analytical considerations should be 
taken into account. For example, iNKT cells are extremely rare among peripheral blood 
mononuclear cells (0.01-1%), and in order to define this population several markers must be 
used, including those for recognizing CD3, CD4, CD8, invariant TCR, as well as those for cell 
viability and several cytokines such as TNF-, IFN-, IL-4 and IL-17 could be of interest, 
meaning that nine markers are required. HIV+ patients who do not take antiretroviral therapy 
are obviously severely immunocompromised, and have a low number of CD3+ T lymphocytes. 
Thus, the amount of blood required to detect a reasonable number of rare cells (according to 
Poisson statistics) canbe as much as 50 mL of blood, since either resting or stimulated cells 
have to be analyzed [10]. 
 
 
3.2.2 Enrichment and choice of markers 
 
On the basis of the experimental endpoint(s) (e.g. phenotyping, functional assays), the rare 
population may be enriched or not, and the number of markers that are needed to 
unambiguously identify a rare cell population needs to be defined. For example, the accurate 
quantification of circulating endothelial cells (CECs) and their progenitors (EPCs), shown in 
Figure 1, is a matter of debate. Several studies have been published, but no consensus has 
thus far been reached on either the markers that should be used to identify these cells, or on the 
necessity of a pre-analytical enrichment (by density gradient, buffy coat and/or magnetic 
enrichment). The enrichment, however, can have negative effects if rare cells are lost, or these 
effects may be positive, if unwanted cells are removed [11-15]. Unfortunately, quite often, the 
lack of well standardized methods influences the decision regarding the number of markers, 
which are necessary for the identification of the population of interest. Depending on the 
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technical characteristics of the flow cytometers, which have a varying number of fluorescence 
channels and the speed of acquisition, the most important marker allowing the identification and 
characterization of such populations should be decided. For example, in the case of iNKT cells, 
the V24J18 invariant TCR allows the unique identification of these cells. Having done that, 
the marker panel has to be built following a general rule that the brightest fluorochrome has to 
be used for the weakest expressed marker. Finally, attention should be paid to compensation, 
and acquisition of fluorescence minus one (FMO) controls, which is covered in more detail in 
Chapter III, Section 1 Compensation and Chapter IV, Section 1: Controls – determining 
positivity by eliminating false positives).  
 
3.2.3 Number of acquired events 
Concerning the number of events which need to be acquired it is recommended to use 
Poisson statistics, which defines the probability that a given number of events will occur in a 
fixed interval of time/space, assuming these events would occur with a known average rate and 
independently of the time elapsed from the previous event [16]. Therefore, Poisson statistics are 
applied to count randomly distributed cells in a certain volume. Let us consider a general case 
of enumerating a total of N events, of which R meet a certain criterion (i.e., they are positive, P). 
In this case a proportion of P events is defined as P=R/N. The probability of any single event to 
be positive is obviously 0≤P≤1, and this is related to the random manner in which cells are 
selected for analysis. As with all statistical distributions, the variance, Var, is a fundamental 
parameter, and is defined as: Var(R)=NP(1-P). The standard deviation, SD, is the square root of 
the variance, and the coefficient of variation (CV) is the SD equal to 1/square root of Var [17]. 
These equations can be used to examine some practical situations. Let’s consider a phenotype 
analysis of human PBMCs stained with a mAb for detection of B cells (e.g. CD19 mAb). In 
healthy individuals, 10% of the cells can be positive, so that:  P=0.1 and P(1-P)=0.09. Good 
experimental practice suggests to keep CV below 5%; thus, acquiring even 5,000 events could 
be sufficient, because the CV is 0.047 (i.e., in percentage, 4.71%). Using a number of cells such 
as 10,000 the CV becomes 3.33%.   However, should positive events be less frequent, a higher 
number of events must be acquired. Table 1 reports an example for events whose frequency is 
0.01%, as often occurs studying antigen-specific T cells.  
This is clearly the ideal methodology. However, real life is different from theory, and very 
often the final number of events cannot be high enough to satisfy this golden rule. For example, 
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we can consider the case in which 1 million peripheral T cells are stimulated with an antigen that 
activates less than 0.1% of them, namely 100 cells in one million. Nowadays, by polychromatic 
flow cytometry, T cell activation can be analyzed by evaluating the polyfunctionality of these 
cells, and protocols have been developed that can identify in a relatively easy manner 4 or even 
5 functions per cell. Thus, among responding cells, up to 32 populations can exist, likely with a 
different frequency, and each subpopulation contains a few cells that are completely absent in 
the control, unstimulated sample. Can we consider such cells positive, even if their number is 
much lower than that indicated by a strict statistical approach? A pivotal paper by Mario 
Roederer, an opinion leader in this field, gives us very useful and clear suggestions [18]. 
Indeed, if alternative explanations for the presence of such positive events can be excluded 
(i.e., if there is no noise due to dead cells or fragments, and if cell activation is really due to the 
antigen used in vitro and not to a pre-activation in vivo of T cells), the events can be considered 
positive, irrespective of their number. Thus, there is no reason to fix a threshold for the number 
of events below which any frequency must be considered "negative" [18]. In this case, 
"positivity” can be determined after comparison of the measurement against a set of control 
samples, among which the adequate negative controls, using standard statistical tools to 
compare the frequencies. For example, assuming that from the technical point of view the 
experiment is well performed, if T cells from "n" unvaccinated controls show no activation after 
the stimulation with the adequate peptides, while T cells from "n" vaccinated individuals do, 
even extremely low frequencies can be taken as positive. The same logics can be applied in 
thousands of other cases, assuming that the relative controls are well chosen. 
 
3.2.4 Sample concentration and flow rate 
Because it is crucial to acquire a high(er) numbers of events for detection of rare cell population, 
sample concentration and flow rate are critical parameters, which can typically shorten 
acquisition time. However, care must be taken that increasing the flow rate results in an 
increase of coincidence, and thus higher CV, if flow cytometers use hydrodynamic focusing 
(which is the system used at present in most commercially available flow cytometers).  
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3.2.5 Thresholds, gating and DUMP channel 
A threshold should be fixed in order to distinguish the signal (using fluorescence or scatter) 
required to define the population of interest from the noise/background (see section 2 of this 
chapter). Hence, maximizing the signal-to-noise ratio of the cells of interest is mandatory. Gates 
should be drawn to exclude dead cells, identified by viability marker, doublets/aggregates/debris 
and all the unwanted cell populations from the analysis, and a “DUMP” channel containing 
antibodies that identify cells of no interest is highly recommended. Moreover, using a dot plot 
with the parameter “time” vs. that of interest allows to remove the event bursts caused by clogs 
or other transient problems during the acquisition. The instrument should be kept clean, and it is 
essential to wash the instrument between acquisition of different samples in order to minimize 
sample contamination, which could cause the detection of false positive events. 
 
3.3 Data analysis 
Finally, data analysis requires adequate software and powerful hardware (more than 8GB RAM 
or higher), because acquired data file tend to be huge, depending on how many events and 
parameters have been acquired (e.g.10 colors and 2 scatters in 10 million events are indeed a 
good test for your computer). To minimize the file size, parameters that are not really needed 
can be unselected, and a fluorescence/scatter threshold trigger can be used. Data analysis will 
be covered in greater detail in Chapter VI, sections 1-3.  In conclusion, flow cytometry is at 
present the most potent technology to address rare cell analysis, and the so called “next 
generation” instruments with very high speed and sensitivity are already allowing an easy 
detection and analysis of such cells. 
 
Figure 1. An example of a gating stategy for rare cells. Gating stategy used to identify 
circulating endothelial cells (CECs) and their precursors (EPCs) among peripheral blood 
leukocytes. (A)Debris and aggregates were eliminated using FSC-Area vs. FSC-Height, (B) 
possible clogs were removed using the parameter Time vs. SSC. (C) a DUMP channel was 
used to remove CD45+ cells and dead cells from the analysis. (D) nucleated cells were identified 
based on Syto16 positivity. (E) Stem cells were identified according to CD34 positivity, (F) EPCs 
(CD133+,CD31+) and CECs (CD133-,CD31+) were identified. The expression of CD276, also 
named B7-H3 (G, I)., and CD309 (H,J), also named VEGFR-2 or KDR, was evaluated in each 
subpopulation. In this example, more than ten million events were initially acquired in order to 
enumerate a population that, according to the literature, is always represented less than 0.1%. 
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Table 1. The number of acquired events, for a cell population with final frequency 0.01%. 
Note that to obtain a CV of 3.16 it is mandatory to acquire 10 million events, while acquiring 
4,010,000 events gives a CV=4.99. 
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Section 4 - Collecting cells 
4.1 Introduction 
Even if a cell sorter is well adjusted i.e. the instrument is able to deflect the right drop with the 
cell of interest at the right moment, it is still possible that the drop does not hit the collection 
vessel, due to issues regarding the relationship between cell size, nozzle size, sheath fluid 
temperature, pressure stability. This results in a low sort yield and sometimes low purity. 
Optimal collection efficiency therefore depends on the setup of the cell sorter as well as the 
position and properties of the sample collection tubes.   
4.2 Cell sorter-specific parameters 
For a cell sort with high purity and yield an optimal gating strategy and detector setup is 
mandatory. Often, the discrimination between stained and unstained cell populations is 
problematic if they have a high overlap. In “dim” populations (i.e. low signal intensity e.g. due to 
low marker expression or weak fluorochrome) the distribution of the cell events is dominated by 
the photon counting statistic of the PMTs and the background light and electronic noise of the 
detection channel. In other words, when the light intensity emitted from a single cell is measured 
by a PMT, the specific signal has an additive part of a constant amount of non-specific signal 
(coming from the background light, electronic noise etc.). Thus, when a specific cell signal 
decreases, the non-specific part remains stable and more and more dominates the entire signal 
and hence the distribution of the population. Consequently, the relative position of a cell inside a 
dim population is dominated by the background signal. This can lead to low cell recovery if 
gates are not well adjusted. Proper staining controls such as FMO (fluorescence minus one) [1]  
controls instead of unstained/ single stained cells are very helpful to find the real boundaries of 
cell populations (see chapter IV, section 1, controls – determining positivity be eliminating false 
negatives). Furthermore, an optimal signal to noise ratio by choosing the required PMT gain is 
essential for good population discrimination2 and optimal cell recovery [2].  
Modern cell sorters can sort up to six cell populations simultaneously in collection devices 
equipped with tubes (e.g. Falcon® 5 ml–50 ml round buttom tubes, 1-2 ml microcentrifuge 
tubes). Depositions of single cells in multi well culture plates or onto slides, are also possible. 
Droplet sorters allow drops to be charged on different charge levels either positively or 
negatively, which allows drops to be deflected either to the left, far left or to right, far right.  
Deflection streams containing populations with the highest number of events to be sorted should 
be placed close to the center stream (i.e. left or right), since the focusing of the deflection 
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streams is often better if their deflection is low. This minimizes the risk of cross contamination 
between the collection tubes. 
Furthermore, the position of the deflection stream should be monitored during the sort process.  
This can be achieved by using the AccuDropTM technology [3] which consists of a red diode 
laser for side stream illumination, a filter block, and a camera mounted in the back of the sort 
chamber. The camera provides an image of the deflection streams with the intercept points of 
the laser beam. This allows the user the monitoring of the deflection stream quality in terms of 
position, focusing, and stability. Some sorters allow the monitoring of the break-off point using a 
camera and control the amplitude of the drop drive frequency depending on the camera image. 
This keeps the break-off point in a stable position by increasing or decreasing the amount of 
drop drive energy to the stream. This is a useful approach as long as the viscosity, density, and 
pressure of the sheath fluid is stable. If not, the cell recovery decreases even if the position of 
the break-off point is stable. Rapid temperature fluctuations of the sheath fluid of 1-2 K inside or 
next to the nozzle can become critical for cell recovery as well as for the side stream focusing4. 
Therefore, good air conditioning or a sheath cooling [4] device is highly recommended.  
The side stream position for cells sorting in multi well plates is essential and needs to be verified 
by test sorting of the target cells because the final drop positioning is often slightly different for 
beads or other cells. For single cell sorting of 384 well plates, a plate cooling device is 
recommended to avoid evaporation of the cell media.  
 
4.3 Sample Collection Tubes 
The collection tubes can differ in terms of material as well as size. Polypropylene tubes are 
preferable over polystyrene tubes because the cells adhere less to the tube wall. Polystyrene 
tubes may build up the charge of the deflected drops on their surface. This can generate cross 
contamination between collection tubes due to ‘jumping drops’ caused by repulsion of incoming 
drops but can be prevented by using a grounded wire connected to a bent injection needle hung 
over the side of tube, such that the needle is in the fluid [5]. Different tubes sizes can be 
combined in a specific tube holder depending on the flexibility of the cell sorter. Moreover, a 
custom made tube holder became available recently as 3D print file [6].    
The size of the collection vessel should fit to the expected volume of the sorted cell suspension 
and is correlated to the drop size and therefore to size of the nozzle. For example, 4x106 cells fill 
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approximately a 5ml Falcon® tube (12 x 75mm ), when using a 70 µm nozzle. The same 
amount of cells would require five 5ml tubes when a 100 µm nozzle is used. Especially for long 
term sorts these correlations should be concerned, in order to prepare enough collection tubes 
beforehand. On the other hand, there is a high risk that cells may not be recovered in the 
collection tube if the tube size is much higher than the expected sample volume.  
Collection tubes should be coated with proteins to avoid that the sorted cells stick to the tube 
wall as this results in reduced recovery and viability. This can be done by filling the tubes with 
10% FCS (fetal calf serum) 30 minutes before sorting or incubated overnight at 4°C with 10% 
BSA (bovine serum albumin). As a general rule, the collection tubes should be prefilled with a 
small volume of media optimized for the cells of interest. This prevents the dehydration of the 
sorted cells and keeps the cells under optimal conditions to ensure their viability [7]. 
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Section 1 – Data Analysis- an overview 
 
1.1 Introduction: 
Flow cytometry data analysis presents a complex problem because of recent rapid increases in 
the number of parameters measured, and because of some peculiarities of flow data.  Current 
datasets include 20 or more parameters even for conventional fluorescence cytometry, and 
other methods yield 35 or more channels.  Traditional bivariate gating, which involves manually 
drawing boundaries on sequential two-parameter plots, can still be performed on high-
dimensional datasets, but this becomes progressively more time-consuming and less thorough 
as the parameter number increases. There has been rapid development of automated gating 
and clustering algorithms, which are likely to be the methods of choice in the future [1-9], and 
these strategies are described in more detail in Chapter VI, Section 3.  However, manual 
analysis is still critically important in flow analysis for providing ‘reality checks’ for the results 
returned by different algorithmic strategies, for investigators who do not yet have ready access 
to automated methods, and for investigators who prefer to continue manual gating for 
consistency with previous results.  This section will describe common issues in analysis, in three 
stages – pre-processing, gating and post-processing.  This section should be read in conjunction 
with chapter VI section 2 on automated data analysis.   
 
1.2  Pre-processing flow data in preparation for sub-population identification: 
1.2.1 Batch effects: 
Flow cytometry data are difficult to standardize between batches that have been analyzed days 
or months apart because cytometer settings can change with time, or reagents may fade.  
Imperfect protocol adherence may also lead to changes in staining intensity or machine settings.  
Such variations need to be identified, and where possible, corrected.  In addition to batch 
variation, individual outlier samples can occur, e.g. due to temporary fluidics blockage during 
sample acquisition.  Identification of these changes can be performed by detailed manual 
examination of all samples.  However, this involves evaluating the mean fluorescence intensity 
(MFI) between samples after gating down to meaningful sub-populations.  For high-dimensional 
data this is difficult to perform exhaustively by manual analysis, and is more easily achieved by 
automated methods.  As an example, samples from a study performed in two batches, on two 
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cytometers, were analyzed by the clustering algorithm SWIFT [6, 10], and the resulting cluster 
sizes were compared by correlation coefficients between all pairs of samples in the study (Fig. 
1). The most consistent results (yellow squares) were seen within samples from one subject, 
analyzed on one day and one cytometer.  Samples analyzed on the same day and cytometer, 
but from different subjects, showed the next smallest diversity (compare subjects 1 vs 2, and 4 
vs 5).  Weaker correlations (blue shades) occurred between samples analyzed on different days, 
or different cytometers. Similar batch effects are seen in datasets from many labs.  These effects 
should be addressed at two levels – first, at the experimental level, day-to-day variation can be 
minimized by stringent adherence to good protocols for sample handling, staining and cytometer 
settings (see Chapter III, Sections 1-2).  For multi-site studies, cross-center proficiency training 
can help to improve compliance with standard protocols.  If shipping samples is possible, a 
central laboratory can reduce variability in the staining and flow cytometer settings.  Clearly, 
performing a study in a single batch is ideal, but in many cases this is not possible. 
1.2.2 Ameliorating batch effects during analysis 
 At the analysis level, some batch effects can be reduced during further analysis.  In experiments 
in which batch effects occur due to variability in staining or cytometer settings, algorithms for 
reducing this variation by channel-specific normalization have been developed (below).  Batch 
effects due to other causes may be more difficult to correct.  For example, increased cell death 
is another potential batch problem that is not completely solved by just gating out dead cells, 
because marker levels on other sub-populations can also be altered before the cells die. 
1.2.3 Curation of datasets:  
 In some datasets, curating names and metadata may be necessary.  The manual entry error 
rate can be greatly reduced by using an automated Laboratory Information Management System 
(e.g.FlowLIMS, http://sourceforge.net/projects/flowlims) and automated sample data entry.  As 
manual keyboard input is a major source of error, a LIMS system can achieve a lower error rate 
by minimizing operator input through automated data input (e.g. by scanning two dimensional 
barcodes) or pre-assigned label choices on pull-down menus.  Although compensation is 
conveniently performed by automated ‘wizards’ in popular flow cytometry analysis programs, this 
does not always provide the best values, and should be checked by e.g. NxN displays showing 
all possible two-parameter plots.  Further information on compensation can be found in [11]. 
CyTOF mass spectrometry data needs much less compensation, but some cross-channel 
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adjustment may be necessary in case of isotope impurities, or the possibility of M+16 peaks due 
to metal oxidation [12]. 
In some datasets, further data curation is necessary.  Defects at specific times during data 
collection, e.g. bubbles or changes in flowrate, can be detected and the suspect events removed 
by programs such as flowClean [13].  Furthermore, compensation cannot be performed correctly 
on boundary events (i.e. events with at least one uncompensated channel value outside the 
upper or lower limits of its detector) because at least one channel value is unknown.  The upper 
and lower detection limits can be determined experimentally by manual inspection or by 
programs such as SWIFT [6].  The investigator then must decide whether to exclude such 
events from further analysis, or to keep the saturated events but note how this may affect 
downstream analysis. 
1.2.4 Transformation of raw flow data.  
Fluorescence intensity and scatter data tend to be log-normally distributed, often exhibiting 
highly skewed distributions.  Flow data also typically contain some negative values, mainly due 
to compensation spreading but also partly because of subtractions in the initial collection of data.  
Data transformations (e.g. inverse hyperbolic sine, or logicle) should be used to facilitate 
visualization and interpretation by reducing fluorescence intensity variability of individual events 
within similar sub-populations across samples [14].  Several transformation methods are 
available in the package flowTrans [15], and should be evaluated experimentally to determine 
their effects on the data with regard to the automated methods used and further downstream 
analysis. 
1.2.5 Registration/normalization of fluorescence intensity values:  
Normalization between data sets with regard to fluorescence intensities can be accomplished 
either by adjusting gates (i.e. manually specified filters or probabilistic models designed to 
enumerate events within defined regions of the data) between samples, or by moving sample 
data closer to the gates via fluorescence intensity registration.  Auto-positioning ‘magnetic’ gates 
can reconcile slight differences between samples in programs like FlowJo (Tree Star) and 
WinList (Verity Software House), but large shifts in sub-population locations are difficult to 
accommodate.  Several semi-automated methods of fluorescence intensity registration are 
available (e.g. fdaNorm and gaussNorm  [16, 17]).  These methods attempt to move the actual 
data-points across samples to similar regions, thus allowing gates to be applied to all samples 
without adjustment.  Both fdaNorm and gaussNorm register one channel at a time, and do not 
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address multidimensional linkages between biological sub-populations.  The methods further 
require pre-gating to expose sub-population ‘landmarks’ (peaks or valleys in one-dimensional 
histograms) to register effectively.  However, this ‘global’ approach does not adequately capture 
the semantics of biologically interesting rare sub-populations that are often obscured by high-
density data regions.  A recent extension [17] of the fdaNorm method attempts to address this 
shortcoming by tightly integrating ‘local’ (sub-population specific) registration with the manual 
gating process, thus preserving the multidimensional linkages of rare sub-populations, but still 
requiring a hierarchy of manual gates derived from a reference sample.  Fully automated 
fluorescence intensity registration methods are in development. 
 
1.3  Identification of sub-population sizes and properties by gating.   
1.3.1 Sequential bivariate gating: 
Sequential gating in two-dimensional plots is the standard method for manual analysis.  
Rectangular gates are convenient for well-separated sub-populations, but more subtle gates are 
often required, e.g. elliptical gates to define sub-populations in close proximity, or ‘spider’ gates 
(available in FlowJo) to allow for fluorescence spreading due to compensation.  The sequence of 
gates can be important because the desired sub-population may be visualized more effectively 
by particular marker combinations.   
 
1.3.2 Back-gating:  
A critically important step for gating high-dimensional data is to optimize the gates using back-
gating, which involves examining the cell sub-populations that satisfy all but one of the final 
gates.  This procedure is performed for each gate in turn, and is critically important because 
small cell sub-populations may be defined by boundaries that are different from the boundaries 
of bulk sub-populations, e.g. stimulated, cytokine-producing T cells display less CD3 than 
unstimulated T cells, so setting the CD3+ gate on the bulk T-cell sub-population will give an 
incorrect gate for the stimulated T cells.  Back-gating partly compensates for the inability of 
manual gating to use all dimensions simultaneously, as can be achieved in algorithmic 
clustering. 
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1.3.3 Validation of gated or clustered sub-populations:  
Another critical issue is to examine the final gated sub-populations carefully, using prior 
knowledge and expectations from the biology.  Figure 2 shows three samples – a negative 
control that has no positive cells in either dimension (left); a positive sample that has small sub-
populations of A+B- and A-B+ cells (middle); and a sample that has no obvious positive sub-
populations, but has a slightly increased fluorescence intensity resulting in cells appearing in the 
A+B- and A-B+ gates (right).  If the results of gating are accepted blindly, then samples 2 and 3 
will be evaluated as having similar A+B- and A-B+ responses, whereas examination of the plots 
suggests a very different interpretation.  Biological insight is also very useful - if a large sub-
population appears to be positive for a marker that is usually expressed only on a minor sub-
population, it should be suspected that there is an unusually high background for that marker on 
some cells and further experiments should be done to confirm the specificity of binding. 
 
A limitation of manual gating in sequential two-dimensional plots is that two sub-populations may 
not be fully resolved in any combination of two dimensions, even though the sub-populations are 
fully resolved if all dimensions are considered simultaneously (which is only possible by 
algorithmic analysis).  Thus in manual gating it is sometimes necessary to make choices based 
either on recovering the largest number of the target cells (wider gates, at the expense of 
increased contamination), or identifying cells with the most certainty (narrower gates, at the 
expense of some loss of positive cells).   
 
An important extension of this careful examination of the results is to validate the results 
obtained by automated methods.  As for manual gating, the results of automated analysis should 
not be accepted blindly, but should be checked in the familiar bivariate scatter plots, or in recent 
dimensional reduction tools such as VISNE [18].  Tools for examining the output of automated 
methods are built in to programs such as FLOCK and SWIFT, and available as plugins in 
FlowJo, Cytobank, and FCS Express. 
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1.3.4 Description of final sub-populations:  
The final sub-populations identified by analysis are identified mainly by their fluorescence 
intensities for each marker.  For some markers, e.g. CD4 on T cells, the positive cells comprise 
a log-symmetrical, clearly separated peak, and the center of this peak can be described by the 
geometric mean, the mode, or the median with very similar results.  However, if a positive peak 
is incompletely separated from negative cells, the fluorescence values obtained by these 
methods can vary substantially, and are also highly dependent on the exact positioning of a 
manual gate.  If a sub-population is present as a shoulder of a larger, negative peak, there may 
not be a mode, and the geomean and median may have substantially different values. 
 
1.4  Post-processing of sub-population data: Comparison of experimental groups and 
identification of significantly altered sub-populations. 
Regardless of the primary analysis method, the output of most flow cytometry analyses consists 
of the sizes (cell numbers) and median fluorescence intensities of many cell sub-populations.  
Differences between samples (e.g. in different groups of a clinical study) can be performed by 
standard statistical analysis, using methods appropriate for each particular study.  It is very 
important to address the problem of multiple outcomes, and this is even more critical in high-
dimensional datasets because the potential number of sub-populations is very large, and so 
there is a large potential multiple outcome error.  By automated analysis, hundreds or even 
thousands of sub-populations can be identified [6, 10], and manual analysis also addresses 
similar complexity even if each sub-population is not explicitly identified.  As in the analysis of 
microarray and deep sequencing data, it is important to consider the false discovery rate, using 
a strong multiple outcomes correction such as the Benjamini-Hochberg strategy [19] or 
alternative strategies [20].  Applying corrections to data from automated analysis is relatively 
easy because the total number N of sub-populations is known [21], but it is very difficult to 
identify N for manual bi-variate gating, because a skilled operator exploring a dataset will 
consider many sub-populations before intuitively focusing on a smaller number of ‘populations of 
interest’.  To avoid errors in evaluating significance due to multiple outcomes in manual gating, 
strategies include: performing the exploratory gating analysis on half of the data, and calculating 
the statistics on the other half; or performing a confirmatory study with one or a few predictions; 
or specifying the target sub-population before starting to analyze the study.   
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Figure Legends: 
Figure 1. Quality control analysis to detect batch effects.  Eight sequential blood samples 
each from six subjects were analyzed by flow cytometry, clustered using the SWIFT algorithm, 
and Pearson correlation coefficients in the number of cells per cluster were calculated between 
all pairs of subjects.  Samples were analyzed on two days, and on two identically configured 
LSR-II cytometers.   
 
Figure 2.  Model data illustrating the very different interpretations of two samples with 
similar proportions of cells in a positive gate.  Left:  A double-negative (A-B-) population with 
a random normal distribution is modeled.  Middle:  Two small sub-populations with random 
normal distributions are added to the A-B- sub-population.  The red and green sub-populations 
contain few cells, but are well separated from the A-B- population.  Right:  The ‘negative’ sub-
population has been shifted slightly, but no distinct smaller sub-populations are present. 
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Section 2 – Data Analysis - Automated analysis: Automated Flow Cytometry 
Cell Population Identification and Visualization 
2.1 Introduction 
The current generation of flow cytometers are capable of simultaneously measuring 50 
characteristics per single cell, thereby identifying up to 350 possible cell populations within 
hundreds of thousands of cells per sample [1]. Given the vast amount of data 
that can be generated, manual analysis techniques lack the capacity and rigor to bring out the 
full potential of signals within such large datasets [2]. Furthermore, human subjectivity has been 
identified as a primary source of variation within analyzed results [3-4]. Automated analysis 
methods have reached a state where they can now provide a solution to the challenge of 
analyzing big sets of flow cytometry data (Figure 1). If chosen and used with care, many of these 
automated tools show as good, or even better, as well as more consistent analytic results 
compared with those performed by “human” users [5-7,13].  
  
Prior to analysis, it is essential to make sure that each file is properly compensated, quality 
controlled, normalized, and transformed (see pink and blue boxes in Figure 1). As well, potential 
outlier data at the event and sample level should be identified and removed as needed. An 
overview of the automation of these steps is outlined in Chapter VI, sections 1 and 2. Once 
these data pre-processing steps are complete, users can identify cell populations using one or 
more of more than 50 automated gating algorithms currently 
available [8]  (see orange boxes in Figure 1).  
  
Automated gating algorithms can be categorized as either supervised or unsupervised. 
Supervised approaches to cell population identification incorporate user knowledge into the 
algorithm at various points. As such, supervised approaches are especially beneficial 
when users have project-specific expectations (e.g., target cell populations of interest, based on 
an existing gating strategy the user is trying to replicate). OpenCyto [9] and flowDensity [10] are 
two such approaches which mimic the manual gating process. Users can specify everything 
from gating parameters to the dimensions on which the algorithm should gate. These gates can 
then be extracted, plotted, and adjusted until they are satisfactory. Since the plots produced can 
be specified to match a gating strategy, they can easily be used to communicate with those who 
are not familiar with the computational aspects of analysis. Moreover, comprehensive analysis of 
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state-of-the-art supervised algorithms through the FlowCAP effort has shown that these 
approaches produce unbiased results and can reduce analysis variability by up to 94% 
compared with that occurring with manual analysis [7].  
  
While supervised algorithms gate two dimensions at a time, unsupervised 'cluster 
analysis' algorithms ‘cluster’ or group cells with similar fluorescent intensities for similar groups 
of markers directly in high-dimensional space. These algorithms often do not require user input 
but do allow users to change a limited number of global parameters, such as the number of cell 
populations expected, to allow tweaking of the results. The main aspect differentiating 
unsupervised clustering methodologies from each other is how they perform clustering. Tools 
assume different distance measures, data distributions, or graph structures to define how the 
cells are positioned in multi-dimensional space. Though there is no best tool for all situations, 
design decisions dictate the types of algorithms that will be suitable for specific samples or 
analysis goals. For example, one of the targets that can be optimized for is the identification of 
rare cell populations. Such populations are often not robustly identified and are grouped together 
with larger clusters, with cell populations that are highly overlapping in all dimensions being a 
general challenge independent of their size. Several unsupervised algorithms have been 
developed to aid users who aim to discover, or target, those cell populations (e.g. SWIFT [11]).   
  
2.2 Visualizing big flow cytometry data  
 Comprehensible visualizations are essential for the communication, validation, exploration, and 
discovery of possibly significant cell populations. In conjunction with cell population identification 
algorithms, visualization is an often overlooked but essential part of the discovery and diagnosis 
process  (see green box in Figure 1). This can be a challenge for unsupervised clustering 
algorithms, as it is sometimes difficult for users to comprehend the cell populations identified in 
high-dimensional space. Therefore, dimension reduction is increasingly being applied to 
map multi-dimensional (i.e. samples using more than two markers) results onto a two-
dimensional plane for viewing. For instance, the algorithm SPADE colors and 
connects significant, structurally similar immunophenotypes together in the form of a minimum 
spanning tree, or a tree like form [4]. Dimensionality reduction techniques such as those based 
on t-distributed stochastic neighbor embedding (t-SNE) arrange cell populations in a way that 
conserves the spatial structure of the cell populations in high-dimensional space. This way, 
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users get a more representative view of cluster distributions [12]. However, some dimensionality 
reduction methods do not explicitly identify and partition cells into subpopulations. PhenoGraph 
algorithm robustly partitions high-parameter single-cell data into phenotypically distinct 
subpopulations and has been shown to perform well in comparative evaluation [13]. 
Algorithms such as RchyOptimyx [14-15], gEM/GANN [16] and FloReMi [17] use already-
labelled samples (e.g., participant has or does not have a certain disease) to extract and display 
only the cell populations that most significantly discriminates between the differently labelled 
samples. These cell populations can then be used as indicators, and thus one can target these 
cell populations, when determining the label of future samples [5]. Such visualizations aim to 
focus in on only the most important data structures present to facilitate human interpretation of 
the data. Another visualization tool is the SPICE data mining and visualization software, 
(https://niaid.github.io/spice/) developed by Mario Roederer and Joshua Nozzi at the NIH. This is 
a powerful freeware program for representing complex cytometry datasets.  A comprehensive 
review of the available visualization algorithms is covered in  [20].  
  
2.3 Next Steps  
Manual analysis may be a quick and sufficient way to identify target cell 
populations if few (~5)  markers are used, the target cell populations are large and well known, 
and the user is an experienced flow cytometrist. However, as the number of dimensions and 
samples scale up, automated analysis quickly becomes the best (and perhaps only) option. 
However, in the end, automated gating algorithms are simply one more tool to aid in the 
generation and validation of a proposed hypothesis. Yet knowing how to do lab work does not 
necessarily prepare the scientist for bioinformatics, and users can collaborate with and exploit 
the expertise and experience of bioinformaticians as do they do other domain experts. Learning 
how to use the algorithms is also an option. The most comprehensive library of flow cytometry 
analysis tools built to date can be found on R/Bioconductor [8]. Although not the most user-
friendly choice, R uses a command-line interface to provide a powerful foundation for many data 
mining and statistical computational tools. A subset of Bioconductor tools are available 
more user-friendly GUIs (graphical user interfaces) such as FlowJo, 
FCSExpress and GenePattern [18].  
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With the growing amounts of data becoming available for analysis, automated analysis is 
becoming an essential part of the analysis procedure [19]. Only by taking advantage of cutting 
edge computational abilities will we be able to realize the full potential of data sets now being 
generated.  
  
Figure 1. Typical automated analysis workflows in flow cytometry. Analysis usually starts 
with several pre-processing steps, including quality assessment  data normalization and data 
transformation, (blue boxes). Pre-processing is followed by identifying cell populations of interest 
(orange boxes) and visualization (green box).   
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Section 3 –Statistics for Flow Cytometry  
 
3.1 Background 
One of the attributes of cytometric systems is that a large number of cells can be analyzed. 
However, the data sets produced are just a series of numbers that need to be converted to 
information. Measuring large numbers of cells enables meaningful statistical analysis, which 
“transforms” a list of numbers to information. 
At the most basic level, the objective of cytometric measurements is to determine if there is more 
than one population in a sample. In the case that two or more populations are completely 
separated, e.g. the subsets studied can be gated by virtue of phenotypic markers or easily 
separated by cluster analysis (for more detail please see Chapter VI, Section 2, Automated data 
analysis: Automated Flow Cytometry Cell Population Identification and Visualisation), then the 
proportions of cells within each subset and additional measurement parameters for each subset 
can easily be calculated, and the analysis would be problem-free. However, problems arise 
when there is overlap between subsets, based on the parameters of the specific measurement 
e.g. fluorescence or light scatter intensity. 
The DNA histogram cytometric cell-cycle analysis fraternity are well used to resolving the 
problem of overlap as this occurs at the G1:S and the S:G2+M interfaces of the histogram. G0, 
G1, S, and G2+M are phases during cell division and obviously have different DNA contents, 
which can be measured with DNA reactive fluorescent dyes by flow or image cytometry.  A 
considerable body of analytical work has addressed this problem [1-4]. In contrast, relatively little 
such work has been carried out in immunocytochemical studies, where the time-honored method 
of resolving histogram data has been to place a delimiter at the upper end of the control and 
then score any cells above this point as (positively) labelled. This approach can lead to large 
errors and is best overcome by improvements in reagent quality to increase the separation 
between labelled and un-labelled populations in a cytometric data set,  or by the addition of extra 
independent measurements like additional fluorescence parameters [5]. But, this may not always 
be possible and any subset overlap needs to be resolved. See chapter VI, section 1.2: 
Automated analysis: Automated Flow Cytometry Cell Population Identification and Visualization 
that discusses data analysis and display. The tools available to resolve any subset overlap in 
mixed populations require an understanding of (i) probability, ii) the type of distribution, (iii) the 
parameters of that distribution, and (iv) significance testing. An overlapping immunofluorescence 
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example is shown below in subsection 3.7 -  Immunofluorescence example. Additionally the use 
of statistical methods for drawing conclusions at the level of data, derived from cytometric 
measurements, is essential, but not covered here specifically. 
 
3.2 Probability  
Qualitative statements on probability are not very useful for quantitative analysis of cytometric 
data, which are affected by variability of sample collection, sample preparation, sampling, 
measurement imprecision, and variability in manual or automated data analysis. Statistics allows 
us to derive quantitative probabilities from cytometric data, especially as many data points are 
generally measured in flow cytometry. Probability designated with a p-value has a measurement 
range of zero, or absolutely impossible, to unity, or absolute certainty. Very few events, if any, 
occur with a p-value at these extremes. “The sun will rise tomorrow,” is a statement with a p-
value very close to unity. In contrast, “Man, one day, will run the 100 meters in 1 second,” has a 
p-value of zero. 
 
3.3 Types of distributions  
There are many distributions but those most commonly encountered in the biological sciences 
are the Gaussian, binomial and Poisson distributions. 
 
3.3.1The Gaussian distribution  
The Gaussian distribution (error function, “normal” distribution) is a bell-shaped curve 
symmetrical about a mean value with the following formula 
  
   
where  is the standard deviation andX is the mean of the distribution. Algorithms, based on 
the Gaussian distribution, have been used extensively for cell cycle analysis by flow cytometry.  
[4] 
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3.3.2 The binomial distribution  
The binomial distribution is concerned with occurrences of mutually exclusive events and is 
given by the formula 
 (p + q)n = 1          Eqn 2 
where p is the chance of something happening and q is the chance of that same something not 
happening. If we throw two regular six-faced dice, n in the binomial equation is 2 and this 
expands the equation to p2 + 2pq + q2 = 1. The chance of getting 2 threes on a single paired 
throw is p2 = (1/6)2, the chance of getting one three and any other number is  
2 pq = 2*1/6*5/6 and the chance that neither die will be a three is (5/6)2. Hence, the total 
probability is given by ((1/6)*(1/6)) + (2*1/6*5/6) + ((5/6)*5/6)) which sums to unity. Rosenblatt JI 
et al. describe the use of a binomial distribution based algorithm to optimize flow cytometric cell 
sorting. [18] 
 
 
3.3.3 The Poisson Distribution  
The Poisson Distribution is used to describe the distribution of isolated events occurring in a 
continuum, originally formulated by [6]. A good example is the number of cells passing the 
analysis point in the cytometer per second. Clearly you cannot ask the question of how many 
cells did not pass the analysis point per second, so neither the Gaussian nor the binomial 
distributions can handle this type of problem. In order to use the Poisson distribution all we need 
is z, the average number of times the event occurs within the continuum, where the probability of 
observing the event n times, p(n), is given by 
 
p(n) = zne-z/n!       Eqn 3   
 
where n! is factorial n. The notation for the whole distribution that sums to unity is 
 
           n=∞ 
  P =   zne-z/n!      Eqn 4 
        n = 0            
 
The Poisson distribution is important in cytometric cell sorting purity for investigating coincidence 
in which there could be a possibility of two or more cells being in the analysis point 
simultaneously. Poisson statistics also applies to the measurement of low intensity signals, 
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where just a few photons contribute to the measurement, and to the counting of rare 
subpopulations, discussed in some more detail below. 
 
3.4 Distribution parameters.  
These include measurement of (i) central tendency namely, the mean, percentiles, median and 
mode and (ii) dispersion parameters namely, the mean deviation, variance, standard deviation 
and coefficient of variation, wherein the last of these, the CV of limited statistical significance, is 
the standard deviation divided by the mean. 
3.4.1 Central tendency.  
The goal of many cytometry measurments is the determination of the expression level of a given 
marker in a cell and it’s distribution in a cell population. The mean of a distribution is the sum of 
all the data divided by the number in the distribution. The median is the point in the distribution 
where half the data lie on either side; it is the special case of percentiles, the point, where 50% 
of the data has been accumulated. 25th percentiles and 75th percentiles are also determined for 
distributions. The mode is the maximum frequency. But, this is an unreliable measurement of 
central tendency in cytometry for two reasons. First, the mode is meaningless if this is located in 
the first or last channel of the histogram. In some cases cytometry histograms have many off-
scale events, which makes the fist or last channel in the histogram the highest point, Second, 
even though a large number of cells will have been sampled, the distribution is not continuous, 
due to the analog-to-digital conversion (ADC) step i.e. intensity values are used as indices for 
incrementing histogram channels (e.g. 0 to 1023), and counting statistics as the standard 
deviation of a count in a discrete “channel” is equal to the square root of the count (more below 
under 1.4.6 – Rare cell analysis). Therefore typical unsmoothed cytometry histograms are often 
very noisy. Any 'noise' around the mode will give an erroneous result. The relationship between 
these parameters is shown in Figure 1. 
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3.4.2 Dispersion parameters  
Just as central tendency gives a measure of the overall “average” difference between Gaussian 
distributions, the dispersion parameters give a measure of the different spreads within and 
between those distributions. 
The mean deviation is given by (X -X). 
The variance, mean squared deviation, is given by (X -X)2. 
The standard deviation is given by √ [(X -X) 2]. 
3.5 Significance testing 
The central axiom in statistical theory is that the variance of the sum or difference of two 
independent and non-correlated random variables is equal to the sum of their variances. These 
tests are designed to give a measure of how different two or more distributed populations might 
be. 
The most commonly asked questions in cytometry are (i) is there more than one subset? and (ii) 
if there is more than one, how many cells are in each ? This is far too naive a perspective, and 
with the statistical tools available we should be asking the following: 
i) Is there more than one subset? 
ii) If there is more than one, how far “separated” are they? 
iii) What is the significance of that separation? 
iv) If the subsets are significantly separated, then what are the estimates of the relative 
proportions of cells in each ? 
v) What significance can be assigned to the estimated proportions? 
The statistical tests can be divided into two groups. (i) Parametric tests include the standard 
error of difference, Student's T-test and variance analysis. (ii) Non-parametric tests include the 
Mann-Whitney U test, Kolmogorov-Smirnoff test and rank correlation. 
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3.5.1 Parametric tests  
These may best be described as functions that have an analytic and mathematical basis where 
the distribution is known. 
3.5.1.1 Standard error of difference 
Every cytometric analysis is a sampling procedure as the total population cannot be analyzed. 
And, the standard deviation of a sample, s, is inversely proportional to the square root of the 
sample size, √N, hence the standard error of the mean, SEm = s/√N. Squaring this gives the 
variance, Vm, where 
Vm = s2/N       Eqn 5 
We can now extend this notation to two distributions withX1, s1, N1 andX2, s2, N2 representing, 
respectively the mean, standard deviation and number of items in the two samples. The 
combined variance of the two distributions, Vc, can now be obtained as,- 
Vc = (s12/N1) + (s22/N2)     Eqn 6 
Taking the square root of equation 6, we get the standard error of difference between means of 
and dividing this by Vc (the the two samples. The difference between means is               
standard error of difference) gives the number of “standardized” standard error difference units 
between the means; this standardized standard error is associated with a probability derived 
from the cumulative frequency of the normal distribution. 
3.5.1.2 Student's t (test).  
The approach outlined in the previous section is perfectly satisfactory if the number of items in 
the two samples are “large,” as the variances of the two samples will approximate closely to the 
true population variance from which the samples were drawn. However, this is not entirely 
satisfactory where the sample numbers are “small”. This is overcome with the t-test, invented by 
W.S. Gosset, a research chemist who very modestly published under the pseudonym “Student” 
[8]. Student's t was later consolidated by Fisher [7]. It is similar to the standard error of difference 
but, it takes into account the dependence of variance on numbers in the samples and includes 
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Bessel's correction for small sample size. Student's t is defined formally as the absolute 
difference between means divided by the standard error of difference: 
     Eqn 7 
When using Student's t, we assume the null hypothesis, meaning we believe there is no 
difference between the two populations and as a consequence, the two samples can be 
combined to calculate a pooled variance. The derivation of Student's t is discussed in greater 
detail in [9].  
3.5.1.4 Variance analysis 
A tacit assumption in using the null hypothesis for Student's t is that there is no difference 
between the means. But, when calculating the pooled variance, it is also assumed that no 
difference in the variances exists, and this should be shown to be true when using Student's t. 
This can first be addressed with the standard-error-of-difference method similar to paragraph 
4.1.1 where Vars, the sample variance after Bessel's correction, is given by 
  Eqn 8 
The standard error of the standard deviation, SEs, is obtained as the square root of this best 
estimate of the sample variance (equation 8). This is now divided into the difference between the 
two sample deviations. 
The second method of addressing the variance analysis is to use the variance ratio [10], 
designated the F-test by Snedcore [11]. F is calculated as the ratio of the greater variance 
estimate of sample variance to the lesser estimate of sample variance. After Bessel's correction 
we get the best estimate of the variances, 2, as, 
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       Eqn 9 
3.5.2 Non-parametric tests  
These rely on ranking methods where there is no known, or suspected, distribution that can be 
assigned to samples being analyzed. 
3.5.2.1 Mann-Whitney U  
This problem was originally addressed by Wilcoxon [12] and was later refined by Mann and 
Whitney [13]. Consider two sets of data, the X-group and Y-group, containing 5 and 4 values 
respectively; these are illustrated in Table 1. These values have been ordered according to 
magnitude in the 3rd row with their rank position in the last row. The populations from which the 
data were drawn are shown in rows 1 and 2, the Y-group and X-group respectively. It is clear 
that the Y-group is tending to be more to the right (greater magnitude) than the X-group, and the 
question is whether this arrangement could have occurred purely on a random basis. To do this, 
we determine how many x-values lie to the right of every y-value and sum the result to get Uy for 
the Y-group. There are three x-values (x3, x4 and x5) to the right of y1 and one x-value to the right 
of y2, thus Uy sums to four. The same process is now carried out for the x-group to give Ux equal 
to 16. For small sample numbers this procedure is satisfactory but it can be prohibitively time-
consuming for large samples for which the following expressions are used. 
     Eqn 10 
Nx and Ny are the number of values in the X- and Y-groups respectively and Ty and Tx are the 
sums of the rank positions for the Y- and X- groups respectively. 
If the X- and Y-values are randomly distributed in the rank, the sum of the rank position T has a 
mean value ofT and a variance of T2 given by the following expressions. 
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  Eqn11 
These values ofTx andTy will be identical if Nx and Ny are equal, but the variance, T2, will be 
the same irrespective of the numbers in each group and is given as, 
      Eqn 12 
If both samples are large, >20, we take the values of T andT associated with the smaller of the 
pair of U-values, in this example the Y-group, to calculate the Z-statistic as follows, 
     Eqn 13 
The numerator in equation 13 represents the difference between the values of T for the Y-group 
and the mean,T that would be expected if the numbers were randomly distributed within the 
rank structure and the denominator is the square root of the variance. Hence, Z represents the 
observed deviation from the mean in standard deviations units and the associated probability 
can be read off from the cumulative frequency of the normal curve because, for large samples, 
the Z-distribution approximates very closely to the Gaussian distribution. 
With small sample sizes, e.g. with less than 30 values,  the Z-distribution does not approximate 
to a Gaussian curve, and Mann and Whitney   computed the probabilities associated with U-
values for different-sized samples. These data are arranged in tables for N2 = 3, 4, 5, 6 etc. and 
within each table there are sample sizes for N1 = 1, 2, 3, 4, 5 etc. versus the U-values and 
associated probabilities for the N2 and N1 sample sizes. The example for N2 = 5 is shown in The 
sample size of the X-group (N2 in table 1) is 5, and the associated U-value is 4. The number of 
data points in the Y-group is also 4, and hence, the probability that this distribution of data points 
in Table 1 can be read off as 0.095 in Table 2 that does not reach “significance” at the 1:20 level 
(0.05). 
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3.5.2.2 Kolmogorov-Smirnoff (K-S) statistic  
In the Kolmogorov-Smirnoff (K-S) statistic, D is a measure of the maximum vertical displacement 
between two cumulative frequency distributions. The one-tailed test compares an experimentally 
derived distribution with a theoretical cumulative frequency distribution and, the two-tailed test 
compares two experimentally derived distributions (for more detail, see Chapter 6 in [14]). In any 
biological system, a test sample should always be compared with a control, ie. the two-tailed 
test, and this was first used in flow cytometry by Young [15]. 
The cumulative frequency distributions containing n1 and n2 cells in the control and test samples 
respectively can be calculated as follows for i = 1  256, 
   Eqn 14 
These cumulative frequencies are now normalized to unity and the null hypothesis is assumed 
(ie. both distributions are samples derived from the same population) where the probability 
functions P1(j) and P2(j) that underlie the respective frequency density functions (the histograms) 
 n1(j) and n2(j) are samples assumed to be drawn from the same populations so that,- 
P1(j) = P2(j), -  j  +      Eqn 15 
The D-statistic is computed as the maximum absolute difference between the two normalized 
cumulative frequency distributions over the whole of the two distributions, where: 
D = maxjFn1(j) - Fn2(j)      Eqn16 
As with the Mann-Whitney U, there is a variance, Var, associated with the assumed common 
population from which the two samples, containing n1 and n2 items respectively, are drawn. This 
is given by 
       Eqn 17 
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The standard deviation s can now be found by taking the square root of this relationship, then 
dividing D by s gives Dcrit, where: 
     Eqn 18 
This type of relationship, in which we divide a difference by a measure of dispersion, has been 
seen in all the other statistical tests described previously. Two-tailed critical Dc for large samples, 
along with their probabilities, are shown in Table 3. 
3.5.2.3 Rank correlation  
Correlation between two or more sets of measurements can be determined with Spearman's 
rank correlation coefficient [16]. This enables an objective assessment to be made regarding the 
consistency between paired laboratory results as in the purely hypothetical data shown in Table 
4. 
When we look through these data, we find that both laboratories score sample 8 with the lowest 
results and in both cases these are ranked 1. Sample 9 from lab A has the next lowest value 
(0.07) and is ranked 2 but, it is sample 10 (0.12) that is ranked 2 in the lab B series, and these 
ranking positions are shown in Table 5. 
In terms of ranking alone, the two laboratories agree exactly for only 4 of the 10 samples, 
namely 1, 4, 6 and 8. Spearman's rank correlation coefficient R is given by the expression 
       Eqn 19 
d2 is the sum of the squared rank differences and n is the number of samples;  in our particular 
example, these values are 20 and 10, which gives R = 0.8787. This coefficient was designed to 
have a value of +1 if there is perfect ranking agreement and -1 where there is total ranking 
disagreement. 
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This value of 0.8787 for R would suggest that there is fairly close agreement between 
laboratories and where there are 10 or more samples being compared we can use Student's t to 
assess the significance of comparison. 
Student's t = R  ((n -2)/(1 – R2))     Eqn 20 
which gives t = 5.2 with 8 degrees of freedom associated with p < 0.01, which is highly 
significant and suggests there is close agreement between laboratories. However, this does not 
tell us anything about the quality of the “inter sample” agreement from the two laboratories. This 
can be addressed by analysis of the differences in results from the laboratories as shown in 
Table 6.  
The mean differenceX is calculated by summing the data in the difference row and dividing by 
n, the number of samples which gives -0.052. If there are no differences between laboratories, 
this mean value should not differ significantly from zero since any random differences should 
cancel out. 
The variance, s2, is calculated from the convenient relationship as, 
s2 = (X2/n) -X2        Eqn 21 
where X2 is equivalent to d2 = 0.0824 yielding s2 = 0.0055. After Bessel's correction and using 
equation 6, we get Student's t = 2.1. This value of t, with 9 degrees of freedom, does not quite 
reach the 5% probability level and we can conclude that the inter-laboratory differences are not 
significant. However, in a quality control exercise such as this, we would be justified in setting 
more stringent statistical criteria. If we now take a probability level of 0.1 for magnitude 
discrepancies between laboratories, which would be reasonable as we know they should be 
getting the same results, we must conclude there is something suspicious occurring in the 
generation of the results, which would require further investigation.  
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3.6 An example from immunofluorescent staining in cytometry.  
Figure 2 shows a histogram representation of weak staining of a small population. Statistical 
analysis of this datum must ask a number of questions. 
First, is there any difference between these two datasets? This is addressed with a Kolmogorov-
Smirnoff analysis, which reveals that there is a maximum normalized vertical displacement of 
0.0655 at channel 37 with 8976, N1, and 8570, N2, cells in the control and test sample 
respectively (Figure 3). K-S statistic gave p < 0.05, suggesting there is a statistical difference 
between the two datasets at the 1:20 probability level. The remaining data shown in this figure 
will become apparent later. 
Second, can we establish the “meaning” of the supposed shoulder in the lower histogram of 
Figure 2?  This is addressed analytically using a concept derived from mechanics; namely, 
taking moments about a point. Imagine a weightless beam with two different weights hanging 
from the beam  that will balance according to equation 22 
W1 (B –X1) = W2 (X2 – B)       Eqn 22 
where W1 and W2 are the “weights” hung from the beam, B is the balance point, andX1 andX2 
are the distances of the respective weights from the balance point, B. On rearranging equation 
22, we get, 
B =( (W1X1 ) + (W2X2))/(W1 + W2)     Eqn 23  
Let us suppose that the distancesX1,X2 and B are known for a normalized total mass of unity, 
where W1 + W2 = 1. We can now calculate the relative proportion of W2 by replacing W1 with (1.0 
– W2) in equation 23 and simplifying to give 
W2 = (B –X1)/(X2 –X1)       Eqn 24 
The “weight” in equation 24 that will now be referred to as “labeled cells”, is defined  by three 
distances namely,X1,X2 and B.X1 is the mean of the control unlabeled fraction, B is the mean 
of the test sample containing labeled and unlabeled cells, and both of these can be obtained 
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directly from the experimental data. We now need to obtainX2, the mean of the labelled fraction, 
as follows. 
It has been shown in [17] that the mean of the distribution obtained by subtracting the N2 
cumulative frequency from the cumulative frequency of N1, is independent of the number of cells 
in N1 and, the mean of the subtracted distribution Dm, depicted in Figure 3, is exactly half way 
between the means of N1 and N2. However, this applies to a continuous distribution and all 
cytometric distributions are not continuous due to the ADC conversion and a half channel 
correction must be applied to give the mean of the N2 distribution as 
X2 = (2.0  (Dm + 0.5)) –X1      Eqn 25 
All the data have now been derived to calculate the proportion of cells in the N2 distribution as 
W2 from equation 24 by substituting theX2 of equation 25 and simplifying to give 
W2 = (B –X1)/(2.0  (Dm + 0.5 –X1))     Eqn 26 
The data depicted in Figure 2 were analyzed according to this ratio analysis of means to giveX1 
= 29.1, Dm = 37.4 andX2 = 46.7 as shown on the figure and the predicted proportion in N2 was 
0.08. These data are shown in Figure 4 where the control, test sample and the predicted labeled 
fraction are labelled on the figure. The test sample results are shown Table 7. We now have to 
ask if this result is reasonable and what significance can be placed on the result: 
 
3.6.1 Kolmogorov-Smirnoff analysis 
The cumulative frequency distributions of the control and test sample were re-analyzed over a 
range of ±3 standard deviations (SD) about the mean of the predicted labeled distribution,X2. 
With the number of cells involved, the K-S analysis showed that the two cumulative frequency 
distributions over this ±3 SD range had a probability of being different at the 99% confidence 
interval, p < 0.01. 
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3.6.2 Student's t 
The results from the analysis of the test sample shown in Table 7 were also submitted to 
Student's t analysis (chapter 7 in [9]). This gave t = 65.58 with 8,568 degrees of freedom, p < 
0.001. 
Hence, we can present the results in probabilistic terms by saying the analysis was compatible 
with two subsets with means separated by 17.6 channels containing 92% and 8% of the 
population at the 99% confidence interval. 
This analysis should only be used for symmetrical data sets with constant, or near constant, 
variance, and these data were chosen for illustration as they conformed to this condition. 
However, there are a number of other factors that should be considered, including positive skew 
that tends to be minimized with log-amplification as discussed elsewhere [17]. Nevertheless, this 
analysis goes some way to producing a more statistically convincing method of presenting 
results of immunofluorescence data. 
 
3.7 Rare cell analysis  
Flow cytometric analysis of cell samples is often applied to characterize subsets of very low 
frequency, ranging from 1% to less than 1 ppm. In those cases, it is very important to 
understand the inherent variation when randomly sampling a small number of events. As 
mentioned above, the standard deviation of a count is the square root of the number, e.g. when 
sampling from a cell/particle suspension several times a volume, which should contain 4 
cells/particles the standard deviation will be 2, the coefficient of variation 50%.  
If enough cells in the full sample are available, cytometric data acquisition should be continued 
until a number of cells is reached in the rare subset which assures the desired measurement 
precision – a feature available in most commercial data acquisition software. If not enough cells 
are available, care must be taken to not come to conclusions, which are not supported by the 
limited precision associated with limited acquisition. 
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Table 8 shows an example, where four consecutive determinations indicated a progressive 
change of a property; but all of the data is from the same distribution, and there is no change 
from series 1 to series 4 (the data is from a simulation with a RANDOM.ORG Gaussian random 
number generator with a mean of 4.0 and a standard deviation of 2.0). This issue is discussed in 
more detail in a paper by M. Roederer [19]. 
In certain cases the limitation of the imprecision of counting small numbers of cells can be 
overcome. For example one can evaluate a bulk cell separation technology by dispensing a 
known number of cells into a sample, subjecting the sample to a separation process, and 
analyzing the total volumes of the resulting fractions. 
 
Figure 1:  
Measurements of central tendencies for cytometric intensity histograms.  The curve is an ideal 
distribution, showing key measurements. Cytometric intensity histograms span a finite intensity 
range with a noisy curve and frequently with off-scale events at the lower and/or upper end(s) of 
the scale. Generally the median is the most robust measure, because the mean is heavily 
influenced by off-scale events and the mode by noise. 
Figure. 2 
The histogram representation of fluorescence  from a weak staining of a small  (rare) population. 
The upper histogram shows an unstained control. A small shoulder from the staining of the rare 
population is visible in the lower histogram. 
Figure. 3 
Cumulative frequencies from the two histograms in Fig. 2 and difference. Details on the 
calculation of X̅1̅, X̅2̅, and Dm are described in the text. 
 
Figure. 4 
Result of the histogram analysis. The two original histograms and the calculated stained 
population are shown with population means. 
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Table 1 
Comparison of two data sets X and Y in a rank analysis. The values have been ordered 
according to magnitude in the 3rd row with their rank position in the last row. The populations 
from which the data were drawn are shown in rows 1 and 2, the Y-group and X-group, 
respectively. It is clear that the Y-group is tending to be more to the right (greater magnitude)  
than the X-group, and the question is whether this arrangement could have occurred purely on a 
random basis. 
Table 2 
Part of the Mann-Whitney probability table example for the X-group  size of Table 1 (N=5).  
Table 3 
Kolmogorov-Smirnoff (K-S) statistic critical values, Dc, with their associated p-values 
(probabilities) 
Table 4 
Hypothetical results of the same determinations from two different laboratories. 
Table 5 
Ranking of the data from table 4 with rank differences, d, and d2 
Table 6 
Differences between valuesfrom Table 4 by subtracting Lab B results from those of Lab A. 
Table 7 
Results of the immunofluorescence analysis example, taken from Watson (2001) [17] 
Table 8 
Illustration of potential interpretation problems, when counting extremely rare cells.  
The table shows hypothetical counts from four different samples with five measurments per 
sample for a total of 20 measurements.  The table indicates a trend from sample 1 to 4, however 
all of the data is from the same distribution, and there is no change from 1 to 4. (The data is from 
a simulation with a RANDOM.ORG Gaussian random number generator with a mean of 4.0 and 
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a standard deviation of 2.0. The cumulative mean and standard deviation from the 20 values 
approximate the real population numbers well.) 
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Section 4 – Analysis presentation and publication (MIFlowCyt) 
 
4.1 Introduction 
The complexity of cytometric data requires careful consideration of how to display results in 
scientific presentations and publications in order to make them understandable “at a glance”. To 
easily reproduce published cytometric experiments the used methods and results need to be 
described and presented comprehensively. 
By flow cytometry, thousands of cells are acquired within seconds by obtaining information about 
their scatter properties and expression of multiple markers. Manual analysis of these multi-
dimensional and complex data requires special software skills, gating knowledge, time and can 
be quite laborious. Manual gating is still considered by most cytometrists to be the "standard", 
although semi-automated algorithms exist. Some basic rules for data visualization allow 
presenting these data in a directly comprehensible format. 
 
4.2 Minimal display requirements 
First of all, the full gating strategy should be displayed so that data analysis strategy used is 
obvious to the reader. This display should also include the position of positive and negative 
controls and essential statistical information, such as the percentage of cells in the region or 
gate or event count. Axis legends should include the marker (e.g. antigen) and the dye used, 
and show the scaling (log/lin). This information should also be provided in the source list-mode 
data and non-informative legends such as FL-1A, FL-1H etc. should be avoided. Simple 
experiments with one or two colors can be presented in one dimensional histograms (Fig.1 A); 
this allows easy comparison of the expression level of the marker of interest for different 
samples in overlay histograms. Within these histograms, positive and negative populations can 
be easily distinguished from one another. For better comparison, the histograms should be 
normalized, i.e. the maximum values set to 100%. 
 
More common is a display using two dimensional pseudocolour density plots (Fig.1 B). Plotting 
the expression of two markers against each other allows a more precise distinction of double 
negative, single positive and double positive, as well as weakly or strongly labelled subsets. The 
2D-plot presentation also helps to identify errors of automated compensation for manual 
correction, as needed. Usually, axes scaling is logarithmic for immunofluorescence and gene 
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expression analysis. Linear axes are mostly used to display light scatter signals and DNA 
content in cell cycle analysis. In order to better visualize the quality of compensation especially 
of dim and negative markers the logarithmic scale should be transformed into a biexponential 
scale. Correctly compensated negative cells should them be evenly distributed as one 
population between the negative and the positive log-scale. 
 
Multi-color experiments are normally analyzed by a sequential gating strategy. A full gating 
strategy is performed in a step by step procedure (an example can be found in [1,2]). To analyze 
discrete populations such as T-cell subsets within blood samples in a first step CD45 negative 
red blood cells (CD45 expression vs. scatter) are excluded. Furthermore, only lymphocytes are 
gated based on their scattering signals (FSClow, SSClow). By exclusion of CD3 negative B cells 
(CD16/56-) and NK cells (CD16/56+) only CD3 positive cells will be analyzed in the next step. 
By the expression of CD16/56 NKT cells (CD3 vs. CD16/56) can be excluded from T cells. In a 
final step CD4+ T-helper cells and CD8+ cytotoxic T cells (CD4 vs. CD8) can be analyzed see 
(Figure 1B). This process is strongly driven by a priori expectation and knowledge of the scientist 
analyzing the data. That means the scientists will expect e.g. to analyze within the T cells at 
least four subsets: CD4+ CD8- T-helper cells, CD8+ CD4- cytotoxic T cells, CD4+ CD8+ 
immature T cells and CD4- CD8- mature T cells. But within these subsets additional T-cell 
subsets might be neglected that will be taken into count by an automated approached. Keep in 
mind, by using small (conservative) gates instead of overlapping gates, disease-specific cells 
might be excluded already in the first step of the analysis, or novel subsets might not be 
recognized. 
 
Analyzing data by the conventional step by step method in sequential 2D-plots has several 
drawbacks: e.g. loss of information by the loss of rare cell subsets by pre-gating, and some 
marker combinations that might help to further subdivide a subset might not be analyzed. With 
the constant increase of the complexity of cytometric measurements and data, there is also a 
need to develop new algorithms to analyze and visualize these complex data. One example for a 
user-friendly visualization of multi-dimensional data at one glance is the radar plot (e.g. provided 
as a visualization tool in the Kaluza® software by Beckman-Coulter), which plots pre-gated 
subpopulations in a multi-parameter way (Fig.1C); this makes it possible to analyze the 
heterogeneity of the pre-gated populations and to identify new subpopulations. We demonstrate 
this using data of a healthy subject and a cancer patient from the German LIFE study [3]. 
Comparing the lymphocyte population of the patient with chronic lymphocytic leukemia (CCL: 
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lymphocyte count >90% of all leukocytes) with an age- and gender-matched healthy subject 
(lymphocyte count <20% of all leukocytes) in a CD3:CD16/56 dot-plot shows a massive increase 
in the B-cell compartment in the leukemia patient vs. the healthy control (Fig.1B). By just one 
glance the different distributions of all leukocyte subsets can be seen in the radar-plot 
presentation (Fig.1C), resulting in two completely different patterns for healthy and diseased 
subjects. Radar-plots also allow the visualization of higher-dimensional features which fail to be 
identified by lower dimensional visualization, such as by conventional 2D projections. Examples 
are (Fig. 1C) at least 3 subsets T-helper T-cell subsets can be clearly distinguished in the 
sample of the healthy individual (marked by *) and two different cytotoxic T-cell subsets (marked 
by #). 
 
Besides manual analysis and their visualization, several methods exist to perform software-
assisted, unsupervised or supervised analysis [4]. For example, using several open source R 
packages and R source codes often requires manual pre-gating, so that they finally work just as 
a semi-automated computational method. For identification of cell populations e.g. FLAME 
(suitable for rare cell detection based on clustering techniques), flowKoh (self-organizing map 
networks are produced) or NMFcurvHDR (density based clustering algorithm) are available [4]. 
Histograms (2DhistSVM, DREAM–A, fivebyfive), multidimensional cluster maps (flowBin) and 
spanning trees (SPADE) are suitable visualization tools for sample classification [4]. To find and 
identify new cellular subsets of the immune system in the context of inflammation or other 
diseases analysis in an unsupervised manner, approaches such as by SPADE (spanning-tree 
progression analysis of density-normalized data [5]) can be a better approach. 
 
Out of a plethora of today existing dimensionality-reduction based visualization tools we will 
show examples with the SPADE tree. SPADE is a density normalization, agglomerative 
clustering, and minimum-spanning tree algorithm that reduces multidimensional single cell data 
down to a number of user-defined clusters of abundant but also of rare populations in a color-
coded tree plot (Fig. 2). The tree plot structure was generated from healthy and CLL samples 
representing 15-dimensions, the clustered expression of 13 markers and scatter characteristics 
[2]. Each node summarizes cells of identical phenotype concerning the 15 parameters. In near 
vicinity nodes with cells of similar phenotype are arranged. Therefore, related nodes can be 
summarized in immunological populations determined by their expression pattern. For instance, 
red blood cells were annotated on the right branch of the tree plot based on the absence of 
CD45 and their scatter characteristics (Fig. 2). SPADE trees are in general interpreted as a map 
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of phenotypic relationships between different cell populations and not as a developmental 
hierarchical map. But finally SPADE tree maps help to (i) reduce multi-parameter cytometry data 
in a simple graphical format with cell types of different surface expression, to (ii) overcome the 
bias of subjective, manual gating, to (iii) resolve unexpected, new cell populations and to (iv) 
identify disease-specific changes. Other ways for comprehensive analysis and display of 
complex data can by unsupervised approaches can be found in [6] and include Heatmap 
Clustering, viSNE and Phenograph. 
 
4.3 Presentation checklist for publication (MIFlowCyt) 
 
Next to the appropriate illustration of flow cytometry data it is crucial that the essential details of 
flow experiments are displayed in order to allow others to accurately reproduce the experiments. 
Lack of reproducibility is of great concern in biomedical research and rough estimates say that 
up to 50 % of the results published are not reproducible, meaning billions or trillions US$ of 
funding money lost [7,8]. To reduce this problem the MIBBI (Minimum Information for Biological 
and Biomedical Investigations) project was launched in 2008 [9]. Its goal is to provide 
comprehensive checklists for different types of experiments so that all essential information for 
repeating the experiment is provided. Relevant for flow cytometry is MIFlowCyt (Minimum 
Information about a Flow Cytometry Experiment) [10]. These standards were defined by an 
international group of cytometry experts from bioinformatics, computational statistics, software 
development, and instrument manufacturers, from clinical and basic research. With this 
information, cross-experiment comparisons are possible. Several scientific journals, the first 
being Cytometry Part A, have adopted these regulations, as have journals from the Nature 
Publishing Group and the European Journal of Immunology but so far journals have only rarely 
implemented them. MIFlowCyt-compliant manuscripts should have a checklist table containing 
information on reagents, instrumentation, and experimental setup, including information on 
controls, gating strategies, among others (for details see [10], table 1). Importantly, it is required 
that original primary list-mode data are made publicly available in an open access data base 
such as the FlowRepository. This allows others to analyze published data by alternative 
methods and better understand the published material. 
 
Although several MIFlowCyt-compliant manuscripts for flow data have been published in 
Cytometry Part A, comparable guidelines for image cytometry (e.g. MIImaCyt) have not been 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VI: Evaluation/Data handling 
Section 2 – Analysis presentation and publication (MIFlowCyt) 
 
191 
 
adapted so far [11]. In order to improve the quality of polychromatic flow cytometry, a special 
publication type for multicolor flow cytometry protocols, Optimized Multicolor 
Immunofluorescence Panels (OMIP), was developed in Cytometry Part A [12]. The central issue 
in multicolor flow cytometry is to demonstrate that the developed multiplexed panel has been 
optimized by testing different reagents and reagent combinations. Until now, 34 different OMIPs 
have been published with the aims of (i) reducing the time to develop similar panels and (ii) 
providing a starting point for the development of new panels, or for optimizing existing ones. 
OMIPs present unique reagent combinations, document the developing progress, explain the 
final choice and should be useful to a wide range of readers.  
 
To avoid biases by manual analysis of high complex flow data software tools are available that 
work partly operator independent. This stresses also the importance of the reproducibility in 
complex, (semi)-automated data analysis [13]. O`Neill and Brinkman have recently suggested 
that certain data besides compensation, gating details and mathematical algorithms, should be 
shared for reproducible FCM bioinformatics [14]. One major aim is to make FCM data easily 
accessible to the users by open-access databases for flow data (e.g. FlowRepository), as well 
as the code sources. A series of data sets have already been provided by the FlowCAP (Critical 
Assessment of Population Identification Methods) project, comparing different mathematical 
models and automated methods for analysis. The cytometry community has already made great 
steps toward reproducible research by standardizing instrumentation, measurement and data 
analysis, but still looks forward to optimize the reproducibility in different cytometry fields. 
 
Figure legends: 
 
Figure 1. Uni-, bi- and multi-parameter presentation of flow data. Comparison of two gender- and age 
matched patients: a healthy one (67 years) and a patient with B-CLL (64 years) from [3]. (A) 1D-histogram 
presentation of CD3 expression on lymphocytes (red: B-CLL, grey: healthy), (B) 2D-dot-plot presentation 
of CD3 expression on x-axis vs. CD16/56 expression on y-axis, (C) multivariate presentation of expression 
of 12 different antibodies on 9 colors (OMIP-023, exclusion of low CD25 expression) for 9 different 
leukocyte subsets in a radar-plot. Abbreviations used: B-CLL (B-cell chronic lymphocytic leukemia), Th 
(CD4+ T-helper cell), Tc (CD8+ cytotoxic T-cell), NK (natural killer cell). 
 
Figure 2. Semi-automated analysis of flow cytometric data by SPADE. Spanning-tree progression 
analysis of density-normalized data (SPADE) is a technique described in [5]. (A) Identification of 
nodes based on scatter characteristics and CD45 expression. (B) Comparison of expression of HLA-DR 
and CD4 on blood cells for two male patients: (1,3) a healthy one (67 years) and (2,4) a patient with B-
CLL (64 years). Color codes correlate with expression level from low (blue) to high (red) and size of the 
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nodes correlate with cell frequencies.  For SPADE tree construction by pre-gating doublets were 
discriminated and removed, 500,000 events were downsampled to 20,000, target node number was 100 
and cluster markers (12) were scatter channels (FSC, SSC) and fluorescence channels (FL1-10). 
 
Table 1: Important provided data for cytometric publications. (*part of MiFlowCyte). 
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Section 5 – Data repositories – sharing your data 
 
Scientific research is more data intensive and collaborative than ever before. Transparency and 
public availability of well annotated data is crucial for independent validation, verification and 
extending research from prior results [1]. The availability of primary data is therefore increasingly 
required by national policies, international regulatory bodies, scientific journals as well as 
research funding agencies [2-6]. 
 
In both, fluorescence-based and mass-based flow cytometry, primary data is generally 
represented by FCS files that contain a matrix (table) of expression values of all measured 
“channels” (characteristics) of all particles (cells) analyzed by the instrument. These files should 
be properly annotated as per applicable domain-specific guidelines. In flow cytometry, such 
guidelines are represented by the Minimum Information about a Flow Cytometry Experiment 
(MIFlowCyt) [7]. In additional, the biosharing.org portal (MIBBI project [8]) should be checked for 
extra requirements that may be applicable. 
 
Depositing data in a public repository is generally the recommended, and increasingly the 
required way of sharing flow cytometry data. Below, we introduce four public repositories 
suitable for flow cytometry data: Cytobank [9, 10] (http://www.cytobank.org/), FlowRepository 
[11, 12] (https://flowrepository.org/), ImmPort [13,14] (https://immport.niaid.nih.gov), and 
ImmuneSpace [15] (https://www.immunespace.org/). An overview with technical notes and 
highlighted features is provided in Table 1. 
 
Cytobank is an online data analysis and management platform developed and hosted by 
Cytobank Incorporated. A community version of Cytobank provides free functionality including 
web access, data storage, experiment sharing and basic online online analysis. The Community 
version of Cytobank contains close to 400 public experiments (datasets) from about 60 different 
authors. In addition, Cytobank offers paid Premium and Enterprise versions with advanced data 
analysis options (including SPADE [16] and viSNE [17, 18]), better customer support and 
dedicated computing resources. If your lab is using Cytobank already, then choosing its 
Community version presents a straightforward option of sharing your data publicly. In addition, 
all versions of Cytobank give you the option of sharing data privately with your collaborators. 
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FlowRepository is a public repository allowing researchers to deposit, annotate, analyze, share 
and publish flow cytometry data, mainly those associated with peer-reviewed manuscripts.  The 
repository is provided free of charge by the International Society for Advancement of Cytometry. 
While FlowRepository was developed by extending Cytobank's code base, the two platforms 
drifted apart by adding different functionality over the past 5 years. However, there are still many 
common aspects allowing users of one system to adapt to the other easily. While Cytobank's 
platform offers more advanced data analysis options, FlowRepository focuses on data sharing 
and annotations, including a full support of MIFlowCyt. In addition, FlowRepository works closely 
with several scientific journals and allows for linking data with related publications. Collaboration 
with Thomson Reuters and FlowRepository's Data Citation Index interface help researchers get 
proper credit for deposited data. Unlike with most other repositories, users don't need to register 
in order to download public data from FlowRepository. They can do so anonymously by using a 
web-based interface, or from within the R statistical language using the FlowRepositoryR 
BioConductor library, or from within FlowJo using the FlowRepositoryServer plugin. At this point, 
FlowRepository contains over 600 data sets uploaded by 300 scientists and links to papers in 23 
different journals. 320 data sets are currently public and most of the remaining data are related 
to ongoing studies where underlying data will be released along with publication of the study 
results. Depositing data to FlowRepository is recommended by Nature, Cytometry Part A and 
PLOS journals.  
 
The Immunology Database and Analysis Portal (ImmPort) system provides an archive of 
immunology research data generated by investigators mainly funded through the National 
Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Division 
of Allergy, Immunology, and Transplantation (DAIT). It is an extensive data warehouse 
containing an integration of experimental and clinical trial data generated by dozens of assay 
types, including 63 flow cytometry and 5 CyTOF data sets. In addition, the ImmPort system also 
provides data analysis tools and it contains implicit knowledge and ‘‘best practices’’ for clinical 
and genomic studies in the form of nearly 50 templates for data deposition, management, and 
dissemination. ImmPort has been developed under the Bioinformatics Integration Support 
Contract (BISC) by the Northrop Grumman Information Technology Health Solutions team for 
the NIH NIAID/DAIT. If your research funding comes from this source and you are generating 
immunology data, you should deposit it in ImmPort. Immport’s support for different data types 
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can be another reason to choose it if you are generating flow cytometry data as well as data 
from different types of assays. A (free) registration and approval by DAIT is required in order to 
deposit and access data from ImmPort.  
 
ImmuneSpace is a database and analysis engine built by customizing the LabKey server for the 
Human Immunology Project Consortium (HIPC). ImmuneSpace can be used to find and explore 
studies, integrate and analyze data across assays, and perform custom analysis directly from 
within R. ImmmuneSpace takes advantage of the infrastructure already developed for ImmPort, 
and in many cases, ImmuneSpace provides a new interface and new complimentary tools to 
data that are also available in ImmPort. Currently, ImmuneSpace can be used to access 12 
large (741 participants) HIPC studies with flow cytometry data, and 4 HIPC studies with CYTOF 
data. The typical data submission work flow consists of data submission to ImmPort using a set 
of standardized data templates. If you are a HIPC participant, then your data should be 
deposited to ImmuneSpace; otherwise, you can still use ImmuneSpace as a valuable resource 
of HIPC data and analysis tools. 
 
If you are in a clinical setting, there is one important thing to consider before you start sharing 
your flow cytometry data by depositing it in any of the repositories. Besides the expression 
matrix, FCS data files contain a segment with keyword/value pairs. Most of the keyword values 
keep basic information essential for the interpretation of the raw data matrix and acquisition 
settings related values. These include the number of acquired parameters, their names, 
acquisition voltage settings, the total number of events (particles), and many other keywords as 
specified in the FCS data file standard. In clinical settings, some of the keywords may include 
information that could be used to identify the subject that was the source to generate the data in 
the file. Such information has to be removed prior to sharing the data file in order to comply with 
patient privacy requirements as specified by the Health Insurance Portability and Accountability 
Act (HIPAA) [19] in the U.S.A. and similar rules enforced by regulatory agencies in most other 
countries. Patient data must be properly protected and cannot be publicly shared; however, 
those rules generally don’t apply as long as the data is properly de-identified. De-identification is 
the process of removing identifiers that could be used to identify an individual. Identifiers include 
items such as patient name, social security number, other public ID numbers, date of birth, etc. 
as specified by HIPAA and other applicable regulations. There are several standalone tools 
available for the de-identification of FCS files as listed, for example, in the FlowRepository Quick 
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Start Guide (http://flowrepository.org/quick_start_guide). Alternatively, if you decide to upload 
your data to FlowRepository, you can use the fully automated FCS de-identification that is 
integrated in the FlowRepository data upload process. In order to use this feature, you will need 
to select the Java-based data upload when depositing data, not the default HTML5-based 
upload. 
 
Table 1: Overview of repositories for flow cytometry data 
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Section 1 - Organisms, cells, organelles and chromosomes  
Flow cytometry allows information about the structural and chemical characteristics of particles 
to be measured. Although the most common applications of flow cytometry use single 
mammalian cells, it is also applicable to studies of bacteria, yeast and viruses as well as whole 
organisms such as nematodes and Drosophila. Conversely, parts of cells such as isolated 
nuclei, chromosomes or organelles may also be examined. This chapter serves as an overview 
of the diverse cell types and particles that may be examined using flow cytometric techniques. 
1.1 Organisms 
Model systems are used to study molecular biology, developmental biology and neurology and 
an example of this is the use of Caenorhabditis elegans. These organisms are around 1mm in 
length, can be cultivated in large numbers and have a short life cycle which makes them ideal 
for studying many areas of developmental biology. Particles of this size are not able to pass 
through the injection port and flow cell of most cytometers so specifically designed analysers 
and sorters are available to identify and separate these organisms as well as, for example, 
Drosophila melanogaster and Zebrafish embryos [1]. These large particle sorters can also be 
used for analysing and sorting groups of cells such as imaginal discs, pancreatic islets or 
embryoid bodies which can be up to 200 um [2, 3, 4]. Unlike traditional droplet sorters, these 
sorters use a puff of air to divert particles of interest into a collection receptacle. 
1.2 Cells 
Flow cytometry is perfectly suited for cells that are naturally in suspension e.g. blood, but any 
multicellular system (cell lines, tissue samples, whole organisms) may be made into single cell 
suspensions using a variety of mechanical and enzymatic techniques. In all cases there is a 
balance between creating a good single cell suspension and keeping cell viability high as well 
as ensuring that any disaggregation technique does not have a detrimental affect on the antigen 
under study (see Chapter IV, Section 3, “Preparation of single cell suspensions”). It is always 
important to make sure that measurement excludes dead cells as these will show increased 
autofluorescence and may bind antibodies and probes non-specifically. Exclusion of dead cells 
may be achieved by adding a viability dye - either a DNA binding dye such as DAPI or 
Propidium Iodide or an amine-reactive dye which will bind to proteins [5, 6]. Although individual 
cells will not be as large as whole organisms there is still a range and it is important to know the 
size of the cells under study. This is particularly important in cell sorting when the nozzle used 
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should be appropriate to the cell type. The nozzle size should be approximately 3-4 times the 
size of the cell. So for small cells such as lymphocytes which will be 8-12 m, a 70 m nozzle is 
appropriate, whereas many cultures cells such as HeLa cells are larger, around 20 m, so a 100 
m nozzle would be used. Some cells sorters can use nozzles up to 200 m for use with very 
large cells such as cardiomyocytes. With flow analysers, the flow cell is usually larger so it is 
possible to use a greater range of cells sizes although greater care should be taken with the 
preparation of larger cells to prevent clogs of the sample injection probe. 
 
Any part of a cell may be labeled with a fluorescent probe but it is important to remember that 
flow cytometry gives whole cell information, there is no localization of the fluorescence in or on 
that cell nor any idea about its distribution within the cell. To determine the location of 
fluorescence an imaging technique is needed e.g. fluorescence or confocal microscopy or 
imaging flow cytometry [7]. 
1.3 Nuclei 
Sometimes only the DNA or a nuclear protein is of interest and in these cases, cell nuclei can 
be produced which often will have less non-specific binding and therefore a cleaner 
background. Production of nuclei from cells can be achieved in unfixed samples by treating cells 
with a detergent e.g. 0.1% Triton-X100 which will lyse cells and release nuclei [8]. Or in fixed 
samples, cells may be treated with an enzyme such as pepsin which will digest the cytoplasm 
and again release nuclei [9]. Isolated nuclei will often give a lower CV (coefficient of variation, a 
measure of data spread) than whole cells making it easier to discern certain parameters, e.g. 
cell cycle phases. 
 
Isolated nuclei may also be used in the technique of FlowFISH, where fluorescently labeled 
probes can be hybridised to DNA to assess, for example telomere length [10] 
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1.4 Cell organelles 
Although flow cytometry looks in general at whole cell information it is also possible to stain 
specific organelles within whole mammalian cells by staining them with fluorescent dyes. This 
would be useful, for example, when looking at calcium mobilization within cells where there is 
often a component from several parts of the cell. This may also be combined with imaging flow 
cytometry to provide specific information about ion transport and mobilization [11]. The dyes 
used to identify organelles may be fluorochrome-labeled antibodies or fluorescent probes. 
Autophagosomes may be identified by staining with LC3 antibody [12], whereas mitochondria 
can be stained with MitoTracker dyes [13]; lysosomes, endoplasmic reticulum, and Golgi can 
also be identified by using fluorescent probes directed against specific components [14]. 
Lysosomes may be tagged with fluorescent LysoTracker dyes [15], Golgi with fluorescent 
ceramide [16] and endoplasmic reticulum with ER Tracker dyes [17]. Care must be taken with 
many dyes that are organelle-specific as the staining time and concentration are strongly cell-
type dependent or be influenced by cell treatments and these factors may need to be 
determined empirically. For example, Salvioli et al [18] showed that the dyes JC-1, DiOC6(3) 
and rhodamine 123, all of which can be used to label mitochondria  showed differences in 
fluorescence when treated with drugs such as valinomycin were used. Also important when 
analyzing organelles are controls; not just a negative control to assess background fluorescence 
but also a positive control to ensure that staining is successful as the majority of these assays 
involve unfixed samples. Furthermore, adding a kinetic element to experiments may be 
important i.e. looking at time points following treatment or stimulation. 
 
Cell signaling events are often studied in immunological cells and a common way to do this is to 
monitor changes in calcium levels that result from the binding of antibodies to surface receptors. 
There are several fluorescent dyes available that can monitor calcium levels such as Indo-1, 
Fluo-4 and Fura Red [19]. Indo-1 is a UV-excited dye which precludes its use in many common 
flow cytometers but it does have the advantage that it uses a ratio of the bound to unbound 
calcium signal and is therefore independent of cell size and variability in dye loading. 
 
If cell organelles are to be analyzed, in some cases it is better to digest the organelle from the 
cell. It is possible to isolate mitochondria, endocytic vesicles, and endoplasmic reticulum by 
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several methods generally using tissue homogenization [20]. Such treatment will inevitably lead 
to some cell loss and a sample that will have a considerable amount of debris. However the 
selection of dyes combined with light scatter characteristics can allow specific organelles to be 
identified. Although isolated organelles can often result in cleaner staining, the smaller the 
particle the more problems there will be with co-incident events i.e. when more than one event 
is being measured in the flow cell of the cytometer. Both in analysis and sorting, the use of light 
scatter and fluorescence is needed to delineate true particles from background. See also 
Chapter VII Section 8.6:  “Cytofluorimetric analysis of mitochondria”. 
1.5 Chromosomes 
Although interphase chromosomes cannot be delineated by standard flow cytometry, 
chromosomes at metaphase may be identified and isolated which is important in genomic 
analysis in many animal and plant species [21]. Mitotic cell division may be blocked in 
metaphase using a drug such as colcemid, and condensed chromosomes can be isolated 
following rupture of the cells in a detergent solution. Isolated chromosomes are stained with two 
DNA binding dyes that have different base-pair specificities [22]. In this way chromosomes may 
be separated on size and base-pair ratio. Chromomycin A3 (G-C binding) and Hoechst 33258 
(A-T binding) is the preferred pair of DNA dyes. This is an extremely powerful technique but is 
not widely used as the dyes used require non-standard excitation wavelengths (355nm and 
457nm) and high-powered lasers which are not widely available. Sample preparation, staining 
buffer and cytometer set-up are all critical in chromosome analysis. Chromosome sorting is 
important in clinical cytogenetics where individual chromosomes may be sorted and used to 
generate “chromosome paints”. These are probes that can be fluorescently labeled and used to 
hybridise to metaphase spreads which will allow translocations and chromosomal breakpoints to 
be detected [23].  
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Section 2 – Surface parameters 
Surface molecules comprise membrane proteins, lipids or polysaccharides but also external 
ligands, either specifically loaded onto their specific receptors e.g. cytokines or antibodies or 
non-specifically attached to the cell surface (reviewed in [1]). These molecules are easily 
accessible by flow cytometry and do not typically require special preparation of cells, such as 
fixation or permeabilization. Most surface markers, in particular those known as lineage 
markers, are also expressed at reasonable density allowing clear-cut discrimination between 
positively and negatively stained cells.  
In principle, surface molecules can be detected with different types of labels in a range of 
affinities, such as antibodies, receptor ligands, complex multivalent reagents, e.g. for increased 
binding avidity, e.g. MHC/peptide-tetramers (see Chapter VII, Section 6 antigen-specific T cell 
cytometry), which in general are chemically conjugated to fluorescent reporter molecules.   
2.1 Minimize artefacts by minimal cell manipulation 
If possible, surface molecules should be stained on live cells to avoid any kind of antigen 
denaturation possibly introduced by pre-treatment, e.g. to clearly differentiate between intra- 
and extracellular localization. For combined intracellular and surface staining, surface markers 
should be stained first, followed by fixation and permeabilization before staining for intracellular 
antigens. Defined reagents such as recombinant antibodies [2] with reduced “non-specific” 
interactions should be used whenever possible (see also Chapter IV, Section 1, Controls – 
determining positivity by eliminating false positives) especially when cells do express high or low 
affinity immunoglobulin Fc receptors, such as CD64 or CD32. Unspecific, Fc receptor-mediated 
binding of immunoglobulins can be suppressed by incubating cells in the presence of blocking 
reagents, such as purified immunoglobulins. 
In contrast to blood cells or cells from liquid exudates, primary cells located in tissues often 
require an enzymatic pre-treatment for tissue dissociation to finally obtain cells in suspension. 
But during this procedure antigenicity of surface proteins can be also affected. Therefore, 
depending on the tissue type and cells of interest, conditions for enzymatic digestions have to 
be carefully established. In general, there are a variety of enzymes available, such as elastase, 
hyaluronidase, dispase and different types of collagenases. They differ in their digestive 
characteristics and therefore, incubation time, temperature and concentration of enzymes have 
to be optimized with respect to cell viability, cell yield and preservation of antigens that will be 
investigated by flow cytometry. In the case of very sensitive antigens, which can be not 
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preserved during tissue digestion, isolated cells may be cultured over night to allow re-
expression of affected cell surface proteins. 
A very detailed protocol to isolate thymic epithelial cells is given by Jain & Gray [3] and for 
human skin mast cells by Grützkau et al [4]. Moreover, “The tissue dissociation guide” from 
Worthington summarizes all aspects of tissue dissociation in a very comprehensive way [5]. 
Even when flow cytometry analyses should be best run with fresh samples there are several 
opportunities to stabilize cells or blood samples before preparation for flow cytometry. Short-
term preservation of blood up to 24 hours by Ficoll 70 kDa is mainly aiming at inhibiting blood 
settling-induced stress that is caused by red blood cell aggregation [6].  For long-term storage 
cryopreservation of PBMCs is another option. But it should to be kept in mind that some surface 
molecules, like CD62L or chemokine receptors in general, can be negatively affected by this 
procedure.  
In addition, there are several commercial reagents available that can be used for long-term 
storage of blood samples, such as TransFix (CYTOMARK, Caltag Medsystems,Buckingham, 
UK), Cyto-Chex BCT (Streck, Omaha, US) and Smart Tube (Smart Tube, San Carlos, US) [7]. 
The latter one even allows analyzing frozen blood samples after appropriate treatment without 
losing granulocytes.  
But for all these stabilizing protocols it is strongly recommended that they have thoroughly been 
validated for the surface markers of interest. 
Live cells may be sensitive to prolonged in vitro handling procedures or may actively internalize 
surface molecules or shed them from the surface, e.g. after labeling with antibodies. This can be 
avoided by gentle treatment, e.g. careful pipetting, short handling time, low temperature (on ice) 
or addition of sodium azide to the staining buffers, which blocks active shedding/internalization. 
After staining cells should be immediately analyzed or strictly be kept on ice and in the dark to 
avoid photobleaching. 
 
2.2 Exclude dead cells 
Depending from the cell type and how they have been obtained from dissociated tissue or liquid 
samples will have an influence on the cellular integrity and viability. In principle, dead cells will 
increase background signals either caused by a general increase in autofluorescence or by an 
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increased behavior to bind antibodies in a low-affinity and unspecific manner. Therefore, dead 
cells should be labeled by high affinity DNA stains such as propidium iodide, DAPI (4’,6-
diamidine-2-phenylindole) or 7-ADD (7-amino-actinomycin D), so that they can be excluded by 
appropriate gating from further analysis (see live/dead discrimination see chapter IV section 5 
and chapter V section 2). In general, fluorochromes for discrimination of living and dead cells 
can be differentiated between those that passively integrate in the DNA of plasma membrane-
permeable dead cells or those that were actively transported into living cells only. But these 
probes are not applicable for intracellular analyses, since all cells have to be fixed and 
permeabilized before staining. For these purposes fixable dead cell stains are available that 
bind to amines of proteins. These probes are available in a wide range of different fluorescence 
colours, and samples are to be stained first before applying the fixation and permeabilization 
protocol. 
2.3 Magnetic pre-enrichment for high-resolution detection and analysis of rare cell 
populations 
For the detection and analysis of cell subsets that are detectable only in very low frequencies (< 
0,1%) appropriate pre-enrichment strategies, as detailed in chapter IV section 4, may help to 
improve gating resolution for the cell population of interest. Typical applications are the 
detection of hematopoietic stem cells [8], circulating tumor cells [9], dendritic cells [10] or T cell 
subsets, such as antigen-specific cells [11]. As one of the most commonly used pre-enrichment 
technologies immunomagnetic positive and negative selection strategies have been 
established. This has been exemplified in the context of detecting antigen-specific T cells 
Chapter VII, section 6.2, Figure 2. 
Surface markers are easily accessible for antibodies conjugated to magnetic beads. Magnetic 
pre-enrichment is a unique tool to improve resolution of cell populations, e.g. via isolation of 
weakly labeled cells to achieve separation of “overlapping” populations, depletion of irrelevant 
cells or enrichment of rare cells. 
 
2.4 Transient surface markers 
Some markers are only transiently expressed on the cell surface and thus may escape 
detection. This can be caused by different mechanisms, such as ectodomain shedding [12] or 
rapid internalization and subsequent endocytic recycling [13]. Cytokine receptors especially 
behave in a very sensitive manner during sample preparation and thus different results may be 
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obtained by analyzing whole blood after hypoosmotic lysis of erythrocytes or enrichment of 
PBMCs after Ficoll density gradient centrifugation [14]. Moreover, incubation temperature and 
time for antibody staining have to be carefully adjusted for each particular antibody. For 
instance, chemokine receptors are often stained rather at room temperature than at 4°C to 
ensure highest sensitivity of receptor detection [13]. Another example is the identification of 
antigen-specific T cells by the detection of CD154 (CD40-ligand), which is transported to the cell 
surface only upon T-cell activation and is then rapidly internalized after binding to its receptor 
(see Chapter VII, Section 6 Antigen-specific T cell cytometry). A final example is the rapid down-
regulation of the CD3/TCR complex upon TCR/CD3-ligation [15]. In principle, depending on the 
marker investigated internalization can be prevented by pharmacological or antibody blockade 
as shown for the chemokine receptor CCR5 by Müller et al. [16] or alternatively the antigen has 
to be continuously stained during culture or by intra-cytoplasmic staining.   
2.5 Genuine membrane molecules versus membrane adsorption 
Not all molecules detected on the cell surface are genuine surface molecules but may have 
been passively adsorbed to the cell surface or exchanged by an intercellular transfer of 
membrane patches. This might lead to significant artefacts and is particularly relevant for cells 
from cell cultures and for cells getting in close contact with each other e.g. within cell pellets 
following centrifugation. On the other hand it can be caused by alternative peptide/protein 
transfer mechanisms, such as trogocytosis, exosome uptake or tunneling nanotubes, which may 
allow an intercellular transfer of preformed MHC class I and class II molecules in the 
immunological synapse [17]. 
Principally, unspecific adsorption may be reduced by short processing time and low 
temperature, addition of Ca2+ chelators (EDTA) or neutral “blocking” proteins such as BSA to all 
staining buffers and by repetitive washing steps, or even short treatment with high salt or low 
pH. Passive adsorption can also be tested for by incubation with the relevant molecule, block of 
transport to the cell surface (e.g. brefeldin A for activation-induced molecules) or by the use of 
purified cell populations to prevent cross-feeding. However, if the results remain insensitive to 
these treatments they have to be confirmed by alternative analysis methods, e.g. fluorescence 
microscopy (to determine spatial distribution on the cell surface), RNA-analysis, transgenic 
expression of the molecule of interest in cell lines, etc.  
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Adsorption of molecules to the cell surface can also actively be exploited for staining of surface 
receptors with the specific ligands, such as chemokines [18], cytokines, soluble ligands/Fc-
fusion proteins, if suitable antibodies are not available. 
2.6 Quantitative considerations 
Quantification of surface marker expression on particular cell types can be principally done in 
two ways: (i) calculation of relative frequencies of cells expressing a particular antigen or a 
combination of several ones according to a threshold determined by an isotope or fluorescence 
minus one (FMO) control; (ii) considering the mean, geometric mean or median value of 
fluorescence intensity that can be used to calculate absolute numbers of a particular surface 
protein. (see Chapter IV Section 1, Controls – determining positivity by eliminating false 
positives).  
For quantitative comparison of surface marker expression it should be kept in mind that the 
surface increases with the square of the cell diameter, i.e. the same marker density results in 
much brighter signals. Thus changes in cell size, e.g. upon cellular activation, have to be 
considered for selection of the proper controls  
References 
1. Scheffold A, Radbruch A, Assenmacher M. Phenotyping and separation of leukocyte 
populations based on affinity labelling. Immunology of Infection. 2002. Second Edition 
32:23-58. 
2. Bradbury AM, Plückthun A. Antibodies: validate recombinants once. Nature. 2015 
520(7547):295  
3. Jain R, Gray DH. Isolation of thymic epithelial cells and analysis by flow cytometry. Curr 
Protoc Immunol. 2014.107:3.26.1-3.26.15.  
4. Grützkau A, Krüger-Krasagakes S, Baumeister H, Schwarz C, Kögel H, Welker P, Lippert U, 
Henz BM, Möller A. Synthesis, storage, and release of vascular endothelial growth 
factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the 
biological significance of VEGF206. Mol Biol Cell. 1998.9:875-84. 
5. Worthington Biochemical Corporation Tissue Dissociation Guide. 2008. (Santangelo, C., 
Ed.), 13. 
6. KHK Wong, RD Sandlin, TR Carey, KL Miller, AT Shank, R Oklu, S Maheswaran, D A 
Haber, D Irimia, SL Stott and M Toner. The Role of Physical Stabilization in Whole Blood 
Preservation. Sci Rep. 2016.15;6:21023. 
7. Plate MM, Louzao R, Steele PM, Greengrass V, Morris LM, Lewis J, Barnett D, Warrino D, 
Hearps AC, Denny T, Crowe SM. Viral Immunol. Evaluation of the blood stabilizers TransFix 
and Cyto-Chex BCT for low-cost CD4 T-cell methodologies. Viral Immunol. 2009.22:329-32. 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 2 – Surface parameters 
 
212 
 
8. Thomas TE, Miller CL, Eaves CJ. Purification of hematopoietic stem cells for further 
biological study. Methods. 1999.17:202-18. 
9. Van der Toom EE, Verdone JE, Gorin MA, Pienta KJ. Technical challenges in the isolation 
and analysis of circulating tumor cells. Oncotarget. 2016.7:62754-766. 
10. Donnenberg VS and Donnenberg AD. Identification, rare-event detection and analysis of 
dendritic cell subsets in bronchio-alveolar lavage fluid and peripheral blood by flow 
cytometry. Front Biosci. 2003.8:s1175-80. 
11. Bacher P and Scheffold A. New technologies for monitoring human antigen-specific T cells 
and regulatory T cells by flow-cytometry. Curr Opin Pharmacol. 2015.23:17-24. 
12. Hayashida K, Bartlett AH, Chen Y, Park PW. Molecular and cellular mechanisms of 
ectodomain shedding.Anat Rec (Hoboken). 2010.293:925-37. 
13. Berhanu D, Mortari F, De Rosa SC, Roederer M. Optimized lymphocyte isolation methods 
for analysis of chemokine receptor expression. J Immunol Methods. 2003.279:199-207. 
14. Kivisäkk P, Liu Z, Trebst C, Tucky B, Wu L, Stine J, Mack M, Rudick RA, Campbell JJ, 
Ransohoff RM. Flow cytometric analysis of chemokine receptor expression on cerebrospinal 
fluid leukocytes. Methods. 2003.29:319-25. 
15. Liu H, Rhodes M, Wiest DL, Vignali DA. On the dynamic of TCR:CD3 complex cell surface 
expression and downmodulation. Immunity. 2000.192:1529-34. 
16. Mueller A, Kelly E, Strange PG. Pathways for internalization and recycling of the chemokine 
receptor CCR5. Blood.2002.99:785-91. 
17. Campana S, De Pasquale C, Carrega P, Ferlazzo G, Bonaccorsi I. Cross-dressing: an 
alternative mechanism for antigen presentation. Immunol Lett. 2015.168:349-54. 
18. Anselmo A, Mazzon C, Borroni EM, Bonecchi R, Graham GJ, Locati M. Flow cytometry 
applications for the analysis of chemokine receptor expression and function. Cytometry A. 
2014 85:292-301. 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 3 – Intracellular Parameters 
 
213 
 
Section 3 – Intracellular Parameters  
Flow cytometry is a powerful tool to measure expression levels of proteins that can be found 
inside cells such as transcription factors, cytoskeletal components, and apoptosis regulators, or 
those that are usually secreted like cytokines and chemokines. Whereas proteins from the 
former category are normally expressed constitutively, cytokine expression usually requires 
restimulation of the cell, as is the case for T cells, which express cytokines approximately 2 h to 
24 h after T-cell receptor engagement [1, 2]. However, some cell types, such as innate lymphoid 
cells, also express cytokines constitutively [3, 4]. To enable the intracellular detection of 
otherwise secreted proteins, secretion can be blocked by Brefeldin A or Monensin A which block 
transport of vesicles from the Golgi to the plasma membrane or transport from the 
endoplasmatic reticulum to the Golgi respectively. 
To activate cytokine expression, T cells can be stimulated in two ways: While cytokine 
expression in some memory T cell subsets can be induced by cytokine signaling, such as IFN- 
which can be induced by IL-12 and IL-18 [5, 6], most T cells have to receive a T-cell receptor 
signal and a costimulatory stimulus. This can be achieved in a polyclonal way by agonistic 
antibodies against CD3 and CD28, coated to the surface of a culture vessel or in an antigen-
dependent manner by the incubation with peptide-pulsed antigen-presenting cells. Alternatively, 
cells can be exposed to the chemicals phorbol 12-myristate 13-acetate (PMA) and ionomycin 
(iono) which mimic TCR signaling by activating protein kinase C/NFB and calcineurin/NFAT 
pathways respectively. The restimulation conditions have a strong impact on the cytokine 
expression results and should thus be chosen carefully: 
(i) PMA/iono is usually a stronger inducer of cytokine expression compared to CD3/CD28 
stimulation. While it might be argued that this trigger is not physiological, it is very well suited to 
reveal the maximal cytokine expression potential of the T cells rather than their actual cytokine 
expression e.g. in vivo at the time point of analysis.  
(ii) For PMA/iono, the Ca2+ concentration of the medium can be critical: Maximal cytokine 
expression requires 1.5 mM of Ca2+ as present for example in Iscove's modified Dulbecco's 
medium, but not in the routinely used medium Roswell Park Memorial Institute 1640 (RPMI 
1640) (Fig 1A) [7] 
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(iii) The cell concentration should not be too high as this will reduce cytokine expression. For 
PMA/iono stimulation we have noticed decreased cytokine expression when using 1-5x107 
cells/ml compared to 2x106 cells/ml. (Fig 1B) 
(4) Expression kinetics can be important. Using PMA/iono, maximal cytokine expression is 
achieved as early as 4 hours following stimulation (Fig 1C) [8].  
For the detection of intracellular antigens, cells have to be fixed and permeabilized. Numerous 
protocols and reagent kits are available for fixation and permebilization, each optimized for the 
detection of certain antigens, such as cytokines, transcription factors, etc. For cytokine 
detection, cells can be fixed after surface antibody staining with 1% - 4% formaldehyde [9] 
although in our experience the use of commercially available fixation kits can be beneficial for 
the integrity of the surface staining. Cells are then permeabilized with a mild detergent, e.g. 
saponin which builds complexes with cholesterol and hence forms holes in the cholesterol-rich 
plasma membrane but not in the cholesterol-poor nuclear membrane [10,11]. It should be noted 
that restimulation of Th cells leads to internalization of CD3/TCR and CD4 proteins from the 
surface of the cell [12,13]. It can thus be beneficial to stain these antigens following fixation and 
permeabilization to also detect the internalized molecules. To control for true positive cytokine 
staining, unstimulated cells, cells that have not been permeabilized, or endogenous negative 
control cells can be used. 
Transcription factors can usually be stained directly, i.e. without prior acute restimulation, as 
they are normally expressed constitutively. Nevertheless, the expression levels of certain 
transcription factors might also change depending on the activation status of the cell (Fig 2A). 
Following surface staining, cells are commonly fixed and permeabilized with commercially 
available kits for transcription factor staining, as saponin-mediated permeabilization is too weak 
to enable nuclear penetration of antibodies. The optimal fixation time and condition may vary for 
each different transcription factor and among different cell types and should thus be established 
for the specific setting of interest (Fig 2B). Using T cells from the inflamed gut of T-cell transfer 
colitis, we have observed that overnight fixation impaired staining of the transcription factor 
eomesodermin, which was clearly detectable when fixing for only one hour. In contrast, ROR-t 
staining in these cells was comparable between the two fixation regimens. In contrast, for 
splenic T cells from the same model, overnight fixation resulted in an even better ROR-t 
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staining compared with fixation for one hour. The topic of transcription factor staining is covered 
in more detail in Chapter VII, Section 15 of this guideline.  
As for any flow cytometry application, optimal titration of antibodies is instrumental for obtaining 
high quality results. Intracellular stainings tend have a higher background due to the abundance 
of biologically active molecules inside of the cell. As transcription factors are rather rare 
proteins, they should be stained with bright fluorochromes when designing a panel. Most 
cytokines accumulate to high density within a cell during reactivation in the presence of 
secretion blockers and can hence be detected with less-bright fluorochromes. There are, 
however, also cytokines expressed at low levels and, thus, the panel design should be adjusted 
according to the expected results. Any intracellular staining panel should include a fixable 
viability dye to discriminate dead cells. This is especially important when analyzing cytokine 
expression, as the restimulation can induce apoptosis in a significant fraction of the cells while 
maintaining their forward scatter / side scatter profile, thus making their distinction based on 
scatter parameters impossible. Fixable viability dyes are now broadly available and are 
commonly based on the unspecific binding of fluorochromes with an active chemical group, e.g. 
succinimidyl esters, to amino groups of cellular proteins. Thus, viable cells are poorly labeled 
through their surface proteins while dead cells with a permeable plasma membrane are labeled 
brightly through the binding to intracellular proteins. 
For certain questions, a costaining of transcription factors and cytokines can be required. While 
transcription factors are poorly detected following saponin-mediated permeabilization, several 
cytokines can be detected with the same protocol as transcription factors, i.e. with commercially 
available transcription factor staining kits. We were able to stain IFN-, IL-17A, T-bet, and ROR-
t with a commercial transcription factor staining kit (Fig 2C, D). However, other cytokines, such 
as IL-22, can hardly be detected using a transcription factor staining kit. In this case, iterative 
staining and fixation steps of first surface antigens, then cytokines, and ultimately transcription 
factors might provide a solution. 
Many researchers want to stain intracellular antigens while maintaining the fluorescence of 
endogenous fluorescent proteins such as GFP. Using commercially available staining kits, GFP 
fluorescence is often lost, most likely due to the passive leakage of the protein outside of the 
cell. This can be prevented by a pre-fixation step with 0.5 - 2 % formaldehyde prior to 
fixation/permeabilization with commercial kits [14,15]. We have obtained good results for 
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GFP/cytokine staining and for GFP/transcription factor staining using a commercial intracellular 
staining kit (Fig 2E, F). 
 
Figure 1. An example of intracellular cytokine detection. Shown are viable, single, 
CD3+CD4+ C57BL/6 WT Th cells from the inflamed colon of T-cell transfer-induced colitis. (A) 
Cells were restimulated for 4 h with PMA/iono (and Brefeldin A added after 1 h) in RPMI, IMDM, 
or CaCl2-supplemented RPMI and stained for intracellular cytokine expression. (B) Frequency of 
IL-17+ cells among colonic Th cells restimulated with PMA/iono at the indicated densities for n=7 
mice. (C) Frequency of IL-17+ cells among colonic Th cells restimulated with PMA/iono for the 
indicated amount of time for n=4 mice per group. *p<0.05, **p<0.01, and ***p<0.001 by one-way 
ANOVA for repeated measurements and Tukey’s post hoc test.  
Figure 2. An example of intranuclear transcription factor detection. (A-D) Shown are 
viable, single, CD3+CD4+ C57BL/6 WT Th cells from the inflamed colon or the spleen of T cell 
transfer-induced colitis. (A) Transcription factor expression can depend on activation state of the 
cell: Interferon regulatory factor 4 (Irf4) and T-box expressed in T cells (T-bet) were stained 
directly ex vivo (grey shaded) or after 4h restimulation with PMA/iono (black line). (B) Fixation 
time can positively or negatively influence staining quality of transcription factors: 
Eomesodermin (Eomes) and Retinoic acid receptor-related orphan receptor gamma t (ROR-
t)were stained after 1 h or after overnight (o/n) fixation with the eBioscience Foxp3/transcription 
factor staining buffer set. (C-F) Transcription factor staining can be combined with cytokine 
staining or fluorescent reporter genes. (C and D) ROR-t, T-bet, Interferon gamma (IFN-), and 
Interleukin 17 (IL-17) were stained simultaneously with the eBioscience Foxp3 staining buffer 
set. (D) Black indicates the full staining and grey the fluorescence minus one (FMO) control for 
the T-bet antibody (ab). (E and F) Depicted are viable, single, CD45+B220-CD11b-F4/80-Gr-1-
CD90+, TCR+TCR- cells from the small intestine of C57BL/6 RorcGFP/+ reporter mice. (E) 
IL-22 was stained after 4 h of restimulation with PMA/iono and 5 µg/ml IL-23 with the Miltenyi 
Biotec inside stain kit. (F) ROR-t stained directly ex vivo with the Miltenyi inside stain kit is 
depicted for ROR-t-GFP- (grey shaded) and ROR-t-GFP+ cells (black line). 
 
References: 
1. Fan J, Nishanian P, Breen EC, McDonald M, Fahey JL. Cytokine gene expression in normal 
human lymphocytes in response to stimulation. Clin. Diagn. Lab. Immunol. 1998; 5:335–
340. 
2. Löhning M, Richter A, Stamm T, Hu-Li J, Assenmacher M, Paul WE, Radbruch A. 
Establishment of memory for IL-10 expression in developing T helper 2 cells requires 
repetitive IL-4 costimulation and does not impair proliferation. Proc Natl Acad Sci USA. 
2003; 100:12307–12312. 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 3 – Intracellular Parameters 
 
217 
 
3. Sanos, S. L., Vonarbourg, C., Mortha, A. and Diefenbach, A., Control of epithelial cell 
function by interleukin-22-producing RORgammat+ innate lymphoid cells. Immunology 2011. 
132: 453-465. 
4. Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, 
A. B., Thornton, E. E., Krummel, M. F., Chawla, A., Liang, H. E. and Locksley, R. M., Type 2 
innate lymphoid cells control eosinophil homeostasis. Nature 2013. 502: 245-248. 
5. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, et al. IGIF does not 
drive Th1 development but synergizes with IL-12 for interferon-gamma production and 
activates IRAK and NFB. Immunity. 1997; 7:571–581. 
6. Sattler A, Wagner U, Rossol M, Sieper J, Wu P, Krause A, Schmidt WA, et al. Cytokine-
induced human IFN--secreting effector-memory Th cells in chronic autoimmune 
inflammation. 2009; 113:1948–1956. 
 
7. Zimmermann, J., Radbruch, A. and Chang, H. D., A Ca(2+) concentration of 1.5 mM, as 
present in IMDM but not in RPMI, is critical for maximal response of Th cells to 
PMA/ionomycin. Eur J Immunol 2015. 45: 1270-1273. 
8. Lohning, M., Richter, A., Stamm, T., Hu-Li, J., Assenmacher, M., Paul, W. E. and Radbruch, 
A., Establishment of memory for IL-10 expression in developing T helper 2 cells requires 
repetitive IL-4 costimulation and does not impair proliferation. Proc Natl Acad Sci U S A 
2003. 100: 12307-12312. 
9. Assenmacher, M., Schmitz, J. and Radbruch, A., Flow cytometric determination of cytokines 
in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma 
and in interleukin-4-expressing cells. Eur J Immunol 1994. 24: 1097-1101. 
10. Lorenz, H., Hailey, D. W., Wunder, C. and Lippincott-Schwartz, J., The fluorescence 
protease protection (FPP) assay to determine protein localization and membrane topology. 
Nat Protoc 2006. 1: 276-279. 
11. Francis, G., Kerem, Z., Makkar, H. P. and Becker, K., The biological action of saponins in 
animal systems: a review. Br J Nutr 2002. 88: 587-605. 
12. Moller, B. K., Andresen, B. S., Christensen, E. I. and Petersen, C. M., Surface membrane 
CD4 turnover in phorbol ester stimulated T-lymphocytes. Evidence of degradation and 
increased synthesis. FEBS Lett 1990. 276: 59-62. 
13. Boyer, C., Auphan, N., Luton, F., Malburet, J. M., Barad, M., Bizozzero, J. P., Reggio, H. 
and Schmitt-Verhulst, A. M., T cell receptor/CD3 complex internalization following activation 
of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-
sensitive step. Eur J Immunol 1991. 21: 1623-1634. 
14. Grupillo, M., Lakomy, R., Geng, X., Styche, A., Rudert, W. A., Trucco, M. and Fan, Y., An 
improved intracellular staining protocol for efficient detection of nuclear proteins in YFP-
expressing cells. Biotechniques 2011. 51: 417-420. 
15. Heinen, A. P., Wanke, F., Moos, S., Attig, S., Luche, H., Pal, P. P., Budisa, N., Fehling, H. 
J., Waisman, A. and Kurschus, F. C., Improved method to retain cytosolic reporter protein 
fluorescence while staining for nuclear proteins. Cytometry A 2014. 85: 621-627. 
 
 
 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 4 – Combinatorial Cytometry 
 
218 
 
Section 4 – Combinatorial Cytometry 
 
Combinatorial cytometry is the subfield of cytometry, or single-cell analysis, whereby 
researchers describe, study, and model complex relationships between multiple combined 
cytometry samples exposed to varying stimuli, environment, treatment, etc.  
Examples include various techniques of multiplexing, such as fluorescence barcoding [1], high-
throughput cytometry, and cytometry-based compound screening [2], as well as multiple 
computational techniques which combine multiple data files either during the data collection [3] 
or post hoc in order to create multifactorial and multidimensional datasets to allow for analytical 
comparisons across properties not readily available or accessible via a single experiment [4].  
Combinatorial cytometry approaches have been implemented successfully with innovative mass 
cytometry (CyTOF) systems (For more information on the equipment and concept, see Chapter 
I, Section 5: “Mass cytometry”) [5], multispectral cytometry [6], multi-angle elastic light scatter 
cytometry [7], high-throughput screening flow cytometry [2], and computational clinical and 
research cytometry of the immune system [8-10]. 
There is often a significant difference in the design of a traditional flow cytometry and a high-
throughput or high-content assay.  This can be visualized in figure 1 where both traditional tube 
(or even plate based) flow cytometry assays are performed, and high throughput assays 
exclusively using 96 or 384 or larger plates. Using such large arrays of data creates a 
fundamental difference in how the data are both collected and analyzed. What is clear is that a 
high degree of organization and structure, complete with significant metadata is required to 
establish high throughput or high content flow cytometry assay systems. 
One of the key advantages of the combinatorial cytometry approach is the opportunity to employ 
advanced statistical and machine-learning methods, such as various techniques of clustering, 
supervised learning/classification, Bayesian techniques, and other state-of-the-art 
methodologies. On the other hand, combinatorial methodologies introduce complexity to the 
experimental planning and design. As a result, they may increase the cost of the experiential 
setup and heighten the risk of failure. Ultimately, the benefits of complex, information-rich “all-in-
one” assays, must be balanced against the cost of assay development which is likely to be 
greater than that of performing assays using regular techniques. 
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Compound screening is a prime example of a combinatorial cytometry approach. Multiple 
multicolor flow-cytometry cell-stress assays can be rapidly executed in a sequential manner 
using an automated robotic sampler. The cellular populations are exposed to different 
concentrations of the compounds tested, but they can also be measured in different 
environments (different media) and/or at different times after exposure to the stress. The assay 
can scan a dense grid of possible combinations incorporating all the stress factors in various 
permutations. Consequently, a huge number of individual cytometry measurements may be 
required to complete the screen. It is self-evident that the key requirement for successful 
execution of such an assay is a well-defined, repeatable, and reproducible assay layout (sample 
organization), which must be consistent throughout the entire cycle of experiments.  
The assay sample organization defines the resultant data structure and organization as well, as 
schematically indicated in figure 1. A typical automated phenotypic assay executed using a 
cytometry screen would employ a 96- or even a 384-well layout which provides space for up to 
32 drugs at 10 doses each, as well as negative and positive controls. Preparing such a layout in 
an automated, repeatable fashion allows glitch-free assay execution and subsequent feature 
extraction. Figure 2 shows a window of one example of a custom-built screening software 
package, PlateAnalyzer, which automatically outputs response curves and fits log-logistic 
models on the basis of the templates and gates pre-defined by an operator [11]. Since such a 
system performs the operations involving up to 384 FCS files per plate, it is crucial that all the 
steps in the analytical procedure be fully automated and be executed without the need for any 
interactive operator input.   
A screening system such as the one described above also relies on automated sample 
preparation and robotic liquid handling, as the probability of pipetting errors and inaccuracies is 
too high to allow for a manual assay setup. Automation of sample preparation not only ensures 
a high level of reproducibility, but also shortens the preparation time and guarantees that the 
minimal required amount of sample and reagents can be accommodated to make the assay 
more cost effective.  
Opportunities for automated or semi-automated analysis of FC screens can be achieved using 
many available toolsets for flow cytometry data processing. R-language for statistical computing 
is a commonly used environment for cytometrists who are interested in developing their own 
analysis tools and unique data processing pipelines. Combinatorial flow cytometry incorporating 
dimensions of time, concentration, media, and other factors certainly expands the horizons for 
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this field. Conversely, the availability of rapid development tools for custom design of data 
processing pipelines is a condition sine qua non for successful implementation of the described 
combinatorial and multifactorial approaches, see also chapter VI section 1 Data analysis an 
overview. When it is desirable to measure biological responses across multiple conditions (e.g., 
concentration, medium type, stress, temperature, time, etc.) with flow cytometry it is 
advantageous to approach the assay in an organized fashion. The technique is enabled by fast 
autosamplers, and informatics pathways aware of the multifactorial nature of the collected data 
as demonstrated in Figure 2 where the differences in analysis of traditional flow data are 
compared with combinatorial analysis routines. These routines can be highly complex, but 
depend upon the ability to automatically extract features for all samples in the array.     
Other examples of combinatorial cytometry are the well-known bead-based assays. Among 
those, cytokine assays are probably the most widely used and broadly accepted [12]. In this 
technology, 2 to 10 types of cytometry-compatible beads of various sizes (recognized by flow 
cytometry by forward light scatter) can be dyed with increasing amounts of a tracer dye to 
encode their ability for capturing/measuring different analytes. For example, Figure 3 shows 13 
cytokines simultaneously recognizable by a commercially available flow cytometry assay (any 
commercial plate could be entered into the system). In this system there are two bead sizes, 
and each bead type carries a different amount of target marker, in this case APC (see Table 1). 
Although the discussed technique employs only a 13-plex method, frequently up to 20 or 30 
different cytokine tags can easily be simultaneously quantified in a minimal volume of plasma. If 
the organization of samples on multiwell plates is consistent, one can execute an automated 
data-processing task immediately after assay completion. Gating, recognition of different bead 
types, computation of calibration curves, and other necessary tasks can be executed 
automatically without operator intervention or a manual setup. 
As mentioned before, multiplexing offers a huge advantage in terms of assay execution time 
and reagent/sample cost saving. As a result, the multiplexed bead assays allow researchers to 
identify concentration of analytes of interest in many samples essentially simultaneously. A 
dedicated software package (such as the PlateAnalyzer Cytokine edition in Figure 4) provides 
the means to show all the calibration and to visualize the concentration of analytes across the 
entire plate. Such visualization techniques are commonly used for other combinatorial 
approaches in biomedical research and are equally valuable for flow cytometry data. 
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A third example of a combinatorial cytometry technique is multispectral single-cell analysis. In 
contrast to traditional multicolor cytometry, which uses a dedicated detection channel for each 
fluorescent label in the hope of separating signals from multiple labels, the spectral system 
essentially acts as a superfast spectroscope connected to a flow cytometer. An approximation 
of the entire spectrum using about 30-40 bands for every cell is measured, and the data can be 
further processed via spectral unmixing techniques or directly used for spectral classification. 
There are a number of advantages to the spectral approach, mainly related to the less complex 
hardware as traditional optical filters are not utilized and neither are individual detectors. This 
approach creates a new opportunity for combining fluorescent probes which may not be feasible 
in conventional flow cytometry [13]. For example, dyes such as GFP and FITC can be used 
together because chemometric techniques to process spectral cytometry data can be utilized to 
classify and/or unmix the resultant signals. There are several excellent recent examples of this 
approach in flow cytometry [14, 15] in which combinations of fluorescent proteins, together with 
a variety of fluorochromes, allowed a total of 11 markers to be used simultaneously and then 
separated by spectral unmixing.  
A final example of combinatorial cytometry and one that demonstrates the extraordinary power 
of multiparameter datasets can be seen in data collected by the CyTOF technology and 
demonstrated in Figure 5 (For an overview of the equipment, see Chapter I, Section 5, Mass 
cytometry). This approach uses lanthanide-conjugated antibodies, as opposed to the 
fluorescently labeled probes of a conventional FC system, and time-of-flight mass spectroscopy 
for analyzing single cells to produce information-rich population statistics [16]. The final 
complexity of such data can be very high indeed, requiring innovative techniques for data 
processing and visualization. An ad hoc “what-if” analysis is possible using visual development 
environments allowing for interactive construction and modifications of data processing 
pipelines. A demonstration of such a pipeline, capable of tackling an input of 30-40 different 
biological parameters encoded by lanthanides, is represented in figure 5. The data processed in 
this example (courtesy of B. Bodenmiller, University of Zurich, Institute of Molecular Life 
Sciences) were produced by analyzing a bulk sample with seven lanthanide tags used to 
encode the position of individual subsamples in a 96-well plate. This experimental approach 
was applied to characterize human peripheral-blood mononuclear-cell signaling dynamics and 
cell-to-cell communication, signaling variability between PBMCs from human donors, and the 
effects of various inhibitors on this biological system. For each inhibitor, 14 phosphorylation 
sites in 14 PBMC phenotypes were measured [17]. 
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The demonstrated data pipeline (or “logic map,” in PlateAnalyzer terminology) can extract 
individual dose-response curves for the 14 phosphorylation states from each of the 14 cell 
phenotypes. This is a striking example of combinatorial FC analysis, which first creates 
relationships between different vectors of FC measurements and subsequently explores and 
quantifies these relationships. Where traditional cytometry is focusing on mapping individual 
cells in a multidimensional space of phenotypic descriptors, combinatorial cytometry looks at 
vectors of multidimensional measurements and explores the differences and similarities 
between those under various conditions.  
 
Conclusion 
The key requirements for combinatorial cytometry are (i) well-defined reproducible assay layout, 
(ii) highly controlled, preferably automated, assay setup and preparation, (iii) data-collection 
method recognizing the relationships between the collected FCS files and organizing the 
measurements in higher-order data structures, and (iv) automated data analysis and reporting 
software.  When this combination of tools is available, complex multiparameter and multifactorial 
experiment designs can be executed and the resultant data can be rapidly processed to 
produce useful insight leading to mechanistic models of the studied biological systems. 
 
Figure 1: This an example of how a traditional flow cytometry assay might be designed using 
test tubes or even a 96 well plate assay. Because of the limitation in the number of tubes or 
samples that can be run by traditional instruments, it is not possible to create very large arrays. 
Using high throughput cytometry, typical assays might be 384 well plates that can be processed 
in 10-20 minutes and produce a huge amount of data which can be processed using advanced 
statistical operations. 
 
Figure 2: Combinatorial cytometry integrates the ideas of screening biological 
responses. Biological responses can be screened across multiple conditions (e.g., 
concentration, medium type, stress, temperature, time, etc.) with flow cytometry. The technique 
is enabled by fast autosamplers, and informatics pathways aware of the multifactorial nature of 
the collected data.   
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Figure 3: Automated processing of bead-based cytokine assay. Results obtained in a 
cytometric bead assay in graphical representation of the cytokine concentration in every well of 
the multi-well plate. Samples were run on an Attune NxT flow cytometer (ThermoFisher) using 
the instrument plate reader. On the left side of the figure is a list of the analytes used in the 
assay. In the center part of the figure is a 96 well plate layout showing a representation of each 
cytokine in a 13-piece pie chart. The colors represent the values in picograms/ml. The top right 
figure shows the bead populations used to define each cytokine. On the bottom left,  the heat 
map describes the fluorescence intensity measurements for each well and each cytokine. The 
figure on the bottom right shows the standard curve derived from the standards run for this 
assay. 
 
Figure 4: Response curves automatically produced from data extracted from multiple 
FCS files. Data across FCS files are collected using a robotic sampler connected to a flow 
cytometer. The PlateAnalyzer software recognizes the plate layout and creates response curves 
on the basis of pre-defined gates. Each curve results in an automatically calculated IC50 value 
as shown on the right side of the figure. 
 
 
Figure 5: The pipeline design canvas of the PlateAnalyzer. This particular example of an 
analysis package (http://vault.cyto.purdue.edu) allows rapid development of data-processing 
maps for complex combinatorial cytometry experiments. In contrast to traditional FC software 
packages, all the operations are by definition applied to vectors or matrices of FCS files, rather 
than to individual datasets. On the left of the figure show histograms of each of the 
phosphorylated proteins in the assay, the central group identifies the phenotype of cells being 
evaluated, and the two boxes on the far right show the stimulating molecules (12 rows) each of 
which contains 8 concentrations. Yellow lines show the active analysis connection pathway – 
i.e. the resulting dose response curves would be based on the phenotypic result of each 
component linked within this pathway. As an example in the figure, the phosphorylation state is 
ZAP70- and the phenotype is NK cells (CD3-, CD7+). 
 
Table 1. Cytokine Assay Reagents. This table shows the multiplex cytokine assay with bead 
location and target molecule. Using beads of different sizes, with increasing amount of bead 
fluorescence, many assays can be performed on very small samples of plasma (<15 µl). This 
example demonstrates how one particular kit (which uses beads identities as A4, A5 ….B2, B3, 
etc.) where each bead is associated with one particular analyte. Each of these beads are in a 
small size (A) or larger size (B) group. These are shown graphically in the upper right panel of 
figure 3.   
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 4 – Combinatorial Cytometry 
 
224 
 
 
 
References 
 
1. Krutzik PO and Nolan GP (2006) Fluorescent cell barcoding in flow cytometry allows 
high-throughput drug screening and signaling profiling. NatMethods 3:361-368. doi: DOI: 
10.1038/nmeth872. 
2. Robinson JP, Patsekin V, Holdman C, Ragheb K, Sturgis J, Fatig R, Avramova LV, 
Rajwa B, Davisson VJ, and Lewis N (2012) High-throughput secondary screening at the 
single-cell level. Journal of Laboratory Automation 18:85-98. doi. 
3. Robinson JP, Durack G, and Kelley S (1991) An innovation in flow cytometry data 
collection & analysis producing a correlated multiple sample analysis in a single file. 
Cytometry 12:82-90. doi: DOI: 10.1002/cyto.990120112. 
4. Aghaeepour N, Finak G, Flow CAPC, Consortium D, Hoos H, Mosmann TR, Brinkman 
R, Gottardo R, and Scheuermann RH (2013) Critical assessment of automated flow 
cytometry data analysis techniques. Nat Methods 10:228-38. doi: DOI: 
10.1038/nmeth.2365. 
5. Newell E, Bendall S, Hong D, Lewis D, Nolan G, and Davis M (2010) Surveying the 
Influenza-specific Cytotoxic T Cell Response in Humans and Mice Using Mass-
cytometry (CyTOF) and Combinatorial Tetramer Staining. Clinical Immunology 
135:S104-S104. doi. 
6. Gregori G, Patsekin V, Rajwa B, Jones J, Ragheb K, Holdman C, and Robinson JP 
(2012) Hyperspectral cytometry at the single-cell level using a 32-channel photodetector. 
Cytometry Part A 81:35-44. doi: DOI: 10.1002/cyto.a.21120. 
7. Rajwa B, Venkatapathi M, Ragheb K, Banada PP, Hirleman ED, Lary T, and Robinson 
JP (2007) Automated classification and recognition of bacterial particles in flow by multi-
angle scatter measurement and a support-vector machine classifier. Progress in 
biomedical optics and imaging 8. doi. 
8. Costa ES, Pedreira CE, Barrena S, Lecrevisse Q, Flores J, Quijano S, Almeida J, Del 
CG-M, Bottcher S, van Dongen JJ, and Orfao A (2010) Automated pattern-guided 
principal component analysis vs expert-based immunophenotypic classification of B-cell 
chronic lymphoproliferative disorders: a step forward in the standardization of clinical 
immunophenotyping. Leukemia 24:1927-1933. doi. 
9. Dundar M, Akova F, Yerebakan HZ, and Rajwa B (2014) A non-parametric Bayesian 
model for joint cell clustering and cluster matching: identification of anomalous sample 
phenotypes with random effects. BMC Bioinformatics 15:314. doi: DOI: 10.1186/1471-
2105-15-314. 
10. Bagwell CB, Hunsberger BC, Herbert DJ, Munson ME, Hill BL, Bray CM, and Preffer FI 
(2015) Probability state modeling theory. Cytometry A 87:646-60. doi: DOI: 
10.1002/cyto.a.22687. 
11. Robinson JP, Rajwa B, Patsekin V, and Davisson VJ (2012) Computational Analysis of 
High Throughput flow cytometry data. ExpertOpinDrug Deliv 7:679-693. doi: DOI: 
doi:10.1517/17460441.2012.693475. 
12. Fulton RJ, McDade RL, Smith PL, Kienker LJ, and Kettman JR, Jr. (1997) Advanced 
multiplexed analysis with the FlowMetrix system. Clinical Chemistry 43:1749-1756. doi. 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 4 – Combinatorial Cytometry 
 
225 
 
13. Robinson JP, Patsekin V, Gregori G, Rajwa B, and Jones J (2005) Multispectral flow 
cytometry: Next generation tools for automated classification. MicroscMicroanal 11:2-3. 
doi. 
14. Futamura K, Sekino M, Hata A, Ikebuchi R, Nakanishi Y, Egawa G, Kabashima K, 
Watanabe T, Furuki M, and Tomura M (2015) Novel full-spectral flow cytometry with 
multiple spectrally-adjacent fluorescent proteins and fluorochromes and visualization of 
in vivo cellular movement. Cytometry A 87:830-42. doi: DOI: 10.1002/cyto.a.22725. 
15. Goddard G, Martin JC, Naivar M, Goodwin PM, Graves SW, Habbersett R, Nolan JP, 
and Jett JH (2006) Single particle high resolution spectral analysis flow cytometry. 
CytometryPart A: The Journal of the International Society for Analytical Cytology 69:842-
851. doi. 
16. Bendall SC, Simonds EF, Qiu P, Amir e, Krutzik PO, Finck R, Bruggner RV, Melamed R, 
Trejo A, Ornatsky OI, Balderas RS, Plevritis SK, Sachs K, Pe'er D, Tanner SD, and 
Nolan GP (2011) Single-cell mass cytometry of differential immune and drug responses 
across a human hematopoietic continuum. Science 332:687-696. doi. 
17. Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV, Simonds EF, 
Bendall SC, Sachs K, Krutzik PO, and Nolan GP (2012) Multiplexed mass cytometry 
profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 
30:858-67. doi: DOI: 10.1038/nbt.2317. 
 
  
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 5 – Measuring antigen specific T cell responses 
 
226 
 
Section 5 – Measuring antigen specific T cell responses  
5.1 Introduction 
T cells recognize antigen in the context of major histocompatibility complex (MHC) molecules. 
Over 20 years ago, Davis and colleagues developed the technique to mimic the interaction 
between the T-cell receptor and the peptide (p)MHC complex in the laboratory [1]. Using 
fluorescently labeled pMHC multimers, antigen-specific T cells could be visualized and this has 
become a crucial tool in the analysis of antigen-specific T-cell immunity in mouse and human. 
For a more detailed description on antigen-specific T-cell cytometry see Chapter VII, section 6. 
The classical approach with pMHC multimer detection is having the pMHC complex coupled to a 
single fluorescent dye. The major drawback of this approach is the limited number of epitopes to 
which T-cell reactivity can be detected in parallel. This limitation is given by the limited number of 
fluorochromes and detectors available as well as limitations in patient material. Multiplexing 
strategies have been developed that increases the number of T-cell reactivities that can be 
detected in a single sample [2,3]. 
The multiplexing strategy developed by us is based on the generation of pMHC complexes with 
dual fluorochrome codes. However additional approaches have been published including work 
from Newell et al [2]. Using the dual fluorochrome labeling approach the number of unique codes 
that can be generated can be calculated using factorial operations.  
As an example 8 distinct fluorochromes yield 28 possible unique dual codes: (8 x 7) / (1 x 2) = 
28. 
 
5.2 UV light-mediated peptide exchange method 
Peptide MHC complexes can be generated by a process called refolding, here the heavy- and 
β2m chain of the MHC allele are placed together with the peptide of interest in an optimized 
buffer which allows correct formation of the pMHC complex. Having a biotin group on the heavy 
chain allows the biotinylation of the complex after refolding. As refolding the pMHC complexes is 
a time consuming and laborious process this approach is not optimal for generation of large 
numbers of different pMHC complexes.  
To overcome this limitation we developed an UV light-mediated peptide exchange method [4]. 
With this technology the MHC complex is refolded using a peptide ligand which holds an UV light 
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sensitive amino acid. Exposure to UV light results in degradation of the p*MHC complex. 
However, when this process takes place in the presence of a rescue peptide, this peptide can 
bind and stabilize the MHC complex, thereby giving rise to pMHC complexes with the peptides 
of choice [4]. This UV-mediated exchange can be performed in a multi-well format, allowing the 
generation of thousands of unique pMHC complexes in parallel. 
Multiple factors can influence the ligand exchange reaction. Crucial is to keep the p*MHC 
complexes in the dark as much as possible as they are light sensitive and as cool as possible as 
the p*MHC complexes can be unstable at temperatures above 4°C. Furthermore, it is important 
that these protein-containing reactions are performed using polypropylene material. This is to 
avoid loss of protein through sticking to the plates/tubes. As the solubility of the peptide 
influences the ligand exchange it is possible to add ligands that have a poor solubility in water 
from stocks in DMSO. It has been shown that the ligand exchange reactions proceed normally in 
conditions up to 10% DMSO4.  
After the exchange of peptides the pMHC complexes can be multimerized by conjugation to 
fluorochromes for the generation of dual color-coded multimers (Figure 1). As the pMHC 
complexes contain biotin groups, streptavidin-conjugated fluorochromes allow easy and strong 
binding to the pMHC complexes. Titrations of the pMHC complex:streptavidin-fluorochrome are 
crucial to ensure optimal signal to noise ratio. After multimer formation addition of D-biotin 
ensures the blockage of any remaining free binding sites on the SA-conjugated fluorochromes, 
thereby preventing the binding of unconjugated pMHC complexes to other fluorochromes when 
collecting the pMHC multimer collections prior to staining. 
 
5.3 Staining and flow cytometry 
Besides the major benefit of increasing the number of specificities that can be screened for in a 
single sample the other advantage of using multiplexing is the fact that the background signal is 
significantly reduced when using dual fluorochrome codes. This is due to the fact that the vast 
majority of background signal is detected in either one or more than two channels detecting 
fluorescent signal.  As the false positive signal decreases, the sensitivity of the assay increases. 
This increase in sensitivity is accomplished using Boolean gating strategies only, including signal 
that is only dual color positive. Due to this gating strategy we are now working with a cutoff of 
0.005% of total CD8+ T cells and a minimum of 10 recorded events. When staining the same 
TCR with two different fluorochromes a two-fold reduction in MFI should be expected. However, 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 5 – Measuring antigen specific T cell responses 
 
228 
 
as data are viewed on log scale a two-fold decrease is a minor issue. We have successfully 
detected e.g., MART-1 specific T cell responses, and MART-1 TCRs are known to be of low 
affinity in general. Nevertheless, if the T cell response of interest is of low affinity/avidity it can 
happen that the dual color coding makes is more challenging to pull out the positive population 
from the background.    
 
Using multiple multimers in a single staining can lead to the formation of aggregates, causing 
background issues in the staining. Therefore, it is important to spin down the pMHC multimer 
panels to eliminate aggregates. In case of increased risk for aggregates (e.g. using rescue 
peptides that may not be able to bind sufficiently to stabilize the MHC complex), the addition of 
an 1% skim milk solution (in PBS) to the multimers directly after adding the streptavidin-
fluorochrome can help to reduce the level of aggregates. 
To ensure that the T-cell reactivities detected are indeed real, a confirmation is required in an 
independent experiment. For this purpose it is recommended to make new reagents for the 
potential hits, changing the fluorochrome code and stain, with the newly prepared reagents, the 
other half of the sample tested. We have previously demonstrated that the reproducibility 
between these independent experiments is high (R2=0.9638)5. 
When selecting what fluorochromes are better suited to include in the making of the multimers 
the main determinant is the configuration of the flow cytometer that will be used. Next is a 
consideration of brightness. In case the goal of using the technology to detect viral responses 
the brightness is of less concern compared to detecting T cell responses against self-antigens. 
Nevertheless it is advisable to select bright fluorochromes, and when using less bright 
fluorochromes to only combine them in the dual-codes with the fluorochromes that give a 
brighter signal. As an example we only use quantum dot 585 together with the brightest dyes in 
our setting, e.g. PE, quantum dot 655 and brilliant violet 421.  
On the basis of the high sensitivity and robustness this is a highly suitable tool for the analysis of 
T-cell responses in patient material. We have previously demonstrated the value of the 
technology to map T-cell responses against shared antigens in large patient cohorts [5,6]  as 
well as T-cell responses against mutated antigens on a patient specific basis [7,8]. 
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5.4 Example: Detection of neo-antigen specific T cell responses in a melanoma patient  
Resected tumor material was used to identify tumor specific mutations using exome sequencing. 
Based on the sequencing 1657 somatic mutations were identified, of which 1075 were non-
synonymous mutations. Based on RNA sequencing the expression of each mutation was 
assessed. Mutations that were found to be expressed based on RNA sequencing data were 
included and HLA restricted epitopes were predicted using a previously published bioinformatics 
pipeline [9]. In total a set of 1036 peptides was predicted and used to generate peptide-MHC 
complexes with the UV-induced ligand exchange method. Complexes were formed using HLA-
A*03:01, A*32:01, B*13:02 and B*27:02 monomers. Using 8 different fluorochromes for multimer 
formation 26 dual color combinations was used in parallel. With this setup screening the TILs 
from this patient for all peptides was possible in 55 tubes with approximately 0.75*10^6 TILs per 
tube (90% CD8+ T cells). 
The analysis of the TILs revealed two neo antigen specific T-cell responses. One of low 
frequency (0.003%, HLA-A*32:01) against a mutated epitope of the ZNF462 gene and a 
response of significant magnitude, 3.3% of CD8 T cells within the tumor were specific for a 
mutated epitope from ATR serine/threonine protein kinase that functions to signal DNA damage.  
In the initial screen the epitope related to the mutation in the ATR kinase was found using a 
multimer in the combination of PE and Qdot705 (Figure 2).  
For the confirmation of the detected responses a new UV exchange with the ATR kinase 
mutated peptide was executed and multimerization was accomplished using streptavidin-
Qdot655 and streptavidin-PE-Cy7.  
 
 
 
 
Figure legends 
Figure 1: An example of a combinatorial staircase giving 28 unique dual color codes to 28 
different peptides. 
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Figure 2: Dot plots showing an antigen specific T cell population detected in T cells isolated 
from a tumor lesion. The antigen specific T cells are positioned in the diagonal of the upper right 
corner of the plot (green circle) as they are dual positive for two fluorochromes.  
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Section 6 - Antigen-specific T cell cytometry  
 
Antigen-specific T cells play a pivotal role in immune protection towards infection or some 
cancers, and are currently used more frequently for adoptive immunotherapy (i.e as donor 
lymphocyte infusion or engineered autologous lymphocytes). Antigen-specific T cells are also 
crucially involved in the pathophysiology of autoimmune diseases, like type I diabetes or multiple 
sclerosis. Therefore, the direct visualization, quantification and characterization of these cells 
have important diagnostic and therapeutic implications. Peptide-major histocompatibility complex 
(MHC) molecules present antigenic peptides (epitopes) to T cells, which are recognized by 
specific binding of a suitable T cell receptor (TCR), which is expressed in multiple identical 
copies (usually > 1 x 105 molecules) on the T cell surface. CD8+ T cells recognize peptides 
presented by MHC class I, while CD4+ T cells recognize antigen via MHC class II molecules. 
Two main experimental approaches have been developed for the detection of antigen-specific T 
cells: function-independent methods such as staining with soluble MHC multimers, and function-
based assays (such as intra-cellular cytokine staining, ELISPOT or cytokine capture 
technology). Their advantages and limitations are described below. 
 
6.1 – MHC multimers  
 
Function-independent antigen-specific T cell identification has the advantage that it can be 
applied directly to a sample ex vivo, and does not rely on in vitro T cell activation, in contrast to 
many function-based assays. 
Compared to the broadly applied detection of antigens by monoclonal antibodies (mAbs), the 
detection of TCR-ligand (=MHC)-binding antigen-specific T cells has turned out to be 
challenging. This is mainly due to the relatively low binding affinity of TCR-MHC interactions, 
which do not allow using soluble (monomeric) MHC for stable T cell staining. Altman and Davis 
addressed this problem by the development of so-called MHC Tetramers [1]. The principle 
behind this approach is the multimerization of the natural TCR ligand e.g. to tetrameric 
complexes, thereby increasing the binding avidity to surface-expressed TCRs (Figure 1A). 
Dimerization of MHC via immune globulin fusion proteins can be sufficient to detect antigen-
specific T cells [2], but such MHC dimers often fail to identify all antigen-reactive T cells present 
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in a polyclonal population [3]. However, also MHC tetramers might not label all epitope reactive 
T cells, which could be due to very low affinity TCRs [4] or TCR/co-receptor downregulation or 
variable surface distribution [5, 6]. 
 
 
Reagents with different degrees of multimerization have been developed, as multimerization 
seemed to be relevant for stable and antigen-specific binding. Surprisingly, a direct comparison 
of MHC tetramers, pentamers, dextramers, octamers and higher polymerization reagents has 
failed to show significantly improving binding properties with increasing degrees of 
multimerization [7]. It seems that an avidity gain with MHC trimers represents the crucial 
threshold to result in stable MHC multimer staining for most TCRs. This interpretation was based 
on the finding that also in conventional PE-conjugated MHC “tetramers”, three out of the four 
MHC molecules simultaneously take part in binding to surface-expressed TRCs, although they 
stain polyclonal T cell populations effectively with high staining intensity [8]. 
 
MHC tetramers are based on multimerization with biotinylated ligands and avidin/streptavidin. 
Conjugation with fluorochromes allows usage in flow cytometry cell sorting -based applications 
and conjugation with paramagnetic particles promotes combination with magnetic purification 
technologies [9] [10] (Fig. 1A). However, binding of TCR ligands can lead to T cell 
stimulation/activation and labeling-reagent internalization, as well as apoptosis and cell death 
[11] [12] [13]. Therefore, the reversible MHC Streptamer technology was developed, allowing 
removal of staining reagents from the cell surface after their application (Figure 1B, 1C) [14] [15]. 
This is achieved by targeted disruption of multimer complexes, leaving only MHC monomers 
which rapidly dissociate from the cell surface. With directly fluorochrome-labeled MHC 
molecules, the dissociation can be precisely measured and serves as an important parameter 
for TCR avidity [16]. Reversible staining has recently been further transferred to low affinity 
antibody-derived Fab fragments (Fab Streptamer), extending the applicability of this labeling 
technology to virtually any surface antigen [15].  
A large spectrum of MHC multimers is commercially available for the analysis of antigen-specific 
CD8+ T cells. In order to enable versatile epitope selection for MHC multimer analyses, a 
technology based on UV light-cleavable surrogate peptides has been developed [17]. 
Multiplexed staining of samples with different fluorescence-conjugated MHC multimers is 
possible and promotes simultaneous analysis or sorting for multiple epitope specificities [18, 19]. 
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Combinatorial MHC multimer staining can now be used not only to combine and distinguish 
large numbers of different MHC molecules within the same sample, but also to increase staining 
sensitivity for the detection of rare cell populations. Cell incubation with two MHC multimers, 
which are specific for the same antigen but are conjugated to different fluorophores, results in 
double-staining of antigen-specific T-cell populations. This approach significantly reduces 
background staining (Fig. 2) [20], which is fundamentally important to identify rare cell 
populations. 
Co-receptor (CD8 or CD4) interaction is often required for stable binding of MHC multimers. 
Therefore, parallel surface staining for CD8 or CD4 has to be controlled carefully to avoid 
artifacts by blocking (or sometimes even enhancement) of co-receptor binding. In order to 
control this problem, most staining protocols are based on an incubation period with MHC 
multimers alone before antibody reagents for co-receptors are added. An initial incubation with 
MHC multimer reagent alone for 25 minutes, followed by the addition of co-staining mAbs for 
further 20 minutes, has proven to be applicable to most MHC multimers in practice. In particular, 
when using phycoerythrin (PE)-conjugated MHC multimers, background staining – especially 
coming from B cells and dead cells – can complicate the analysis. Therefore, implementation of 
a CD19 dump channel and live/dead discrimination has become standard for most MHC 
multimer staining protocols. By using covalently-linkable DNA staining probes (such as ethidium 
monoazide bromide (EMA)), it is also possible to combine live/dead discrimination with cell 
fixation [21]. 
Optimal MHC multimer concentrations have to be determined for each batch by using positive 
and negative controls, as done for all other cellular labels used in flow cytometry. Besides 
reagent concentration, the duration of incubation-time as well staining temperature are crucial 
parameters for MHC multimer labeling. Since this technology relies on binding of the natural 
TCR ligand to the cell surface, at higher temperatures (above 10 – 15°C) signaling events and 
potential cell changes (e.g. cell surface markers markers, activation-induced cell death) can 
occur. Therefore, whenever possible, MHC class I multimer staining should be performed at low 
temperatures i.e. 4°C. For reversible MHC multimer staining, cell labeling/sorting at low 
temperatures is particularly essential, as reagent internalization would negatively interfere with 
its subsequent removal. In contrast, for most of the currently available MHC class II multimers, 
successful antigen-specific cell labeling is only possible at higher temperatures (usually at 37°C 
for approx. 1 h), since signal accumulation by reagent internalization seems to be required in this 
case [22] [23].  
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In addition to conventional experimental controls (single color-, compensation- and FMO-
controls), biological controls for MHC multimer staining are recommended to determine the 
degree of background staining (e.g. by MHC mismatch controls). General considerations 
regarding minimal numbers of positive events that have to be acquired and optimal gating 
strategy (FSC/SSC, singlets, live/dead discrimination, co receptor/multimer, etc.) are essential to 
achieve meaningful and highly reproducible results. A detailed protocol for MHC multimer 
staining including some examples for staining artefacts is described in Cellular Diagnostics – 
Karger 2009 [24]. 
For more information, including instructions for the development of MHC class I reagents, please 
visit the website http://www.mikrobio.med.tum.de/node/51. 
 
Figure Legends: 
Figure 1: Principle of MHC multimer staining by increasing the binding avidity of MHC-
TCR interactions. (A) Conventional MHC tetramers (B) MHC modification for generation of 
reversible MHC Streptamers; (C) principle of reversibility of MHC Streptamers. 
 
Figure 2: MHC multimer staining of human PBMCs for CMV peptide pp65 with BV421 and 
APC. Pregating CD8 and CD3 improved separation. Additional staining with pp65 APC MHC 
multimer separates a distinct population of antigen specific cytotoxic T cells. 
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6.2 –Functional read-outs 
 
As antigen-specific T cells are rare, a major goal in antigen-specific cytometry is to analyze as 
many parameters as possible from each single antigen-specific T cell. Recent advances in multi-
color flow-cytometry have increased the number of markers that can be analyzed, but have also 
complicated the design and optimization of multi-color antibody panels, as well as the multi-
dimensional analysis of such experiments. These important topics have been reviewed 
elsewhere [1-5] and are also discussed in Chapter IV. Section 8 - Key Concepts for the Design 
and Testing of Multicolor Panels and Chapter VI Evaluation/Data handling. In this chapter we will 
focus on use of flow cytometric methods for the detection of antigen-specific T cells following 
stimulation with an antigen. 
 
Direct labeling of specific T cells can be achieved by peptide/MHC(MHC)-multimers (see 
Chapter VII. Section 6.1 – Antigen-specific T-cell cytometry - MHC multimers). However, MHC-
multimers can only be generated for a limited number of pre-defined MHC combinations, in 
particular for MHC class I peptides and CD8+ T-cell analysis. In contrast, MHC class II multimers 
for identification of antigen-specific CD4+ T cells are still less well established. In addition, 
tetramer use is limited for complex antigens or antigens not fully characterized, e.g. microbes, 
tumors or autoantigens, and for the heterogeneous MHC background in humans. As an 
alternative, functional tests provide more flexibility, since they rely on T-cell stimulation by 
autologous antigen-presenting cells (APCs), which can process and present all types of 
antigens, peptides, proteins, or crude cellular extracts in the context of the physiological MHC 
background. Following in vitro antigen-stimulation, the antigen-induced T-cell response is 
analyzed as an indirect read-out indicating specific T cells, i.e. proliferation, activation-induced 
surface or secreted molecules or cytotoxicity [6] (Figure 1). 
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6.2.1 Selection of the right parameter - Minimal manipulation 
Functional assays require stimulation, which may affect T-cell frequency, function and 
phenotype [7]. Cellular proliferation as a result and readout of stimulation requires several days 
(typically 3-5 days) of stimulation (see also Chapter VII. Section 7 – DNA synthesis, cell cycle 
and proliferation) and introduces an unpredictable bias due to significant in vitro selection and 
“bystander” proliferation. Therefore, it is difficult to extrapolate from frequency and phenotype of 
cells after proliferation to the original sample, and proliferation-based assays should be used 
with caution for quantitative or qualitative T-cell analyses. Therefore, short stimulation times may 
be preferred; for instance cytokines and rapid activation markers (e.g. CD154, CD69) typically 
require only 5-8 hours of stimulation before their levels are measurable intracellularly, on cell 
surfaces or in culture supernatants, ensuring minimal manipulation [6]. 
For antigen-specific stimulation experiments, it should also be considered that the source of 
material (whole blood; peripheral blood mononuclear cells (PBMCs); different tissues sources), 
as well as the treatment of the cell source (fresh or frozen material; resting periods before 
stimulation; culture medium), might have a profound influence on T-cell marker expression and 
the detection of antigen-specific T-cell responses [8-12]. In our hands, overnight resting (<16h) 
of freshly isolated PBMCs has been proven to reduce background expression of activation 
markers and cytokines, while retaining responsiveness of antigen-specific CD4+ Tcon and Treg, 
leading to an increased signal-to-noise ratio for antigen-specific T-cell analyses (unpublished). 
However, in multi-center trials, cryopreservation of PBMCs is often unavoidable. Therefore 
standardized procedures are needed to compare antigen-specific T-cell data from different 
laboratories [13, 14]. When analyzing and comparing antigen-specific T-cell responses from 
blood and tissue, also the presence of functional APCs with comparable processing and 
presenting capacity should be considered. 
 
 
6.2.2 Selection of the right parameter - Integrate all T-cell subsets 
T cells are heterogeneous and cover a wide range of different phenotypical and functional 
subsets. Information about the frequency, differentiation stage (e.g. naive, memory), phenotype 
and functional properties of antigen-specific T cells is essential to gain a comprehensive picture 
about the immune response against a certain antigen and the immune status of an individual. As 
CD4+ and CD8+ T cells provide different functions, also different read-outs apply for the 
detection of antigen-specific CD4+ and CD8+ T cells (see Table 1). 
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In particular CD4+ T cells can acquire a highly diverse set of functional properties. Therefore, 
antigen-induced cytokine secretion is widely used as functional read-out for CD4+ T cells. 
Cytokines can be detected on the cell surface by retention of the secreted cytokine on the 
surface of the secreting cells via a capture matrix [15, 16] or intracellular when cytokine 
secretion is inhibited by addition of secretion inhibitors like Brefeldin A or Monensin [17] (see 
also chapter VII. Section 3 - Intracellular parameters). Differences may apply regarding the 
usage of different secretion inhibitors [13], for example, Monensin has been shown to only 
insufficiently inhibit TNF- secretion [18]. Due to the heterogeneity of CD4+ T cells, ideally, the 
functional read-out should encompass all relevant T-cell types to obtain a complete picture of the 
immune status, i.e. all conventional T (Tcon) cells, i.e. naïve, all memory subsets as well as 
Foxp3+ regulatory T (Treg) cells, which typically comprise 5-10% of all CD4+ T cells and are 
essential for tolerance. An alternative to individual cytokines, such as IFN-γ which are often only 
expressed by a minor fraction of all antigen-specific CD4+ T cells [19-21], and thus may ignore a 
significant fraction of specific T cells, are so called activation markers that are up-regulated on 
the T-cell surface upon specific T-cell receptor triggering. We recently showed that the 
combination of the activation markers CD154 (CD40L; which is expressed on all Tcon subsets) 
and CD137 (4-1BB; which is expressed on Treg) following short-term (6h) stimulation allows in 
parallel detection of naive and memory Tcon and Tregs reacting against the same antigen [21-
25].  
For CD8+ T cells, cytokines like TNF, IFN- are widely used, which are expressed by the majority 
of the antigen-activated CD8+ population. The activation marker CD137 is also expressed by 
CD8+ T cells following stimulation for >12 hours [26-28], but may also be induced due to 
bystander activation. Furthermore, for CD8+ T cells detection of cytotoxic activity by staining for 
cytotoxic effector molecules (e.g. granzyme or perforin) can be used. In contrast to most other 
mediators, these molecules are found pre-formed in the cells and can be immediately released 
following antigen stimulation. An alternative approach for measuring cytotoxicity is the detection 
of CD107a, which is only present on the cell surface transiently following degranulation [29, 30] 
(see also chapter VII, section 11 - Cytotoxicity). 
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6.2.3 Combination with magnetic enrichment of rare cells 
Antigen-specific T cells typically comprise <1% and often <0.1% of the total T-cell population [6]. 
Therefore, magnetic pre-selection of rare antigen-specific T cells from large cell samples is 
frequently used to decrease background and improve optical resolution. Pre-selection increases 
the sensitivity for the detection of antigen-specific T cells (frequencies of 10-5-10-6, detection of 
specific T cells within the naïve repertoire is possible) [15, 19, 31-34]. Enrichment allows the 
collection of sufficient target cells for subsequent multi-parameter analysis and resolution of 
small cell subsets. Magnetic enrichment may employ surface markers, e.g. tetramers, CD154, 
CD137, or secreted cytokines [15] (Figure 2) (see also chapter VII, Section 3 - Intracellular 
parameters)).  
 
 
6.2.4 Type of antigen 
As for the functional read-out, there are differences between the antigens used for stimulation of 
CD4+ and CD8+ T cells. CD4+ T cells recognize antigens that are presented via the exogenous 
pathway of antigen presentation on class II MHC molecules [36]. Accordingly, for CD4+ T cells, 
peptides, proteins and even cellular extracts can be used for stimulation. Presentation of 
peptides from whole proteins depends on the processing activity of the available APCs, which 
may vary between cell sources (blood, (lymphoid-) organs) and donors. Antigen preparations 
containing potential innate immune signals (pathogen-associated molecular patterns, PAMPs) 
may cause bystander activation and specificity of the antigen-reactive T cells has to be 
confirmed for each antigen (see also section 6.2.5 Controls and statistical analyses).  
In contrast, stimulation of CD8+ T cells with whole proteins is not reliable, since MHC class I 
epitopes are not easily generated from endocytosed proteins which depends on cross 
presenting capacity of the APCs. Therefore, short synthetic peptides are preferable. The use of 
peptides as antigen stimulants is advantageous as peptides are instantly presented by all APCs 
expressing MHC molecules, including B cells or other non-classical APCs. Peptides can be used 
individually or in pools, such pools being able to cover complete protein amino acid sequences 
(protein spanning peptide pools). The use of peptides of 15 amino acids length and 11 overlaps 
has proven very successful for both CD4+ and CD8+ T cells [37, 38]. The use of 15mers is in 
conflict with the concept that the binding groove of class I MHC molecules can only 
accommodate a peptides of 8-109 amino acids in length. Since 15mer peptides are successfully 
used for CD8 T cell stimulation in many experimental systems, it is assumed that mechanisms 
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exist that shorten these peptides in the extra cellular space (clipping, trimming, peptide 
degradation) [39, 40]. However, since these mechanisms have so far not been characterized, 
15mers have to be used with caution since individual MHC class I binding peptides might not be 
generated efficiently.  
 
 
 
6.2.5 Controls and statistical analyses 
Standard controls for flow-cytometric multicolor analyses which apply here (single color, 
compensation, FMO-controls, exclusion of doublets and dead cells, as well as a dump channel), 
are described in Chapter IV. Section 1. Controls – determining positivity by eliminating false 
positives. However, special emphasis has to be given to elimination of background due to the 
low frequencies of antigen-specific T cells, as noted above. A non-stimulated sample processed 
under identical conditions is absolutely required to determine background. Specificity should be 
verified for each MHC-multimer and antigen, especially for preparations containing PAMPs, as 
well as for different cell sources (blood, tissue). Specificity can be determined, for example, by 
MHC blocking antibodies, the use of fixed APCs (for processing dependent antigens) or 
expansion of cell lines and single cell clones for confirmation of specificity by antigen re-
stimulation [24].  
Also, a positive control for the assay should be included, to determine functionality of the T cells 
and APCs. Polyclonal stimulation can be achieved by e.g. agonistic antibodies against CD3  
and CD28 or by stimulation with the chemicals phorbol 12-myristate 13-acetate (PMA) and 
ionomycin (iono). However, these controls only apply for the T cells and are independent of the 
presence of functional APCs. Alternatively, super-antigens like Staphylococcus enterotoxin B 
(SEB) can be used, which crosslinks MHC molecules and specific Vβ regions of T-cell receptors. 
Thus, usage of SEB might be limited in samples with restricted Vβ repertoires. An antigen-
specific control might represent a more physiological control, e.g. an antigen derived from an 
ubiquitous pathogen like Candida albicans, or a standard vaccine like tetanus, to which typically 
all donors react [24]) .When frequencies of antigen-specific T-cell are calculated, background 
values have to be subtracted from that of the antigen sample. Regarding statistical significance 
of rare event analyses, considerations have to be applied to determine the minimal number of 
events that have to be acquired for statistically relevant analyses. To describe the precision of 
flow-cytometry data, the coefficient of variance (CV) can be calculated from the variance and the 
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standard deviation [35]. For example, for a CV of 5% at least 400 antigen-specific T cells have to 
be acquired (see figure 2). If the antigen-specific cells occur with a frequency of 0.1%, at least 
400.000 total events should be acquired. If the frequency of specific cells is just 0.01%, at least 
4.000.000 have to be acquired and so on. This illustrates that for many antigens, magnetic pre-
selection of the rare antigen-specific T cells from large cell samples is necessary to increase the 
sensitivity of the assay and obtain sufficient target cells for statistically relevant analyses (see 
also Chapter VI. Section 3 - Statistics for Flow cytometry). 
For methods employing enrichment, the absolute count of target cells obtained from a certain 
input cell number has to be determined to calculate frequencies in the original sample. The 
frequency of positive cells after enrichment is not relevant for quantification. A minimal signal-to-
noise ratio and minimal number of events per input cell number has to be determined for each 
test system independently (see also Chapter V Section 3 - Rare cells (general rules)). 
 
 
6.2.6 Interpretation of results 
Originally, specific T-cell analysis relied on the idea that antigen-specific T cells can only be 
detected in antigen-experienced individuals. However, recent advances, in particular in the 
enrichment of rare cells, has allowed detection of rare specific T cells even within the naïve 
repertoire [19, 33, 34, 41-44] (Figure 2B). These analyses also showed that the memory 
compartment contains a significant fraction of specific T cells against bona fide “neo-antigens,” 
i.e. antigens not previously encountered by the immune system. This may result from specific 
(structurally related epitopes) or from statistical cross-reactivity, i.e. recognition of a neo-epitope 
by TCRs from a polyclonal repertoire [42, 44]. Thus, the presence of memory-type T cells does 
not per se imply that this results from a genuine antigen-specific immune response. Therefore, 
additional biological parameters have to be considered to determine the actual immune status: 
overall ratio between specific memory to naive and Treg cells, ratio of memory T cells in the 
antigen-specific population versus the total T-cell population (is expected to be >1 in genuine 
memory responses), clonal composition of TCRs (deep sequencing), and affinity or functional 
avidity which can be estimated be restimulation of expanded antigen-specific clones or cell lines 
with decreasing antigen concentrations or via reversible MHC-multimers [45] if available. 
 
Taken together, antigen-specific cytometry allows combination with multiparametric single cell 
analysis tools for full resolution of the antigen-specific immune response. 
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Figure Legends 
 
Figure 1. Principle of antigen-specific stimulation assays. 
Peripheral blood mononuclear cells (PBMC) or single cell suspensions from tissues are 
incubated with the antigen of interest or without antigen as negative control to determine 
background levels of the assay. If whole proteins are used for stimulation, the antigen has to be 
taken up by the autologous APCs of the cell source, processed and presented on MHC 
molecules. Peptides of a certain length can bind externally to MHC molecules. The antigen-
specific T cells will start to secrete cytokines and/ or cytotoxic molecules (5-12 hours), express 
activation markers (5-16 hours) and at later time points start to proliferate (3-5 days). For all 
these different functions of T cells, such as cytokine release, cytotoxicity, expression of 
activation markers and proliferation single-cell flow-cytometric assays are available and for most 
technologies also selection markers on the cell surface are available allowing additional isolation 
of the specific cells. 
 
 
Figure 2. Enrichment of antigen-specific T cells increases sensitivity for the detection of 
rare cells. (A) CD154 and TNF- expression was analyzed on CD4+ T cells without addition of 
an antigen and following stimulation wit the neo-antigen keyhole limpet hemocyanin (KLH). Cells 
are gated on CD4+ T cells and percentage and absolute numbers of CD154+ cells after 
acquiring 5x10e5 PBMCs (upper plots) or obtained from 1x10e8 PBMCs after enrichment of 
CD154+ cells (lower plots). (B) Phenotypic characterization of the enriched CD154+CD4+ T 
cells to discriminated between CD45RO+ memory cells and CD45RO-CCR7+ naive T cells, 
following stimulation with a peptide pool of C. albicans MP65 as recall antigen or KLH as 
neoantigen. (C) Parallel detection of antigen-specific Tcons (CD154+) and Tregs (CD137+) 
following stimulation with birch pollen lysate and magnetic enrichment for CD154+ and CD137+ 
cells from 2x10e7 stimulated PBMC. Upper plots: cells are gated on CD4+ T cells and absolute 
cell counts of CD154+ and CD137+ cells with and without stimulation are indicated. Lower plots: 
Overlayed flow-cytometric analysis of birch-specific CD154+ and CD137+ cells. Numbers 
indicate percentages among CD137+CD154-CD4+ T cells and absolute numbers of 
CD137+CD25+FOXP3+ Treg. (D) To describe the precision of flow cytometry data, the 
coefficient of variance (CV) can be calculated from the variance and the standard deviation (SD). 
For rare cell analysis, the approximations SD = √r and CV [%] = 100/√r can be used, where r is 
the number of positive events [35]. From CV [%] = 100/√r follows r = [100/CV]2. Using this 
approximation the number of total required events is illustrated depending on the frequency of 
target cells for different CVs. 
 
Table Legend 
Table 1. Methods for the detection of antigen-specific T cells 
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Section 7 – DNA synthesis, cell cycle and proliferation 
 
Cell cycle analysis was one of the very first applications for which flow cytometry was used, and 
has since been used in a large range of different settings such as interrogating the biology of 
cancer, drug development and toxicology studies [1]. In mammals, non-dividing cells in the G0 
Phase enter the G1 Phase when they are preparing for division. G1 Phase does not result in an 
increase in DNA, but does involve the synthesis of proteins that are required for subsequent 
progression. DNA synthesis occurs when cells enter the synthetic (S) Phase of the cell cycle, in 
which they will remain until the DNA content has doubled, at which time they will enter the G2 
Phase and undergo mitosis. Cells in G0 and G1 therefore contain the same amount of DNA and 
will exhibit the same fluorescent properties when stained with a DNA-binding dye. The 
fluorescent intensity of cells will progressively increase as cells increase their DNA content as 
they move through S Phase until they have twice the amount of DNA than cells in G0 when they 
reach the G2 and M Phases. 
7.1 DNA synthesis and cell cycle analysis 
The determination of DNA synthesis and cell cycle analysis involves the use of fluorescent dyes 
that bind to DNA, of which there are many (e.g. propidium iodide - PI, Hoechst stains, TO-PRO-
3, SYTOX, acridine orange, pyronin Y, 7 aminoactinomycin D – 7-AAD, Diamino-2-phenylindole 
– DAPI, DRAQ5 and DRAQ7). The selection of the dye to be used will be dependent on the 
instrument which is available and the spectral parameters which it can detect. One should also 
be aware of the binding characteristics of the dyes and their preference for particular base pairs. 
The compatibility of an instrument for a particular dye will be dictated by the wavelength of the 
lasers that are available, and the optical characteristics of the filters with which each laser is 
associated. This highlights the issue of understanding your instrument and its capabilities, as 
without this understanding, it will not be possible to design and deliver valid experimental data. 
The investigator should consult the manufacturer’s instruction manual for specific information 
regarding the operation and capabilities of their flow cytometry platform. Online flow cytometry 
resources such as Chromocyte (www.chromocyte.com) provide a repository of key information 
and tools for informing and facilitating good experimental design, and for improving flow 
cytometry practice.  
Another consideration relates to whether there is a need to analyze viable or fixed cells, and 
whether to only fix or fix and permeabilize samples. Given that permeabilization can remove 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 7 – DNA synthesis, cell cycle and proliferation 
 
251 
 
intracellular components, this approach can give more definite peaks on the fluorescent 
histograms. Crosslinking agents such as formaldehyde lower dye binding as a consequence of 
chromatin crosslinking. Dehydrating fixatives such as methanol and ethanol can also be used, 
but at high concentrations these can cause cell clumping due to the coagulation of 
proteins. Dehydrating fixatives can also negatively impact on fluorescent dyes if DNA is being 
stained in association with surface marker staining for the expression of antigenic determinants, 
as many protein-based fluorescent molecules are sensitive to the dehydrating effects of the 
alcohols. One should also be aware that signals from Green Fluorescent Protein (GFP), 
mCherry, and Cerulean can be destroyed by alcohol treatment. The addition of permeabilizing 
detergents to disrupt the plasma membrane such as Triton, NP-40 and saponin can improve 
access of the DNA dye. Another issue to consider is that the concentration of the DNA dye must 
be sufficient so that it binds in proportion to the amount of the DNA in the cell. It is therefore 
essential to determine the DNA profiles that are generated at different concentrations and 
incubation times for a defined cell number, and identify the approach which generates the lowest 
coefficient of variation (CV), but in the absence of any cytotoxic effect (i.e. check the viability of 
cell populations, and the influence of the dye thereupon). One should also remember that some 
dyes (PI, for example) will bind to both DNA and RNA. In such instances, it is necessary to 
include a ribonuclease (RNAse) in the staining buffer, otherwise the fluorescence histograms 
that are generated will be sub-optimal as they will include a signal from the RNA. A typical 
experimental protocol using propidium iodide (PI) for staining and generating a typical staining 
profile (Figure 7.1) will involve the following: 
1. Fix cells that have been harvested and washed in phosphate-buffered saline (PBS) in 
70% v/v ethanol. Adding the ethanol dropwise to the cell pellet while vortexing will 
ensure that all cells are fixed and will minimize clumping. 
2. Fix cells for 30 min at 4°C, after which wash cells twice in PBS (850 xg). Be careful to 
avoid cell loss when discarding the supernatants. 
3. Treat cells with RNAse (50 μl, 100 μg/ml) in order to ensure that only DNA is stained 
4. Add propidium iodide (200 μl PI, 50 μg/ml stock solution) immediately before 
analyzing. 
The ‘quality’ of the DNA histogram which is generated is typically indicated by the appearance 
and CV (data spread) of the G0/G1 peak, which must be as low as possible (Figure 7.1). Factors 
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which can influence this element of the data acquisition include the flow rate (which must be low) 
and laser alignment and hydrodynamic focusing (both of which should always be optimized as 
part of the routine maintenance and quality control procedures that are stipulated by the 
instrument and calibration bead manufacturers).  It is essential to maximize the electronic signal 
intensity and minimize variability of the measurement of the beads in order to achieve accurate 
DNA measurements. The precise definition of ‘low’, medium’ and ‘high’ flow rate will depend on 
the instrument and its configuration. It is better to run a more concentrated sample at a slower 
flow rate, than a diluted sample at a higher flow rate. 
Although it would appear obvious, it is crucial that the presence of cell aggregates or doublets is 
minimized, and that these are excluded from the analysis. Doublets or cells going through the 
cytometer together can mimic cells in the G2/M phase. Such problems can be avoided by 
employing good experimental techniques for the preparation of samples and filtering samples 
before the analysis [1] (see Chapter IV, Section 3: Preparation of single cell suspensions). The 
analysis gate can be set to acquire data on singlet cells by acquiring data using a ‘Pulse/Cell 
Width’ versus ‘Pulse/Cell Area’ plot or ‘Pulse/Cell Height’ versus ‘Pulse/Cell Area’ which can be 
set using the instrument software (Fig. 7.2). This approach allows doublets and aggregates to be 
easily identified and excluded from the analysis. As with all experiments, controls should be 
included. Chicken and trout erythrocytes have been proposed as internal standards for analysis 
of DNA content by cytometry in order to control and maintain consistency in the staining and 
measurement approaches. However, it should be noted that the ploidy of DNA in fish can also 
vary, and so it is important to be aware of ploidy when using cells as a standard [2].  
It is also crucial to exclude non-viable cells from any analysis, as the presence of these can 
introduce heterogeneity into the datasets that are generated. Although DNA analysis, by its 
nature, requires that cells are fixed and therefore non-viable, it is possible to stain cells using 
non-fixable dyes (protein-binding dyes) prior to their fixation for DNA staining. Details on these 
approaches are provided in the relevant section (see Chapter VII, Section 8.1: DNA-binding dyes. 
A typical instrument set up and sample acquisition could use the following sequential series of 
plots, and 10,000 to 20,000 relevant (NOT total) events should be collected: 
 Forward Scatter (FSc) versus Side Scatter (SSc) plot to identify relevant cell 
population(s) 
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 ‘Pulse Width’ versus ‘Pulse Area’ plot or ‘Pulse Height’ versus ‘Pulse Area’ plots (to 
exclude doublets) 
 Live/Dead versus FSc (to exclude dead cells) 
 DNA stain (e.g. PI) versus FSc (to monitor instrument performance) 
 DNA histogram (using a linear scale) 
A typical analysis could use the following sequential series of plots: 
 ‘Pulse Width’ versus ‘Pulse Area’ plot, or ‘Pulse Height’ versus ‘Pulse Area’ plots (to 
exclude doublets) 
 Live/Dead versus PI (to exclude dead cells) 
 FSc versus SSc plot (to exclude unusual-looking populations)  
 DNA histogram (using a linear scale) 
The placement of markers on the G1, S and G2 peaks for the analysis of cell cycle profiles can 
be subjective, as a consequence of which the analysis and interpretation of cell cycle analysis 
data now involves a number of mathematical models, all of which attempt to deconvolute the 
peaks and provide a more objective approach. Specialized programs such as ModFit LT from 
Verity Software House (http://www.vsh.com/products/mflt/mfFeatures.asp) and Multicycle AV 
from Phoenix Flow Systems (http://www.phnxflow.com/MultiCycle.stand.alone.html) have been 
designed for this purpose. 
Although cell cycle analysis is a powerful tool, it requires a great deal of optimization for the data 
to be robust, interpretable and meaningful. Cell cycle analysis provides information on the 
proliferation of cells, but other approaches must be used if you are quantifying how many times 
cells have replicated (See part 7.2 Proliferation).  
7.2 Proliferation 
The analysis of cell proliferation is at the core of many biological studies, and is typically used for 
cell growth and differentiation studies, and for the evaluation of toxicity and therapeutic 
responses to stimulators and inhibitors in a variety of settings. Cell proliferation can be 
determined on the basis of direct cell counting, on the basis of DNA synthesis (using an 
approach which typically involves measuring the uptake of 3H-thymidine), or by measuring 
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metabolic activity such as mitochondrial dehydrogenase activity using colorimetric assays such 
as the MTT (3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. For the latter, 
cells are incubated with MTT, and the yellow MTT is converted into an insoluble purple formazan 
product by mitochondrial succinate dehydrogenase. The product is solubilized and level of 
proliferation determined by measuring the absorbance of the medium with a spectrophotometer. 
An alternative colorimetric approaches uses the [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS) tetrazolium salt which results in 
a soluble, rather than an insoluble, formazan product. Although all of these approaches are 
effective, their common disadvantage is that they provide a measure of proliferation in the bulk 
population, and do not provide insight into the proliferative responses of cell subpopulations. The 
multi-parameter capabilities of flow cytometry offers a number of options for studying cellular 
proliferation in complex settings, and the majority of the approaches involve the measurement of 
nucleotide incorporation or dye dilution. The approach which needs to be used will very much 
depend on the experimental setting (Table 7.1) 
7.2.1 DNA Synthesis - Nucleotide incorporation 
Analogous to the measurement of proliferation on the basis of 3H-thymidine incorporation, cell 
division can be monitored by flow cytometry using 5-bromo-2'-deoxyuridine (BrdU), a synthetic 
nucleoside analogue of thymidine. For this, BrdU is incorporated into the newly synthesized DNA 
of replicating cells (during the S phase of the cell cycle), and its incorporation detected using 
conjugated antibodies specific for BrdU, which are widely available from a number of commercial 
sources. Binding of the antibody requires denaturation of the DNA, usually by exposing the cells 
to acid or heat. The measurement of BrdU is typically undertaken in conjunction with viability 
dyes and/or DNA stains for cell cycle analysis.  
Although appearing to be a straightforward assay, sample preparation and DNA denaturation for 
BrdU-based measurements of cell division must be performed carefully, as too little treatment 
will result in a low signal and too much treatment will influence the DNA and the signal which is 
generated. Samples need to be washed well (at least 3 times), as any residual acid will denature 
the detecting antibody. Furthermore, BrdU is labile even at 4°C and so must be used fresh. A 
typical experimental protocol producing a typical staining profile (Figure 7.3) involves the 
following: 
1. Incubate cells with BrdU (~10 M) for 30-60 minutes  
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2. Fix harvested and pelleted cells by suspending in ice-cold 70% v/v ethanol at 4oC for 
at least 30 minutes (samples can be left for up to 7 days).  
3. Pellet cells, wash in phosphate-buffered saline (PBS) and incubate for 30 minutes at 
room temperature (RT) (with occasional mixing) in freshly prepared 2M HCl.  
4. Wash cells twice in PBS, and then in PBS-Tween (PBS containing 0.1% w/v BSA and 
0.2% v/v Tween 20, pH 7.4).  
5. Add an appropriate amount of anti-BrdU monoclonal antibody (mAb, conjugated / 
unconjugated), as determined by titration experiments, to the cell pellet and incubate 
samples at RT for 20 minutes in the dark (BrdU is photo-unstable).  
6. Wash samples twice in PBS-Tween and, if an unconjugated monoclonal antibody has 
been used, incubate samples with an appropriate secondary antibody at RT for 20-30 
minutes.  
7. After washing in PBS, incubate cell pellets with RNAse (50 l, 100 mg/ml) for 15 
minutes at RT or 37°C.  
8. Add an appropriate volume of the required viability stain (e.g. propidium iodide, 200 l, 
50 mg/ml).  
9. Analyze the viable cell populations(s) by flow cytometry, collecting a minimum of 
10,000 relevant events per sample. 
An alternative to BrdU is the modified nucleoside, EdU (5-ethynyl-2′-deoxyuridine). Assays such 
as the Molecular Probes™ Click-iT™ EdU cell proliferation assay are based on the labelling of 
proliferating cells with a bright, photostable Alexa Fluor dye in a fast, highly specific click 
reaction. Unlike BrdU assays, EdU assays are not antibody-based and therefore do not require 
DNA denaturation for the detection of the incorporated nucleoside. Click-iT™ EdU can also 
easily be multiplexed with fluorescent proteins like R-PE, R-PE tandems, and Green Fluorescent 
Protein (GFP). Only a mild fixation and detergent permeabilization is sufficient for the small 
molecule-based Click-iT™ EdU detection reagent to gain access to the DNA. A typical 
experimental protocol producing a typical staining profile and improved DNA histograms has 
previously been reported [3, 4]. 
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7.2.2 Dye dilution 
The essence of dye dilution approaches is that cells are labelled with fluorescent dyes that 
intercalate into the cells such that the dye is approximately equally distributed between the two 
daughter cells following division. As the cell divides, the dye is diluted out and, by counting the 
peaks (or modelling the pattern), the number of original dividing cells can be calculated (Figure 
7.4). 
As originally described in 1994 by Lyons and Parish [5], cells were stained with the protein-
binding, amino-reactive dye carboxyfluorescein succinimidyl ester (CFSE). One limitation of 
CFSE is that there is a proliferation-independent loss of fluorescence in the first 24-36 hours, 
and therefore, this must be taken into account during the analysis and interpretation of the data. 
Although alternatives for which there is no loss of signaling after labelling include membrane-
labelling lipophilic dyes include the PKH2 (green), PKH67 (green), PKH26 (orange) and 
CellVue claret (far red) dyes from Sigma-Aldrich, these are more suitable for cell tracking 
experiments. More suitable for dye dilution studies are protein-binding dyes such as the 
CellTrace range from Molecular Probes, the eFluor® Cell Proliferation dyes from eBioscience, 
the BD Horizon dyes from BD Biosciences and the Tag-it Violet™ Proliferation and Cell 
Tracking Dye from BioLegend. If cells require fixing, then it is important to avoid organic solvents 
when using membrane dyes. It is also important to use the correct dilution of dyes, as they can 
have adverse effects on cell viability and function. Use the highest concentration which does not 
induce such negative effects for a given cell number. Protocols for the staining and analysis 
approaches can be accessed from the many suppliers of the reagents that are being used. 
As with all experiments, it is essential to include the relevant negative and positive controls. 
Moreover, once the instrument settings have been optimized, it is important to place 
unstimulated cells at the highest decade on the fluorescence plot. Non-viable cells should be 
excluded, as they lose the dye as they enter apoptosis. Doublets should be excluded as a 
doublet of two cells in the G0/G1 phase would exhibit the same fluorescence intensity on a DNA 
stain as a single cell in the G2/M phase. G0/G1 doublets would therefore create false positive 
results for G2/M cells [6].  Furthermore, a doublet formed between a positive and negative cell 
would be seen as being positive during a cell sort, as a consequence of which the sort would be 
contaminated with negative cells. The presence of doublets would also cause problems for DNA 
content/ploidy analyses, and could lead to misinterpretation of double positives during 
immunophenotyping studies, in that a double positive cell could in fact be a mixed doublet of two 
individually positive cells. 
Guidelines for the use of flow cytometry and cell sorting in immunological studies 
Chapter VII: Cytometric parameters 
Section 7 – DNA synthesis, cell cycle and proliferation 
 
257 
 
7.3 Useful Resources 
 Chromocyte Limited – Resource for flow cytometry and cell-based assays 
(www.chromocyte.com) 
 Expert Cytometry – Flow cytometry training (www.expertcytometry.com) 
 Purdue University Cytometry Laboratories (www.cyto.purdue.edu) 
 International Society for Analytical Cytology (ISAC, http://isac-net.org) 
 European Society for Clinical Cell Analysis (ESCCA, www.escca.eu) 
 BitesizeBio Flow Cytometry Channel (http://bitesizebio.com/category/technical-
channels/flow-cytometry) 
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Figure Legends 
Figure 7.1. Representative DNA fluorescence histogram of PI-stained cells. Isolated cells 
are fixed and stained as described above, and their fluorescence determined on a linear 
fluorescence scale. The presence of a sub-G1 peak can be used to indicate the presence of 
cells undergoing apoptosis (programmed cell death), see also Chapter VII Section 8.4). 
Figure 7.2. Identification of single cell populations for analysis using flow cytometry. 
Cultured tumor cells were harvested, washed and stained as described in [1]. A. Tumor cells are 
identified on a forward scatter (FSc) versus side scatter (SSc) plot and gated to exclude debris 
which is found in the lower left corner. B. Single cells can be separated from cell aggregates by 
analyzing cell height and area (upper right) - single cells will show as a correlated line, with any 
clumped cells below. C. Viable cell populations can be identified using viability stains such as 
the LIVE/DEAD® fixable range of products from Life Technologies, the eFluor fixable dyes from 
eBioscience, BioLegend’s Zombie range of fixable dyes, Tonbo biosciences’ Ghost Dyes™ and 
the Fixation and Dead Cell Discrimination Kit from Miltenyi Biotec, as described in Chapter VII 
Section 8.2. Images kindly provided by Dr Gemma A. Foulds (PhD Thesis, University of 
Sheffield, Sheffield, UK, 2015). 
Figure 7.3. Schematic representation of fluorescent dot plot for the flow cytometric 
analysis of cell proliferation on the basis of BrDU incorporation. Human peripheral blood 
mononuclear cells have been labelled with BrDU and a phenotypic marker, with unlabeled cells 
acting as the control. The total viable cell population was used for the analysis. 
Figure 7.4: Schematic fluorescence histogram depicting a progressive decline in the 
fluorescent intensity of proliferating cells stained with CFSE. For the assays, 106 isolated 
cells (e.g. human peripheral blood mononuclear cells) are incubated with CFSE (~ 5mM final 
concentration) at room temperature for 8 min, at which time the reaction is blocked by the 
addition of fetal bovine serum (FBS, 2% v/v final concentration). Cells are washed in phosphate 
buffered saline containing 2% v/v FBS, after which they are stimulated. The fluorescence of the 
stimulated cells is then measured at appropriate time-points using flow cytometry. A: The 
bright/strong, undiluted fluorescent signal of non-proliferating / arrested cells. B. The (serially) 
diluted fluorescence intensity of cell populations from successive generations of proliferated 
cells. 
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Table Legend 
Table 7.1. Approaches for determining cell proliferation. 
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Section 8 – Cell death 
The analysis of cell death in flow cytometry experiments can be required for a number of 
reasons. In some instances, the aim of the experiment is to determine the influence of different 
treatments on cell viability or apoptosis (programmed cell death). These experiments could 
determine direct, and possibly selective, toxic effects of agents on the cell population of interest. 
They could also be undertaken in the context of cytotoxicity assays such as antibody dependent 
cellular cytotoxicity (ADCC), cytotoxic T-cell activity or natural killer (NK) cell cytotoxicity [1] 
against relevant target cells. In addition to such applications, the determination of cell viability 
and the detection and exclusion of dead cells is also an essential component of any flow 
cytometric analysis for the following important reasons: 
 Non-viable cells and debris can non-specifically take up and bind probes and antibodies, 
and so must be excluded from the analysis 
 Non-viable cells are likely to exhibit a higher level of autofluorescence 
 Non-viable cells release DNA which can promote cell clumping and aggregation, both of 
which are problematic for fluorescent single cell analysis and cell sorting platforms 
The increase in background fluorescence that accompanies the non-specific binding/uptake of 
fluorescent probes by non-viable cells and/or the enhanced autofluorescence of non-viable cells 
will reduce the sensitivity of analyses and their capacity to detect weakly positive signals. 
Cellular autofluorescence is commonly associated with myeloid cells, as their intracellular flavins 
are easily excited by the 488-nm laser line. As the peak emission of flavins occurs at 
approximately 525 nm, any signal generated by autofluorescent cells will be registered and 
processed by the same photomultiplier tube (PMT) that processes FITC and equivalent 
fluorescence. It is therefore essential that cell viability is routinely assessed in all experiments. 
The approach for assessing cell viability will be dependent on whether the aim of the experiment 
is to determine the levels of cell death in response to a treatment, cytotoxicity or exclude non-
viable cells from the analysis. 
Before considering the approaches that can be used to detect non-viable cells and cell death, it 
will be helpful to highlight approaches which can be used to minimize cell death in those 
experiments which do not involve cell death as being an endpoint for the assay. Although the 
viability of cells that have been directly isolated from animal lymphoid tissues is typically high 
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(>95%), the viability of cells that have been mechanically isolated from other tissues, and that of 
cultured cells can be highly variable. The loss of viability and integrity of cells during isolation, 
harvesting and processing can be minimized by performing all cell preparations and staining 
procedures (including wash steps) at an appropriate temperature and in the presence of bovine 
serum albumin (BSA), heat-inactivated fetal bovine serum (FBS) or other proteins. In the 
majority of instances, samples should be processed at 4°C or on ice, as this slows down 
metabolic activity and other cellular events which could influence the data that are generated. 
For all experiments, cells should be stained promptly and, if not fixed, analyzed as soon as 
possible. 
Cell aggregation during staining can be inhibited by including a small amount of DNase (~200 
g/ml) in the staining solution. Cell clumping can also be inhibited by including an Mg2+ ion 
chelating agent such as EDTA (~1-5 mM), which inhibits cell adhesion events in the suspension 
buffer. If a DNase needs to be included, then it is better to use EGTA which has a lower affinity 
for Mg2+ ions, which the DNase requires.  
The information provided herein is focused on the analysis of cells by flow cytometry. A number 
of additional considerations need to be taken into account to preserve cell viability in cell sorting 
experiments:  the medium in which cells are suspended, the physical attributes of the 
instrument, especially the nozzle size, the speed of sorting and the approach which is used for 
collecting sorted populations. 
Although it is possible to eliminate dead cells from appropriate experiments prior to staining 
using techniques such as density gradient centrifugation, this is not recommended as it could 
lead to an unpredictable and inadvertent loss of viable, and potentially important, cell 
populations from the sample and, as a consequence, generate erroneous results. Under some 
circumstances, the sample could be ‘cleaned’ by isolating the cell populations(s) of interest using 
magnetic bead approaches (see Chapter V, Section 3: Rare cells (general rules)). It is typically 
better to eliminate cells from the analysis, rather than the tube in the majority of cases. However, 
even when using this approach, one should be very cautious when interpreting data from 
samples that are exhibiting high proportions of non-viable cells, as the presence of these cells 
and the intracellular components that they release could influence the biology of the viable 
populations that are being analysed. It is therefore essential that the viability of the population 
under examination is known, irrespective of the sample preparation approach used. 
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The presence of non-viable cells and the analysis of cell death can be determined using a 
number of different approaches, as listed and described in the Sections below: 
 DNA-binding dyes 
 Protein-binding dyes 
 Vital dyes 
 Plasma membrane changes 
 Caspase activation 
As for all experimental procedures, it is essential that the relevant literature is sought out and 
reviewed prior to embarking on any studies, as this is likely to contain key information on the 
parameters that others have identified as being optimal for that particular application. 
8.1. DNA-binding dyes 
The principle of identifying dead cells using DNA binding dyes is based on the concept that 
these dyes are impermeable to the plasma membrane and so cannot enter viable cells having 
intact membranes. Viable cells will exclude these dyes and therefore exhibit little to no 
fluorescence. Cell viability can therefore be assessed by incubating samples with a DNA dye 
such as propidium iodide (PI) or 7-aminoactinomycin D (7-AAD); dead cells will stain positively 
for either of these two nuclear dyes. It is important to be aware that dyes such as PI and 7-AAD 
can be taken up into viable cells over time, and so these stains should be added immediately (~ 
10 minutes) prior to analysis, and the staining protocol should be standardized across the 
experiments. It is also important to note that DNA binding dyes cannot be used on fixed or 
permeabilized cells such as those that would be used in studies interrogating the expression of 
intracellular ‘targets’ using intracellular flow cytometry. 
For the analysis, a data acquisition region is placed around the positively stained cells, and 
color-eventing or ‘back gating’ on the PI+ or 7-AAD+ cells present is used to identify most, but not 
all, dead cells as exhibiting lower forward scatter (FSc) and higher side scatter (SSc) than viable 
cells. Although it is possible to gate around the viable cell population on the basis of their light 
scatter profile and use this for all subsequent samples, even if these samples do not include a 
viability indicator, by far the best method for excluding dead cells from data analysis is to use a 
vital DNA dye in all samples. Although common dyes used in multicolor analyses include 
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propidium iodide (PI), 7-AAD, TO-PRO-3, pyronin Y(G) [PY(G)] and SYTOX, a plethora of 
options are now available from a range of commercial suppliers. A note of caution is that the 
broad emission spectrum of 7-AAD (600-750 nm at 20% normalized emission maximum) can 
result in a significant level of spectral overlap into other detectors and exclude its use in the 
context of other fluorochromes such as PE-Cy5, PerCP, PerCP-Cy5 in large multi-parameter 
panels. Furthermore, it is quite a ‘dim’ (low quantum efficiency) fluorescent molecule when 
compared to PI which is very ‘bright’. However, the minimal spectral overlap between 7-AAD 
emission and that of fluorochromes such as FITC and PE can be useful in some instances. One 
will also need a compensation control for these dyes, and this could be generated by staining 
cells that have been heat treated (70°C, 30 minutes). 
Although these approaches use one of the fluorescent detection channels and thereby reduce 
the number of other parameters that can be interrogated, the issue of viability is an important 
one and the integrity of the experimental data and their interpretation should not be 
compromised by not including a viability stain in all experiments. The far‐red viability dye 
DRAQ7™ (Biostatus Ltd, UK) is another viability dye which can be used in similar settings to PI 
and 7-AAD and allows the identification or exclusion of apoptotic, damaged or dead cells. A 
particularly useful feature of DRAQ7™ is that its dual excitation using blue (488 nm) and red 
(633/638 nm) lasers and its emission at 650-800 nm allows multi-beam excitation and the 
exclusion of dead (DRAQ7+) cells without ‘consuming’ what could be a vital, and much needed, 
additional fluorescent channel [2, 3]. 
The advantages of the classical DNA-binding dyes are that this is a well-established approach 
which involves a short incubation at the end of the staining procedure, and that the reagents are 
of low cost. However, they are limited in their spectral (excitation, emission) characteristics and a 
significant disadvantage is that they are not suitable for experiments which are interrogating 
intracellular expression of relevant antigens that require fixation and permeabilization. A typical 
staining protocol involves the following: 
1. Add 500 μl of cell suspension (1–2×106 cells – unfixed) to a 12×75 mm polystyrene 
tube 
2. Add nuclear staining compound dissolved in PBS [propidium iodide: 5 μl, 200 μg/ml, 
7-AAD: 4 μl, 250 μg/ml, TO-PRO-3: 4 μl, 250 μg/ml, or PY(G):  5 μl, 200 μg/ml] to tube 
3. Incubate cells on ice for at least 5 min 
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4. Analyze cells by flow cytometry 
8.2 Protein-binding dyes  
In some instances, the aim of the analysis will be to determine and compare the expression of 
intracellular molecules / proteins, in which case cells must be fixed and permeabilized in order to 
allow the probes and antibodies to enter the cells. The use of DNA binding dyes is inappropriate 
in these circumstances. In these instances, the use of dyes binding to the amine groups of 
proteins (amine-binding dyes), not DNA, is recommended. 
The identification of non-viable cells under such circumstances can be achieved using products 
having varied fluorescence spectral properties such as the LIVE/DEAD® fixable range of 
products from Life Technologies, the eFluor fixable dyes from eBioscience, BioLegend’s 
Zombie range of fixable dyes, Tonbo biosciences’ Ghost Dyes™ and the Fixation and Dead Cell 
Discrimination Kit from Miltenyi Biotec. These dyes covalently react with protein so that the 
discrimination is completely preserved following fixation of the sample. It should be noted that 
these dyes are membrane impermeable and so will be internalized only by non-viable cells. 
However, the level of fluorescence emitted by viable cells (with which the dye has had access to 
only a few amines on the cell surface), and non-viable cells (in which the dye has had access to 
many more amines intracellularly) will be clearly distinguishable. A word of caution: it is crucial to 
ensure that staining protocols are performed in the absence of proteins in the staining buffer, to 
which the dye will bind. Experiments can be compensated using commercially-available amine-
reactive beads.  
 
8.3 Vital dyes  
A third category of reagent which can be used for determining cell viability and cell death are the 
vital dyes. These dyes indicate viability by emitting fluorescence in response to metabolic activity 
in cells. Cellular esterases cleave the acetomethoxy group to yield calcein inside metabolically 
active cells. ‘Free’ calcein binds intracellular calcium and fluoresces brightly green. Calcein AM 
dyes can be passively loaded into adherent and non-adherent cells. These cell-
permeableesterase substrates serve as viability probes that measure both enzymatic activity, 
which is required to activate their fluorescence, and cell membrane integrity, which is required 
for intracellular retention of their fluorescent products. Available with blue, violet, and green 
fluorescence, these dyes are ideal for short-term staining (signals can be measured within 5 
minutes, but once the AM group is cleaved, it can be actively transported out of the cell within a 
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few hours) of live cells and can be used in multiplexed flow cytometry experiments. However, as 
the fluorescence generated by these dyes is driven by the presence of metabolic activity, it is not 
easy to include them in staining protocols that require fixation and permeabilization. 
8.4 Measurement of apoptosis  
The above approaches for identifying the induction and presence of cell death are based on the 
loss or maintenance of membrane integrity, and thereby reflect cellular necrosis. They provide 
little insight into the nature of that cell death. In instances where the induction of cell death is a 
primary endpoint of the experiment, interrogating changes in the plasma membrane provide an 
opportunity to generate insight into the mechanisms that are involved. By far the most common 
approach is to determine the induction of apoptosis (programmed cell death). Apoptosis is a 
tightly controlled pattern of cell death which is required for the maintenance of normal cell growth 
and development. Defective apoptosis can result in abnormal development and pathogenesis. 
Understanding cell death mechanism(s) is important as the mode of cell death (necrosis versus 
apoptosis) can influence the pro- and anti-inflammatory responses which cell death can induce. 
The importance of this area was recognized by the award of the 2002 Nobel Prize in Physiology 
or Medicine to Sydney Brenner, H. Robert Horvitz and John E. Sulston ‘for their discoveries 
concerning genetic regulation of organ development and programmed cell death’. 
During early apoptosis, phosphatidylserine (PS) is translocated from the cytosolic side of the 
intact plasma membrane to the extracellular surface. Early apoptotic cells cannot therefore be 
reliably identified using approaches that are based on membrane permeability. Annexin V 
belongs to a family of proteins consisting of over 160 members, and has high affinity, specificity, 
and sensitivity for PS. Thus, the binding of Annexin V to cells can be used as a marker of early 
apoptosis [4]. In order to rule out "leaky" necrotic cells, Annexin V staining must always be used 
in conjunction with reagents that determine the integrity of the cell membrane, such as PI or 7-
AAD. Of course, such assays cannot be performed using fixed cells. 
The protocol for such assays is relatively straightforward, but should be undertaken according to 
the protocol which is provided by the supplier of the reagents. This is especially important in the 
case of Annexin V binding, as all Annexin family members share the same characteristics of 
Ca2+-dependent binding to negatively charged phospholipid surfaces. It is essential that the 
correct staining buffers are used, as changing or variations in Ca2+ ion concentrations can have 
dramatic effects on the staining profiles. Furthermore, the binding of Annexin V to PS is 
reversible, and so samples must be analyzed as soon as possible (typically 1-3 hours after 
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labelling), using a consistent and reproducible protocol.  A typical experimental protocol 
producing a typical staining profile (Figure 8.4.1) involves the following: 
1. Wash cells (1x105) in Annexin V Binding Buffer (PBS containing 10% v/v FCS, 1.0 
mM MgCl2 and 2.5 mM CaCl2) 
2. Pellet cells (5 minutes, 400 x g), remove the supernatant, either by decanting or 
vacuum aspiration and resuspend cells in 100μL of Annexin V Binding Buffer. 
3. Incubate cells with an appropriate volume (e.g. 5μL) of fluorescently-conjugated 
Annexin V (e.g. Alexa Fluor 647-Annexin V, Biolegend), vortex mix in order to ensure 
even distribution of the stain) for 15 minutes at room temperature whilst protected 
from light 
4. Wash cells in Annexin V Binding Buffer and resuspend cells in 250μL fresh buffer 
5. Transfer cells to 12x75 mm polypropylene tubes, stored on ice protected from light 
before being analyzing by flow cytometry 
6. Immediately prior to analysis, add DNA-binding dye [propidium iodide: 5 μl, 200 μg/ml 
7-AAD: 4 μl, 250 μg/ml] to allow identification, and exclusion, of any non-viable cells. 
Although Annexin V staining is probably the most common approach used for determining 
apoptosis, other approaches can also be used. For instance, the TdT-mediated dUTP nick end 
labelling (TUNEL) method involves labelling the ends of DNA breaks with dUTP using terminal 
deoxynucleotidyltransferase (TdT). These labelled breaks can then be detected using an anti-
BrdU antibody. In this case, fixation is required. However, given that this approach depends on 
DNA damage rather than staining actual components of the apoptotic pathway, it can be 
insensitive. Another alternative to the Annexin V assay is the Violet Ratiometric Membrane 
Asymmetry Probe, F2N12S from ThermoFisher. This is excitable at 405 nm and detects 
variations in surface charge associated with PS flipping. Viable cells produce an orange 
emission which shifts to green with apoptosis, resulting in a decreased orange/green emission 
ratio. 
The later stages of apoptosis involve chromatin condensation and DNA fragmentation, a 
consequence of which is that the nuclei of apoptotic cells become smaller than those of viable 
cells and display higher fluorescence when labeled with dyes such as UV-excited Hoechst 
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33342 (which is available from a number of suppliers) or 405 nm-excited Vybrant® DyeCycle 
Violet stains (ThermoFisher). When paired with an impermeable dead cell stain, it is possible to 
distinguish live, apoptotic and necrotic cell populations using such chromatin condensation 
assays. 
The loss of mitochondrial membrane potential is another hallmark of early apoptosis. In cells 
undergoing apoptosis, the mitochondria will release cytochrome C and the apoptosis inducing 
factor - both of which are necessary for caspase activation (yet another critical step in 
apoptosis). It is also possible to assess apoptosis on the basis of mitochondrial membrane 
polarization using fluorescent dyes such as JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl-
benzimidazol-carbocyanine) or JC-10 which can be obtained from a number of different 
suppliers. As the mitochondrial potential is lost during the course of apoptosis, the emission 
shifts from red to green, thereby resulting in a decreased red/green fluorescence ratio. The 
principle of this approach is that the dye accumulates in healthy mitochondria, in which it is 
present as a multimer. Upon disruption of the mitochondrial membrane, the dye is released, and 
changes color due to it transforming into a monomer in the cytoplasm. However, a word of 
caution is that some dispute the collapse of the mitochondria membrane potential as being a 
critical step in apoptosis. 
DiIC1(5) (1,1’3,3,3’3’-hexamethylindocarbocynanine iodide) is another positively charged dye 
that accumulates in active mitochondria. It is excited at 635 nm, is read in the allophycocyanin 
(APC) channel and its fluorescence intensity decreases as membrane potential is 
lost. MitoTracker Red CMXRos is another useful mitochondrial probe which is excited as 488 
nm excitation, read in the phycoerythrin (PE) channel and also shows a decrease of 
fluorescence as membrane potential is lost. 
A key issue to be aware of is that the sample preparation process can all lead to preferential loss 
of apoptotic cells during sample preparation (i.e. prolonged trypsinization, mechanical or 
enzymatic disaggregation from tissues, centrifugation steps). Remember to collect cells that 
have been released into the media when experimenting with adherent cell cultures. Density 
gradient separation of cells can also selectively deplete apoptotic cells due to differing relative 
densities. 
8.5 Caspase activation  
A distinctive feature of the early stages of apoptosis is the activation of caspase enzymes. The 
caspases constitute a family of aspartate-specific cysteine proteases that cleave protein 
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substrates at specific amino acid residues. This triggers a sequence of cleavage events, 
including the cleavage of other caspases, and generates a caspase signaling cascade that leads 
to apoptosis. In mammals, the ‘initiator’ caspases-2, -8, -9, -10, and -12 are closely coupled to 
upstream, pro-apoptotic signals, and cleave and activate downstream effector or "executioner" 
caspases-3, -6, and -7 that modify the proteins that ultimately drive apoptosis [7, 8]. In most 
cases, caspase activation is one of the earliest measurable markers of the apoptotic cascade, 
and precedes the induction of cell permeability, DNA fragmentation, cytoskeletal collapse, and 
the flipping of PS. The pivotal and early involvement of caspases in cell death events has 
prompted the development of a number of assays which can be applied alone, or in conjunction 
with assays for detecting other aspects of the cell death process. A number of commercial 
suppliers provide validated assays for the detection of apoptosis on the basis of caspase 
activation.  
Caspase activation assays can involve the intracellular staining of cell populations using 
monoclonal antibodies that are specific for the activated forms of the relevant caspase (Fig 
8.5.1), or can employ small inhibitor peptides conjugated to a fluorophore which specifically 
target the active site of the chosen caspase. 
As an example, the CellEvent® Caspase-3/7 Green Detection Reagent from ThermoFisher is a 
cell-permeable reagent consisting of a four-amino acid peptide (DEVD) conjugated to a nucleic 
acid-binding dye. The activation of caspase-3 and caspase-7 proteins enables them to cleave 
the caspase 3/7 recognition sequence which is encoded in the DEVD peptide. Cleavage of the 
recognition sequence and binding of DNA by the reagent labels the apoptotic cells with a bright, 
fluorogenic signal that has absorption/emission maxima of ~511/533 nm. When used together 
with the SYTOX® AADvanced™ Dead Cell Stain, apoptotic cells can be easily discriminated 
from live and necrotic cells. 
Caspase activity can also be determined using the PhiPhiLux® system, which employs a non-
fluorescent substrate for the enzyme that yields a fluorescent product if the enzyme is active. 
The PhiPhiLux® caspase substrates are cell permeable, demonstrate relatively good caspase 
specificity, possess high signal-to-noise ratios between their uncleaved and cleaved forms, and 
have fluorescence spectral properties that are compatible with other fluorescent probes. ApoStat 
(R&D Systems) identifies and quantifies caspase activity in apoptotic cells by irreversibly 
labeling cells with a cell permeable, FITC-conjugated pan-caspase inhibitor (ApoStat). Any 
unbound reagent diffuses out of the cell and is washed away and an increased fluorescence is 
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indicative of caspase activity. The CaspGLOW™ staining system detects active caspase-9 in 
mammalian cells using FITC-conjugated LEHD-FMK, a specific inhibitor of caspase-9 which is 
cell permeable and irreversibly binds to the active enzyme. 
Another approach involves the use of a fluorescently labelled inhibitor peptide that binds to the 
active site of the caspase or FLICA® - Fluorescent Labelled Inhibitor Caspase. FLICA® probe-
based assays, which are available from a number of Suppliers, are comprised of an affinity 
peptide inhibitor sequence, a fluoromethyl ketone (FMK) moiety that facilitates an irreversible 
binding event with the activated caspase enzyme, and a fluorescent tag reporter. The FLICA® 
are therefore retained in apoptotic cells, but not in non-apoptotic cells following washing. 
Necrotic and late apoptotic cells can be concurrently identified in green FLICA®-labelled cells 
using red fluorescent dyes such as PI or 7-AAD, or the far red dye DRAQ7™. The ability to 
measure three apoptotic phenotypes in a single assay provides a powerful and comprehensive 
view of the apoptotic process, applicable to both suspension cells by traditional flow cytometry. 
The approach selected for measuring cell viability, cell death and apoptosis will very much 
depend on the experimental question, the supplier of the reagents, and the analysis of the 
strengths and weaknesses for each assay. Conventional internet searches will readily identify 
the plethora of kits and approaches that can be used for measuring caspase activation. 
 
8.5.1 Useful Resources 
 Chromocyte Limited – Resource for flow cytometry and cell-based assays 
(www.chromocyte.com) 
 Expert Cytometry – Flow cytometry training (www.expertcytometry.com) 
 Purdue University Cytometry Laboratories (www.cyto.purdue.edu) 
 International Society for Analytical Cytology (ISAC, http://isac-net.org) 
 European Society for Clinical Cell Analysis (ESCCA, www.escca.eu) 
 BitesizeBio Flow Cytometry Channel (http://bitesizebio.com/category/technical-
channels/flow-cytometry) 
Legend to Figures 
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Figure 8.4.1 Identifying healthy and apoptotic cells on the basis of Annexin V staining. 
The human prostate cancer cell line LNCap was seeded into 6 well plates and allowed to adhere 
overnight. The following day, cells were left untreated (A) or incubated for 6 hr with 4µg/mL 
human recombinant granzyme B [5, 6] (B). After the incubation period, cells were harvested and 
processed as described above, with 105 cells being stained with Alexa-Fluor647 Annexin V 
(following the manufacturer’s instructions) and propidium iodide (final concentration 1µg/mL). 
Cells were analyzed on a Beckman Coulter Gallios™ flow cytometer. Plotting Annexin V binding 
on the X-axis of a 2-dimensional dot/density plot and PI/7-AAD on the Y-axis enables the 
identification of healthy (Annexin VnegativePI/7-AADnegative, bottom left quadrant), apoptotic 
(Annexin VpositivePI/7-AADnegative, bottom right quadrant) and late apoptotic / dead (Annexin 
VpositivePI/7-AADpositive, top right quadrant) cells. The cells incubated in the presence of granzyme 
B showed induction of apoptosis and increased cell death. 
Figure 8.5.1. Identifying healthy and apoptotic cells on the basis of activated caspase-3 
expression. The human breast cancer cell line MDA-MB-231 was seeded into 6 well plates and 
allowed to adhere overnight. The next day, cells were left untreated or incubated for 24 hours 
with the topoisomerase I inhibitor camptothecin (4µg/mL, induces apoptosis). After the 
incubation period, cells were harvested and stained using the FITC active caspase-3 apoptosis 
kit (BD Biosciences) following the manufacturer’s instructions and analyzed on a BD Biosciences 
LSRII flow cytometer. Cells were identified using FSc and SSc measurements (A) and the 
expression of active caspase-3 determined on the basis of FITC fluorescence (B; control sample 
shown on open histogram and camptothecin treated shown on grey histogram). The cells 
incubated in the presence of camptothecin showed activation of caspase-3. 
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8.6 - Cytofluorimetric analysis of mitochondria  
Mitochondria are essential mediators of cell metabolism, being producers and targets of reactive 
oxygen species (ROS), regulators of ATP levels and calcium homeostasis, and hubs of the 
biosynthetic pathways involved in the synthesis of amino acids, lipids and nucleotides [1]. 
Mitochondria are present in all cells, including those that rely mostly on glycolysis rather than on 
oxidative phosphorylation for ATP synthesis. They are very heterogeneous in size, shape, and 
number, depending on the metabolic requirement of the cells, the underlying tissue, and several 
other factors. Given their crucial role in cellular and organismal functions, it is not surprising that 
mitochondrial (mt) dysfunctions have been observed in a number of genetic and non-genetic 
diseases, as well as in cancer and aging [2]. In the vast majority of cases, distinctive features of 
mt dysfunction include changes in mitochondrial membrane potential (MMP), mt mass and redox 
potential.  
Flow cytometry allows the rapid monitoring of all these parameters in intact cells, avoiding 
artifacts associated to mt isolation and/or permeabilization, and offering the benefits to work in a 
preserved cellular environment [3]. A number of mt-specific fluorescent probes have been 
developed, which can be used to measure MMP, mt mass, and intra-mt reactive oxygen species 
(Table 1) [4]. 
MMP is the main component of the proton-motive force, which is established by protons pumped 
from the mt matrix to the intermembrane space, and combines the MMP to the mt pH gradient. 
This potential varies according to the status of mitochondria, it is related to their capacity to 
synthetize ATP, and is a common indicator of cell health. According to the Nernst equation [5], 
the mt matrix is negative, thus indicating that hyperpolarized or depolarized mitochondria 
present a more or less negative mt matrix, respectively. Dyes for measuring MMP are typically 
lipophilic cationic compounds, i.e. positively charged molecules that can cross membranes 
without binding them, and accumulate in the mt matrix in direct proportion to MMP. 
Hyperpolarized mitochondria accumulate more dye, whereas depolarized mitochondria 
accumulate less dye. When MMP is assessed by flow cytometry, two major recommendations 
have to be taken into account. First, dye concentration should be carefully titrated. High dye 
concentrations lead to fluorescence quenching, which generates artifacts and misleading results. 
Even if quenching threshold varies depending on the dye, concentrations in the range 1-30 nM 
should be low enough to avoid unwanted quenching phenomena [6]. Second, functional controls 
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must be used to ensure that changes in the dye signal are interpreted properly and are not 
caused by other parallel changes, including those in mt mass. Appropriate controls are 
represented by:  
i) carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), carbonyl cyanide m 
      chlorophenyl hydrazine (CCCP), and valinomycin, which are uncouplers;  
ii) oligomycin, an ATP synthase inhibitor  
iii) nigericin, a K+/H+ ionophore.  
While FCCP, CCCP, valinomycin and oligomycin induces depolarization, nigericin induce 
hyperpolarization.  
A list of the main fluorochromes used to assay MMP in living cells is shown in Table 1. Among 
them, 3,3’-dihexyloxacarbocyanine iodide (DiOC6) has been extensively used in flow cytometric 
studies [7]. However, DiOC6 activity as NADH inhibitor, together with its toxicity toward mt 
respiration, strongly limits the use of this probe [8, 9]. Similarly to DiOC6, rhodamine 123 
(Rh123) was initially used in several studies [10]. However, Rh123 enters easily into the cells 
and rapidly equilibrates, but is not well retained. In addition, in certain conditions, Rh123 binding 
to mitochondria can be independent of mitochondrial energy status, and this further restricts its 
use [9, 11]. Conversely, tetramethylrhodamine ethyl ester (TMRE) and tetramethylrhodamine 
methyl ester (TMRM) are widely used to probe MMP by flow cytometry [12, 13]. These dyes are 
nontoxic, specifically stain polarized mitochondria and do not display quenching effects [13]. 
They should be used at relatively low concentrations, and the analysis can be performed 
immediately after staining, even in the absence of wash steps. Upon excitation at 488 nm, 
TMRE and TMRM emits at 574 nm. As monochromatic dyes, the median fluorescence intensity 
(MFI) relative to the proper channel should be measured for TMRE and TMRM. Typically, an 
unstained sample (also known as “blank”) should be prepared, in order to set the levels of 
background fluorescence, and subtract this background fluorescence to fluorescence of the 
stained sample. When assayed by TMRE or TMRM, changes in MMP are thus evaluated as 
changes in MFI of a given sample (Figure 1). 
 Carbocyanine dyes, especially 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl-benzimidazol-
carbocyanine (JC-1), are considered the most reliable probes for the detection of MMP. JC-1 
has polychromatic fluorescence emission spectra, and allows a ratiometric semi-quantitative 
assessment of mt polarization [14, 15]. In the monomeric state, it emits a green fluorescence 
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(529 nm), whereas in the aggregate state, which is highly dependent upon MMP, it emits an 
orange-red fluorescence (>590 nm), well detectable in healthy cells. In the presence of 
compounds that cause a collapse in MMP, JC-1 become monomers. This means that while in 
healthy cells both green and orange-red fluorescence are expected, cells with depolarized 
mitochondria display only green fluorescence [16]. Considering the shift in fluorescence due to 
MMP changes, the best way to display results is that of indicating the percentage of cells with 
high or low MMP, rather than the ratio between green and orange-red fluorescence. Since 1993, 
JC-1 has been reported as a reliable membrane potential indicator for several cell types and 
assay conditions [14, 17, 18], and its compatibility with other fluorescent probes has also been 
demonstrated in the design of multi-color panels [19, 20]. However, the sensitivity of JC-1 
towards hydrogen peroxide, its photosensitivity, and the slow rate of equilibration between 
monomers and aggregates, could partially limit its use. Other dyes, similar to JC-1, are also 
available but are scarcely used JC-9 is characterized by polychromatic fluorescence emission, 
with excitation at 522 nm, and emission at 535 or 635, in the monomeric or aggregate forms, 
respectively. The green fluorescence of JC-9, characterized by a different chemical structure 
respect to JC-1, is essentially invariant with membrane potential, whereas the red fluorescence 
is significantly increased at hyperpolarized membrane potentials. JC-10 is excited at 490 nm, 
and emits at 520 nm (monomeric form) or 590 nm (aggregated form). Compared to JC-1, JC-10 
is characterized by higher water solubility and diffuses out of mitochondria in apoptotic and 
necrotic cells 
Mitochondrial mass can be monitored by using dyes able to bind specific mt components 
regardless of mt polarization status. For this reason, the amount of fluorescence is directly 
proportional to mt content. Mito ID and nonyl acridine orange (NAO) bind to cardiolipin in the 
inner mt membrane, whereas mitotracker dyes react with the thiol groups of cysteine residues 
present in mt proteins [21, 22]. Some of these dyes, including mitotracker deep red 633, also 
form covalent bonds with mt proteins, thus allowing fixation after cell staining. As described for 
TMRE and TMRM, the MFI relative to the proper channel should be measured for mitotracker 
dyes, and the MFI of the unstained sample should be subtracted to the MFI of the stained one 
(Figure 2). 
Regarding mt ROS, two fluorescent probes, i.e. MitoSOX red mitochondrial superoxide indicator 
(MitoSOX) and mitochondria peroxy yellow-1 (mitoPY1), have been recently developed to stain 
specifically anion superoxide and hydrogen peroxide in mitochondria, respectively [23-25]. 
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MitoSOX is the mitochondria-targeted form of hydroethidine. It accumulates into mitochondria 
depending on MMP, and it emits fluorescence upon oxidation and binding to mitochondrial DNA 
[26]. As already reported for other probes, when using MitoSOX and mitoPY1, preparing 
adequate positive and negative controls is crucial to fully validate the presence of mt H2O2 in 
biological systems. Antimycin A or doxorubicin are best-suited positive controls for MitoSOX 
staining, whereas exogenous H2O2 or other molecules that increase the fluorescence signal of 
the probe represent proper positive controls for mitoPY1. Negative controls for MitoSOX staining 
are cell-permeable superoxide dismutase mimetics or mt uncouplers, depending on the cell type. 
Additional controls can be represented by antioxidants, such as N-acetylcysteine, or other 
specific scavengers that highly reduce free radical production [27]. MitoSOX and mitoPY1 have 
been tested by flow cytometry for selective quantification of mt anion superoxide and mt 
hydrogen peroxide in keratinocytes, endothelial cells, fibroblasts, several cancer cell lines, 
among others [28-31]. The possible simultaneous use of MitoSOX and mitoPY1 in the same 
panel for the analysis of mt reactive oxygen species in living cells has also been reported (Figure 
3) [28].  
Flow cytometry is undoubtedly a useful tool to assay mt functions in biological samples. 
Protocols to assay mt parameters can be applied to several cell models, and are relatively fast, 
as the time required to complete staining and data analysis (even in the case of multi-color 
panels) rarely exceeds three hours. In addition, the analysis of several thousands of cells in a 
few minutes allows accurate measurements. Nevertheless, as a general rule, the use of more 
than one probe, as well as the use of complementary methods to assess changes in mt 
membrane potential or mt mass, is strongly recommended.  
 
Figure 1. TMRM and JC-1 staining of CD4+ T cells. The K+ ionophore valinomycin depolarizes 
mitochondria of CD4+ T cells, as revealed by the decrease in TMRM fluorescence, and by the 
decreased fluorescence of JC-1 aggregates and increased fluorescence of JC-1 monomers. 
Untreated cells (CTRL) are shown in left panels. For TMRM, unstained sample is also shown in 
right panel. Dot plot combining untreated sample and valinomycin-treated sample is also 
reported (lower right panel). 
 
Figure 2: Mitotracker Green staining of different subsets of CD8+ T cells. Different CD8+ T-
cell subsets, i.e., central memory (CM), naïve (N), effector memory (EM), and terminally 
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differentiated effector memory (EMRA) were identified according to the expression of CD45RA 
and CD197. Among them, the use of Mitotracker Green (MT Green) allows to determine mt 
mass, which is clearly different among cell subsets. 
 
Figure 3: MitoSOX Mitochondrial Red superoxide indicator and Mitochondria Peroxy 
Yellow-1 staining of different subsets of CD8+ T cells. Doublets were excluded from the 
analysis of peripheral blood mononuclear cells by using FCS-A and FSC-H (upper left panel); 
viable cells were selected according to negativity for annexin-V (ANX-V) Pacific Blue (PB) 
conjugate and TO-PRO-3 iodide (upper right panel). Then, CD4+ or CD8+ T lymphocytes were 
selected on the basis of positivity for a CD4-APC-H7 mAb or a CD8-PO mAb respectively. 
Among these, fluorescence intensity of MitoSOX Mitochondrial Red Superoxide Indicator 
(MitoSOX) and Mitochondria Peroxy Yellow-1 (mitoPY) was analyzed. 
 
Table 1 Main fluorescent probes used to stain mitochondria in intact, living cells. 
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Section 9 – Phagocytosis 
9.1  Background 
Phagocytes are essential components of the first defensive line of the innate immune 
system. Professional phagocytes include neutrophils, monocytes, macrophages, 
dendritic cells, osteoclasts, and eosinophils [1].  Phagocytosis is, indeed, one of the 
most ancient functions of immunity conserved through evolution [2]. 
Ingesting and killing of microorganisms involves intrinsic functions of phagocytes as 
well as complex interactions between phagocytes, pathogens and plasma factors such 
as opsonins. Deficiencies in these functions or interactions are associated with 
increased susceptibility to infection. Defensive phagocytosis involves sequentially 
chemotactic migration of the phagocytes, recognition of pathogen determinants, 
ingestion of microorganism and, finally, destruction by oxygen-dependent (“oxidative 
burst”) and -independent mechanisms [1].  
It is important to note that the interaction with extracellular pathogens may lead to the 
apoptotic death of phagocytes [3]. On the other hand, phagocyte recognition of 
apoptotic cells helps clearance of unwanted self cells from tissues. Phagocytosis of 
apoptotic cells prevents the release of cell components that might otherwise trigger 
inflammatory response [4]. Phagoptosis, also called primary phagocytosis, is a form of 
cell death caused by phagocytosis and destruction of viable cells. Phagoptosis 
mediates turnover of erythrocytes, neutrophils and other cells, and thus is one of the 
main forms of cell death in the body. Phagoptosis is triggered by exposure on plasma 
membrane of 'eat-me' signals (such as phosphatidylserine or calreticulin) and/or loss of 
'don't-eat-me' signals (such as CD47) by viable cells, causing their phagocytosis by 
phagocytes. Live cells may modify the expression of such signals as a result of cell 
stress, damage, activation or senescence [5].  
Also of interest, is the study of phagocytic ingestion of synthetic nanoparticles (NPs) in 
the range of 1 to 100 nm. These particles are increasingly used in industrial and 
commercial products [6]. 
 
9.2 Flow cytometric assays of phagocytosis: fundamentals and general applications  
Flow cytometry (FCM) has been used for many years to study phagocytosis [7-13]. 
Although frequent applications include the clinical study of human immunodeficiencies 
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and septic conditions [14] phagocytosis assays also serve veterinary [15] 
andenvironmental settings [16] as well as a growing multiplicity of other experimental 
settings.  
 
In classical FCM phagocytosis assays, phagocytes are incubated at 37ºC with 
fluorescent target particles pre-opsonized with an appropriate dilution of serum. 
Phagocytosis is measured as the mean fluorescence of effector cells and or the 
percentages of fluorochrome-positive phagocytes, or serum dilutions at which a defined 
endpoint value is calculated. These techniques have intrinsic drawbacks, such as 
quenching of fluorescence upon internalization, difficulty distinguishing between 
adherent and internalised bacteria in most cases, or a failure to determine antibody-
mediated phagocytosis [7-13]. 
Phagocytosis studies benefit from the unique integration of functional and phenotypic 
information provided by FCM and the large availability of phagocytic cell types and 
targets (both natural and synthetic) that are suitable for the technical capabilities of 
FCM [7-13]. In many cases, FCM assays of phagocytosis are available as commercial 
kits, and may include simultaneous assessment of other functional aspects or 
consequences of phagocytosis, typically the oxidative burst [14] or apoptosis [14, 17]. 
9.3 Critical points in the pre-analytical and analytical phases of assays  
9.3.1 Phagocytic cell types and sample preparation 
FCM assays of phagocytosis and other phagocytic-related functions can be performed 
on a large variety of primary phagocytic cells, including but not restricted to peripheral 
blood monocytes and neutrophils from humans [14], rats [18],  dogs [19], cats [20], 
cows [21] or cetaceans [16], human dendritic cells [22], human peritoneal [23] or 
monocyte-derived macrophages [24], peritoneal- or bone-marrow murine macrophages 
[25], and coelomocytes from earthworms [26].  In addition, several established cell 
lines with phagocytic capacity can be used for experimental studies, typically the 
human monocytic cell lines U937 and THP-1 or the murine macrophage cell lines 
J774A.1 and RAW 264.7 [27]. 
When using whole blood samples, heparin is often the choice anticoagulant, and 
anticoagulated blood samples should be processed within 4 hours of collection. 
Prolonged storage may lead to abnormal results.  Specimens should typically be 
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maintained at 18 - 22 °C, and temperatures below 10°C and above 30°C must be 
avoided if possible when using whole blood. If cryo-preserved blood cells are used for 
assay, it is essential to thaw and use the cells rapidly. Neutrophils are especially 
fragile, and can be activated by endotoxins, excessive agitation or repeated 
centrifugations, with resultant cell death. Endotoxin-free polypropylene tubes should be 
used. Cell clumping after standing at room temperature can be avoided by using the 
cells promptly or by adding DNase to the cell suspension [10]. 
Human peripheral blood mononuclear cells and neutrophils can be isolated by using 
different classical procedures, with dextran sedimentation preferable for neutrophil 
purification and gradient centrifugation by Histopaque 1077 for monocyte enrichment 
[28]. In addition, magnetic separation can be used successfully to isolate functional 
primary phagocytic cells based upon immunophenotypic myeloid cell determinants [29]. 
Human monocytes are often cultured in serum-free or serum-supplemented media to 
create macrophages or dendritic cells [29]. 
9.3.2 Phagocytosis Targets 
A multiplicity of fluorescent biological and synthetic micro- or nanoparticles can be used 
as suitable targets for phagocytosis with FCM assays reflecting, on the one hand, the 
different roles and clinical failures of phagocytosis and, on the other hand, the diversity 
of plasma membrane receptors that mediate phagocytic recognition of microbes, 
apoptotic cells or synthetic particles [1].  
The best biological targets can be live microorganisms, including pathogenic and non-
pathogenic bacteria and yeast. Because of their hazardous nature, pathogens can be 
inactivated by different means. However, inactivation by heat killing (e.g. boiling) may 
result in loss of cell wall components, which are extremely important for phagocyte 
recognition, thus potentially reducing phagocytosis [30]. Inactivation by fixation with 4% 
paraformaldehyde may preserve some pathogen-associated determinants and 
improves recognition [31]. Another typical target for phagocytosis assays are zymosan 
particles, prepared from the cell wall of Saccharomyces cerevisiae and consisting of 
protein-carbohydrate complexes [9-11, 32]. FCM assays of phagocytosis can use 
fluorescent microbeads of different optical properties, chemical composition and 
diameter which may be, in addition, coupled with components relevant for receptor-
mediated particle recognition [10].  
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Since physiological phagocytosis occurs mainly after binding of opsonized particles to 
receptors of the constant fragment of immunoglobulins (Fc) or complement receptors 
expressed on phagocytes, it may be essential to ensure opsonization of phagocytosis 
targets. Engagement of phagocyte Fc receptors can be done by pre-incubation of 
targets with appropriate sera or Immunoglobulin G (IgG) solutions, as well as by 
coating of fluorescent beads with IgG antibodies. In this aspect, whole-blood assays of 
phagocytosis have the advantage of not requiring additional steps of target 
opsonization. 
 As rates of phagocytosis are highly dep on the target-to-cell ratio, accurate counting of 
targets and effector phagocytes and the use of a suitable ratio is important [32]. Target: 
effector ratios ranging from 1:1 [32] to 260:1 [33] have been applied in different assay 
settings. Similarly, the determination of the duration of the assay must take into 
account the difference of phagocytosis kinetics between synthetic and natural targets, 
as well as among different types of biological targets . One-hour incubation is usually 
sufficient and typically, phagocytosis assays require incubation times of  15-30 min 
[34].  
 
 
9.3.3 Fluorescent Labelling of Targets 
There are several convenient commercial sources of to fluorescently conjugate 
biological and synthetic particles [12]. In some cases, such particles are components of 
assay kits which can be used in conventional FCM using a suitable laser. For custom 
labelling of targets, the most common fluorescent labels are incorporated as N-
hydroxysuccinimide esters, which react covalently with –NH2 groups [12]. Fluorescein 
derivatives (e.g. fluorescein, dicarboxyfluorescein, Oregon Green™, 
dihydrodichlorofluorescein) have been popular, but their fluorescence is quenched in 
the acidic compartments of phagocytes and, moreover, their emission wavelength 
overlaps markedly with green autofluorescence, which is especially present in 
macrophages and monocytes [35]. Other fluorophores such as Alexa Fluor®, 
BODIPY® FL, tetramethylrhodamine and Texas Red® have stable, intense emission 
over a broad pH range (pH 4-9). Most interestingly, pHrodo™, a new series of probes 
with green- or red fluorescence emission increasing with decreasing pH has been 
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recently developed [12, 36]. Fluorescent-protein expressing E.coli can be also suitable 
for FCM assays [37-39].  
9.3.4 Identification of live subpopulations of phagocytic cells by Light Scatter and 
surface immunophenotype 
The nucleated phagocytes in whole blood assays may be distinguished from debris 
and from smaller targets (microorganisms and fluorescent beads) by gating on the 
granulocyte and monocyte populations using forward and side scatter properties [10, 
12]. As phagocytosis may lead to degranulation and, even, apoptosis of phagocytes, 
especially neutrophils, it is recommended to include at least a viability marker and 
eventually, appropriate immunophenotypic markers (e.g. CD45, CD14, CD13, CD15, 
CD16, CD11b) [40].  It is worth to mentioning that the lymphocyte population in whole 
blood assays may often serve as an internal negative control of non-phagocytic cells. 
In FCM assays using homogeneous phagocytic populations (e.g., U937, TPH-1, RAW) 
and small targets it is recommended to include viability markers, in order to exclude 
non-specific attachment of targets to dead or dying phagocytic cells. In those 
specialized assays in which target cells (e.g. apoptotic cells, infected erythrocytes) may 
have similar size as phagocyte effectors, it is recommended to bar-code separately 
label effectors and/or targets with appropriate tracking dyes [33, 41]. 
In all cases, phagocytosis assays involving immunophenotyping with multicolor 
cytometry should include the appropriate controls for fluorescence compensation 
(single-stained tubes) and gating (Fluorescence-minus-One, or FMO, controls).  This is 
further discussed in Chapter III, Section 1, Compensation. 
9.3.5 Distinguishing non-internalized from internalized particles 
In order to accurately assess accurately the phagocytosis process it is mandatory to 
demonstrate that the particles are in fact ingested as opposed to coincident with the 
phagocyte in the laser-illuminated volume or adherent to the neutrophil surface. 
While coincidence of phagocytes and targets can be minimized by running dilute 
samples at the slower flow rates, quantification of internalized particles as distinguished 
from surface adherent may be approached by different strategies:  
A) Comparing the cell-associated fluorescence intensity in conditions avoiding 
(negative controls) or allowing particle internalization. Negative controls of this type 
should include cells incubated without fluorescent targets (autofluorescence) and of 
cells and targets co-incubated at 4º C (Figure 1) or in the presence of inhibitors of 
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cytoskeleton rearrangement, as the mostly used cytochalasins, or other inhibitors of 
phagocyte function, such as N-ethylmaleimide [34] 
B) Using targets labelled with a dye that is sensitive to quenching agents (e.g. FITC-, or 
Calcofluor White can be quenched by trypan blue and cristal violet [10-12], while Sytox 
Green is quenched by propidium iodide [30]. In this approach, extra washing steps are 
necessary to remove the quenching dye, thus increasing assay time and making the 
assay prone to artefacts and cell loss.  
C) Using fluorescent targets emitting fluorescence at different wavelengths at neutral or 
acidic pH. Probes of this type include the pHRodo™ series, and the Eos-FP fluorescent 
protein. pHRodo™ dye can be used for the labeling of targets, as it reacts with the 
primary amino groups on the particle to yield a covalently linked pH probe, which 
increases fluorescence emission as the pH of its environment becomes more acidic. 
The optimal absorption and fluorescence emission maxima of the pHrodo® Green dye 
and its conjugates are approximately 509 nm and 533 nm, respectively, while pHrodo® 
Red excites at 560 nm and emits at 585 nm. Both pHrodo® Green and pHrodo® Red 
can also be excited with the 488 nm argon-ion laser installed on most flow cytometers 
(https://www.thermofisher.com/es/es/home/brands/molecular-probes/key-molecular-
probes-products/phrodo-indicators.html). Due to the low pH of the phagolysosome, 
phagocytized targets can be quantified without interference of adherent particles [12, 
36, 42].  
Eos-FP can be transfected into infectious microorganisms. After UV-irradiation of 
bacateria, peptide cleavage in Eos-FP occurs and the transfected bacteria emit green 
(≈516 nm) and orange (≈581 nm) fluorescent light at 488 nm excitation. Orange 
fluorescence is sensitive to acidic pH, and the phagocytosed bacteria stop emitting 
orange fluorescent light as soon as the phagosomes fuse with lysosomes. The green 
fluorescence is maintained in the phagolysosome until bacterial degradation is 
completed [38] 
D) Applying Imaging FCM. This novel technique of cytometry combines the statistical 
power and fluorescence sensitivity of standard FCM with the spatial resolution and 
quantitative morphology of digital microscopy, as it is based on the capture of images 
of particles in flow and subsequent pixel-based image analysis of objects [42]. Imaging 
FCM allows defining the intracellular localization of fluorescent targets in phagocytes, 
thus ruling out the need of quenching or blocking steps (Figure 1) [43]. 
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9.3.6 Assessing or quantifying phagocytosis kinetics and capacity 
The simplest calculation is the proportion of phagocytosing cells within the evaluated 
population, defined as the percentage of gated cells with target fluorescence, present 
in the appropriate gate (established by morphological, viability and immunophenotypic 
criteria) [10]. 
Regarding the quantification of ingested fluorescent targets, calculation may be 
relatively straightforward if pH-independent fluorescent particles (biological or 
synthetic) are used. The mean number of particles ingested per effector cell can be 
calculated by dividing the mean fluorescence intensity (MFI) of the cell population by 
the fluorescence of a single, extracellular target [44]. When using labeled with pH-
dependent dyes however, this calculation is inaccurate and must be modified by 
subtracting the number of free targets per phagocyte from the initial number of targets 
per phagocyte [10, 11]. 
An interesting parameter to quantify phagocytosis capacity is the Phagocytosis Product 
(PP) parameter [10]. PP is defined as the percentage of phagocytosing cells multiplied 
by the number of targets per phagocytosing cell. PP reflects that the total elimination of 
targets from a given assay preparation depends both of the percentage of 
phagocytosing cells and the number of targets ingested by each effector cell [10]. 
LEGEND TO FIGURE 1. 
Fig 1. Representative examples of strategies to differentiate between attached 
and internalized fluorescent bacteria in whole-blood phagocytosis assays by 
conventional flow cytometry (A-C) and imaging flow cytometry (D-F). In both 
assays, whole-blood samples anticoagulated with heparin were stained with CD45-
APC (A) or CD45-PE (D) antibody and incubated for 30 min at 37ºC (B) or at 4ºC (C) 
with a suspension of Escherichia coli (ATCC 11775) transformed by electroporation 
with a plasmid containing the GFP gene (pMEK91 GFP). The ratio bacteria/leukocytes 
was 1:4. Then, samples were lysed with BD FACS Lysing Solution, put on ice and 
analysed immediately in a BD Accuri C6 conventional flow cytometer (A-C) or in an 
Amnis ImageStream 100 multispectral imaging flow cytometer (D-F), both using a 488 
nm blue laser. Graphs B and C show the intensity of GFP fluorescence emission in 
granulocytes distinguished by higher granularity (SSC) and lower CD45 expression 
(purple-colored events in graph A) after incubation of whole blood with GFP-expressing 
E. coli at 37ºC (graph B) or at 4ºC (graph C). Comparison of B and C shows the 
difference between granulocytes with adherent and/or internalized bacteria (74.5% of 
the population after incubation at 37ºC) and granulocytes with only adherent bacteria 
(3.8% of the population after incubation at 4º C). Graph D shows the features of the 
main leukocyte populations identified on an imaging flow cytometer by their light scatter 
under darkfield illumination (intensity_ SSC) and the expression CD45 
(Intensity_CD45-PE). Composite graphs E and F shows the intracellular localization of 
GFP bacteria in single cells of the granulocyte subpopulation (gate on NEUTRO, graph 
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D) after incubation of whole blood with GFP-expressing E. coli at 37ºC.  Merged 
images (BF/GFP) from the brightfield illumination channel (BF) and the green 
fluorescence channel (GFP) allow distinguishing cells with external bacteria (graph E) 
from cells with internalized bacteria (graph F). Numbers on the BF image in E and F 
composites indicate the sequential number of the event in the sample run.   
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Section 10 - Autophagy 
10.1 Introduction 
Autophagy is a catabolic lysosomal survival pathway for the degradation and turnover 
of cytoplasmic constituents during times of nutrient starvation and in response to 
stress. There are three main types of autophagy; chaperone-mediated [1], 
microautophagy [2] and macroautophagy [3]. The techniques described in this section 
detect macroautophagy and hereafter will be referred to as autophagy.  
The catabolic degradation of cellular constituents generates metabolites, which are 
reused as sources of energy or synthesis of new macromolecules. Much less is known 
about how autophagy produces cell biological change, but it is known to be an 
important player in the regulation of proliferation, cell growth, remodelling and 
differentiation in a number of systems [3].  
Autophagy is tightly regulated by complex signalling pathways, key players include 
AMPK, PI3K, mTOR, ULK1 complex and Vps34 complex. Close to 40 core autophagy 
genes have been identified that mediate the completion of a double-membrane 
autophagosome, which engulfs unwanted cytosolic material such as aged and 
damaged organelles, protein aggregates or pathogens. Subsequent fusion of the 
autophagosome to the lysosome degrades its cargo (Figure 1). Autophagy related 
genes (ATGs) were originally identified in yeast, but most of these are evolutionary 
conserved in higher organisms such as mammals [4]. A key player often used to 
quantify autophagy is the ATG8-family member MAP1LC3B (LC3I). During 
autophagosome elongation, the cytosolic protein LC3I is lipidated by conjugation to 
phosphatidylethanolamine (PE) to become LC3-II, and thereby inserts into the 
membrane of the growing autophagosome.  
Many compounds are known to affect the autophagy process [5] and are used in its 
study such as Chloroquine [6], which inhibits lysosomal acidification, and Bafilomycin 
A1 [7], which blocks lysosomal proton transport and leads to inhibition of lysosomal 
hydrolases. Both of these block autophagosome-lysosome degradation and are 
common inhibitors used to measure autophagic flux (Figure 1).  
Autophagic flux (or flow through the autophagy pathway) is used to measure 
autophagic activity. One such approach is to measure the rate of protein breakdown by 
autophagy by arresting the autophagic process at a given point and recording the time-
dependent accumulation of an organelle or organelle marker. The most common way 
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to induce this block is to inhibit lysosomal proteolysis, thus, increasing levels of LC3-II 
and autophagosomes, which can be measured.  
 
10.2 Flow cytometry autophagy assays. 
In recent years autophagy has been successfully measured with commonly used 
techniques such as western blot and microscopy [8]. However, these assays are 
limiting since a certain number of cells are needed or cell sorting is required to 
measure autophagy in a specific cell type within a mixed cell population. More recently 
developed techniques for flow cytometry and imaging flow cytometry opened new 
possibilities in the field of autophagy. Not only can primary cells be analyzed, these 
techniques also allow a higher throughput and the possibility to look at multiple 
parameters simultaneously. As the available antibodies to LC3 do not discriminate 
between lipidated and non-lipidated LC3, these techniques rely on detecting punctate 
LC3 visible by imaging or removing the non-lipidated form prior to staining [9]. 
Detection of fused autophagomes also relies on the identification of lysosomes, as 
required for the Amnis ImageStream autophagy assay described later. Lysosomes 
contain many proteases, which a number of substrates detect the activity of. One such 
reagent are the LysoTracker probes (ThermoFisher Scientific) which are hugely 
selective for acidic organelles. They must be used at low concentrations (usually 50nM) 
and only require a short incubation time (1-5mins) before imaging otherwise they 
induce an increase in lysosomal pH. They can however be fixed with aldehydes, but 
the autoflourescence or non specific staining means their specificity for quantifying 
lysosomes by flow will depend on cell type. However, it has had some success in flow 
assays with cells showing an increase in signal after treatment with Chloroquin (an 
autophagy inducer) [10]. LysoTracker dyes (ThermoFisher Scientific) are similar, but 
exhibit a pH dependent increase in fluorescence intensity upon acidification. They still 
have the same issue with increasing lysosomal pH with longer incubation times and 
nonspecific staining when used for flow cytometry. Lyso-ID (Enzo) is another acidic 
organelle-selective dye but doesn’t increase lysosomal pH over time lending itself to 
short and long term tracking of lysosomes. An alternative are lysosome specific 
antibodies, such as LAMP family members. Anti-LAMP1 staining was shown to give the 
same results when compared to Lyso-ID in the autophagy imaging flow cytometry 
assay discussed below [11]. 
Autophagy flow cytometry assays include: 
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a) Amnis ImageStream autophagy assay. The imaging features of the 
ImageStream (See Chapter I, Section 4, Imaging flow cytometry make it possible 
to quantify endogenous LC3 puncta while detecting surface markers. To detect 
autolysosomes the co-localization between LC3 and lysosomes using a bright 
detail similarity analysis feature can be used [11,12,13]. 
 
b) FlowCellect Autophagy LC3 kit (Merck Millipore). Selective cell membrane 
permeabilization allows discrimination between cytosolic non-lipidated LC3-I from 
membrane bound LC3-II by washing out the soluble cytosolic form.  
 
c) Cyto-ID Autophagy detection kit (Enzo) 
This is a novel proprietary dye that selectively stains autophagic vesicles including 
newly formed double membrane vesicles, autophagsomes and autolysosomes. 
 
 
10.3 Measuring autophagy in primary cells. 
Primary cells typically have high basal levels of autophagy and only show small 
changes in autophagy after treatments in comparison to cell lines. It is advisable to 
choose appropriate controls for each treatment and experiment since basal autophagy 
is cell type/state dependent (Table 1).  
 
 
Notably, when using any compounds to induce autophagy the vehicle needs to be 
considered. DMSO is known to induce autophagy [14] and should therefore be avoided 
if possible. Always include vehicle-treated, ‘untreated’ controls in experiments. To 
measure autophagic flux, cells need to be treated with inhibitors such as Bafolomycin 
A1 and Chloroquine. (Figure 2). Both block autophagosome-lysosome fusion allowing 
LC3 to accumulate in the autophagosome. Autophagy inducers such as Rapamycin or 
starvation do not always show differences in autophagy levels in primary cells. 
Generally, it is wise to test some inducers and inhibitors to find the best read out. 
 
One also needs to be aware of off target effects of compounds used to modulate 
autophagy. Some may require specific concentrations or incubation times [5]. The most 
widely used inhibitor 3-MA (a target of Vps34) is low potency requiring it to be used at 
~10mM to prevent autophagy at which concentration it can also affect other kinases 
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including class I PI3K, p38MAPK or c-Jun kinase therefore affecting many cellular 
processes, for this reason 3-MA is not our inhibitor of choice [15]. Bafilomycin A1 
widely used in our laboratory, but one should be aware that it needs to be used at low 
concentration for >4 hours or it will also inhibit the proteasome, endocytic trafficking 
and other cellular processes [16]. 
 
Another note of caution is when using adherent cells. Care must be taken when 
preparing single cell suspensions from adhered cells as this requires disruption and 
injury of the plasma membrane, which can itself induce autophagy. For some cells we 
found Accutase® induced less autophagy when compared to scraping or trypsinisation. 
However, different methods should be tested for the cell type of interest. 
 
The FlowCellect LC3 flow cytometry assay is our assay of choice. Selective detection 
of LC3-II gives an enormous advantage to investigate autophagy in primary cells and 
requires fewer cells and is significantly quicker than the ImageStream autophagy 
assay. It has been described previously that this method must be used carefully since it 
includes several washing and permeabilization steps on live cells [17]. To monitor 
inconsistencies, we have performed experiments on fresh and frozen cells from several 
healthy donors at multiple time points. We could show that in our hands the assay was 
reliable and consistent for different cell types such as T cell, B cells and monocytes 
(data not published).  
 
Differences in autophagy levels can be presented in different ways. Using flow-based 
techniques make it easy to apply quantification of statistical analysis. For the flow 
cytometry assays after compensation and gating on the cell population of interest, the 
geometric mean of LC3-II fluorescence intensity can be measured. Basal or induction 
levels (e.g. Bafilomycin A1 treatment in Figure 2) of LC3-II can be quantified or 
autophagic flux can be calculated from geometric mean values (treatment-basal / 
basal). The latter takes variations in basal autophagy levels into account and allows 
comparisons across multiple samples.  
  
However, every technique has its limitations and it is important to choose the best one 
for the experimental question. All compounds should be titrated and tested carefully. 
 
Figure Legends 
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Figure 1. Autophagy pathway showing key modulators used in detection of 
autophagy. A double-membraned elongation vesicle is formed, which elongates to 
form an autophagsome (left). During the elongation, a cytosolic protein LC3-I is 
lipidated to LC3-II and inserts into the membrane of the growing autophagosome. The 
autophagosome circularises, engulfing the material to be degraded (middle). The 
autophagosome then fuses with a lysosome to breakdown the autophagy vesicle and 
its contents (right). 
Figure 2. Autophagy induction and flux measured with the FlowCellect LC3 kit. 
Human PBMCS were treated for 24 hours with Bafilomycin A1 (BafA) present for the 
last two hours. Cells were treated with LPS and gated on CD14+ cells for monocytes, 
CD3/CD28 beads with CD3+ gating for T cells and IgM and MegaCD40L with CD19+ 
gating for B cells. After all treatments cells were stained with the appropriate antibody 
for detection of the cell population of interest and for LC3-II using the FlowCellect LC3 
kit. This involves staining cells with an anti-LC3 FITC conjugated antibody that is 
selectively washed out to only detect membrane bound LC3-II. Data is shown as 
histograms of LC3-II FITC expression after compensation and gating on the population 
of interest. 
 
Table 1. Autophagy inducers for primary immune cells. Treatments which 
successfully induce autophagy after 24 hours. *  
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Section 11 – Cytotoxicity 
 
Priming of naive pathogen or tumor-reactive CD8+ T lymphocytes (TN) occurs in 
secondary lymphoid organs (SLOs) where they undergo clonal expansion and 
differentiate into effector CD8+ T (TE) lymphocytes. In the course of their functional 
maturation, CD8+ TE acquire the ability to leave SLOs, enter non-lymphoid organs 
(NLOs), produce inflammatory cytokines and lyse target cells displaying appropriate 
MHC class I-peptide complexes [1,2]. Some CD8+ TE survive the expansion/effector 
phase and convert into long-lived CD8+ memory T lymphocytes (TM). CD8+ TM can be 
found in SLOs and NLOs where they exert immediate effector functions upon 
secondary antigen contact [3,4].  
Peptide-specific target cell lysis is a cardinal feature of cytotoxic CD8+ TE/TM (CTLs) 
[4,5] and its quantification is a valuable means to track CD8+ T cell responses. 
Traditionally, in vitro CTL assays relied on the detection of compounds released from 
dying target cells. For example, target cells loaded with radioactive sodium chromate 
lose their radioactive label as a result of CTL-mediated lysis. Hence, the amount of 
radioactivity in the supernatant of effector (CTL)/target cell co-cultures directly 
correlates with the lytic activity of the respective CTL population [6]. To achieve 
suitable effector-to-target cell (E:T) ratios of at least 50:1, high numbers of CTLs are 
required for this type of assay. This usually requires antigen-dependent CTL expansion 
in vitro, a process that may alter the composition and/or function of the starting CTL 
population.   
In order to replace radioactive CTL assays, several flow cytometry-based techniques 
were established in the past years. Their major aim is to visualize the biochemical 
processes involved in CTL-mediated target cell lysis. 
CTLs induce target cell apoptosis via the Fas/Fas ligand pathway or the release of 
cytotoxic granules containing perforin and granzymes. Either pathway results in the 
activation of caspase-dependent target cell apoptosis. To visualize this process, cell-
permeable fluorogenic caspase substrates can be used [7]. They consist of two 
fluorophores, which are linked by a caspase-sensitive peptide. Only upon caspase-
dependent cleavage these substrates become activated and can be detected by flow 
cytometry [8]. Hence, fluorescence intensities correlate with CTL-dependent target cell 
destruction. However, similar to the chromium release assay, relatively high E:T ratios 
are required for this experimental approach. 
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A more sensitive assay relies on the co-incubation of CTLs with a mixture of target 
cells consisting of at least two different populations. The first population is loaded with 
the MHC I-restricted peptide of interested and stained with one dye (e.g. PKH-26). The 
second population is loaded with an irrelevant peptide, stained with a different dye (e.g. 
CFSE) and serves as negative control [9]. Alternatively, different concentrations of the 
same dye can be used to stain both target cell populations, which still can be 
discriminated based on their differential fluorescence intensities. The extent of CTL 
activity is determined by the relative decrease in the number of labeled target cells 
loaded with the desired peptide over non-specific target cells after a period of time, 
usually 5 hours. An example is shown in Figure 1. A significant advantage of this 
assay is its high sensitivity and favorable signal-to-noise ratio. In most cases this allows 
the measurement of CTL function directly ex vivo without prior expansion and at 
comparably low E:T ratios. 
Target cells may be immune (e.g. splenocytes) or somatic cells (e.g. epithelial cells or 
fibroblasts) to more closely resemble the physiological CTL targets. CTLs can be 
purified from any organ of interest, either lymphoid or non-lymphoid. Depending on the 
research question, purification of total CD8+ T cells or antigen-specific CD8+ T cells 
may be required. In the former case, the frequency of antigen-specific CTLs can be 
determined in parallel by MHC/peptide multimer staining to determine CTL frequencies 
and adjust E:T ratios for different tissue samples. Figure 1 shows an example of ex 
vivo cytotoxicity by influenza-specific CTLs isolated from the broncho-alveolar space of 
infected mice without the need of a prior sort for influenza-specific CTLs. 
 
However, if the frequency of antigen-specific CD8+ T cells is very low, it may be 
necessary to enrich them prior to the cytotoxicity assay. In this case, it is not advisable 
to sort antigen-specific CD8+ T cells by means of TCR labeling (e.g. by MHC/peptide 
multimers) since this may alter their lytic function. If available, the use of congenically-
marked TCR-transgenic (TCRtg) CD8 T cells might be useful to circumvent this 
problem. This allows their marker-based, TCR-independent enrichment prior to the ex 
vivo CTL assay. Hence, direct ex vivo CTL assays have several advantages: (1) they 
are very sensitive,  (2) CTLs may be isolated from any organ, (3) the type of target cell 
may be adapted to the nature of the experiment, (4) E:T ratios can be adjusted to 
compare different samples. However, it is important to note that the tissue 
microenvironment affects CTL activity [10]. Hence, the lytic potential of tissue-resident 
CTLs may differ from those purified for ex vivo CTL assays.  
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To circumvent this problem, CTL activity can be measured in vivo [5,11,12]. Again, for 
this approach, at least two target cell populations are required. One is labeled with the 
peptide of interest and e.g. a high concentration of a suitable dye such as CFSE 
(CFSEhi population). The control population is loaded with an irrelevant peptide and a 
tenfold lower concentration of CFSE (CFSElo population). Equal numbers of CFSEhi 
and CFSElo cells are co-injected into effector mice. After 4-18 hours, SLOs can be 
isolated to analyze single cell suspensions by flow cytometry (Figure 2). Similar to the 
direct ex vivo assay described above, the relative loss of CFSEhi target cells over 
CFSElo cells indicate the extent of CTL-mediated lysis. This method provides the most 
sensitive and physiological assessment of CTL activity. Figure 2 shows an example of 
influenza-specific CTL activity in lung-draining mediastinal LNs and non-draining distal 
LNs in mice undergoing flu infection. 
 
In vivo CTL assays can also be used to determine the lytic potential of multiple CTL 
populations with different specificities in the same analysis. This requires the 
simultaneous use of more than two target cell populations. A simple method to achieve 
this goal is the use of splenocytes from homozygous CD45.1+/1+ and heterozygous 
CD45.1+/2+ congenic mice as target cells in CD45.2+/2+ effector mice. Using 
monoclonal antibodies against CD45.1 and CD45.2, mixed CD45.1+ target cells can be 
discriminated from host cells. Furthermore, the different target cell types can be 
distinguished based on their differential CD45.1/.2 expression and varying CFSE 
intensities.   
Although in vivo CTL assays offer obvious advantages, they are not suitable for all 
experimental systems. For example, somatic cells such as SLO fibroblasts [13], lung 
epithelial cells [14] or hepatocytes [15] are often the primary targets of viral infections. 
After i.v. injection into mice, however, somatic cells hardly reach the parenchyma of 
SLOs or other organs, but are rather trapped within the lung and liver vasculature ([16] 
and unpublished observation). Thus, they are of limited use as target cells for in vivo 
CTL assays. 
The use of naive splenocytes as target cells may help to circumvent this problem. 
However, naive splenocytes usually do not enter NLOs effectively. Hence, the 
appropriate tissue tropism of the desired target cell type is a prerequisite for the 
successful application of the flow cytometry-based in vivo kill assay. A disadvantage of 
in vivo CTL assays is the fact that E:T ratios cannot be adjusted. Hence differences in 
lytic activity may result from differences in CTL numbers and/or the lytic potential of 
individual cells. The quantification of specific CTLs by MHC/peptide multimers in the 
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respective target organs may be useful to judge whether differences in target cell lysis 
rely on differences in CTL number and/or function.  
All assays described so far are suitable to quantify the lytic action of CTL populations. 
However, the lytic potential of individual CTLs cannot be judged. To approach this 
problem, antibodies directed against e.g. CD107a can be used. This molecule is 
present on the membrane of cytotoxic granules and becomes detectable on the cell 
surface of degranulating CTLs. CD107a levels correlate closely with the lytic potential 
of CTLs [17]. Monoclonal antibodies directed against CD107a can be combined with 
MHC/peptide multimers and cytokine-specific antibodies to determine multiple effector 
functions of individual antigen-specific CTLs by flow cytometry. This method might be 
helpful to complement the ex vivo and in vivo CTL assays described above.  
 
Figure legends:  
Figure 1. Quantification of ex vivo cytotoxicity by influenza-specific CTLs. (A) 
Seven days after pulmonary infection with influenza A/WSN/33, untouched flu-specific 
CTLs in unfractionated bronchoalveolar lavage (Effectors, E) were incubated in vitro 
with a titrated number of target cells (T). Targets consisted of an equal mixture of 
spleen cells loaded with an MHC-I-binding influenza peptide (flu) or an irrelevant MHC-I 
ligand (control). Flu peptide-loaded spleen cells were labeled with a higher 
concentration of Cell Proliferation Dye eFluor 670 than their control counterparts. Five 
hours later, the relative frequency of the remaining target cells was quantified by flow 
cytometry. The exact frequency of flu-specific CTLs can be determined in parallel by 
staining with the corresponding MHC-I multimer. (B) Quantification of technical 
duplicates shown in (A). The % of flu-specific kill was calculated as: 100 – [100 × (Tflu / 
Tcontrol)with E / (Tflu / Tcontrol)without E].    
 
Figure 2. Quantification of in vivo cytotoxicity by influenza-specific CTLs. Seven 
days after pulmonary infection with influenza A/WSN/33, infected and naive mice 
received targets cells intravenously. Targets consisted of an equal mixture of spleen 
cells loaded with an MHC-I-binding influenza peptide (flu) or an irrelevant MHC-I ligand 
(control). Flu peptide-loaded spleen cells were labeled with a higher concentration of 
Cell Proliferation Dye eFluor 670 than their control counterparts.  Four hours later, 
target cells in lung-draining mediastinal LNs and non-draining inguinal (distal) LNs were 
quantified by flow cytometry.  
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Section 12 - Reactive Oxygen Species production with minimal sample 
perturbation 
12.1 Introduction 
Reactive oxygen species (ROS) have been shown to be associated with oxidative 
stress [1]. Toxic oxygen free radicals contribute to aging [2], apoptosis [3, 4], and 
pathological processes [5] in many clinical disorders, such as cardiac dysfunction and 
myocyte injury [6, 7]. More recently ROS have been also involved in signaling 
processes [8 - 11], having a role as signaling molecules that generate specificity in 
ROS homeostasis. ROS are generated during mitochondrial oxidative phosphorylation 
or after interacting with xenobiotic compounds [11], and its rate production increases 
under hypoxia or after inhibition of mitochondrial respiration [12, 13]. The term ROS 
includes superoxide anion (O2-), hydrogen peroxide (H2O2), and hydroxyl radical (HO·) 
[11]. ROS are formed by the incomplete reduction of oxygen. ROS are mainly free 
radicals which many times are not very reactive and have too short a half-life [10]. 
Oxygen-derived free radicals are molecular species with unpaired electrons [14] and 
are the product of multiple biological oxidation and reduction pathways [11]. 
Although ROS are generated during mitochondrial oxidative normal metabolism, are 
also generated in cellular response to exogenous compounds, cytokines, and bacterial 
invasion [15]. ROS including all highly reactive molecules that contain oxygen are 
members of important mechanisms of protection against infections [16]. However, ROS 
generation can result in cell and tissue damage, as a result of the interaction with cell 
membranes, nucleic acids, proteins and enzymes [10, 17]. Oxidative stress is a 
consequence of the excessive production of oxygen reactive species or a decrease in 
the antioxidant defense [18]. Oxidative stress causes cytotoxicity through structural and 
functional alterations, resulting in the disruption of cell homeostasis [19].  
One of the main sources for production of anion superoxide (O2·-) is the electron 
transport system of mitochondria. Anion superoxide is the first reactive oxygen species 
to be produced after oxygen enters living cells and and this radical may generate many 
other ROS of different reactivity. Superoxide is produced by one electron reduction of 
molecular oxygen, has a short half-life and is little reactive, and does not result in 
oxidative attack of polyunsaturated lipids and DNA. However, defects in SOD, a 
powerful enzyme that catalyzes the dismutation of superoxide into O2 and H2O2, can 
cause membrane damage due spontaneous dismutation of O2- into H2O2, result in 
elevated levels of superoxide, which can lead to cell membrane damage because of 
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the accumulation of this oxygen reactive specie [20]. Its instability is related to the rapid 
O2·- dismutation reaction to hydrogen peroxide (H2O2) catalyzed by SOD [21]. 
Hydrogen peroxide is not a free radical but it can give rise to other reactive oxygen 
species. Most ROS are free radicals which cause little damage due to their short half-
life, but they are always reactive. H2O2 is a molecule much more stable and less 
reactive than superoxide anion. However, it can cause cell damage at a relatively lower 
concentrations when compared with O2·- damage [22]. This hydrosoluble molecule can 
diffuse across cells and can reach distant targets even its formation was produced in 
remote tissues [22]. Hydrogen peroxide is formed by O2·- dismutation, catalyzed by 
SOD, and an unstable intermediate, hydroperoxyl radical [23]. However, dismutation 
can also be spontaneous and it can also be formed through direct oxygen reduction 
with participation of two electrons. Hydrogen peroxide can generate other reactive 
oxygen species with enhanced reactivity, such as the hydroxyl radical (·OH) [22]. The 
direct activity of H2O2 can be damage cells by cross-linking sulfhydryl groups and 
oxidizing ketoacids, causing inactivation of enzymes and mutation of DNA and lipids 
[22]. Hydroxyl radical is highly reactive and toxic. With a relatively short half-life, 
hydroxyl radical can also react with many biomolecules, including DNA, proteins, lipids, 
aminoacids, sugars or metals [22].   
Production of ROS by human monocytes was originally described using the nitroblue 
tetrazolium salt assay [24] or luminol-dependent chemiluminiscence [25]. Flow 
cytometry is progressively replacing these assays [26] and has several advantages: it 
is rapid, sensitive and multiparametric, and allows cell subpopulations to be studied 
[27]. However, in many of these cytofluorometric assays, samples are subjected to 
manipulation in the form of centrifugation, washings steps, erythrocyte lysis and, in 
some cases, fixation of cells or enrichment of the target cells by means of density 
gradients [28, 29]. Hence, sample manipulation can give rise to both cellular depletion 
and artifactual activation and may result in inaccurate measurements, especially in 
those cases where target cells are the minority. 
 
 
12.2 Sample preparation and flow cytometry setup for measuring ROS generation 
Ideally, cytofluorometric functional studies on oxidative burst should be performed in 
whole blood with minimal sample manipulation (stain, no-lyse, and no-wash) in order to 
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mimic physiological conditions. Studies on minimal sample perturbation can be 
achieved with single and multicolor laser instrumentation. We have developed two no-
wash, no-lyse strategies for identifying leukocytes in whole human blood on the flow 
cytometer that can be used for ROS production. One approach (Figure 1) is to use a 
nucleic acid stain to label and analyze only nucleated cells, avoiding anucleate mature 
red blood cells . A series of dyes have low cytotoxicity, are permeable DNA-specific 
dyes and can be used for DNA content cell cycle analysis and stem cell side population 
by flow cytometry. Many of these dyes can be excited with ultraviolet, blue or violet 405 
nm laser light and can be used for simultaneous staining with antibodies. A 
fluorescence threshold is applied to the nucleic acid stain detector to eliminate the non-
nucleated cells from detection by the cytometer during acquisition.  
A second approach using a light scatter threshold (Figure 2) exploits the difference in 
light-absorbing properties between red blood cells and leukocytes. Red blood cells 
contain hemoglobin, a molecule that readily absorbs violet laser (405 nm) light, 
whereas leukocytes and platelets/debris do not, resulting in a unique scatter pattern 
when observing human whole blood in the context of blue (488 nm) and violet (405 nm) 
side scatter (SSC). This can be done by switching to a new filter configuration for the 
violet laser. The  440/50 fluorescence bandpass filter is replaced with  a 405/10 violet 
side scatter bandpass filter to allow simultaneous measurement of both blue and violet 
side scatter and the differentiation of red blood cells and leukocytes based on light-
scattering properties alone. Moreover, the 495 Dichroic Longpass (DLP) filter should be 
also replaced using a new 415DLP to allow fluorescence detection above 495nm if 
desired (Figure 3). 
In this approach non-nucleated cells are detected by the instrument during acquisition, 
but excluded by gating during analysis. Care must be taken when using the method to 
keep event rates below instrument limitations for Poisson coincidence. Red blood cell 
concentration in whole blood is on the order of 5 million cells per microliter so  whole 
blood must be properly diluted (1/100) to avoid instrument saturation. 
Dead cells often give false positive results, as they tend to bind nonspecifically to many 
reagents. Therefore, removing dead cells from your flow cytometry data is a critical 
step to help ensure accurate results and analysis. Different manufacturers market 
nonfixable cell viability assays for flow cytometry to distinguish live and dead cell 
populations that are more accurate than forward- and side-scatter data. For more detail 
on this control aspect see Chapter IV, Section 5, – Frozen Samples and Cell Viability .  
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For ROS production studies, different dyes can be used on a flow cytometer based on 
auto-oxidation, photochemical reactions, mitochondrial respiration, cytochrome P450, 
NADPH oxidase, and other enzymes. Most of these reagents are photostable 
fluorogenic probes that can also be detected by conventional fluorescence microscopy 
or high-content imaging and screening. One of the most common cytofluorometric 
assays uses dihydrorhodamine 123, an uncharged and nonfluorescent ROS indicator 
that can passively diffuse across membranes where it is oxidized to cationic rhodamine 
123, which then localizes in the mitochondria and exhibits green fluorescence [30]. 
Designing an experiment to measure ROS production in blood can be simple and 
elegant. Blood samples with volumes ranging from 20 µL to 40 µL can be used [31]. 
Figure 4 shows a representative experiment of resting and activated leukocytes in 
unlysed whole blood. Cells were stained with Vybrant DyeCycle Violet (DCV) stain to 
discriminate nucleated cells, in combination with dihydrorhodamine 123 (DHR) PE-
CD33, APC-CD11b, and 7-ADD. Cells were stimulated with PMA dissolved with DMSO 
and incubated in presence of DHR for 30 min at 37ºC.  Subsequently, cells were 
stained with DCV and PE-CD33 and APC-CD11b antibodies for 20 min at room 
temperature. Following incubation, blood was diluted in HBSS and immediately 
acquired for flow cytometry measurements. As shown, ROS production can be easily 
distinguished using these markers with a multi-laser flow cytometry protocol with no 
color compensation, making support to no-wash no-lyse strategies as the better choice 
for phenotypic and functional measurements using freshly drawn blood samples [31]. 
For more than fifteen years, we have used these no-lyse no-wash methods for ROS 
production, but also for the detection of rare cells. ROS production should be studied 
using this simple and fast methodology, but also for rare cell detection (chapter V, 
section 3 Rare cells (general rules), minimal residual disease studies or human 
hematopoetic progenitor cell counting.  
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Figure legends: 
Figure 1. Identification of leukocytes in human whole blood using violet laser and 
Vybrant DyeCycle Violet stain on the Attune NxT Flow Cytometer. Leukocytes are 
outnumbered by red blood cells ~700-fold in whole blood and generally require enrichment by 
red blood cell lysis or gradient centrifugation prior to analysis (4). This strategy exploits the use 
of Vybrant® DyeCycle™ Violet stain (DCV), a low cytotoxicity permeable DNA-specific dye that 
can be used for DNA content cell cycle analysis and stem cell side population by flow 
cytometry. DCV threshold levels were set empirically to eliminate from detection the large 
amounts of red blood cells that are found in unlysed whole blood. A proper threshold is shown 
in a SSC-Height vs. DCV-Height dotplot. DCV can be excited with violet lasers and can be used 
for simultaneous staining with antibodies. This protocol is ideally suited to study the numbers of 
nucleated cells in unlysed whole blood. Using a gate in this figure as the parent gate, the three 
main leukocyte cell populations in human blood are identified using classic forward and side 
scatter plots.  
  
Figure 2. Identification of leukocytes in human whole blood using violet side 
scatter on the flow cytometer. Resolution of leukocytes from red blood cells in whole 
blood is improved by incorporating violet 405 nm side scatter. Using both violet and 
blue side scatter allows identification of leukocytes in whole blood. Using a gate in this 
figure as the parent gate the three main leukocyte cell populations in human blood can 
be identified using classic forward and side scatter plots. 
Figure 3. Use of the Attune NxT No-Wash No-Lyse Filter Kit. The standard 
configuration for the 405 nm violet laser optical filter block is shown in (A) and the same 
optical filter block using the No-Wash No-Lyse Filter Kit shown in (B), with changes 
outlined in red. To use the filter kit, remove the 440/50 bandpass filter in VL1 slot 1 and 
place the 405/10 bandpass filter that is placed in the VL1 slot 1in slot 1. Remove the 
495 Dichroic Longpass (DLP) filter in a lot A the  415DLP. The Blank filter in slot 1A is 
switched with the 417LP filter in slot 0.  
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Figure 4. Reactive oxygen species production. Representative experiment of 
resting and activated leukocytes in unlysed whole blood. Cells were stained with 
Vybrant DyeCycle Violet stain to discriminate nucleated cells fro erythrocytes 
(Excitation/Emission (nm): 405/437), in combination with dihydrorhodamine 123 
(Excitation/Emission (nm): 488/530) PE-CD33 (Excitation/Emission (nm): 561/578), 
APC-CD11b (Excitation/Emission (nm): 637/660), and 7-ADD (Excitation/Emission 
(nm): 488/647). Cells were stimulated with PMA dissolved with DMSO and incubated in 
presence of DHR for 30 min at 37ºC.  Subsequently, cells were stained with DCV and 
PE-CD33 and APC-CD11b antibodies for 20 min at room temperature. Following 
incubation, blood was diluted in HBSS and immediately acquired for flow cytometry 
measurements. 
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Section 13 – Intracellular Ca2+ mobilization by means of Indo-1 AM 
 
13.1 Introduction 
Ca2+ ions play an essential role as an intracellular messenger in nearly all cellular systems and 
regulate a multiplicity of cellular functions [1]. In the immune system Ca2+ mobilization induces 
direct processes as activation of platelets, degranulation of mast cells or killing of target cells by 
cytolytic T cells but it is also an essential component of the signaling cascades downstream of 
several receptors, such as the B- and T-cell receptor, activating Fc receptors, chemokine 
receptors and others, regulating the transcription of target genes and subsequently driving 
processes such as proliferation, differentiation and others [2,3,4] implying that Ca2+ mobilization 
has to be considered in many aspects of immunologic research. Based on patch clamp methods 
Ca2+ currents can be measured very precisely on a single cell level [5]. Provided that this method 
is not feasible in many laboratories, determination of Ca2+ mobilization by means of widely 
available flow cytometry may represent an easy alternative providing relative values of Ca2+ 
mobilization on a single cell level.  
 
13.2 Theory of measuring intracellular Ca2+ mobilization via Indo-1 AM staining 
Indo-1 Acetoxymethyl (AM) is a cell-permeant ratiometric Ca2+ indicator, used to determine 
intracellular Ca2+ mobilization at the single cell level [6]. The dye is excited at 355 nm and 
therefore requires a UV laser. The Indo-1 AM emission peak at 475 nm in the absence of Ca2+ 
shifts to 400 nm upon binding Ca2+ ions. Therefore, changes in the ratio of Ca2+-bound Indo-1 
AM signal at 475 nm to Ca2+-unbound Indo-1 AM signal at 400 nm allow the immediate detection 
of alterations in intracellular Ca2+ concentration (Figure 1A).  
Since mixed populations of cells, as is the case with peripheral blood, might respond differently 
to stimulation, a comparison between defined homogeneous cell populations should be 
attempted. This can be achieved by using additional staining for cell surface markers. Data 
acquisition by flow cytometry enables the analysis of various subpopulations (e.g. different B-cell 
or T-cell subpopulations) at the same time, provided that Ca2+ mobilization is induced by the 
same agent or stimulus (such as B-cell or T-cell receptor stimulation). 
Alternative methods for detecting Ca2+ by flow cytometry include Fluo-3 [7] and its respective 
analogues, which have the advantage that they provide sufficient sensitivity and can also be 
excited with at 488 nm, which is a standard laser wavelength more readily available than the UV 
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laser wavelength. The advantage of Indo-1 AM is primarily due to the possibility of measuring it 
as a ratiometric assay, which includes the advantages of controlling for differential uptake of the 
dye between different cells and a lower sensitivity to photobleaching [8].  An additional significant 
advantage of using Indo-1 AM is that the commonly used 488 nm laser remains available for the 
detection of other surface markers [6]. Flow cytometers such as the LSR II® or LSR Fortessa® 
from Becton Dickinson (BD Biosciences, San Jose, CA) or the ZE5 Cell Analyzer from Bio-Rad 
(Bio-Rad Laboratories, Inc., Hercules, CA) can be equipped with a UV laser for Ca2+ mobilization 
experiments using Indo-1. This manuscript will focus on using Indo-1 AM for detection of Ca2+ 
flux. 
 
13.3 Sample preparation:  
As for all functional assays, for Ca2+ mobilization control samples which have ideally undergone 
the same pre-analytical steps as the test samples are required. This is especially important 
when samples were shipped or previously frozen. The optimal temperature for the investigation 
of Ca2+ mobilization, as for all signaling studies, is 37° C. While some facilities or institutes 
provide this option by individual solutions, standard instruments are not equipped with a 
heatable acquisition chamber to maintain the samples at a constant temperature of 37° C during 
the measurement. Strong fluctuations in temperature during cell preparation and between the 
different experiments should be avoided, since this may influence the Ca2+ flux. Although most 
cell types are capable to induce Ca2+ mobilization at room temperature (e.g. human lymphocytes 
subpopulations), some cell types are more sensitive and may need 37° C to run the assay. In 
most cases pre-warming of the samples to 37° improves Ca2+ mobilization, but subsequent 
cooling during the measurement may lead to changes of the Ca2+ baseline levels in some 
subpopulations and may thus render the analysis inaccurate (Figure 1B). Therefore, in the 
absence of an option to run the experiment at a constant temperature of 37° C we perform the 
entire process of loading, staining, washing and measuring the cells at room temperature. Of 
note, during cell isolation or preparation (e.g. isolating PBMCs through Ficoll), labeling and 
staining, the use of cold PBS and other media should be avoided. Furthermore, mechanical 
forces may induce Ca2+ flux. Therefore, carefully dragging the sample tubes over a tube rack to 
mix them during the entire procedure is better than vigorous shaking or vortexing of the cells.  
A density of up to 10x106 cells, e.g. peripheral blood mononuclear cells (PBMCs), is commonly 
suspended in cell culture medium such as RPMI/10% FCS, containing 4.5 µM Indo-1 AM in the 
presence of 0.045% of the detergent Pluronic F-127, in a process known as loading. Loading is 
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commonly carried out for 45 minutes at room temperature in the dark [9]. For cell lines it might 
be necessary to serum starve the cells prior to Ca2+ determination, therefore both loading and 
washing steps could occur in the absence of FCS, or in the presence of lower concentrations of 
FCS.  Alternatively, lower concentrations of Indo-1 AM, shorter incubation times and the 
omission of Pluronic F-127 can be tested, depending on the cell type and the precise 
application, leading to changes in the fluorescence intensity of Indo-1 AM. During the loading 
procedure the cell suspension should be mixed every 15 minutes. After loading is complete, the 
cells are washed twice with media (300 g, 5 minutes, at room temperature), followed by staining 
for cell surface markers with fluorescence-conjugated antibodies for 15 minutes at room 
temperature in the dark. After the cell surface staining the samples are washed again and 
resuspended in the respective medium, RPMI 10% FCS for example. The spectral measurement 
should be performed within the next one to two hours. If datasets from different days have to be 
compared, it is recommended to keep the times between loading and staining and data 
acquisition the same for all samples.  
Cell culture medium usually contains Ca2+. To differentiate between internal store release (ISR), 
from the endoplasmic reticulum into the cytoplasm, and store-operated Ca2+ entry (SOCE), from 
the extracellular space into the cell, Ca2+-containing medium has to be removed by washing and 
resuspending the cells in Ca2+-free PBS or other Ca2+-free buffers. Alternatively, EGTA, a 
chelator related to EDTA but which preferentially binds Ca2+ ions, can be used. The transient 
ISR is detected after the appropriate stimulation, while subsequent addition of CaCl2 during the 
measurement reveals the sustained SOCE. 
It is important to make sure that the antibodies used for cell surface staining do not themselves 
induce Ca2+ mobilization. This can be tested by adding the staining antibody to Indo-1 AM 
loaded cells and detecting the resulting Ca2+ levels. Since kinetics may vary, the period of 
acquisition for these tests should be for at least 10 to 15 minutes. If the Ca2+ baseline shifts in 
response to the staining antibody that antibody should not be used. To test whether one of the 
staining antibodies interferes with binding of the antibody used for stimulation, the measurement 
should be compared in the presence and absence of the respective cell surface antibody. 
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13.4 Flow cytometer settings 
Before acquisition it is important to ensure that the filter combination is correct, for example for 
Indo-1 AM bound (FL12 405/10) and Indo-1 unbound (FL13 520/35, 445 LP). Both parameters 
must be displayed on a linear scale. It is recommended to view Indo-1 AM unbound on the y-
axis and Indo-1 AM bound on the x-axis. The photomultiplier (PMTs) should be adjusted so that 
unstimulated cells occur on a line about 45° to the y axis (Figure 1C). A dot plot showing time on 
the x-axis versus the ratio of Indo-1 bound/unbound on the y-axis displays the kinetics of Ca2+ 
mobilization. Ensure that the baseline and the maximal peak upon stimulation are within the 
displayed range. If this is not the case the PMTs must be adjusted. Of note, different cells have 
different intracellular Ca2+ levels. For instance, the appropriate PMT settings for B cells would 
not necessarily fit those for granulocytes or cell lines, and the PMTs should be reset accordingly.  
 
13.5 Data acquisition 
The UV laser should be turned on at least 15 minutes beforehand to allow it to stabilize prior to 
use, since it is highly sensitive and more prone to fluctuation than other lasers. To ensure data 
reproducibility it is also useful to wait a few seconds after loading the tube before recording the 
events. This will provide a better definition of the baseline. The flow rate should be kept constant 
throughout the measurement at low or intermediate rates. However, if the population of interest 
represents only a very small percentage of the acquired cells, it will be necessary to measure at 
higher speed to be able to record enough events/second. After acquisition of the baseline for 30 
to 45 seconds, the respective stimulus is added. To allow for comparison of different data sets 
this time should be kept constant. Ionomycin is a Ca2+ ionophore, inducing a rapid influx of Ca2+ 
ions from the extracellular space into the cytosol. At the end of measurement ionomycin is 
added as a loading control, meaning that in the presence of Ca2+ in the medium and proper 
labeling of the cells with Indo-1 AM all cells have to show a maximal increase of the intracellular 
Ca2+ concentration, thus an increased ratio of Indo-1 bound/unbound. Since residual ionomycin 
can directly induce Ca2+ mobilization in the subsequent sample it is important to wash the flow 
cytometer thoroughly before the next tube is loaded. While some investigators prefer to use 
DMSO or special cleansing solutions, followed by PBS for one minute running fresh tubes of 
PBS twice may also be sufficient to avoid this.  
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13.6 Analysis: 
Depending on the required resolution of the information, data analysis can be performed by 
using standard acquisition software, as BD FACSDIVA™ (BD Biosciences, San Jose, CA) or 
others. The analysis software FCS Express™ from De Novo Software (Glendale, CA), 
Flowlogic™ from Inivai Technologies (Victoria, Australia) and FlowJo™ (Treestar Inc., Ashland, 
OR)  offer a “kinetics” tool to analyze the acquired Ca2+ mobilization data. An example for anti-
IgM-induced Ca2+ mobilization in human B-cell subpopulations analyzed by Flowjo™ is shown in 
Figure 1D. Prior to further gating, Indo-1 AM-negative cells must be excluded. Subsequently, 
commonly used gating strategy including FSC/SSC, exclusion of doublets and gating on the 
specifically stained subpopulations is performed. Looking at the respective subpopulations in a 
dot plot showing the ratio of Indo-1 AM bound/unbound vs. time gives a better impression than 
merely looking at the kinetics function, since Ca2+ kinetics provide multiple read-out parameters. 
For example, the mean peak intensity and the time to peak, imply the early phases of Ca2+ 
mobilization, in B cells essential for the induction of  NF-B and JNK [10]. In contrast, the decline 
represents the later phase important for the activation of NFAT [8]. When analyzing ISR and 
SOCE separately (see above), specific information can be gained on both processes. Of note, 
the response of lymphocyte subpopulations is usually less homogeneous than those from cell 
lines, for example. The percentages of responding cells can differ, and the non-responding 
population will strongly influence the read out, especially with regard to the mean values. Thus, 
we advice to perform an additional analysis of the parameters mentioned above, referring to the 
responding cells only, by setting the baseline as the threshold and excluding non-responding 
cells are from the further analysis. 
 
Figure 1. Measuring intracellular Ca2+ mobilization in human B cells in response to anti-
IgM stimulation after labeling with Indo-1 AM by flow cytometry. 
(A) The shift in Indo-1 bound to Indo-1 unbound at low intracellular Ca2+ concentrations (grey) 
and high intracellular Ca2+ concentrations (black). Ca2+ increase was induced in Indo-1 labeled 
PBMCs by addition of ionomycin. (B) The influence of temperature on Ca2+ baseline levels is 
demonstrated by gating on CD19+ B cells (black) and CD19- non-B cells (grey) after warming to 
37° prior to the measurement and cooling off during the recording over 10 minutes. In B cells the 
Indo-1 bound/unbound is progressively decreasing with the reduction of temperature. (C) Setting 
of Indo-1 AM bound versus Indo-1 AM unbound on x-axis and y-axis respectively. The 
photomultiplier (PMTs) should be adjusted so that unstimulated cells occur on a line about 45° to 
the y-axis. (D) Gating strategy for the analysis of Ca2+ mobilization in naïve, IgM Memory and 
switched memory B cells after stimulation with anti-IgM. PBMCs were labeled with Indo-1 AM 
and cell surface staining with CD27, CD19, IgG and IgA After gating on living Indo-1 bound cells, 
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lymphocytes were determined. Gating of CD19+ B cells is followed by differentiation of IgG/IgA-
/CD27- naïve (na) B cells, IgG/IgA-/CD27+ IgM Memory B cells (M Mem) and IgG/IgA+/CD27+ 
class switched B cells (sw). Time versus the ratio of Indo-1 bound/unbound is shown for the 
three subpopulations (lower panels). After baseline acquisition anti-IgM (arrow) was added 
inducing a shift of Indo-1 AM bound/unbound in IgM-expressing naïve and IgM Memory B cells 
whereas this ratio is at baseline levels in IgM- class switched memory B cells. After addition of 
ionomycin the ratio of Indo-1 AM bound/unbound is rapidly increasing in all subsets. Data were 
acquired with a BD LSR Fortessa™ and analyzed by FlowJo™.  
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Section 14 – mRNA 
 
The quantification of messenger RNA (mRNA) production is key to understanding the immediate 
responses of cells to changes in the environment and also facilitates the comprehension of 
signaling pathways. The response to stimuli can be very heterogeneous in different cell types or 
even within the same cell population. Several techniques have been traditionally developed to 
quantify mRNA, such as RT-qPCR, Northern Blot analysis, nuclease protection assays (NPAs) 
and in situ hybridization but none of them allows complex high-throughput single-cell analysis. 
This chapter will introduce a novel flow cytometry technique based on fluorescent in situ 
hybridization (FISH) that allows for the simultaneous quantification of mRNA species, 
intracellular and cell surface proteins on a single-cell level [1-3]. 
  
14.1 Introduction 
 
The immune system compiles a heterogeneous population of cell types, each of them bearing 
specialized functions. Upon stimulation, a cell-specific immediate response can be detected at 
the mRNA level that can trigger the production of specific proteins, for example, the production 
of antiviral cytokines upon viral infection [1]. Until recently, the simultaneous detection of specific 
nucleic acid sequences in combination with intracellular proteins and cell-type specific markers 
on a single-cell basis had been restricted to microscopy, granting the analysis of a few hundred 
cells. Fluorescent in situ hybridization (FISH) is an example of such a method, although high-
throughput acquisition is not applicable. Flow cytometric analysis of nucleic acids, especially 
RNA species, including messenger RNA (mRNA) and long non-coding RNA (lncRNA) targets, 
would allow the high-throughput acquisition of several million cells on a single-cell basis. The 
PrimeFlow™ RNA Assay (Affymetrix, eBioscience) makes use of branched DNA technology 
(bDNA) to measure the expression levels of up to three RNA targets of interest, using a 
conventional flow cytometer and, therefore allows for the simultaneous detection of further 
antigens. Specifically, the technique is based on an initial surface staining, followed by 
permeabilization and two fixation steps. Probes specific for the RNAs of interest hybridize to 
their target sequences with high stringency and the signal is increased by serial of amplification 
steps. Using bDNA technology, a tree-like structure is built to achieve signal amplification. The 
pre-amplifier molecules, the trunk of the tree, directly bind to the pairs of primers. Subsequently, 
multiple amplifier molecules hybridize to a single pre-amplifier molecule, as the tree branches. 
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Finally, as tree leaves, multiple label probe molecules that are conjugated to a label dye, bind to 
an amplifier molecule (Figure 1). 
 
14.2 Sample preparation  
The use of healthy cells is critical for optimal results, since the handling of less viable cells will 
consequently lead to an increase in cell lysis during assay performance, and thus, decrease the 
sensitivity detection. For cell lines, it is highly recommended to use cells in an exponential 
growth phase and to avoid overconfluent or overly concentrated cells. One main advantage of 
this assay is the simultaneous staining of cell surface antigens such as lineage markers and the 
binding of probes to RNAs of interest, allowing for the discrimination between different cell types. 
After staining for cell surface markers, one permeabilization and two fixation steps are required. 
Permeabilization allows for the intracellular staining of antigens, whereas fixation warrants that 
surface and intracellular antigens, as well as the target RNA, are immobilized and stable. The 
first generation of the flow cytometry-based in situ hybridization assay was based on methanol 
fixation, which limited the number of suitable fluorochromes for surface staining to only 
methanol-resistant fluorochromes and was not recommended for parallel intracellular protein 
staining. Indeed, methanol-based permeabilization buffers, due to their dehydrating effects, may 
lead to protein denaturation and antibody-epitope loss, causing a signal intensity decrease. 
However, the second generation assay has overcome this limitation by avoiding the use of 
methanol as a fixative. Unfortunately, the use of the improved fixatives largely diminishes the 
detection of fluorescent proteins such as green fluorescent protein (GFP). If their detection is 
required as an experimental readout, antibodies directed against fluorescent proteins should 
rather be used. During the assay procedure, RNase inhibitors and storage solutions included in 
the kit are integrated into the protocol to assure the stability and integrity of the target RNAs for 
up to 3 days, allowing for sample collection and batching. In addition, the increased stability 
allows for the usage of the samples not only for flow cytometry, but also for direct visualization 
by a confocal microscope after the application of the cells to an object slide.  
 
14.3 Acquisition 
The detection of RNA species with the PrimeFlow™ RNA Assay is based on hybridization and 
branched DNA technology. In a first hybridization step, specifically designed probes targeting the 
desired RNA sequences are co-incubated with the already fixed and stained cells. The probes 
are a key component to the whole process and they need to be accurately designed to avoid 
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non-specific binding to other RNAs. The number of oligonucleotide pairs in a designed set of 
probes strongly depends on the target RNA size and the desired accuracy of discrimination 
between different gene isoforms. A typical set of probes consists of 20 to 40 oligonucleotide 
pairs, but if there is a need for isoform discrimination or the target RNA is small, the amount of 
specific oligonucleotide pairs might be reduced to a minimum of eight. In order to mediate signal 
amplification, the cells are serially incubated with PreAmplifier and Amplifier molecules, which 
build up a branched tree (Figure 1). A last incubation step adds label probes conjugated to a 
fluorescent dye such as type 1/ AF647, type 4/ AF488 and type 6/ AF750 to the amplification 
tree, enabling the detection of the signal with a conventional flow cytometer. Of those types, 
AF647 gives the strongest signal, and should be used for low-expressed RNAs or RNAs with 
unknown expression levels. AF488 is considered as a signal of medium intensity and AF750, 
giving the lowest signal, should be used for highly expressed RNA targets. However, fixation 
steps in the protocol induce an increase of the cells autofluorescence, leading to higher 
background fluorescence in the FITC, PE and other channels after excitation with the blue 488 
nm laser. Therefore, it is recommended to avoid the use of type 4 probe sets to detect low 
expressed targets. According to the manufacturer´s instructions, an 8,000 - 16,000 fold 
amplification of the RNA transcript is achieved after optimal assay performance. Importantly, 
type 1-, 4- or 6 – single stained samples (ideally with the housekeeping control) have to be used 
to set the voltages while performing the sample compensation at the flow cytometer. It is not 
recommended to use APC, FITC or APC-Cy7 stained beads or samples instead, since the 
fluorescence signal will be different.  
 
14.4 Technical Guidelines  
To control for the background expression levels for each of the probe types, a control sample 
should be stained with the full antibody panel and included to the sample run. This is a crucial 
step in order to determine the autofluorescence and the background signal of the cells. One 
sample has to be performed with an internal RNA control targeting a housekeeping RNA to 
ensure that the whole protocol was properly performed. In case of low signal resolution of the 
signal a few technical improvements can be added to the protocol (see step-by-step protocol). 
For instance, the background levels can be diminished in certain samples with extra washing 
steps between the different incubations. In the case of low expression levels of the target RNA 
or if the amount of oligonucleotide pairs used is reduced, increasing the signal may be desired. 
This can be achieved by longer incubation times of target probes, PreAmplifier, Amplifier and 
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label probe. As an extra step to increase the signal, increasing the amount of target probes 
during 3 hours of incubation significantly ameliorates the signal of the target RNA detection 
without increasing the background expression levels. 
 
14.5 Step-by-step protocol 
 
PrimeFlowTM RNA Assay can be performed in a conventional laboratory equipped with a CO2 
incubator, capable of stably maintain 40 ºC+/-1ºC, and a flow cytometer supplied with a 488nm 
and a 633nm laser.   
 
Day 1. Cell-surface, intracellular staining and target probe hybridization 
The washing buffer should be pre-warmed at room temperature.  
1. Centrifuge at 500g for 5 minutes in polystyrene flow cytometry tubes 1-5x106 cells. 
Authors have the experience of using fewercells but if the target mRNA is expressed at a 
low level, the total sensitivity of the assay will drop.  
2. Decant the supernatant and resuspend cells in the cell-surface antibody master mix at a 
final volume of 100ul with staining buffer (SB: PBS+2%FBS). Incubate in the fridge for 30 
minutes. 
            Note: this step can be avoided if there is no need for surface antigen staining.  
3. Wash by adding 1ml of SB per tube and centrifuge at 500xg for 5 minutes.   
4. Prepare the Fixation 1 buffer: mix equal parts of Buffer 1A and 1B: volume/sample: 1ml.  
Note: the buffer is foamy, so prepare at least for 1-2 samples extra.  
5. Discard supernatant, gently resuspend the pellet and add 1ml of Fixation Buffer 1 to the 
sample.  
6. Incubate for 30 minutes at 4 °C.  
7. Centrifuge at 600xg for 5 minutes. During centrifugation, prepare the Permeabilization 
Buffer. Resuspend the Perm Buffer at a 1/10 ratio with distilled autoclaved water and add 
RNAse inhibitor 1 and 2 at 1/1000 and 1/100 ratio, respectively. The amount of buffer per 
sample needed is 3ml.  
Note: the buffer is foamy, so prepare at least for 1-2 samples extra.  
8. Discard supernatant and resuspend in 1ml of Perm Buffer. Centrifuge at 800xg for 5 
minutes.  
9. Repeat step 8.  
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10. Discard supernatant and add the required amount of intracellular antibody and incubate 
for 30 minutes at 4 ºC.  
Note: this step can be avoided if there is no need for intracellular antigen staining.  
11. Wash with 1ml Perm Buffer by centrifuging 5 minutes at 800xg.Prepare Fixation Buffer II 
in bulk (you will need 1ml per sample) at 1x concentration by combining PrimeFlow RNA 
Fixation Buffer 2 (8x) with Wash Buffer.  
12. Discard supernatant and resuspend the pellet carefully by inverting. Incubate for 60 
minutes at room temperature in the dark.  
Note: the protocol can be stopped at this step. The cells can be incubated overnight in 
the dark in Fixation Buffer II at 4ºC.  
13. Transfer the samples into the 1.5mL tubes provided in the kit and centrifuge them at 
800xg for 5 minutes.  
14. Thaw at room temperature Target Probes and pre-warm Target Probe diluent to 40ºC in 
the incubator. 
15. Aspirate the supernatant carefully, leaving the last 100μl of each sample. Add 1mL of 
Wash Buffer, mix by inverting and centrifuge at 800xg for 5 minutes.  
16. Repeat step 14.  
Note 1: The remaining volume in the 1.5mL tube should be as close as possible to 100μl, 
since all the following steps take in account this exact volume. Utilize the markings in the 
1.5mL tubes.  
Note 2: The protocol can be stopped at this step. In the wash step, add RNAse Inhibitor 1 
to Wash Buffer at a 1/1000 concentration and store the samples overnight in the dark at 
4ºC.  
17. Prepare each Target Probe at a 1/20 dilution in Target Probe diluent (5μl of Target Probe 
and 95μl of Target Probe diluent) and mix the solution by pipetting up and down. 
volume/sample: 100μl of one Target Probe. Prepare for 1 extra sample.  
Note 1: if you are combining more than one Target Probe in a sample, please adjust the 
final volume to 100μl. 
Note 2: For some low-expressed RNA targets and to increase the final signal, the 
authors have experience using lower dilutions of Target Probes, up to 1/4 dilution per 
sample (20μl of Target Probe and 80μl of Target Probe diluent). 
18. Add directly to each cell suspension 100μl of the prepared solution of Target Probe. Mix 
by vortexing briefly, place the tubes in a special metal heat block and incubate for 2 
hours at 40ºC in the special incubator. Mix by inverting samples after 1 hour.  
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Note 1: To increase the signal, up to 3 hours incubations can be performed.  
Note 2: The traffic of the incubator has to be minimized. The temperature must be 
controlled to maintain stably 40ºC+/-1ºC. If you have more than three samples, first put 
the tubes in the metal heat block in the hood and then place the whole system in the 
incubator. 
19. Wash by adding 1mL of Wash Buffer, inverting to mix and centrifuging at 800xg for 5 
minutes. Prepare Wash Buffer with RNase Inhibitor 1 at 1/1000 dilution (see step 16). 
volume/sample: 1mL, but the buffer is foamy, so prepare at least for 1-2 samples extra. 
This buffer has to be used fresh.  
20. Aspirate the supernatant carefully, leaving the last 100μl of each sample. Resuspend 
gently the cell pellet. Add 1mL of Wash Buffer with RNase Inhibitor 1, mix by inverting 
and centrifuge at 800xg for 5 minutes.  
21. Aspirate the supernatant carefully, leaving the last 100μl of each sample. Resuspend 
gently the cell pellet. 
Note: For the manageability of the whole procedure, the protocol should be stopped at 
this step. The cells can be kept overnight in the dark at 4ºC.  
 
Day 2. Signal Amplification 
 
22. Prewarm at 40ºC (in the incubator) PreAmp Mix, Amp Mix and Label Probe diluent. 
23. Prewarm at room temperature all samples (in the dark) and Wash Buffer.  
Note: authors leave the samples for 10 minutes at room temperature.  
24. Add directly into the cell suspension 100μl of warm PreAmp Mix and mix gently by short 
vortex.  
25. Incubate at 40ºC (in the incubator) for 1.5 hours.  
Note 1: Do not open the incubator during this step to maintain the 40ºC temperature 
stable.  
Note 2: To increase the signal, up to 2 hours incubation can be performed. 
26. Wash by adding 1mL of Wash Buffer, inverting to mix and centrifuging at 800xg for 5 
minutes. Aspirate the supernatant carefully, leaving the last 100μl of each sample. 
Resuspend gently the cell pellet. 
27. Repeat step 26 two extra times.  
28. Add directly into the cell suspension 100μl of warm Amp Mix and mix gently by short 
vortex.  
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29. Incubate at 40ºC (in the incubator) for 1.5 hours.  
Note 1: Do not open the incubator during this step to maintain the 40ºC temperature 
stable.  
Note 2: To increase the signal, up to 2 hours incubation can be performed. 
30. Thaw Label Probes on ice in the dark during this incubation step. 
31. Wash by adding 1mL of Wash Buffer, inverting to mix and centrifuging at 800xg for 5 
minutes. Aspirate the supernatant carefully, leaving the last 100μl of each sample. 
Resuspend gently the cell pellet. 
32. Repeat step 31 two extra times. 
33. Prepare 100μl/sample of Label Probe by diluting it at 1/100 in warm Label Probe diluent 
(10μl of Label Probe in 90μl of Label Probe diluent). Add directly into the cell suspension 
100μl of warm Label Probe and mix gently by short vortex.  
Note: if you prepare the label probes in advance during the step 32, be sure to maintain 
them at 40ºC.  
34. Incubate at 40ºC (in the incubator) for 1 hour.  
Note 1: Do not open the incubator during this step to maintain the 40ºC temperature 
stable.  
Note 2: To increase the signal, up to 1.5 hours incubation can be performed. 
35. Wash by adding 1mL of Wash Buffer, inverting to mix and centrifuging at 800xg for 5 
minutes. Aspirate the supernatant carefully, leaving the last 100μl of each sample. 
Resuspend gently the cell pellet. 
36. Repeat step 35 once more. 
37. Add 1mL of Storage buffer (provided in the kit) or Staining buffer (SB, PBS+2%FBS), 
invert to mix and centrifuge at 800xg for 5 minutes. Aspirate the supernatant carefully, 
leaving the last 100μl of each sample. Resuspend gently the cell pellet.  
38. Add 100μl of Storage buffer or SB and transfer each sample to a polystyrene FACS tube 
and measure samples in a flow cytometer.  
Note: You may keep the samples at 4ºC and store them up to 3 days before analyzing 
them on a flow cytometer.  
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14.6 Limitations 
Although the stability and the number of applications have improved the technique still harbors 
some limitations. Currently, the protocol allows for the simultaneous detection of only three 
RNAs of interest, restricting the study of complex interactions. In addition, the expression levels 
of the RNA targets are the major pitfalls towards a successful application, as rare expression 
events might not be detectable with this assay. The sequence specificity is absolutely necessary 
to allow for correct binding of the probes to the target sequence. Minor sequence variations as 
well as splicing variants will not be detected, and therefore can restrict the use of this technique. 
As pointed out previously, the size of the target RNA is also critical to design a specific set of 
probes that will confer an optimal signal.  
 
14.7 Conclusion 
In conclusion, the PrimeFlowTM RNA Assay opens up new options in studying complex cellular 
interactions, especially if specific antibodies for the suited proteins are not commercially 
available [1-5]. This assay also offers high-throughput screening of certain conditions, with the 
possibility of simultaneously measuring mRNA and protein expression even from the same 
target in a specific cell type on a single-cell basis.  
 
 
Figure 1: PrimeFlowTM RNA Assay procedure 
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Section 15   – Transcription Factors 
 
15.1 Introduction 
 Cell functionality and differentiation are all controlled by transcription factors within cells that 
regulate gene expression. As these factors are generally proteins, they may be detected using 
an antibody directed against some specific epitope within the protein. In this way, detection of 
transcription factors is in essence no different to detecting proteins on the surface of the cell. 
However, as the proteins of interest will be located within the cell, either in the cytoplasm, within 
a cellular sub-compartment or in the nucleus, cells must be permeable to allow access of the 
antibody to its binding site. As the factors need to be preserved in their sub-cellular location and 
in their physiological condition at the time of sampling, any fixation must be very rapid and 
pervasive. 
  
Detection of transcription factors by flow cytometry thus requires careful planning, with attention 
paid to several specific questions that will dictate the best protocols to follow.  The most 
important of these questions is “Will surface staining (i.e. phenotyping) be necessary to identify 
the cells of interest?” 
  
The answer to this question is critical, as it will dictate the best way to prepare the cells, allowing 
the antigens access to the intracellular compartment and their target.  It will also impact the 
choice of fluorochromes used because different fixation methods can have dramatic impact on 
the fluorescent molecules [1]. The two most common fixation reagents are alcohols and 
aldehydes, each have their strengths and drawbacks. 
  
Alcohols, such as ethanol and methanol or acetone, are dehydrating fixatives which both 
coagulate proteins (fixation) and create holes in the lipid membrane (permeabilization).  Many of 
the cyclins and phospho-specific proteins are readily detectable post-alcohol fixation [2].  
Unfortunately, alcohol fixation adversely affects fluorescent proteins such as green fluorescent 
protein (GFP) which is will be affected by alcohol fixation in such a way that it will no longer be 
fluorescent after conformational changes or may even leach out of the cell [3]. 
 
Alcohol fixation will also adversely affect commonly used fluorochromes including phycoerythrin 
(PE), peridinin-chlorophyll (PerCP) and allophycocyanin (APC), making these fluorochromes a 
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poor choice for surface staining.  Small cyclic ring fluors such as fluorescein (FITC), the alexa 
fluor and the cyanine dyes are more resistant to alcohol fixation.  Surface markers may also be 
stained post-fixation if the protein structure, or at least the specific recognized sequence is 
unaltered by the chemical process of fixation. If no evidence is available, this may have to be 
determined empirically. 
 
Aldehyde fixation is performed usually with formaldehyde in the range 1-4% [4].  Aldehydes are 
cross-linking fixatives so they lock protein structure in place by forming cross-links between 
lysine residues forming methylene bridges. This generally means antibodies will still recognize 
their epitope. However, formaldehyde on its own is not a good permeabilizing agent and it would 
normally be combined with a detergent – this is the basis of many Fix and Perm kits that are on 
the market (although the exact composition of commercial kits is often not common knowledge 
due to Intelectual Property policies). A range of detergents is available such as Triton X-100, 
lysolecithin, Nonidet –P40 and saponin. The choice may depend on localization of the protein. 
Transcription factors tend to be nuclear and the use of a stronger detergent such as Triton X-100 
(generally around 0.1%) is a good choice as it can permeabilize both the plasma and the nuclear 
membrane. Saponin on the other hand is not a good permeabilizing agent for nuclear factors 
due to its more “gentle” and reversible nature and has often seen more use in cytokine staining.  
However, it should also be noted that cytokine staining is also compatible with detergents such 
as NP40 (see also Chapter IV, Section 6: Cell Fixation and Permeabilization for Flow Cytometric 
Analyses)  [5]. 
It is important to note, as with any flow cytometry protocol, the exclusion of dead cells is critical 
for analysis.  Commonly used viability dyes such as propidium iodine (PI) or 7-aminoactinomycin 
D (7AAD) rely on an intact membrane to all for differentiation of live versus dead cells (see 
Chapter IV, Section 5, Frozen samples and cell viability).  When targeting intracellular markers 
by flow, the use of fixable amine-reactive dyes must be used (see also Chapter IV, Section 6: 
Cell Fixation and Permeabilization for Flow Cytometric Analyses)  [6]. These dyes still allow for 
the discrimination of dead and live cells from live even after the fixation and permeabilization 
processes. 
 
As fixation chemically alters the cells, it will also change to some extent the autofluorescence of 
the cell. Changes in morphology may be seen as alterations in light scatter patterns in a flow 
cytometer. Again, alcohols will have a more dramatic effect. Conversely, alcohols do not cause, 
in general, a change in levels of background autofluorescence which may be important if a low 
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level specific signal is expected. If an aldehyde is used, fixation should be brief and cells should 
be stored in a phosphate buffer prior to staining as aldehydes, especially glutaraldehyde, will 
cause an increase in autofluorescent background. 
 
Reagent manufacturers each sell specific buffers and kits for staining of specific transcription 
factors, often with proprietary reagents, but these buffers have been designed to allow detection 
of nuclear antigens without comprising surface antigen detection. Some of these kits will have 
separate fixation and permeabilization steps, while others will be in a single solution.  The choice 
of which kit or reagents to use is often dictated by the intracellular target, so reading of the 
technical specification of the given antibody is critical.  
 
The location of the target may also influence the fluorochrome used to label the antibody. 
Fluorochromes such as PE, APC and PerCP and their tandems are large proteins which add 
considerably to the molecular weight and the size of the antibody. This means that to detect a 
nuclear protein, a harsher permeabilization/fixation regime may be needed which may also lead 
to selective loss of small molecules from the cell.  But it may also mean that the comparatively 
larger fluorochrome will restrict access of the antibody to the nucleus altogether. 
 
A good example of detection of a transcription factor is FoxP3, which is expressed by the 
regulatory subset of T cells (Treg cells) [7]. This is a nucleus-located protein and as with most 
transcription factors, can influence gene expression up or down. Dysregulation of FoxP3 has 
been implicated in the etiology of several autoimmune disorders. As the protein is specifically 
expressed by cells also expressing CD3, CD4 and CD25, these antigens must also be detected 
using fluorescently-labeled antibodies. Many reports in the literature also use CD127 as a further 
marker of the Treg-cell subpopulation [8]. A typical protocol for detection of FoxP3 cells is 
described below, in section 15.2.  It should however be mentioned again that FoxP3 staining 
tends to use kits containing propriety buffers.  As such we have also included a “generic” 
protocol for performing intra-nuclear staining that has been used successfully on a range of 
transcription factors and intra-nuclear targets.  In the example provided in figure 1, staining for 
DNA content using Propidium Iodide (PI) combined with the detection of histone H3 
phosphorylation on serine residue 28 [10] is shown.  The design of any multicolor flow cytometry 
panel is critical to the success of the identification of the specific sub-population. The choice of 
fluorochromes will be influenced by the cytometer available but should be determined by dye 
characteristics, spectral overlap, and antigen expression and density (for further detail see 
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Chapter III, Section 1, Compensation). Importantly the design should allow the critical analyte, in 
this case the FoxP3 expression, to be measured in the channel with the brightest fluorochrome 
or the least spillover and/or data spreading (for further detail see Chapter III, Section 1, 
Compensation). 
 
In conclusion, there is not a universal protocol applicable to all transcription factors, which can 
be expressed in different cellular locations (see table 1), - the type of fixation, the length of 
fixation, the type of permeabilization, the choice of fluorochromes, the staining protocol, 
including incubation times of antibody staining, must all be optimized. The principle advantage of 
flow cytometry in this area is the ability to multiplex an assay, and by using multiple analytes be 
able to very specifically define subsets of interest - this will only be limited by the cytometer 
available. One downside of flow cytometry is the lack of morphological information and inability 
to specifically localize the fluorescence within the cell. If this is important then imaging either 
fluorescence microscopy, confocal microscopy or imaging flow cytometry should be considered. 
  
15.2 Example general protocol - FoxP3  
15.2.1. Reagents for FoxP3 Staining 
Staining buffer:           PBS + 2% FCS (0.5% sodium azide optional) 
15.2.2  Staining 
1. After harvesting cells, resuspend cells in phosphate buffered saline (PBS) without 
protein.  Added protein will interfere with step 2. 
2. Stain cells with live/dead fixable according to vendor’s protocols.  Typical protocol 
requires 20 minutes incubation at room temperature.  
3. Wash cells and resuspend in PBS containing protein (Staining Buffer - SB). 
4. Stain cells with appropriately-labelled and properly titrated antibodies.  Typical 
protocol requires 20-30 minute incubation on ice in the dark.  
5. Wash cells and resuspend in fixation buffer. Typical protocol will involve 1 ml of 
reagent with a 30-60 minute incubation at 4℃.   
6. Wash with SB 
7. Resuspend cells in SB and add appropriately-labeled and properly titrated FoxP3 
antibody.  Typical protocol requires incubation for 60 minutes at room temperature.   
8. Wash cells in SB and resuspend in appropriate volume before analysis on flow 
cytometer. 
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Note:  Don’t forget to treat all controls including compensation, fluorescence minus one 
(FMO), reference, positive and negative controls the same way! 
 
15.2.3 Data acquisition 
Gating protocol should include steps:  
1. Removes doublets (using pulse geometry gating - e.g. FSC-height vs FSC-Area) 
2. Remove dead cells (viability dye dim/negative)  
3. Identify lymphocytes (based on forward and side scatter parameters) 
4. Subset lymphocytes into T cells (based on CD3 and CD4 expression) 
  
Once those cells are identified, a dot plot of CD25 vs FoxP3 can be generated.  Since Treg 
cells are a minor percentage of cells (around 2-4% of mature CD4+ T cells [9], it is critical to 
use FMO controls to help identify the appropriate cells of interest (Figure 2). 
 
15.2.4. Reagents for “generic” intra-nuclear  Staining 
Staining buffer:           PBS + 2% FCS (0.5% sodium azide optional) 
FIXATION buffer:  PBS + 4% Formaldehyde (made from a 16% solution obtained from 
Polysciences cat no:  18814-20 (make up 1 week prior) 
PERM buffer:          PBS + 2% FCS + 0.1% Triton X-100 
 
 
15.3 Example generic protocol for intra-nuclear antigen – pH3   
15.3.1 Staining (adapted from [10]) 
Staining is done in a 96 well U- or V-bottom plate.  
1. Count cells from culture/primary sample and resuspend at 10 million cells per ml, aliquot 
100ul per well (~106 viable cells per sample for staining).  Spin down plate at 1200 rpm for a 
minimum of 3 min at room temperature. Flick SN and vortex plate to re-suspend. (This will 
be the conditions for all wash steps). 
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2. OPTIONAL.  Stain for Live/Dead and surface markers prior to fixation.  Follow 
manufacturers recommendations for Live/dead staining.  Make up Ab cocktail in Staining 
buffer at optimized dilutions.  Add 100 µl per well per million cells and incubate for optimized 
time (1hr minimum). 
3. Add 100 µl of Staining buffer per well and spin down as in 2.  Add 200 µl of fresh Staining 
buffer and spin down again. 
4. Resuspend cells in 100 µl of PBS only and pipette up and down to ensure cells are fully 
in suspension.  Then add 100 µl of 4% FIXATION buffer to final concentration of 2%.  The 
pre-suspension in PBS minimizes the formation of cell clumps during the fixation process.  
Leave at room temperature for a minimum of 60 min. 
5. Spin down cells and treat as in step 1 
6. Resuspend pellet in 100 µl of PERM buffer using a P200 pipette. Incubate tubes at room 
temperature for exactly 5 min (stagger addition of PERM buffer if needed). 
7. Add 100 µl of Staining buffer to each well in staggered fashion to end permeabilization 
step.  Spin down and process as in step 2. 
8. Add 100 µl of primary Ab cocktail and mix in PBS +2% FCS.  Incubate at RT for 
optimized time (usually 1-2 hr). 
9. Add 100 µl of Staining buffer and spin down and process as in step 2. Repeat this wash 
step with 200 µl fresh Staining buffer. 
10. If necessary, incubate cells with secondary Ab cocktail mix for the optimized time (usually 
min of 30 min) at RT in the dark. 
11. Wash the cells as outlined in step 2 twice in fresh Staining buffer. 
Final resuspend volume should be 200-400 µl of Staining buffer.  
Figure and table legends: 
 
Table 1: Most common transcription factors measured by flow cytometry. For more information 
about them http://www.uniprot.org/uniprot/ 
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Figure 1:  Typical sequential gating analysis performed on samples of cycling cells stained for 
DNA content and intra-nuclear histone modifications.  Asynchronously proliferating Jurkat cells were 
harvested, processed and stained exactly as outlined in Chapter VII section 15.3.  1.- A bi-variate plot 
showing FSC-A (X axis) versus SSC-A (Y axis) with a polygonal gate set to include “intact cells” and 
exclude debris (low FSC-A/SSC-A).  2.- A bi-variate plot showing the area of the DNA signal (PI) on the X 
axis versus the height of the same parameter on the Y axis.  A gate has been set to include single events 
and exclude events that are likely doublets based on a breakdown in the linear relationship between area 
versus height.  3.- A second step of doublet exclusion using the width of the SSC signal pulse (Y axis) 
versus the FSC-A signal (X axis).  4.- A plot of PI DNA area signal (X axis) versus the area signal for the 
phosphor-serine H3 residue 28 modification as revealed by an AF488 tagged monoclonal antibody (Y 
axis).  Data is shown for cells that have been left untreated (left panel) and cells treated for 16 hours with 
0.1 µM Nocodazole as a positive biological control for staining.  Unt, Untreated; Noc, Nocodazole 
 
Figure 2. FoxP3 staining to detect T-regulatory cells.  Human PBMCs were stained following standard 
protocols followed by fixation and permeabilization as per the protocol (above).  The following gating 
strategy was applied to identify CD4+ T-regulatory cells: 1.- Flow stability gating (Time vs Side Scatter) – 
to ensure the instrument had good stable flow over the run of the sample. 2.- Doublet gating (Forward 
Scatter height vs area) – removal of doublets based on pulse geometry gating. 3.-Scatter gating (Forward 
vs Side Scatter) – to remove debris and events off-scale. 4.- Dump & Viability - removal of dead cells and 
non-T cells.5.- CD3 (T-cell) gate – gating to identify the CD3+ subset. 6.- T-cell subsetting (CD4 vs CD8) – 
further subsetting of the CD3+ cells to identify CD4+. 7.-T-reg gating (CD25 vs FoxP3) – identification of 
T-regulatory cells.  The final gate was set based on the FMO controls (shown to the right of the plot). 
As shown, the event file started with 507,471 events, and the percentage of cells in each gate are 
identified on each plot, resulting in approximately 2,800 cells in the final gate. 
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Section 16 – Measurement of signal transduction pathways by flow cytometry 
 
16.1 Introduction 
The large majority of proteins involved in the regulation of cell signaling, survival, and growth 
regulation are intracellular. This section covers the technical aspects of intracellular antigen 
staining for flow cytometry, using activation and simultaneous monitoring of multiple pathways in 
human peripheral blood monocytes as a practical example. The approaches we use for cell 
fixation and permeabilization that optimize intracellular labeling while preserving light scatter and 
phenotypic markers are presented in the section on Cell Fixation and Permeabilization (Chapter 
IV, Section 6).  Although more demanding than cell surface staining, mastery of intracellular 
cytometry enables the study of fundamental regulatory mechanisms of normal and abnormal cell 
biology, many of which remain under-explored.   
Signaling pathways typically relay instructions from outside the cell to the nucleus, where an 
appropriate genetic program such as DNA synthesis or enhanced cell survival is executed in 
response to inputs from growth factors, cell-cell contacts, or extracellular matrix interactions.  
The biochemical basis of signal transduction involves the addition (by kinases) and removal (by 
phosphatases) of phosphate groups from the amino acids serine, threonine, and tyrosine that 
contain –OH side chains.  Phosphorylation alters the charge distribution, hence the 
conformation, of proteins.  Typically this activates the catalytic site of an enzyme, although some 
phosphorylations are inhibitory, inactivating the kinase function of the protein.  Individual proteins 
involved in signal transduction are arranged in pathways, where an incoming phosphorylation 
activates the kinase activity, allowing it to pass the phosphorylation signal on to the next 
signaling element.  There are other key cellular pathways that similarly result in different types of 
post-translational protein modifications, including methylation, hydroxylation, acetylation, 
ubiquination, etc, and the basic fixation and permeabilization technique described in Chapter IV, 
Section 6 has been used to study some of these [1]. 
Signal transduction is clearly a complex area of biology.  Although it is likely that the major 
signaling pathways in mammalian cells have now been identified, basic research into how these 
are regulated and interconnect continues at a rapid pace.  The complexity of signal transduction 
pathways allows for multiple activating and inhibitory inputs, and for networking between 
pathways.  Considering that signal transduction is essential for the survival of multicellular 
organisms, this is to be expected. 
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Derangements in signal transduction are extremely common in human cancers, and appear to 
play a major role in the development and progression of both solid and hematological 
malignancies. Similarly, signal transduction pathways play a pivotal role in multiple aspects in 
both the development of the immune system, and in regulating responses to antigenic 
challenges. 
 
16.2 Sample preparation for signal transduction analysis 
The analysis of phospho-epitope expression in clinical samples (whole blood, bone marrow, 
body fluids) is complicated by the need to lyse red blood cells, while at the same time preserving 
surface immunophenotypic markers as well as light scatter. For this, we have developed a 
technique which starts with fixation of the entire cell suspension, ensuring that phospho-epitopes 
are stabilized as soon as possible, followed by red cell lysis using Triton X-100 (see  Chapter IV, 
Section 6). As discussed there, some epitopes (e.g. phosphorylated-STAT proteins) require an 
additional methanol “unmasking” step for optimization of their expression [2]. We have also used 
this technique for the analysis of signaling in bone marrow samples [3,4]. 
 
16.3 Activation of signal transduction pathways regulating acute inflammatory responses  
Like most signaling pathways, the MAP kinase pathways are arranged in cascades in which one 
member becomes catalytically active following phosphorylation by its upstream activating 
kinase. The activated upstream kinase is able to pass on the signal by phosphorylating its 
downstream substrate. This complexity allows multiple levels of feedback regulation, and 
interconnections involving pathways that are critical to the normal maintenance of tissues.  
There are three MAP kinase (Membrane Activated Protein kinase) pathways that in mammals 
have very distinct functions, although they are highly conserved in evolution.  The ERK pathway 
(Extracellular-Signal Regulated Kinase), often simply called the “MAP kinase pathway” is 
involved in growth factor stimulation, whereas the SAPK/JNK (Stress-Activated Protein Kinase/c-
JUN N-terminal Kinase) and p38 MAP kinase pathways are more sensitive to other 
environmental cues including osmotic stress and heat shock. 
In the innate immune response, the bacterial endotoxin lipopolysaccharide (LPS) induces the 
activation of multiple signaling pathways (“pan-kinase” activation) which lead to an inflammatory 
response in monocytes. Among these pathways are the MAP kinase (Membrane Activated 
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Protein kinase) pathways.  Like most siginaling pathways, the MAP kinases are arranged in 
cascades in which one member becomes catalytically active following phosphorylation by its 
upstream activating kinase. The activated upstream kinase is able to pass on the signal by 
phosphorylating its downstream substrate. This complexity allows multiple levels of feedback 
regulation, and interconnections involving pathways that are critical to the l maintenance of 
healthy tissues.  There are three MAP kinase pathways in mammals, all three of which have 
very distinct functions, although they are highly conserved in evolution.  The ERK pathway 
(Extracellular-Signal Regulated Kinase), often simply called the “MAP kinase pathway” is 
involved in growth factor stimulation, whereas the SAPK/JNK (Stress-Activated Protein Kinase/c-
JUN N-terminal Kinase) and p38 MAP kinase pathways are more sensitive to other 
environmental cues including osmotic stress and heat shock. 
As shown in Figure 1, LPS activation of signaling pathways in peripheral blood monocytes is 
somewhat unique, in that it results in the activation of multiple signaling pathways, including all 
three major MAP kinases, PI3 Kinase>AKT, and NFκB pathways. NFκB activation induces the 
production of inflammatory cytokines. These pathways have widespread effects on cell function, 
which together coordinate the host response to acute bacterial infection. 
 
Although the original canonical signaling maps indicated that LPS activates ERK in monocytes 
via the “classical” Ras>Raf pathway [5], in monocytes LPS activation of ERK is via TPL-2, a 
MAPKKK, which is sequestered in one of the forms of IκB, is phosphorylated/activated by IKK, 
and released from the complex by proteasomal degradation of IκB. Phosphorylated TPL-2 
subsequently phosphorylates/activates its downstream target, MEK 1/2, which then 
activates/phosphorylates ERK 1/2 [6]. Signaling pathways are complex, and a specific pattern or 
pathway seen in one type of cell does not predict the same pattern or pathway in all cells. 
Therefore, it may be important to study a broad set of specific signaling proteins/modifications 
for comprehensive understanding of signaling pathways in a specific cell type. 
 
16.4 Kinetics 
In studying the activation (and inactivation) of signaling pathways, it is critical to include multiple 
time-points within the experiment. For example, the phosphorylation of ERK in human bone 
marrow CD34+ cells (at 37o C incubation) reaches a peak and returns to unstimulated cell levels 
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in less than 10 minutes [3], indicating that the dephosphorylation of P-ERK occurs rapidly in this 
cell population. 
 
16.5 Kinase and Phosphatase Inhibitors 
Specific (or relatively specific) kinase inhibitors are very useful when analyzing pathways 
downstream from a signaling “node”. For example, U0126 binds to MEK1/2 and prevents it from 
phosphorylating (activating) its downstream partner ERK1/2 (see Fig 1, above). Adding U0126 to 
a whole blood sample will block activation of ERK1/2 and activation of any downstream target 
such as ribosomal S6 protein (in monocytes). In addition, by comparing the level of a target 
phospho-epitope expressed in cells exposed to an inhibitor with that of untreated cells, it is 
possible to reveal background or constitutive levels of activation of a specific kinase and its 
downstream partners. In Figure 2 below, whole blood was treated (here for 4 minutes) at 37o C 
with LPS alone, or with UO126 (MEK inhibitor) or with Ly294002 (PI3 kinase inhibitor). In the 
presence of UO126, activation of both ERK 1/2 and the downstream S6 ribosomal protein are 
inhibited. Also shown here, the PI3 kinase inhibitor Ly294002 (we have also used the more 
specific PI3K inhibitor GDC-0941 with similar results) likewise inhibits activation of both ERK 1/2 
and S6 at this time point. Neither inhibitor changes the responses for p38 or SAPK/JNK, 
although PI3K inhibition does prevent AKT activation (see below). These results are consistent 
with a model in which ERK 1/2 can be activated (in human monocytes) via PI3k>AKT. However, 
a better understanding of the responses and inhibitions of specific pathways requires monitoring 
the responses to different stimuli over time.  
 
As shown in figure 2, after appropriate  inhibitor and LPS treatment, cells were fixed and 
permeabilized using formaldehyde/Triton X-100, and subsequently stained using antibodies to 
phospho-ERK 1/2 (p44/42 MAPK), phospho–S6 ribosomal protein, plus CD14 and CD45 to 
identify monocytes (not shown in figure) and eliminate debris from the analysis. Figure 2 
demonstrates several key points mentioned above. LPS activates the ERK pathway rapidly, and 
only the monocytes showing maximal levels of ERK phosphorylation also show phosphorylation 
of S6 (top left). U0126 inhibition of ERK activation (top right) inhibits the activation of both ERK 
and S6. It should be noted that the “canonical” pathway usually shown in signaling documents 
indicates that S6 is activated by PI3K>AKT [7]. The data shown in figure 2 are consistent with 
the concept that activation of ribosomal S6 protein is via the ERK pathway in human peripheral 
blood monocytes, highlighting the need to carefully investigate the appropriate upstream 
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activation pathways. Finally, both the activation of ERK and S6 are inhibited (at this time point) 
by the PI3 kinase inhibitor Ly294002, consistent with the concept that ERK activation in human 
peripheral blood monocytes can be via AKT (not the “canonical” RAS>RAF pathway, bottom left) 
[5]. At first, these data seem inconsistent with the comment above that ERK activation in 
monocytes is via TPL-2 [6]. 
Signaling pathways (particularly phosphorylation/dephosphorylation) in normal cells are 
frequently activated and then rapidly inactivated. Inactivation of a kinase involves 
dephosphorylation of the target phosphorylated amino acid(s) by a phosphatase. One of the 
predictions of this model is that inactivation of a phosphatase should result in maintaining the 
activated kinase for longer time periods [8]  
 
16.6 Simultaneous monitoring of multiple signaling pathways in the context of response 
kinetics 
The results shown above in Figure 2 can be interpreted to indicate that both ERK and AKT 
pathways are activated by LPS. While this conclusion is correct, the use of different pathway 
inhibitors in conjunction with detailed kinetic analyses reveals important details of the specific 
pathways that are activated in human peripheral blood monocytes by LPS. 
Using the same logic that is commonly used to understand complex biological systems (e.g. 
hematopoietic cell differentiation and lineage reconstruction in bone marrow), for simultaneous 
measurement of multiple signaling targets, we routinely measure multiple signaling targets in 
each sample. As in all complex immunophenotyping experiments, attention to details is essential 
in the design and execution of these types of experiments. For example, large fluorophores such 
as PE or APC should only be used for nuclear localizing target phospho-epitopes after running 
preliminary experiments to ensure the antibody-conjugate can get to the target. Similarly, 
tandem dyes (PE-Cy5) should be used with caution, with appropriate controls to ensure integrity 
of the tandem at the time of the assay. 
As an illustration of simultaneous measurement of four different signaling targets, Figure 3  
demonstrates the whole blood analysis of LPS-stimulated human peripheral blood using CD14-
PE-Cy7 to detect monocytes, plus P-p38 (MAPK)-Alexa Fluor™488, P-AKT-PE, P-ERK- Alexa 
Fluor™647, and P-S6-PacBlue. 
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These results demonstrate that the majority of monocytes (shown in red) are positive for all four 
phospho-epitopes at 10 min incubation with LPS. As also shown in Figure 3, the analysis of 
each phospho-epitope response includes an evaluation using side scatter (SS), demonstrating 
that in this donor, only the monocytes show significant activation of these phospho-epitopes (in 
many donors, the granulocytes also show a positive P-p38 population following LPS activation, 
not seen here).  However, the details of the individual signaling pathway responses can only be 
appreciated using both multiple time points for LPS activation and the simultaneous use of 
specific pathway inhibitors. As shown in Figure 4, looking at the kinetics of both P-ERK and P-
AKT activation simultaneously over a 15 min period of LPS activation shows two different peaks 
of P-ERK expression (upper response in red in both panels); one extremely rapid, peaking at ~2-
4 min (left panel), the second peaking at 8-10 min (at 37o C incubation). In most (though not all 
normal human donors) we see both peaks, while in a minority of donors we only see the “later” 
P-ERK. In a sample pre-treated with the PI3K inhibitor (here GDC-0941, right panel), only the 
“early” (2-4 min) P-ERK response is inhibited. In contrast, pre-treatment with U0126 (as shown 
in Figure 2) inhibits both the early and the late P-ERK peak, indicating that the first peak goes 
through PI3K, but requires P-MEK. The second peak of activation of P-ERK actually goes 
through IKK>IκB>TPL-2 [6]. Consistent with this concept, we have demonstrated that the 
“second” P-ERK peak is inhibited by proteasome inhibitors, such as MG-132 (inhibition of 
proteasomal destruction of IκB prevents the release of TPL-2, preventing it from activating 
MEK). 
The kinetics of AKT activation (Figure 4) demonstrate a peak at 4-8 minutes (left panel, lower 
response in orange) with a sustained response for the time period measured here. As shown in 
the right panel of Figure 4, GDC-0941 causes complete inhibition of AKT activation, a useful 
internal control which strengthens the concept that the “early” ERK activation is through 
PI3K>AKT. These data also suggest that there is a constitutive activation of AKT in peripheral 
blood monocytes, which is inhibited by PI3 Kinase inhibitors (GDC-0941).  
 
 
16.7 Sample protocol for LPS activation of human whole blood 
This same approach can be used to study the impact of specific signaling pathway inhibitors to 
determine which downstream signaling pathways are affected.  Overall, monitoring signal 
transduction pathways in stimulated whole blood (and other similar types of samples) offers a 
unique way to test and validate antibodies, specific agonists, or antagonists, using a relevant 
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biological system.  In addition, this approach can be used to monitor the activity of targeted 
therapies (inhibitors) in vivo, or to monitor the prior exposure of individuals to LPS/Endotoxin [9]. 
 
16.8 Materials 
1. 4.0-5.0 ml human whole blood collected into K2EDTA or sodium heparin; 4.0-5.0 ml; 
stored at room temperature until tested. The blood sample must be used as soon as 
possible in order to preserve appropriate signaling capabilities. Sample testing should 
(ideally) begin within 1-4 hours of collection. 
2. Directly conjugated antibodies to phospho-epitopes (e.g. Cell Signaling Technology, 
Danvers, MA) and cell surface-specific conjugates, are necessary. We generally use 
multiple (generally 4) phospho-epitope specific antibodies in each tube, using lower 
molecular weight fluorophores (e.g. Alexa Fluor™ 488, or 647, Pacific Blue) for staining 
nuclear or ribosomal targets, and PE or APC for cytoplasmic targets. The same 
guidelines must be used here for the selection of fluorophore-antibody pairs for phospho- 
as for other targets (e.g. use “bright” conjugates for non-abundant targets and “dim” 
conjugates with abundant targets). 
a. CD14-PC7 
b. CD45-KrO 
c. P-ERK-Alexa Fluor™ 647 [T202/Y204], also known as P-p44/42 MAPKP 
d. S6-Pacific Blue [S235/236]P-AKT-PE [Ser473] 
e.  P-p38 MAPK-Alexa Fluor™ 488 [Y180/182],  
16.9 Reagents: 
1) LPS (liposaccharides);– from E. coli 0127 :B8 ; dilute to 50 µg/ml in PBS; store this 
working dilution at 40 C; stable for up to 6 months  
2) Triton X-100, 10% aqueous solution ; prepare working solution by diluting 116 µl stock 
with 10 ml PBS; store stock and working solution at room temperature; working dilution is 
stable for 1 month  
3) Appropriate pathway inhibitors (e.g. U0126 MEK>ERK, GDC-0941 PI3K>AKT, 
bortuzamib for proteasome inhibitor), as necessary 
4) Formaldehyde, 10% (methanol-free); store at room temperature in the dark;  
5) Albumin Solution from Bovine Serum; store at 40 C. 
6) Phosphate Buffered Saline (PBS); calcium- and magnesium-free  
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7) Wash Buffer – 4% Bovine Serum Albumin (BSA) in PBS; filtered through 0.22 µm sterile 
filter;  
8) Deionized water (for Triton X-100 dilution). 
 
16.10 Procedure - Whole blood fixation and permeabilization protocol for kinetics and use of 
inhibitors 
Before starting this procedure, prepare an experiment worksheet to aid in the critical 
timing steps (see sample Worksheet presented in Table 1). The experiment described 
below is for time points of up to 10 minutes of LPS activation. LPS is added to the tube(s) 
with the longest incubation time first (here, 10 min), followed by staggered LPS addition 
for shorter incubation times. For experiments adding specific signaling pathway inhibitors 
(not outlined here), whole blood samples are incubated at 37o C with inhibitor(s) for an 
appropriate time (generally 30-60 min, depending on the specific inhibitor) before the 
addition of LPS.   
 
1) Label twelve 75 mm polypropylene test tubes for the experiment.  There will be one control 
tube for each cell surface antibody-conjugate, and appropriate control tubes for each 
phospho-epitope (remember that the compensation control for each phospho-epitope target 
should express maximal levels of each target).     
(For phospho-epitopes requiring methanol treatment, have a 50% methanol solution 
ready for use in the freezer and right before use, remove from freezer and place into an 
ice bucket. See Chapter IV, Section 6 for details 
2) Just before use, mix blood by inverting vacutainer tube several times, then transfer blood 
into a 50 ml conical tube. Mix blood while aliquoting samples into twelve 75 mm tubes from 
step 1. 
3) Pipette 100 µL of blood sample into the bottom of each appropriately labeled tube.  Use a 
cotton-tipped applicator to remove any blood from the side of the tube 
4) Add 100ng LPS (2µl of working dilution) to the first of the designated stimulation tubes and 
mix by shaking tube.  Place that tube into the water bath and start a stopwatch.  At the 
appropriate time interval, add LPS to the next tube, vortex and place it into the water bath.  
Continue for all tubes in the stimulation part of the experiment. 
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5) Continue to use the staggered start to place the 37o C “no LPS” control tube and the CD14-
only tube into the water bath (last tubes to be placed into the 37o C water bath. 
6) At the 10-minute mark, remove the first tube in the timed sequence from the water bath and 
add 65ul of 10% formaldehyde to the tube.  Immediately mix well by shaking tube and place 
it into a tube rack. Continue adding 65µl of formaldehyde to each tube in the timed 
sequence, mixing between each one. Note: This is a critical step.  Formaldehyde stops the 
LPS activation and fixes the cell.   
7) Incubate each tube for a total of 10 minutes at room temperature. 
8) After exactly 10-minutes of incubation in formaldehyde at room temperature, pipette 1 ml of 
Triton-X-100 solution into each tube at the appropriate time interval, vortex well and return 
tube to rack. After Triton is added to the last tube, vortex all tubes, place into the 37o C bath 
and set timer for 15 minutes. 
a. After 15 min, inspect tubes for complete RBC lysis (clear non-turbid red color). If lysis 
is incomplete, continue incubation for a maximum of 15 additional minutes.   
b. If lysis is still incomplete, centrifuge, decant supernatant, loosen pellet by vortexing, 
resuspend with 1 ml of Triton working solution and incubate in 37 oC bath up to 30 
minutes to obtain maximal red blood cell lysis. 
9) Remove tubes from the water bath, dab on paper towel to remove water from the bottom of 
the tubes and place in rack. Add 1 ml of cold (4o C) wash buffer (4% BSA/PBS) to each of 
the tubes, and then vortex all tubes well. 
10) Centrifuge all tubes at 500 x g for 4 minutes. Remove supernatant. Vortex each tube to 
loosen pellet. 
11) Resuspend pellet by adding 1 ml of cold (4o C) wash buffer (4% BSA/PBS) to each of the 
tubes, and then vortex all tubes well. 
12) Centrifuge all tubes at 500 x g for 4 minutes.  Remove supernatant. Vortex each tube well to 
loosen pellet 
For phospho-epitopes that require 80% methanol treatment to “unmask” (e.g. P-STATs) 
a) Add 1 ml of cold (4o C) 80% methanol while vortexing. NOTE: This is critical to 
reduce cell aggregation.  Place the tube on ice. 
b) After the last tube, set timer and incubate for 10 minutes. 
c) At the end of the incubation, centrifuge all tubes at 500 X G for 4 minutes. 
Remove supernatant. Vortex each tube well to loosen up the pellet. Pipette 2 ml 
of cold (4o C) wash buffer (4% BSA/PBS) to each tube.   
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d) Centrifuge all tubes at 500 X G for 4 minutes.   
e) Remove supernatant.  Note:  Not necessary to loosen up the pellet before the 
addition of antibody cocktail..  
13) Add antibodies (concentrations and volumes previously defined) and cold wash buffer to a 
final volume of 100 uL. (Prepare a cocktail containing all desired antibodies.  This ensures 
that the antibody concentration for each tube is “identical”.) All antibodies should be diluted 
in PBS/4% BSA (protease free). 
14) Incubate all tubes at room temperature for 30 minutes in the dark. 
15) At the end of the incubation, add 2 ml of cold (4o C) wash buffer (4% BSA/PBS) to each tube. 
16) Centrifuge all tubes at 500 X G for 4 minutes. Remove as much of the supernatant as 
possible exercising care to preserve the cell pellet. Vortex each tube well to loosen up the 
pellet. 
17) Resuspend the cells in 350 ul of 0.5% paraformaldehyde in PBS, and store at 40 C in the 
dark, until sample can be analyzed. Samples in 0.5% paraformaldehyde are stable for 24 
hours. 
 
Figure legends 
Figure 1. “Canonical” pathways for LPS activation of multiple signaling pathways in peripheral 
blood monocytes via TLR-4. (adapted from Guha and Mackman, 2001). Inhibition of PI3K (right) 
by Ly294002 or GDC-0941) or of MEK 1/2 (left) by U0126 is also illustrated here. Also shown, in 
monocytes, activation of the ribosomal S6 protein is predominantly through activated ERK. 
Figure 2. LPS activation of the ERK pathway in human peripheral blood monocytes. Samples 
were pre-incubated with the indicated inhibitors for 60 min at 37o C before the addition of LPS to 
all samples. After 4 min incubation with LPS, all samples were fixed using formaldehyde and 
permeabilized using Triton X-100 (see Chapter IV Section 6 for details on fixation and 
permeabilization steps). Only monocyte responses are shown here, based on CD45 and CD14 
gating (not shown here) 
Figure 3. Simultaneous measurement of four different signaling targets. Human peripheral blood 
was incubated with LPS for 10 minutes at 37o C. Here, each of the measured phospho-epitopes 
is shown versus side scatter, with the CD-14pos monocytes in red. 
Figure 4. Kinetics of LPS activation of the AKT and ERK pathways in peripheral blood 
monocytes. Whole blood samples were pre-treated with the PI3K inhibitor GDC-0941 (right 
panel), or vehicle controls (left panels), followed by activation with LPS for 0 to 15 minutes at 37o 
C. P-AKT (orange, lower line in both panels) and P-ERK (red, upper line in both panels). Note 
that in the GDC-0941 treated sample (right), the P-ERK peak seen in the untreated sample is 
missing (arrow, right panel). 
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Table legend: 
Table 1: Worksheet for timed addition of reagents for 15 minute (max) LPS activation of whole 
blood 
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Section 17 - Lymphocyte metabolism through functional dyes 
 
 
17.1 Introduction 
The aim of this chapter is to provide rapid and simple protocols to measure lymphocyte 
metabolism. We briefly layout general pathways and the relevance of some selected pathways 
for lymphocyte biology before going into methodological detail. Lymphocytes upregulate 
glycolysis and mitochondrial oxidative phosphorylation (OxPhos) during their activation [1]. 
Metabolic reprogramming differs between B cells and T cells, and also within regulatory T-cell 
subsets [1]. For instance, naïve murine splenic CD4+ T cells upregulate glycolysis and glucose 
uptake and reveal a strongly enhanced ratio of glycolysis versus OxPhos upon anti CD3/CD28 
stimulation. In contrast, B cells upregulate both glycolysis and OxPhos upon lipopolysaccharide 
or anti-B-cell receptor stimulation, and maintain the glycolysis/OxPhos ratio of resting B cells [2]. 
Although OxPhos ensures efficient ATP production under aerobic conditions, mitochondria also 
contribute cytosolic biosynthetic precursors such as acetyl-CoA and pyrimidines, and are 
responsible for the production of reactive oxygen species (ROS) and cell death by the intrinsic 
apoptosis pathway [3]. Glycolysis does also take place under aerobic conditions and can be an 
actively induced program to meet the cells’ energy demand for instance in cancer cells [4] but 
also in certain lymphocyte subtypes [1]. Counterintuitively, during hypoxia, which is encountered 
by lymphocytes in the bone marrow and the thymus [5][6], ROS production by complex III of the 
respiratory chain, which usually contributes to OxPhos, has also been observed [7]. The three 
cellular ROS species are superoxide anions (·O2-) which are the precursors of hydrogen 
peroxide (H2O2) and hydroxyl radicals (·OH). ROS at high levels can cause oxidative stress to 
cells by either directly inducing single- and double-stranded DNA breaks or by oxidizing fatty 
acids, amino acids in proteins or enzymatic co-factors [8]. At low levels and under normoxic 
conditions ROS do, however, represent important cellular signaling molecules. For instance, in 
stem cells, ROS act as second messenger to ensure cycling of the cells [8]. The ROS species 
involved in intracellular signaling is H2O2 as it has a long half-life and diffuses easily [8]. 
Numerous proteins are redox sensors. For instance, the oxidation of cysteine inactivates PTEN 
or Akt, which are critically involved in B cell development [8]. Bach2, involved in antibody class 
switch recombination, is a redox-sensitive transcription factor [9]. Thus, metabolism may reflect 
the activation status and predict the fate of an immune cell. In fact, anergic B cells are 
metabolically less active than naïve B cells, and even less than hyperactive B cells from B-cell 
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activating factor of the TNF family (BAFF) transgenic mice [2]. These selective examples show 
that immune cell metabolism comprises ROS, glycolysis and mitochondrial activity, which 
intersect with signaling pathways.  
The gold standard to measure glycolytic and mitochondrial activities in real time is via 
extracellular flux analysis using a SeahorseTM device. However, this experimental setup requires 
access to such a device and a substantial amount of cells (~ 2 x 106 per single experiment), 
which might be difficult to achieve, especially when looking at rare lymphocyte subsets. To 
perform a quick first screen or to analyze complex cell populations without enrichment and 
purification, such as bone marrow, rapid flow cytometric techniques can provide first clues of 
whether a given treatment, genetic deletion or a cytokine alters glucose uptake, mitochondria or 
generation of ROS.  
 
17.2 Experimental Design  
We describe here the use of cell permeable functional dyes (see Table 1) to measure basic 
parameters such as 1. glucose uptake (6-NBDG; 6-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)Amino)-2-Deoxyglucose), 2. mitochondrial mass (Mitotracker Green/Red FM), 3. mitochondrial 
membrane potential (mtmP) (DIOC6; 3, 3′-dihexyloxacarbocyanine iodide; TMRE; 
Tetramethylrhodamine), 4. ROS (DCFDA; 2'-7'-Dichlorodihydrofluorescein diacetate). We found 
it feasible to choose one color for all dyes (FL1/green emission; 6-NBDG; Mitotracker Green FM, 
DIOC6, DCFDA) to analyze complex cell populations, such as bone marrow. This has the 
advantage that one single, titered cocktail of antibodies can be combined with each functional 
dye to analyze glucose uptake, mitochondrial mass, mtmP and ROS. Of course, the same 
strategy can be applied to use dyes with a different emission (Mitotracker Red FM, TMRE) and 
different Mitotracker dyes can be combined [9].  
 
17.2.1 Measurement of mitochondrial mass and activity 
MitoTracker Green FM labels mitochondrial proteins via mildly thiol-reactive chloromethyl 
moieties within the dye. MitoTracker Green FM diffuses through the plasma membrane and is 
then taken up by active mitochondria irrespective of their mtmP. Once inside, the dye cannot be 
washed out of the cells again. MitoTracker Green FM is used to semi-quantify mitochondrial 
mass using standardized conditions for cell numbers, dye concentration and incubation time. 
This also holds true for the other cell permeable dyes. Increased MitoTracker FM staining can 
either signify more or larger mitochondria or more structured mitochondria, i.e. increased protein 
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content providing more reaction targets for the dye, and henceforth refers to the total 
mitochondrial mass of a cell. In contrast to MitoTracker Green FM, the lipophilic and cationic 
fluorescent dye DiOC6 specifically accumulates in mitochondria in relation to their mtmP at low 
concentrations [10]. It has to be noted that loss of mtmP is a marker for early apoptotic cells [11]. 
Thus, care has to be taken to gate on non-apoptotic cells if alterations of mtmP that are not 
related to apoptosis are to be analyzed by DiOC6 or TMRE.  
 
17.2.2 Measurement of reactive oxygen species ROS 
In lymphocytes, the major source of ROS are the two respiratory chain complexes I and III. The 
fluorogenic dye DCFDA detects cellular ROS irrespective of its origin. Inside a cell, DCFDA is 
first deacetylated but does not emit fluorescence until oxidized by ROS into DCF (2’, 
7’-dichlorofluorescein). Of note, the probe is not selective for a particular ROS species [12] but 
elicits a broad specificity particularly in the presence of other oxidizing enzymes and factors like 
Fe2+ [13][14].  
 
17.2.3 Measurement of glucose uptake 
The fluorescent glucose analogue 6-NBDG is used to directly track uptake of this 
monosaccharide sugar into cells. By incubating cells in glucose-free medium supplemented with 
6-NBDG, the analogue is taken up instead of glucose and accumulates in the cells. The 
specificity of this assay can be verified by competitively adding glucose. It has to be noted that 
this assay does not directly measure glycolysis, i.e. pyruvate or lactate production, as it is 
restricted to measure glucose uptake. 
 
17.2.4 Caveats and their solutions 
A problem is, especially when measuring the organelle content of a cell, such as mitochondria, 
that fluorescence intensity correlates with cell size. Therefore, we firstly recommend to choose 
Median fluorescence intensity (MdFI, more robust against outliers) over mean fluorescence 
intensity (MFI). Secondly, it is recommended to normalize MdFI to cell volume by adjusting MdFI 
to the cubic value of FSC pulse width (that is, [FSC pulse width]3), which is the preferable 
parameter to evaluate cell size rather than the height or area of FSc or SSc [15].  
Other critical issues are concentration and incubation time. In particular, DiOC6 can also be 
maintained in cells by membrane potentials of other organelles, such as endoplasmic reticulum. 
Therefore, it has to be kept at the recommended low concentrations (low nM range). The 
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specificity of dyes mirroring mtmP (DiOC6, TMRE) can easily be verified by adding micromolar 
concentrations of the protonophore Carbonyl cyanide 3-chloro phenyl hydrazine (CCCP), even 
in real time (Figure 1). By titrating CCCP, this assay can be used to test the stability of mtmP of 
different cell types or under different environmental or genetic conditions [16]. As mentioned 
above, care has to be taken to gate on viable cells. 
 
To validate the desired specificity and working concentration of DCFDA, positive controls and 
negative controls can be included. For instance, we used ammonium peroxodisulfate (APS; 
0.001-0.1%), a radical starter, to assess the dynamic range of DCFDA. DCFDA oxidation can 
vice versa be blocked by the addition of vitamin C (mM Range) to the assay (Figure 2). For 
further reading on this issue we recommend Ref. [12]. 
 
Taken together, results obtained with the methods described here can provide first indications of 
the very basal metabolic and oxidative status of a given cell population. They may nevertheless 
be helpful to decipher complex mechanisms, such as antibody class switch recombination [9]. 
 
17.3 Sample preparation 
The cell permeable functional dyes that can be used are detailed in Table 1. 
1. Desired single cell preparation 
2. Staining medium (in the case of lymphocytes): OptiMEM without any additives or 
Glucose free DMEM 
3. Flow cytometry buffer (2% fetal calf serum in PBS, 0.02% NaN3; for measurement of 
mtmP, NaN3 should be omitted) 
4. Antibodies for staining of surface antigens for cellular subsets 
 
17.4 Acquisition and analysis 
17.4.1 Mitotracker, ROS and mtmP 
● Resuspend cells at 1-3x 106/ ml in 100-300 µl medium without supplements (serum will cause 
unspecific Mitotracker staining) 
● Incubate for 30 min at 37°C, 5% CO2 with 100 nM MitoTracker Green FM or 1-40 nM DiOC6 
(titer down as far as possible) or 1µM DCFDA  
● Wash cells once in the same medium 
● Stain for surface antigens with fluorescent antibodies in medium for 20 min at 4°C in the dark 
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● Wash cells with 500 µl flow cytometry buffer, resuspend in 250 µl of the same buffer and 
analyze by flow cytometry 
● To adjust the mitochondrial activity to the volume of the cells, normalize data to the cubic value 
of FSC pulse width (that is, [FSC pulse width]3) of the different samples. Important note: In 
certain cytometric softwares, recording FSC pulse width may have to be activated before 
acquisition  
17.4.2 6-NBDG 
● Wash cells once and resuspend in glucose-free DMEM with 300 µM 6-NBDG for 30 min at 
37°C, 7.5% CO2 (1-3x 106/ ml) 
● Wash cells with 500 µl flow cyometry buffer, resuspend in 250 µl of the same buffer and 
analyze by flow cytometry 
Legends 
 
Figure 1. Analysis of the sensitivity of mtmP towards CCCP in real time. Splenic B cells of 
a C57Bl/6 mouse were left unstained or stained with TMRE (Tetramethylrhodamine). Live cells 
were analyzed by flow cytometry for ~40 seconds, then medium or Carbonyl cyanide 3-chloro 
phenyl hydrazine (CCCP; 100 µM) were added and cells were analyzed for another ~120 
seconds. For comparison, TMRE-stained and CCCP-treated apoptotic/necrotic cells are shown 
in the lower panel. Apoptotic/necrotic cells reveal a lower and irregular TMRE fluorescence and 
are not responsive to CCCP treatment anymore, indicating a collapse of mtmP. MFI, mean 
fluorescence intensity. Data were acquired with a BD FACS Calibur and analyzed by FlowJo 
software.  
 
Figure 2. Testing the specificity of DCFDA. Splenocytes of a C57Bl/6 mouse were stained 
with DCFDA (2'-7'-Dichlorodihydrofluorescein diacetate). 0.01% ammonium peroxodisulfate 
(APS) or 0.01% APS together with 1 mM vitamine C were added or cells were left untreated. 
Viable cells (lymphocyte gate, left) were analyzed in a BD Gallios flow cytometer. Data were 
analyzed with Kaluza software.  
 
Table 1. List of cell permeable dyes described in this chapter, along with solvents, working 
concentrations and storage conditions. 
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Section 1 – Differentiation stages of T cells 
 
1.1 – Differentiation stages of human T-cell differentiation 
 
The body is under constant threat of pathogen attack. Microbes and viruses lurk in the 
environment and are evolutionary adapted to seize every opportunity to invade the system. The 
network of cells that make up the immune system works tightly together to protect against 
foreign invaders. If pathogens manage to get through the body’s physical barriers the first line of 
immunological defense is made up of innate immune cells. Innate cells are rapidly activated by 
pathogen-associated molecules in a non-antigen specific way. As a consequence, innate cells 
can react equally well to a variety of pathogens. Simultaneously innate cell activation also paves 
the way for the second line of immunological defense by presenting antigen processed 
peptides, which primes the adaptive phase of the T-cell response. After priming in the 
secondary organs, T cells migrate to the affected tissue where they execute cytotoxicity and 
other effector functions. In addition, antigen-specific T-cell memory is formed. T-cell immunity is 
complex and there are an increasing number of subsets defined by differentiation stage, 
function and cellular location. In the last decades flow cytometry proved itself to be the key 
technology to study heterogeneity among human T-cell subsets.  However as the options for 
multi-color flow cytometry panel design emerged due to technical innovation, this went hand-in-
hand with the increasing complexity to define T-cell subsets. In this chapter we like to review the 
cellular markers that can be measured to shed light on these complexities. 
                      
1.1.2 A four-dimensional model to address CD8+ T-cell differentiation stages 
Conventional human T cells are a subpopulation of lymphocytes that can be characterized by 
the expression of a T-cell receptor (TCR), through which they can recognize peptides presented 
in the context of HLA-molecules. The conventional TCR is composed of a transmembrane 
alpha- and beta-chain heterodimer that is embedded in the cell membrane in combination with 
the CD3 protein complex. In the thymus T cells differentiate into two main cell lineages of CD4+ 
and CD8+ single positive T cells that are released into circulation as naïve cells (TN) (Figure 1). 
In response to antigen exposure TN start to proliferate and differentiate rapidly into large 
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numbers of effector and memory precursor T cells. Following pathogen clearance the majority of 
effector cells die while the memory precursor cells develop into long-lived memory T cells[1;2]. 
Although the precise model of T-cell differentiation has not been fully deciphered, two models, 
progressive versus asymmetric differentiation, are currently discussed that explain how T-cell 
diversify into effector and memory subsets. Despite this discussion a consensus was reached 
about markers that define naïve and memory T-cell subsets[3].  
Markers that can be used to phenotypically differentiate TN, effector and memory cells 
are two isoforms of the CD45 family. While TN express the CD45RA molecule, both the central 
memory (TCM) and the effector type RA- (TE RA-) cells preferentially express CD45R0. Another 
marker that can be used to identify TN and a fraction of memory cells is the L-selectin CD62L 
which guides T cells to the lymph nodes. Expression of this marker can only be honestly 
assessed using freshly isolated cells as cryopreservation results in a profound decrease of 
CD62L expression[4]. Several markers are proposed in combination with CD45RA/R0 to 
precisely define phenotypically different T-cell subsets. Among these markers is CD27, a 
member of the tumor necrosis factor receptor family which promotes survival of T cells, CCR7, a 
chemokine receptor which mediates lymph node homing and the co-stimulatory molecule CD28, 
which is required for T-cell activation and survival[5-7] (Figure 2). Monoclonal antibodies 
directed against these markers are widely available and conjugated to plenty of different 
fluorescent dyes which enables broad application in various multi-color phenotyping panels. 
The four-dimensional model to address T-cell differentiation stages starts with TN 
(CD27+CD28+CCR7+CD45RA+). After priming TN differentiate through early-differentiated 
(CD27+CD28+CCR7-CD45RA-), early like (CD27-CD28+CCR7-CD45RA-) and intermediately 
differentiated (CD27+CD28-CCR7-CD45RA-) T cells to give rise of TE RA+ (CD27-CD28-CCR7-
CD45RA+), TE RA- (CD27-CD28-CCR7-CD45RA-) and TCM (CD27+CD28+CCR7+CD45RA-) cells. 
TE RA- are memory cells that in contrast to TCM lack constitutive expression of CCR7. In healthy 
individuals without any clinical signs of viral infection, from now on referred to as steady state, 
naïve and early differentiated type form the most abundant circulating CD8+ T-cell subsets. In 
humans that are chronically infected with Cytomegalovirus (CMV) or Human immunodeficiency 
virus (HIV) the effector type RA+ also contributes substantially to the CD8+ T-cell compartment 
composition. Similar phenotypic heterogeneity exists in the CD4+ T-cell compartment although 
subdivisions of differentiation stage base on the expression of CD28 and CCR7 are not 
generally recognized. However, although effector type CD4+ T cells are virtually absent during 
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steady state, increasing evidence suggest that cytolytic CD4+ T cells play an important role 
during infections and these cells are appreciated to lack CD28 expression[8]. 
 
1.1.3 The use of adhesion and chemokine receptor expression to address CD4+ T-cell 
differentiation 
To date, the most appreciated model to define CD4+ T-cell differentiation stages relies on the 
differential expression of adhesion and chemokine receptors (Figure 3). Type 1 helper (TH1) 
cells are critical for cell-mediated immunity as they produce fast amounts of the anti-viral 
interferon gamma (IFN). TH1 cells can be identified by the expression of CXCR3 with guides 
these cells to the infected tissues. Other chemokine receptors expressed by TH1 are CCR5 and 
CXCR6[9]. While TH1 cells are critical for cell-mediated immunity, CD4+ TH2 cells are required to 
support activation of other leucocytes such as B cells and are associated with the production of 
the cytokines IL-4, IL-5, and IL-13. TH2 cells can be identified by the expression of the 
chemokine receptor CCR4, but also CCR3 and CCR8 may be expressed. Differentiation of T 
cells into TH1 and TH2 subsets is controlled in a biphasic model by the transcription factors T-bet 
and GATA binding protein 3 (GATA3)[10;11]. T-bet has been shown to antagonize with GATA-
3, the master regulator differentiation and maintenance of TH2 cells[12]. In recent years, TH 
subsets have been identified that differ from the traditional TH1 and TH2 subsets by the 
preferential production of IL-9 (TH9), IL-17 (TH17) and IL-22 (TH22) multiple functions have been 
attributed to the interferon regulatory factor 4 (IRF4) driven TH9 cells[13], the pro-inflammatory 
TH17 cells play an important role in pathogen clearance of extracellular pathogens at barrier 
sites. TH17 cells can be identified by the mutual expression of CCR6 and CD161. Several 
studies have demonstrated that a fraction of TH17 can also secrete IFN[14;15]. Differentiation 
of TH17 cells is driven by the expression of RAR-related orphan receptor gamma t (RORt) 
which is controlling IL-17 transcription[16]. In addition, the skin-homing TH22 cells appeared to 
be regulated by the aryl hydrocarbon receptor (AHR) transcription factor[17;18]. Finally, a 
decade ago a specific subset of TH cells was discovered that resided in B-cell areas of follicular 
regions in secondary lymphoid tissues. Consequently, these cells were named follicular helper 
cells TFH and are identified by the constitutive expression of the chemokine receptor CXCR5. 
Since their discovery multiple TFH have been characterized, both in tissue and circulation that 
can be distinguish based on the expression of programmed cell death protein 1 (PD-1), CXCR3, 
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CCR6 and the secretion of IL-21[19]. TFH differentiation is orchestrated by the transcription 
factor B-cell lymphoma 6 (BCL6) and regulates the activation of B cells in germinal centers and 
are therefore crucial for the induction of humoral immune responses[20]. Finally, CD4+ T cells 
can also directly mediate viral clearance and suppress tumor growth through cytotoxic function. 
Loaded with cytotoxic molecules such as Granzyme B and perforin these cells can be identified 
by the surface expression of the Fractalkine receptor CX3CR1. 
 
1.1.4 T-cell differentiation during acute infection 
In multiple well established models of acute infection expression of the IL-7 receptor -chain 
(CD127) is used to discriminate between the short-lived effector cells (SLEC) and the memory-
precursor effector cells (MPEC)[21]. Although mice and human differ significantly in life span 
and pathogen encounter, immune cell gene expression demonstrated high similarities[22;23] . 
In humans, combinations of different markers have been used to define T-cell differentiation 
during acute infections, among them are CD127 and KLRG1. In combination with the cell-
surface markers CD45RA and CD27, the human equivalent of MPEC cells can be identified by 
an increased expression of CD127 that goes hand-in-hand with a decreased expression of the 
killer cell lectin-like receptor G1 (KLRG1) (Figure 4). In addition, the human equivalent of SLEC 
can be identified by the selective expression of KLRG1. In contrast to the bi-phasic model in 
mice, the majority of the human effector CD8+ T-cell compartment consists of double positive 
effector cells (DPEC). In addition, low number of early effector cells can be identified that lack 
both CD127 and KLRG1 expression. Although in mice and humans phenotypically similar 
effector T-cell populations can be identified during an acute infection, it remains to be elucidated 
to what degree these populations are functionally comparable. 
 
1.1.5 Transcriptional regulation of T-cell differentiation 
The relationship between phenotype and function has been subject of much investigation. 
Although the association between the above mentioned surface markers and T-cell function are 
mostly well established, ultimately not all phenotypically similar T cells share the same cell fate 
and effector response. The emerging complexity among T-cell subsets and their potential to 
elicit a plethora of effector functions require a more thorough characterization of each subset 
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that would reflect its function. The actual regulator of T-cell development and function is the 
circuitry of transcription factor expression. Complex interactions of transcription factors drive 
expression of target genes that ultimately determine T-cell functionality and many use opposing 
mechanisms to counter-regulate each other [24]. Multi-color flow cytometry is the preferred cell 
method of choice to detect low frequent T-cell subsets with differential transcription factor 
expression within heterogeneous T-cell populations. As these factors bind to DNA they are 
concentrated in the nucleus. To allow antibodies to reach their nuclear epitopes T cells need to 
be fixated and permeabilized. There is a variety of commercial kits and procedures available to 
accommodate these stainings. Permeabilization may induce cell shrinkage and loss of surface 
marker staining intensity and protocols should therefore be validated and optimized. Generally 
the FSC and SSC voltage are amplified for intracellular protein staining.  
The CD8+ T-cell lineage is enriched for cytolytic cells (CTL) that are very effective in 
direct lysis of infected target cells. During chronic infections CTL like cells can also be detected 
among the CD4+ lineage. These cells can be recognized by the expression of Granzyme B 
(GZMB) and Perforin which are stored in acidic lysosomes (Figure 5A). Differentiation of CTL, 
but also TH1 differentiation was demonstrated to be regulated by expression of the T-box 
transcription factor Tbx21 (T-bet)[25]. While T-bet drives terminally differentiation of effector T 
cells, expression of a second T-box transcription factor, Eomesodermin (Eomes), enabels TH1 
cells to generate memory with a certain degree of redundancy (Figure 5B)[26]. Recently, the 
zinc finger protein ZNF683 (Hobit) was identified as a transcriptional regulator of effector type T 
cells in humans[27]. Expression of Hobit strongly correlates with T-bet and regulates production 
of IFN (Figure 3C). To prevent immune-mediated pathology by ongoing effector function and 
unrestricted expansion of CTL and TH1 cells, the stimulatory activities of these subsets are 
counterbalanced by of naturally and induced Treg. These suppressor cells, most of which are 
CD4+ T cells, exert their modulatory function by direct interaction with target cells, by the 
secretion of immunosuppressive cytokines such as TGF and IL-10 and by increasing the 
consumption of IL-2. Two major subsets of Treg cells can be distinguished. Both express the IL-
2 receptor alpha chain (CD25) and the transcription factor forkhead box 3 (FoxP3)[28;29] 
(Figure 3D). Natural Treg originate from the thymus and can be distinguished from peripheral 
generated induced Treg by the expression of the transcription factor Helios[30]. Peripheral 
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induced Treg are derived from antigen exposed conventional T cells and participate in the 
control of immune homeostasis at sites of inflammation, especially mucosal tissues. 
 
1.1.6 T-cell differentiation and effector function 
To define specific T-cell subsets on basis of cytokine production usually in vitro stimulation is 
required. Since cytokine are not preformed their levels are typically low in resting cells. 
Accumulation of cytokines within the endoplasmic reticulum is achieved by adding an inhibitor of 
protein transport to stimulated cells. The two most frequently used inhibitors are Monensin (MN) 
and Brefeldin A (BFA). The choice of protein transport inhibitor is very important as they can 
have differential effects on surface and intracellular protein expression after stimulation. For 
example, BFA will help to maximize the capture of TNF, IFN and IL-17 but blocks the surface 
expression of the T-cell activation marker CD69 (Figure 6). In addition, MN maximizes the 
detection of the T-cell degranulation marker CD107. After polyclonal stimulation of T cells 
cytokines are produced with different kinetics. For most cytokines a stimulation an accumulation 
period of 4 to 6 hours is optimal. However for several cytokines such as IL-10 and IL-12 the 
production kinetics are relatively slow and up to 24 hours stimulation may be required for 
optimal detection. As both MN and BFA are toxic, exposure of stimulated cells should be limited. 
Consequently, for the longer stimulations (>6 hours) MN and BFA may be added during the last 
4 to 6 hours. MN was demonstrated to be less toxic and can be added for periods up to 24 
hours. When there is no prior knowledge regarding the specific cytokines that will be produced 
by the stimulated T cells, expression of activation induced markers can be considered. Both 
CD4+ and CD8+ T cells depict CD69 and HLA-DR expression as early as 4 hours after 
stimulation. Other markers like the CD8+ biased 4-1BB (CD137) and the CD4+ T-cell biased 
CD40 ligand (CD154) peak at 24 hours after stimulation. One problem with defining T-cell 
phenotypes after stimulation is the internalization of TCR and the CD4 and CD8 coreceptors. 
This will result in a decreased staining intensity for CD4, CD8 and especially CD3 which makes 
it more difficult to define T cells. By either staining the cells before stimulation or by intracellular 
staining of these markers this problem can be circumvented.  
1.1.7 Protocol 
1. Freezing PBMC 
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1.1. Isolate PBMC from heparinized blood or buffy coat by using ficoll or lymphoprep 
according to manufacturer’s protocol 
1.2. Collect the PBMC in 50 ml tubes 
1.3. Add washing medium up to 50 ml and centrifuge for 10 min at 500 g at RT 
1.4. Aspirate supernatant, resuspend pellet in 50 ml washing medium and centrifuge for 10 
min at 250 g at RT 
1.5. Aspirate supernatant, resuspend pellet in 35 ml washing medium and centrifuge for 10 
min at 250 G at RT 
1.6. Resuspend in 1-2 ml of thawing medium and put on ice 
1.7. Count cells and adjust concentration to 10-25x106 cells/ml 
1.8. Prepare a similar amount of freezing medium and put on ice 
1.9. Make sure your cells, cryovials and freezing medium are cold before freezing 
1.10. Add drop by drop, while gently shaking, 1 ml of freezing medium for every ml of 
cell suspension 
1.11. Transfer 2 ml of the cell suspension to each vial 
1.12. Freeze the cryovials by using a Mr. Frosty (Nalgene), CoolCell (Corning) or a 
freezing apparatus 
1.13. Store the vials until further use in liquid nitrogen 
 
2. Thawing PBMC 
2.1. Thaw the vials by gently shaking in a 37 ºC water bath, until little ice remains. 
2.2. Transfer the contents of the vial to a 50 ml tube 
2.3. Add drop by drop, while gently shaking, 18 ml of cold thawing medium 
2.4. Let the cell suspension rest for 20 min on ice and centrifuge for 10 min at 500 g at 4ºC 
2.5. Aspirate supernatant, resuspend pellet in 50 ml washing medium and centrifuge for 10 
min at 250 G at 4ºC  
2.6. Aspirate supernatant, flick resuspend pellet in desired volume of flow cytometry buffer 
(for surface and intracellulair stainings) or culture medium (for stimulations) and count 
cells 
 
3. Surface staining 
3.1. Transfer up to 2x10e6 PBMC to a 96 well roundbottom plate (Greiner BioOne) 
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3.2. Centrifuge the plate at 390 g at 4ºC for 3 min. 
3.3. Aspirate supernatant and resuspend cells by gently vortexing the plate. 
3.4. Add 30 µl flow cytometry buffer containing a pre titrated appropriate amount of tetramer 
for each well (prepare 1x extra). 
3.5. Incubate for 30 min at 4ºC, shaking, protected from light 
3.6. Meanwhile prepare surface staining (including the live/dead exclusion dye) in a total 
volume of 30 µl flow cytometry -buffer for each well (prepare 1x extra). 
3.7. Add 30 µl surface stainingmix, without washing the cells, directly into the well and 
incubate a further 30 min at 4ºC, shaking, protected from light. 
3.8. Add 150 µl flow cytometry -buffer and centrifuge at 390 g at 4ºC for 3 min. 
3.9. Resuspend cells by gently vortexing the plate. 
3.10. Add 100 µl flow cytometry buffer, and analyze by flow cytometry cell sorting in the 
desired format, or continue with the intracellular staining protocol. 
Note: Always use appropriately titrated antibodies and tetramers, which is usually not the 
concentration suggested by the supplier. The ins and outs of titration antibodies can be 
found in the publication of Lamoreaux et al[31]. 
 
4. Intracellular stainings of transcription factors and cytolytic molecules 
4.1. After surface staining add 200 µl Fixation/Permeabilization buffer 
4.2. Gently resuspend the cells by pipetting up and down 3 times 
4.3. Incubate 20 min at 4ºC, shaking, protected from light 
4.4. Centrifuge for 5 min at 700 g at 4ºC 
4.5. Aspirate supernatant and resuspend cells in 200 µl flow cytometry buffer and centrifuge 
for 5 min at 700 G at 4ºC 
4.6. Aspirate supernatant and resuspend cells by pipetting up and down 3 times in 50 µl of 
the intracellular staining mix prepared in Permeabilization Buffer 
4.7. Incubate 30 min at 4ºC, shaking, protected from light 
4.8. Add 150 µl Permeabilization Buffer to each well and centrifuge for 5 min at 700 g at 4ºC 
4.9. Aspirate supernatant and resuspend cells in 200 µl Permeabilization Buffer and 
centrifuge for 5 min at 700 g at 4ºC 
4.10. Aspirate supernatant and resuspend cells in 100 µl flow cytometry buffer and 
analyze by flow cytometry cell sorting in the desired format 
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5. Cytokine staining 
5.1. Transfer PBMC overnight in non-tissue cultured flasks (Greiner) at 1x106 cells/ml in 
culture medium (flask standing upright, or 45º tilted depending on volume) and rest 
them overnight in a 37ºC 5% CO2 stove 
5.2. Transfer cells to a 15 ml tube and centrifuge for 10 min at 500 g at RT 
5.3. Aspirate supernatant, resuspend cells and add 1 ml of culture medium 
5.4. Count the cells and adjust concentration to 10-20x106 cells/ml 
5.5. Add 100 µl control mix to the correct wells of a non-tissue cultured 96 well round bottom 
plate (Corning) 
5.6. Add 100 µl stimulation mix to the correct wells of the 96 well plate 
5.7. Then add 100 µl cell suspension 
5.8. Incubate 4 hours in a 37ºC 5% CO2 stove 
5.9. Put plate on ice for 15 min after incubation 
5.10. Centrifuge plate for 5 min at 700 g at 4ºC 
5.11. Aspirate supernatant, resuspend cells in 200 µl flow cytometry buffer and 
centrifuge plate again for 5 min at 700 g at 4ºC 
5.12. Aspirate supernatant, resuspend cells in 50 µl flow cytometry buffer containing an 
pre titrated appropriate amount of surface staining mix 
5.13. Incubate for 30 min at 4ºC, shaking, protected from light 
5.14. Add 150 µl  flow cytometry buffer and centrifuge at 700 g at 4ºC for 3 min 
5.15. Aspirate supernatant and add 100ul of Cytofix/Cytoperm reagent (554722, BD 
Biosciences) to each well and resuspend by pipetting 3 times up and down 
5.16. Incubate 20 min at RT protected from light 
5.17. Add 100 µl flow cytometry buffer and centrifuge at 700 g at 4ºC for 3 min 
5.18. Aspirate supernatant and add 50 µl intracellular stainingmix prepared in 1x 
perm/wash and resuspend by pipetting 3 times up and down 
5.19. Incubate 30 min at 4ºC, shaking, protected from light 
5.20. Add 150 µl 1x perm/wash to each well and centrifuge for 5 min at 700 g at 4ºC 
5.21. Aspirate supernatant, add 200 µl 1x perm/wash to each well and centrifuge for 5 
min at 700 g at 4ºC 
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5.22. Aspirate supernatant and resuspend cells in 100 µl flow cytometry buffer and 
analyze by flow cytometry cell sorting in the desired format 
Note: protocol adapted from Lamoreaux et at[31] 
 
6. Monoclonal antibodies 
6.1. Surface staining: 
BD Biosciences: CD45RA FITC (HI100), CD28 PE (clone L293), CD8 APC (clone RPA-T8), 
CD4 APC (clone RPA-T4), CXCR5 Alexa Fluor 647 (clone RF8B2), CD25 PE (clone 2A3) 
eBioscience: KLRG1 PerCP-eFluor 710 (clone 13F12F2), CD4 PerCP-eFluor 710 (clone 
SK3), CD127 PE-Cy7 (clone eBioRDR5), CD27 APC-eFluor 780 (clone O323), CD107a 
FITC (clone H4A3), CCR7 BUV 395 (clone 150503) 
Biolegend: CCR6 Alexa Fluor 647 (clone G034E3), CCR7 BV421 (clone G043H7), 
CX3CR1 FITC (clone 2A9-1), CD3 BV510 (clone OKT3), CD8 BV785 (clone RPA-T8). 
R&D Systems: CXCR3 PE (clone 49801)   
6.2. Live/dead exclusion dyes:  
Live/dead fixable dyes (Thermofisher) or Fixable viability dye (eBioscience). We here use 
Live/Dead fixable Red (Thermofisher) 
6.3. Intracellular stainings: 
BD Biosciences: granzyme B Alexa Fluor 700 (clone GB11), IL-2 PE (clone 5344.111), 
TNFα Alexa Fluor 700 (clone MAb11), Perforin FITC (clone delta G9), Hobit (clone 5A).  
eBioscience: Granzyme K PerCP-eFluor 710 (clone G3H69), IFNγ APC-eFluor 780 (clone 
4S.B3).  
Biolegend: FoxP3 APC (clone PCH101), Eomes PerCP-eFluor 710 (clone WD1928), T-bet 
PE-Cy7 (clone 4B10), Anti-IgM PE (clone ma-69).  
 
7. Flowcytometer 
All experiments were performed on a LSR Fortessa flowcytometer with a 365 nm, 405 nm, 
488 nm, 561 nm and 640 nm configuration (BD Bioscience).Filters: 379/34(365) for 
BUV395; 530/30(488) for FITC or AF488; 665LP(488) for PerCP-eFluor 710; 450/50(405) 
for BV421; 525/50(405) for BV510 and V500; 660/20(405) for BV650; 710/40(405) for 
BV711; 800/50(405) for BV785; 585/15(561) for PE; 610/20(561) for live/dead fixable red; 
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780/60(561) for PE-Cy7; 675/20(640) for APC or AF647; 730/45(640) for AF700; 
780/60(640) for APC-eF780. 
 
8. Media and buffers: 
 
Thawing medium:  
IMDM 
20% (v/v) FCS 
0.00036% (v/v) 2-mercaptoethanol)  
 
Freezing medium (after addition of DMSO use within 1 hour): 
IMDM 
20% (v/v) FCS 
20% (v/v) DMSO 
0.00036% (v/v) 2-mercaptoethanol)  
 
Washing medium:  
HBSS  
5% (v/v) FCS 
10% (v/v) TRIS-HCL pH 7.0 (as extra buffering) 
 
Culture medium: 
RPMI 
10% (v/v) FCS 
 
 Flow cytometry buffer: 
Phosphate buffered saline (PBS) 
0.5% (w/v) bovine serum albumin 
0.01% (w/v) sodium azide  
2mM EDTA pH 8.0 (to prevent cloths) 
 
Fixation/Permeabilization buffer (FOX-P3 kit eBioscience)   
75% Fixation/Permeabilization Diluent (cat. 00-5223) 
25% Fixation/Permeabilization Concentrate (cat. 00-5123) 
 
Permeabilization Buffer (FOX-P3 kit eBioscience)   
90% Fixation/Permeabilization Diluent (cat. 00-5223) 
10% Permeabilization Buffer (10X) (cat. 00-8333) 
 
Stimulationmix: 
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Culture medium  
2 µg/ml Ionomycin  
20 ng/ml PMA  
20 µg/ml BFA  
2.8 µl/ml GolgiStop (BD Bioscience) 
 
Controlmix: 
Culture medium  
20 µg/ml BFA  
2.8 µl/ml GolgiStop (BD Bioscience) 
 
1x perm/wash:  
10% 10xperm/wash (554723 BD Biosciences)  
90% ddH2O 
 
1.1.8 Materials: Staining of human peripheral blood 
Thawed PBMC from healthy volunteers isolated from buffy coat with lymphoprep (Lucron) that 
were cryopreserved in liquid nitrogen until use. For cytokine stainings PBMC were rested 
overnight in non-tissue cultured flasks at 1x10e6 cells/ml in RPMI supplemented with 10% FCS. 
PBMC were subsequently stimulated for 4 hours with Ionomycin (1 µg/ml) and PMA (10 ng/ml) 
in the presence of BFA (10 µg/ml) and GolgiStop (0.14 µl/200 ul; BD Bioscience). All 
experiments were performed on an LSR Fortessa flowcytometer with a 365 nm, 405 nm, 488 
nm, 561 nm and 640 nm configuration (BD Bioscience). 
    
 
Figure legends 
 
Figure 1. Gating of CD4+ and CD8+ T cells in peripheral blood.  Lymphocytes are identified 
on based of the forward (FSC) and side (SSC) scatter. Single cells are discriminated from 
doublets by plotting the pulse width and height against each other for both the SSC and FSC. 
CD3+ T cells are gated and excluded from apoptotic cells by viability dye. Including death cells 
can result in large errors because of their property to bind nonspecifically to antibody 
conjugates. In the same channel other cell types are excluded by using a DUMP channel, 
meaning a challel that contains all cellular markers in one color that should be excluded e.g. 
antibodies against CD14 (monocytes), CD19 and CD21 (B cells). Peripheral blood ratios of 
CD4+ and CD8+ T-cell vary from donor to donor. A normal CD4:CD8 ratio is between 1 and 2. 
Low frequencies of double negative CD3+CD4-CD8- cells are common and contain populations 
of NKT cells.  
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Figure 2. A four-dimensional model to address T-cell differentiation stages. At least seven 
stages of T-cell differentiation can be distinguished for peripheral blood derived CD8+ T cells by 
using the markers; CD45RA, CD27, CD28 and CCR7. 
Figure 3. Adhesion and chemokine receptor expression identify four functional subsets 
within the human CD4+ memory pool.  Five T-helper subsets can be distinguished for 
peripheral blood derived memory CD4+ T cells by using the markers; CCR4, CCR6, CXCR3, 
CXCR5, CX3CR1 and CD161. 
Figure 4. Effector CD8+ T-cell differentiation during acute infection using KLRG1 and 
CD127. In humans four different effector populations can be identified during acute infection 
based on the expression of KLRG1, CD127, CD45RA, and CD27.  
Figure 5. T-cell subsets as identified by intracellular cytokine and transcription factor 
staining. Peripheral blood derived CD3+ T cells are divided between CTL and TH cells. (A) CTL 
can be identified by the mutual expression of GZMB and Perforin. (B) CTL but also TH1 cells can 
be identified in both the CD8 and CD4 lineage by the expression of T-bet and further divided by 
the expression of Eomes. (C). Hobit expression strongly correlates with T-bet expression in 
CD8+ T cells. (D) 
Figure 6. T-cell stimulation and visualization of antigen specific cells using MHC-
tetramers. Peripheral blood T cells were stimulated for 4 hours with Ionomycin and PMA in the 
presence of BFA  and MN. (A) Stimulated CD8+ and CD4+ T cells were stained for expression of 
IFN and IL-2. (B) TNF production was captured in combination with degranulation of 
stimulated CD8+ T cells as detected by capture of CD107. 
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1.2 – Differentiation stages of murine T-cell differentiation 
 
Flow cytometry and cell sorting have been instrumental to unravel the basic principles of T-cell 
differentiation. The combined results of analyzing human samples and experimental animal 
models has given us great insights about thymic selection of T cells, induction of T-cell 
responses and the generation of long lived T-cell memory. Although for the most part the same 
mechanisms apply to the differentiation of T cells in humans and mice, as the primary animal 
model in T-cell biology, there are also fundamental differences in the way T cells are analyzed. 
In this chapter we will provide guidelines for the analysis of murine T-cell differentiation and 
highlight differences in terminology and analysis of human and murine T cells.  
1.2.1 T cells - Of mice and men 
In our environment we encounter different microorganisms, pathogens and foreign substances 
every day. These agents trigger and shape our immune system constantly during our life. This 
includes an enormous range of potential antigen exposure including non-persistent and 
persistent latent viruses, bacteria, vaccinations, neoplastically transformed cells, as well as the 
flora of our individual microbiota. The current life expectancy of 70+ years in the western world 
leaves a lot of time to perturb the immune system from its original naïve state. In contrast, most 
lab mice are used 8-12 weeks after birth and are bred and maintained in clean areas under 
specific pathogen free conditions (SPF) with minimal exposure to foreign materials. 
Consequently the phenotype of CD8 T cells of SPF mice is more similar to CD8 T cells found in 
neonatal humans [1].  
These disparities lead to a different starting point of analysis. Mice at steady state without 
experimental induction of immune responses contain a largely naïve immune system without 
current infections, whereas even in healthy adult humans we find an experienced immune 
system under constant attack. However, the use of lab animals enables us to selectively induce 
disease states and study the T-cell response at defined synchronized time points. To a limited 
degree this is also possible in human clinical studies that e.g. monitor the immune response 
following vaccination [2, 3] or primary infection after organ transplantation [4]. This longitudinal 
view on T-cell responses is generally more common in murine T-cell biology and has formed 
definitions of terminology that are distinct from the one used in human T-cell biology.  
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1.2.2 Flow cytometric analysis of T-cell differentiation in mice 
T-cell precursors differentiate in the thymus into mature naïve CD4+ or CD8+ T cells depending 
on the affinity of their T-cell receptor (TCR) for MHCI or MHCII presented peptides. In flow 
cytometry mature CD4+ and CD8+ T cells can be identified by gating on lymphocytes according 
to scatter, exclusion of doublets and dead cells and gating on CD3+ cells and CD4 or CD8 
single positive cells (Figure 1). Mature naïve T cells are defined by the high expression of 
CD62L, which enables migration to secondary lymphoid organs, and low expression of CD44. 
After infection or immunization an immune response is induced and naïve T cells are primed. 
During this first phase of activation after antigen exposure naïve T cells proliferate, differentiate 
into effector cells specialized for the type of pathogen encountered and acquire higher 
expression of CD44 and loose CD62L expression. CD127 and KLRG1 are classical markers to 
distinguish between short-lived effector cells (SLEC, CD127-/KLRG1+) and T cells with higher 
memory potential (MPEC, CD127+/ KLRG1-) during the effector phase of CD8+ T cells. After 
the peak of infection (7-14 days), the T-cell response contracts and T-cell memory begins to be 
formed. Within the CD44high memory T cells, CD62L distinguishes between CD62L+ central 
memory (CM) and CD62L- effector memory (EM) cells (Figure 2). These memory subsets are 
maintained in lymphoid and peripheral tissues and provide protection in case of rechallenge with 
the same pathogen. In contrast to human T cells, where next to CM and EM T cells long lived 
quiescent effector cells or CD45RA-expressing effector memory cells can be found during 
steady state, in mice a temporal definition of T-cell differentiation state is used. In this case, 
effector T cells are present during early infection to ensure pathogen clearance and then 
following successful resolution of the immune response, antigen specific memory T cells are 
generated and maintained. 
Several methods are used to analyze and follow T-cell immune responses in mice. Antigen 
specific cells can be detected by MHC tetramers/multimers, analysis of dividing cells using BrdU 
or the proliferation-associated marker Ki67, functional assays like cytokine/ activation marker 
expression ex-vivo or after restimulation as well as using transfer of TCR transgenic T cells. 
Moreover, animal studies allow for directed breeding and genetic manipulation, which can 
introduce features such as congenic markers and reporter genes that find broad application in 
flow cytometric analysis of murine T cells. For example, allelic variations of the cell surface 
molecules CD90 (Thy-1) and CD45 (Ly-5), which can be distinguished with selective antibodies, 
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are used to track adoptively transferred T cells in recipients. Additionally fluorescent molecules 
such as GFP are not only used to follow transferred cells but also as reporters for deletion or 
expression of genes in genetically modified mice. 
1.2.3 T-cell in tissues 
The location plays a big role for the maintenance and functional capacity of T cells. Analysis of 
human T cells is largely confined to blood, whereas in murine experimental models lymphoid 
organs like the spleen are generally used for the investigation of T cells differentiation. Also 
other tissues like skin, intestine and bone marrow are more easily available in mice and 
accordingly a more frequently used subject of investigation.  
Next to the circulating T cells, which form the majority of T cells in lymphoid organs like the 
spleen, lymphoid organs as well as peripheral tissues like the bone marrow, lung and intestine 
contain tissue resident memory T cells (Trm). Trm are non-circulating T cells that form a first line 
of defence at barrier tissues and a privileged reservoir of memory T cells in the bone marrow. 
CD69 expression is maintained by Trm in the absence of antigen, functionally important for the 
residency of Trm and consequently a commonly used marker for Trm. Trm in epithelial and 
neuronal tissues might also express CD103, the α-chain of the αEβ7 integrin, and CD49a, the 
α-chain of the α1β1 integrin (VLA-1) [5]. CD103 is also expressed by a subset of naïve T cells, 
which makes the usage of CD44 or CD62L essential to discriminate Trm and naïve T cells. 
Furthermore, it cannot be excluded that Trm that lack expression of CD69 or CD103 exist. 
Additionally, in vivo labeling provides information about the location of T cells. Intravenous 
injection of antibodies directed against CD4, CD8 or pan-T-cell markers such as CD90 and 
CD45, can be used to distinguish between the labeled cells in circulation and unlabeled T cells 
in tissues [6]. 
 
1.2.4 Analysing T-cell subsets by flow cytometry 
During the defence against pathogens, an immune response is elicited, resulting in expansion of 
pathogen-specific T cells that are equipped with a specialized set of effector functions, 
transcription factors, cytokine- and chemokine receptors. CD4 T cells can be divided into 
multiple lineages including Th1, Th2, Th9, Th17, Th22, Treg and Tfh cells. Recent results 
suggest that the generated specialized CD4 T subsets are not separate lineages but a 
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continuum of mixed functional capacities [7]. Also for CD8 T cells Tc1, Tc2, Tc9 and Tc17 cells 
are described [8]. However, as Tc1 cells are the primarily generated CD8 T-cell type in most 
used murine infection models, it is more common to distinguish between CM, EM and Trm CD8 
T cells. Here, we will describe how to use flow cytometry to distinguish CD4 and CD8 T-cell 
subsets based on transcription factors, chemokine receptors and effector molecules.  
 
1.2.5 T-cell subsets in flow cytometry – transcription factors 
Each CD4 T-cell subset expresses its own master transcription factor, which controls the 
expression of downstream effector molecules that are essential for their function. The first Th 
subsets described were Th1 and Th2 cells [9]. Th1 cells are vital in the defence against viral 
infections, while Th2 cells protect against parasitic infections, but also mediate much of the 
pathology associated with allergic reactions. Th1 cells are primed via the production of the 
cytokines IL-12 [10] and IFNγ [11], resulting in expression of their master transcription factor T-
bet [12]. Th2 cells, primed by IL-4 production [13, 14], are regulated by the master transcription 
factor GATA-3 [15]. Th17 cells are a more recently described subset of Th cells. They were 
originally described in mice as being pathogenic in murine models of autoimmune disease [16, 
17], but they have also been shown to be protective against certain pathogens including fungal 
infections [18]. Their master transcription factor is RORγt [19], and the subset was named Th17 
due to expression of the inflammatory cytokine IL-17 [20]. Th9 and Th22 cells are relatively 
newly described subsets of CD4 Th cells which produce IL-9 or IL-22 respectively. Th22 cells 
are regulated by expression of the transcription factor Ahr [21], while Th9 cells do not appear to 
be regulated by an individual transcription factor, but rather a combination of factors such as 
IRF4 and PU.1 [21, 22]. Follicular T helper cells (Tfh) and their cross-talk with B cells stimulate 
the production of high affinity antibodies in germinal centre reactions. Tfh cells are controlled by 
the transcription factor Bcl6 [23] and express surface markers such as ICOS to interact with B 
cells. Finally, a regulatory subset of Th cells exists which are necessary to keep inflammatory 
processes in check. These cells are known as regulatory T cells (Treg) and are regulated by 
their transcription factor FoxP3 and expression the IL-2Ra chain, CD25, which is normally 
upregulated on T cells after activation [24, 25].  
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The majority of antigen experienced CD8 T cells in experimental murine models are of Tc1 type. 
The effector/ memory differentiation of CD8 T cells is coordinated by a network of transcription 
factors and favour either effector differentiation (Tbet, ID2, BLIMP1) or memory differentiation 
(EOMES, BCL-6, ID3) [26]. Additionally, Blimp and Hobit (homolog of Blimp1 in T cells) mediate 
the development of Trm [27]. 
Staining of transcription factors for flow cytometry has been made possible through the 
production of staining buffers which efficiently permeabilize the nucleus of cells (Figure 3). The 
fixation and permeabilization prevents further functional assays. Functional assays based on 
transcription factor expression have become available through the development of transgenic 
fluorescent reporter mice. 
1.2.6 T-cell subsets in flow cytometry – effector function and expression of chemokine receptors  
During their primary activation, T cells start to express chemokine receptors, surface molecules 
and secrete cytokines that are necessary for their effector function (Figure 3, 4).  
CD4 T cells characteristically express the co-stimulatory molecule CD40L after activation [28], 
which is crucial for most of their helper functions [29, 30]. The classical effector cytokine 
produced by Th1 cells is IFNγ [9], which is vital in the defence against viral and intracellular 
bacterial pathogens. Th1 cells also express key effector molecules which are directly 
downstream of T-bet expression, such as the chemokine receptor CXCR3 [31] (Figure 3) which 
is thought to help to guide these cells into inflamed tissues, where they fight against infection. 
Th2 cells produce IL-4, IL-5 and IL-13 and express the chemokine receptor CCR4, which helps 
them to migrate out of the blood and into tissues such as the skin to mediate their actions [32]. 
Th17 cells, as their name suggests, produce IL-17 and express the chemokine receptor CCR6 
[33]. While these cells can be pathogenic when activated against self-antigens, they also 
provide protection against fungal infections. In addition to the cell contact mediated actions of 
Tfh, these cells also produce cytokines including IL-21 to help mediate B-cell activation in 
germinal centre immune responses. Moreover, the expression of the chemokine receptor 
CXCR5 is vital in the positioning of Tfh out of the T-cell zone and into B-cell follicles which 
allows their interaction with activated B cells [34] (Figure 3).  
Antigen experienced CD8 T cells largely have the capacity to produce IFNg and/ or TNFa and in 
this respect mainly overlap with Th1 cells. Next to the direct effect of these cytokines on the 
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target cells, they also support the recruitment of other immune cells. A subset of CD8 T cells is 
able to perform CD40L-mediated helper like functions [35], however the development of 
cytotoxic functions and the directed killing of infected or malignant cells is the main effector 
function of the majority of activated CD8 T cells. The cytotoxic function of CD8 T cells is typically 
achieved via the release of cytotoxic granules containing Granzymes and Perforin, or via 
expression of FasL, which can induce apoptosis of Fas expressing cells.  
The production of these effector molecules by T cells can be analysed in a number of ways. 
Generally, T cells are stimulated in vitro by polyclonal (PMA/Iono, aCD3) or antigen specific 
stimulation (pathogen lysates, proteins, peptides). Cells are treated with protein transport 
inhibitors such as brefeldin A or monensin during the stimulation period to allow accumulation of 
cytokines and surface molecules like CD40L within the cell. As these inhibitors are toxic, it is 
important to limit the time of cell exposure. Typically 4-6 hours are used. For CD8 T cells, 
degranulation is an important effector function. When cytotoxic granules are released towards 
the target cell surface, lysosomal markers like CD107a/b become detectable at the cell surface. 
As extracellular expression of CD107a/b is transient during degranulation due to recycling of the 
granules, staining for CD107a has to be performed during T-cell stimulation. T cells also contain 
pre-stored effector proteins, such as the cytotoxic molecules Granzymes and Perforin that are 
produced by effector CD8 T cells and can be detected by intracellular staining without the need 
for stimulation. Additionally, in vitro or in vivo killing assays with fluorescently labelled and 
peptide loaded target cells are used to assess the antigen specific CD8 T-cell response and 
their cytotoxic potential. 
The detection of effector functions by flow cytometry can be used to gain information about the 
properties of specific T-cell subsets, but it is also utilized to enumerate antigen-specific T-cell 
responses. For this purpose, effector functions that are present in the majority of the T cells 
after antigen-specific activation with protein or peptides are used, such as CD40L expression for 
CD4 T cells and IFNg expression or degranulation via CD107a for CD8 T cells in infections. 
1.2.7 Conclusions 
Although mice might not represent humans on all levels, the use of inbred mice with predefined 
HLA molecules, experimental immunisation/ infection with defined antigens, the possibility for 
genetic, in vitro and in vivo manipulation of cells and the easier access to tissues other than 
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peripheral blood enables us to answer many T-cell biological questions. Mice with defined 
microbiota or mice exposed to a broader range of natural pathogens might complement the 
knowledge build on SPF mice. Due to the vast amount of cell biological and flow cytometrical 
tools for the analysis of T-cell responses, the analysis of experimental murine models will 
continue to be instrumental to unravel basic principles and functional mechanisms of T-cell 
biology. 
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Figure legends 
Figure 1 Gating on CD4 and CD8 T cells 
Lymphocytes are identified based on their forward (FSC) and side (SSC) scatter. Single cells 
are discriminated from doublets by plotting the pulse width and height against each other for the 
FSC. In order to exclude non-specific binding of antibodies by dead cells, non-viable cells are 
excluded using a viability dye and live CD3+ stained cells are gated on. The majority of CD3+ T 
cells should either be CD4 or CD8 single positive, however, depending on the organ analysed, 
there may be either double positive or double negative cells. 
Figure 2 Discriminating naive, effector and memory T cells 
Naive T cells can be distinguished from activated and memory T cells based on their low 
expression of CD44 and high expression of CD62L. In this example, live CD8+CD3+ T cells 
have been gated on and antigen specific T cells can be further distinguished from endogenous 
T cells using tetramer staining. The majority of CD8 T cells during the effector phase of an 
immune response typically upregulate CD44 and downregulate CD62L. In the memory phase of 
an immune response, T cells retain high expression of CD44 and can be either CD62L positive 
or negative. 
Figure 3 Using transcription factors or chemokine receptors to identify CD4 subsets 
Subsets of CD4 T cells can be identified based on their expression of master transcription 
factors. Surface markers such as CD4, CD3 and viability dyes are typically stained on the 
surface before washing, fixing and permeabilizing the cells to allow the transcription factor 
antibodies to bind in the nucleus. Th1 cells are identified by expression of T-bet, Th17 cells by 
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RORgt, Treg cells by FoxP3 and Tfh cells by Bcl6 expression. Chemokine receptor staining can 
also be used to distinguish CD4 Th subsets. Examples shown include Th1 cells which express 
the chemokine receptor CXCR3 and Tfh cells which express CXCR5.  
Figure 4 Effector molecules produced by T cells 
T-cell subsets produce cytokines according to the subset to which they have been polarized 
towards. To analyse production of cytokines in vitro, cells are restimulated with either antigen or 
with PMA and ionomycin, together with brefeldin A. Th1 cells produce IFNγ, Th2 cells produce 
IL-4 and Th17 cells produce IL-17. Antigen specific CD8 T cells at the effector and memory 
phase after infection can also be identified based on their cytokine expression, in these 
examples, IFNγ, TNFα, IL-2 and CD107a are used. 
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Section 2 - B cells and their subsets 
 
B cells represent the antibody-producing cells developing from naïve B cells to antibody-
secreting plasma cells. The stages of B-cell development share a lot of common features 
between the human and rodent immune system. In this section, we focus on human B cells and 
their peripheral subpopulations but most of the markers are also applicable for the murine 
system, in particular.  
 
After PBMC preparation or lysing whole blood, lymphocytes should be gated according to their 
scatter properties and by exclusion of doublets and dead cells from the analysis (Figure 1 A, B). 
In order to detect plasma cells simultaneously, the initial FSC/SSC gating should be larger and 
not limited to a conventional lymphocyte gate [1].  
To identify B cells among the remaining cells, the B-cell specific markers CD19 and/or CD20 
serve as specific surface markers (Fig 1). CD19 is a B-cell surface molecule expressed at the 
time of immunoglobulin heavy chain rearrangement [2], CD20 is expressed by all mature B cells 
beyond the pro B-cell stage in the bone marrow and disappears on the surface of mature 
plasma cells [3, 4]. For further discrimination of developmental stages in B-cell maturation, 
combinations of additional markers such as CD27, CD38, CD23, CD77 and expression of 
surface immunoglobulins are used (Table 1). Immature CD19+ B cells in the bone marrow 
express high levels of CD38 and variable levels of CD20 and IgM, which increase with their 
further differentiation [5]. CD38++ CD20++ immature B cells express IgM and IgD, leave the bone 
marrow and become CD38++ CD24++ CD10+ transitional B cells [5]. Naïve B cells express IgM 
and IgD and are CD27- and CD38-, they comprise about 60% of B cells in the peripheral blood 
[6, 7]. After antigen encounter and T-cell help, memory B cells and antibody-secreting plasma 
cells are generated in the germinal center reaction. Human memory B cells can be identified by 
the expression of CD27 and carrying mutated immunoglobulin VDJ gene rearrangements [6, 8]. 
In the peripheral blood, between 30 and 40 % of circulating B cells express CD27 [6, 9]. Plasma 
cells carry distinct FSC and SSC characteristics, express high levels of CD27 and lack the 
expression of CD20 but are also highly positive for CD38 and partially CD138++ [1]. A CD19- PC 
population is uniquely enriched in the bone marrow [10]. 
When gating on B cells using CD19, CD3+ T cells and CD14+ monocytes need to be excluded. If 
these cells are not of further interest, one can assign them in a so called “dump channel” with 
CD3 and CD14 mAbs together with other markers for cells that should be excluded from 
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subsequent analyses, e.g. CD16 mAb/CD56 mAb for NK cells. One approach frequently taken 
is to gate on CD3- CD14- 4′,6-Diamidin-2-phenylindol (DAPI)- cells (Fig 1 C) and, in a 
subsequent step, on CD19+ and CD20+/- cells (Fig 1 D). This gating permits a reliable 
identification of CD20+ B cells and additionally of CD20low plasmablasts.  
For the analysis of B-cell subsets, a classical combination using CD27 and CD20 of CD19+ B 
cells has been established. Using CD27, a number of B-cell subsets can be identified 
independent of the expressed Ig subclasses. As a result, CD27- CD20+ naïve B cells, CD27+ 
CD20+ memory B cells (mBCs) and CD27++ CD20low plasmablasts (PBs) can be identified (Fig 1 
E). While the distribution of these subsets can vary between different diseases with slight 
variations [11], it has been demonstrated that CD27 can serve as a reliable marker for human 
healthy controls memory B cells, since CD27-expressing B cells differentiate timely into 
antibody-secreting cells after stimulation and carry somatic mutations in their immunoglobulin V 
regions [6, 8].  
An alternative staining protocol of CD20+/CD19+ B cells has applied co-staining of CD38 and 
IgD together with CD77 and CD23 to mark differentiation stages of B cells in human tonsils [12]. 
CD23 is a Fcε receptor and associated with activation of B cells. It was found to be co-
expressed with IgM and IgD in the tonsil and in peripheral blood but not with IgA and IgG and 
hence is lost during isotype class-switching [13]. CD77 is strongly expressed by germinal center 
B cells and can be used to differentiate centroblasts from centrocytes [12, 14]. In this protocol, 
naive IgD+ CD38- B cells are separated by CD23 into Bm1 (CD23-) and Bm2 (CD23+) B cells. 
IgD- CD38+ germinal center B cells can be further discriminated into CD77+ centroblasts (Bm3) 
and CD77- centrocytes (Bm4). IgD- CD38- B cells comprise the memory compartment (Bm5). 
The expression of IgD could be used as marker to further discriminate certain naïve and 
memory B-cell populations (Fig 2). CD19+ CD20+ B cells can be separated in a CD27 versus 
IgD dot plot (Fig 2A). In this regard, naïve B cells express IgD and are CD27-. Further quadrants 
represent different subsets of memory B cells: in detail, CD27+ IgD+ are memory B cells which 
mostly express high levels of IgM and carry somatic mutations of their V(D)J rearrangements, 
whereas CD27+ IgD- memory B cells are class-switched and also carry somatic mutations [6]. 
Interestingly, the CD27- IgD- B-cell subset appears to be very heterogeneous. It has been 
shown that it contains a memory B-cell subset expressing CD95 with an activated phenotype 
(Fig 2 B), which is especially enhanced in patients with systemic lupus erythematosus and 
correlated with disease activity and serologic abnormalities, whereas healthy donors only show 
minor frequencies of CD95+ cells [15]. Among other disturbances, B cells lacking expression of 
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the complement receptor CD21, which is part of a signaling complex, together with CD19 have 
been reported to be expanded in patients with SLE [16, 17]. 
 
Figure legends 
Figure 3. Gating strategy for the identification of B cells. (A) Lymphocytes are identified by 
their scatter properties. (B) Exclusion of doublets. (C) Cells positive for markers in the “dump 
channel„ and DAPI stained dead cells are excluded. (D) B cells are identified by their expression 
of CD19 and CD20 including CD20low plasmablasts. (E) B-cell subsets are discriminated by 
CD27 and CD20: naive B cells are CD27- CD20+; memory B cells CD27+ CD20+ and 
plasmablasts CD27++ and CD20low. 
Figure 2 B-cell subsets. A) Further B-cell subsets can be discriminated by the expression of 
IgD together with CD27. IgD+ CD27- cells are the naive B cells (Q3). The CD27-expressing 
subsets are different types of memory B cells: the IgD+ CD27+ cells are non-switched memory B 
cells (Q2) and the IgD- CD27+ cells are switched memory B cells (Q1). The double-negative 
(IgD- CD27- B cells is heterogeneous and also contains memory B cells. B) CD95 expression in 
B cells of a healthy donor. Quadrant Q6 shows activated CD27+ CD95+ memory B cells and Q7 
activated CD27- CD95+ naive B cells. 
 
Table 1 Phenotypic differentiation of B lineage cell subsets based on their characteristic 
expression of surface markers*. 
*Footnote: intracellular expression of the spleen tyrosine kinase Syk represents a intracellular 
expressed protein, while the expression of the ABCB1 transporter is required to excrete mito 
tracker orange (MTO) which serves a functional discrimination of naïve and memory subsets. 
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Section 3 - Antibody-secreting cells (plasmablasts and plasma cells) 
 
 Antibody-secreting cells (ASCs) in humans and rodents are terminally differentiated B 
cells [1] and can be characterized by the intracellular staining of immunoglobulins (Igs). After the 
fixation of cells to permeabilize the cell membrane, plasma cells can be further analyzed 
according to the isotype [2, 3] or the antigen-specificity of the antibody they generate and 
secrete [4, 5]. The intracellular staining of Igs is considered as gold standard for the detection of 
ASCs. No surface marker uniquely specific for plasma cells currently exists. Surface markers 
that are often used to identify plasma cells, such as CD38 and CD138, are also expressed on 
other B-cell lineage and non-B-cell lineage cells. In mice, CD138 staining is frequently used for 
analyzing splenic ASC, while intracellular Ig staining is required for the detection of bone 
marrow ASC since other B-cell subpopulation express CD138. In addition to the isotype that 
ASC secrete the antibody reactivity of the cells can be detected by staining with the labeled 
antigen (Figure 1). In humans, circulating ASC can be analyzed as CD20-/CD19+/CD27bright 
cells (Figure 2) [2] or CD19+/CD27bright/CD38bright cells [6]. An expansion of circulating 
plasmablasts was identified in patients with active autoimmune diseases such systemic lupus 
erythematosus [2, 7] and Takayasu arteritis [8]. The secondary immunization e.g. with tetanus 
toxoid leads to an increase of circulating plasmablasts as well. In contrast, the appearance of 
these tetanus specific plasmablasts (enumerated by intracellular staining with a recombinant C 
fragment of the tetanus toxin conjugated with digoxigenin) in the peripheral blood is subject to a 
time limit on days 6 and 7 after the immunization [5]. Very recently, a lamprey monoclonal 
antibody reacting with a unique epitope of the CD38 ectoenzyme seems to be highly specific for 
ASCs. The antibody recognizes ASCs in tonsils, spleen, bone marrow and peripheral blood 
from healthy individuals and on most multiple myelomas [9].  
A staining pattern consisting of CD20low/CD138+/CD31+ was recently described; it detects 
bone marrow ASC in rhesus macaques, a model, which is frequently used for the evaluation of 
human vaccines. This panel also stains human bone marrow ASCs [10].  
It has become an important issue to distinguish between newly generated plasmablasts and 
mature plasma cells. Plasmablasts are proliferating cells that are able to migrate towards a 
chemokine gradient to the bone marrow and inflamed tissues, where they become mature and 
may get long-lived plasma cells. Although the chemokine receptors CXCR3 and CXCR4 are 
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expressed on all ASC only the plasmablasts have the migratory capability [1]. In preclinical mice 
models the incorporation of the nucleotide analogue BrdU (bromodeoxyuridine, administered via 
drinking water) into the DNA of proliferating plasmablasts allows, together with a plasma cell 
marker, the clear differentiation between BrdU positive plasmablasts and BrdU  negative long-
lived plasma cells (Figure 1)[4, 11]. As an alternative to BrdU, EdU (5-ethynyl-2'-deoxyuridine) 
can be used (see Chapter VII, section 7: DNA synthesis, cell cycle and proliferation) [12]. Since 
the incorporation of nucleotide analogues is not possible in studies of human cells, markers 
indicative of plasmablasts and long-lived plasma cells, such as MHC class II molecules and Ki-
67 can be used. It was demonstrated that plasmablasts express more MHC class II molecules 
on their surface [4]. MHC class II expression was therefore used to distinguish between 
circulating plasmablasts and mature plasma cells in SLE patients (Figure 2)[7]. Another option is 
the nuclear staining of the proliferation marker Ki-67 in plasmablasts [13]. 
Recently, it was shown that bone marrow plasma cells are more heterogeneous than thought. In 
bone marrow there is a CD19-negative plasma cell population expressing intracellular IgG, and 
its characterization suggests that it represents the real long-lived plasma cells contributing to the 
humoral memory [3, 14].  
Figurelegends 
Figure 1  
Flow cytometric analysis of murine ASC derived from spleen and bone marrow. A) ASC were 
detected by surface staining of CD138 and intracellular staining of kappa. ASC were further 
characterized by surface expression of MHC class II and intranuclear BrdU, which was 
incorporated into the DNA of proliferating cells after administration via the drinking water. Non-
proliferating BrdU low ASC express less MHC class II, which characterizes long-lived plasma 
cells while proliferating BrdU high and MHC class II high cells indicate newly generated 
plasmablasts. The intracellular staining of IgG and IgM allows the differentiation of ASC with 
regard to the antibody isotype that they generate. The cells were derived from a NZB/W F1 
mouse that represents a model of lupus. B) Identification of ASC in an antigen-specific manner 
in Balb/c mice three days after a booster immunization with ovalbumin (OVA). Anti-OVA ASC 
were enumerated by intracellular staining with OVA conjugated with FITC. Almost all splenic 
anti-OVA are BrdU positive proliferating plasmablasts three days after secondary immunization 
with OVA. The majority of bone marrow ASC including these with intracellular OVA staining 
does not express BrdU characterizing them as long-lived plasma cells.  
Figure 2:  
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Flow cytometric analysis of circulating peripheral blood ASC derived from an active SLE patient. 
PBMCs were gated for CD19+ cells excluding CD3+/CD14+/CD16+ cells. ASC highly express 
CD27 and are negative for CD20. The majority of ASC express HLA-DR, which characcterises 
newly generated plasmablasts. PBMCs: peripheral blood mononuclear cells, mB: memory B 
cells, nB: naive B cells. 
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Section 4 – Innate Lymphoid cells 
 
During the past years, an emerging family of CD45+ innate lymphoid cells (ILCs) has been 
described.  CD45+ ILCs lack rearranged antigen receptors as well as lineage (Lin) markers 
typically expressed on T cells, B cells or dendritic cells (DCs) [1]. The ILC family includes 
previously identified innate lymphocytes, such as natural killer (NK) cells, and novel cell 
populations, namely ILC1, ILC2 and ILC3, classified according to the expression of surface 
markers, transcription factors and effector cytokines, in analogy to the CD4+ T helper (Th) 
subsets Th1, Th2 and Th17 [1, 2]. NK cells and ILC1 (also named group 1 ILCs) express NKp46 
(or also NK1.1 in B6 mice) and the T-box transcription factor T-bet (Tbx21); group 1 ILCs 
produce IFN- in response to IL-12+IL-18 or activating receptor engagement, thus contributing to 
the response against viruses and intracellular pathogens [3-6]. ILC2 express GATA binding 
protein-3 (GATA3), produce IL-13 and IL-5 in response to IL-25, IL-33, and Thymic stromal 
lymphopoietin (TSLP) and contribute to the defense against helminthic infections as well as to 
the pathogenesis of allergic inflammation [7]. ILC3 express retinoic acid receptor (RAR)-related 
orphan receptor RORt, and produce IL-17 and/or IL-22 in response to IL-1 and IL-23 or 
activating receptor engagement. ILC3 include fetal lymphoid tissue-inducer (LTi) cells and post-
natally expanding ILC3; LTi are required for the prenatal development of lymph nodes and 
Peyer’s patches, while ILC3 contribute after birth to defense against extracellular pathogens, 
containment of commensals, epithelial tissue homeostasis and regulation of inflammatory 
disorders, such as inflammatory bowel disease (IBD) and psoriasis [8]. 
NK cells have been largely investigated in mouse spleen and human peripheral blood (PB), 
where they mainly represent circulating lymphocytes. Splenic circulating mouse NK cells are 
defined as CD3- CD19- NK1.1+ DX5 (CD49b)+ and are characterized, in addition to T-bet and 
IFN- production, by cytotoxic capacity and expression of Eomesodermin (Eomes) (Figure 1) [6, 
9]. Instead of NK1.1, which is not expressed in all mouse strains, staining of NKp46 can be 
used. Among splenic NK cells, expression of CD27 and CD11b defines distinct stages of 
maturation, with CD27- CD11b+ cells being the more mature subset (Figure 1) [10-12].  
In humans, circulating PB-NK cells are defined as Lin- CD56+ cells expressing T-bet and Eomes 
(Figure 2). Human PB-NK cells can be distinguished according to the level of CD56 expression 
into CD56bright (CD16low) and CD56dim (CD16+) NK cells [13] and further dissected according to 
the expression of CD57 (Figure 2) (or CD62L) into distinct maturation stages, being CD57+ 
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(CD62L-) NK cells more terminally differentiated [14-16]. Further characterization of NK cells is 
described in chapter VIII section 5 “Natural killer (NK) cells”. 
In addition to circulating NK cells, several ILC populations have been identified [5, 6, 17-29], 
which are largely tissue resident [6, 30]. In mouse small intestinal (SI) lamina propria (LP), all 
ILCs, namely NK cells, ILC1, ILC2 and ILC3 could be described [5, 31]. In Figure 3 a gating 
strategy for murine ILCs derived from SI LP is shown; however, it should be stressed that ILC 
populations are not equally distributed in all organs and display some tissue-specific phenotypic 
differences. Combination of intranuclear staining of master transcription factors, namely T-bet 
(expressed on ILC1, NK cells and a subset of murine ILC3), Eomes (NK cells), RORt (ILC3) 
and GATA3 (ILC2) together with NKp46 and CD127 (IL-7R) (Figure 3) or CD90 (not shown) 
enables identification of ILC subsets in all organs analyzed. Among SI LP CD45+ Lin- cells, 
NKp46 (or NK1.1) can be expressed not only on NK cells but also on ILC1 and a subset of ILC3. 
Thus staining of transcription factors is helpful to dissect their identity. It has been proposed that 
SI LP NK cells can be defined as NKp46+ RORt- T-bet+ Eomes+ cells, while ILC1 are 
NKp46+RORt- T-bet+ Eomes- cells [5] (Figure 3). However, a population of cytotoxic NKp46+ 
RORt- T-bet+ Eomes+ intraepithelial ILC1 has been also described [28]. Moreover, the analysis 
of NK cells/ILC1 in different mouse compartments revealed a high degree of phenotypic and 
functional complexity [6, 9], suggesting that distinction between ILC1 and NK cells might be 
more challenging.  
ILC2 and ILC3 are enriched among SI LP CD45+ Lin- CD127+ lymphocytes and can be identified 
after intranuclear staining of GATA3 and RORt as GATA3hi RORt- ILC2 and of GATA3lo 
RORt+ ILC3 (Figure 3) [31, 32]. Surface markers such as ST2 (IL-33R), CD25, ICOS or KLRG1 
have also been commonly used to identify ILC2 [24, 25, 31]. As previously mentioned, 
expression of these markers slightly varies in different compartments. 
SI LP RORt+ ILC3 can be dissected into three major subsets according to NKp46 and CD4 
expression (Figure 3), namely CD4+ ILC3, which functionally and phenotypically resemble fetal 
LTi and preferentially produce IL-17 and IL-22; NKp46+ ILC3, which expand post-natally, co-
express RORt and T-bet and produce IL-22 and IFN-; and CD4- NKp46- ILC3, which actually 
represent a heterogeneous population of CCR6+ cells (related to LTi) and CCR6- ILC3, co-
expressing RORt and T-bet, similar to NKp46+ ILC3 [33-35]. As it has been shown that ILC3 
can be plastic in vivo, and down-regulate RORt expression while acquiring ILC1/NK-cell 
features such as T-bet expression and IFN- production, the use of RORt fate mapping 
(RORtfm) can be helpful to distinguish ex-ILC3 (RORtfm+ RORt- T-bet+) from ILC1 [35, 36]. 
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Although this distinction is conceptually important, ex-ILC3 functionally behave similar to 
ILC1/NK cells.  
In humans, ILCs have been documented in several tissues (and more recently also in PB), 
although the most extensive characterization has been performed in tonsils, where all ILC 
subsets have been described [18, 27-29, 37-39]. In tonsils, magnetic depletion of CD3+ T cells 
and of CD19+ B cells is recommended for better detection of ILCs, due to their low frequency. 
After pre-enrichment and further gating on Lineage negative cells, staining of CD94 and CD127 
enables the identification of NK cells, as CD94+/lo CD127neg/lo CD56+ cells, which express high 
levels of T-bet and Eomes, and of other ILCs enriched among Lin- CD127hi CD94- cells (Figure 
4).  
It has been proposed that staining of CD117 (the receptor for stem cell factor, c-kit) and CRTH2 
(prostaglandin D2 receptor chemoattractant receptor-homologous molecule expressed on T 
helper type 2 cells) facilitates identification of ILC3 and ILC2 in tonsils. ILC3 are enriched among 
CD117+ CRTH2- cells and express RORt, while lacking T-bet and Eomes [19, 29]. ILC2 are 
enriched among CD117-/lo CRTH2+ cells and express GATA-3, while lacking T-bet and Eomes 
(Figure 4) [27, 29]. Among Lin- CD127hi CD94- CD117- CRTH2- cells, a population of ILC1 has 
been described which lacks NKp44 and CD56 and is enriched in the SI LP of patients affected 
with inflammatory bowel diseases [29]. This population displays only low amount of T-bet protein 
expression (Figure 4). In line with mouse data, additional populations of NK cells/ILC1 subsets 
with different phenotypic characteristics have been described in human tissues, including tonsils 
[28, 38, 40-42], making the selection of markers for the identification of NK cells/ILC1 quite 
challenging.  
Notably, the resolution of transcription factor staining in humans is not as good as in murine 
tissues and, therefore, combined staining of the above mentioned surface markers is highly 
recommended in order to reliably gate on different human ILC subsets. However, as for their 
murine ILC counterparts, tissue-specific differences of surface markers should be taken into 
account, as it has been shown for expression of CRTH2 for lung ILC2 [39]. A selection of 
additional markers shown to be expressed by human and/or mouse ILC subsets is depicted in 
Table 1.  
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4.1 Materials and Methods Section 4 – Innate Lymphoid cell: 
Cell isolation: Written informed consent was obtained from all patients prior to sample acquisition 
and experiments have been approved by the Ethics Committee of the Charité Medical 
University, Berlin (EA2-078-16, EA1/149/1). Human peripheral blood mononuclear cells were 
isolated from buffy coats by density gradient centrifugation using Ficoll-Paque PLUS (GE 
Healthcare). Mononuclear cells (MCs) from human tonsils were isolated from patients 
undergoing tonsillectomy as previously described [43]. After density gradient centrifugation using 
Ficoll-Paque PLUS, ILCs were enriched by using magnetic cell depletion of CD3+ T cells with 
CD3 microbeads and LD columns (Miltenyi) according to the manufacturer’s instructions. For 
isolation of murine circulating splenic MCs, spleen was mashed through a 70 µM strainer in the 
presence of PBS/BSA. Cell suspension was centrifuged for 10 min at 350g, supernatant was 
aspirated and erythrocytes were lysed. For isolation of murine SI LP MCs a previously described 
protocol was used [44]: Residual fat tissue, Peyer’s Patches and feces were removed, and the 
intestine was cut open longitudinal and washed with PBS. After clearing, tissue was cut into 
pieces of 1 cm length and digested with a lamina propria dissociation kit (Miltenyi), according to 
the manufacturer’s instructions. Lymphocytes were further enriched on a 40%/80% Percoll 
gradient. 
Flow cytometry: Phenotypic analysis of human lymphocytes was performed using the following 
antibodies reactive to human surface or intracellular antigens: eFluor780 Fixable Viability Dye, 
APC-eFluor780 CD14 mAb (61D3), CD19 mAb (HIB19), CD3 mAb (SK7),CD123 mAb (6H6), 
eFluor660 anti-Eomes (WD1928), PE anti-T-bet (eBio4B10) or anti-GATA-3 (TWAJ), PE-Cy7 
anti-T-bet (eBio4B10),  APC anti-RORt (AFKJS-9) (eBioscience);  APC -Vio770 CD141 mAb 
(AD5-14H12), anti-FcεRIα (CRA1), and CD11c mAb (MJ4-27G12), Fitc CD127 mAb (MB15-
18C9), PE-Dazzle594 CD56 mAb (HCD56), PE-Vio770 NKp44 (2.29) (Miltenyi Biotec); Zombie 
Aqua Fixable Viability Dye, BV605 CD117 mAb (104D2), PerCP-Cy 5.5 anti-CRTH2 (BM16),  
BV510 CD14 mAb (M5E2), and CD19 mAb (HIB19), PE-Cy5 CD3 mAb (UCHT1), PE-Dazzle594 
CD56 mAb (HCD56), Pacific Blue CD57 mAb (HCD57) (BioLegend); Pacific Blue CD94 mAb 
(XA185) (conjugated in house).  
Phenotypic analysis of murine lymphocytes was performed using the following antibodies 
reactive to murine surface or intracellular antigens: eFluor780 Fixable Viability Dye, APC-
eFluor780 anti-FcεRIα (MAR-1), PerCP-Cy5.5 anti-TCR (H57-597), PerCP-eFluor710 anti-
TCR (GL-3), eFluor660 anti-T-bet (4B10), Alexa488 anti-Eomes (Dan11mag) (eBioscience); 
APC-Vio770 anti-B220 (RA3-6B2), PE anti-GATA3 (REA174) (Miltenyi);  APC-Cy7 CD11b mAb 
(M1/70), CD11c mAb (N418), anti-Gr-1 (RB6-8C5), anti-F4/80 (BM8), BV785 CD127 mAb 
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(A7R34), BV605 anti-KLRG1 (2F1/KLRG1), BV711 CD4 mAb (RM4-5), PE-Cy7 anti-NKp46 
(29A1.4) ( BioLegend); V500 CD45 mAb (30F11) and BV421 anti-RORt (Q31-378) (BD); 
Alexa700 CD90 mAb (T24) (conjugated in house). 
Staining for transcription factors was performed using the Foxp3 Transcription factor staining 
buffer set (eBioscience) according to manufacturer’s instructions and cells were immediately 
analyzed. Flow cytometric analysis was performed by using BD LSRII or Fortessa employing 
FACSDiva Software (BD Biosciences), and data were analyzed by using FlowJo software (Tree 
Star). 
 
Figures Legends: 
 
Figure 1. Identification of murine circulating splenic NK cells. Representative gating 
strategy to identify circulating NK cells from the spleen of 6-week-old C57BL/6 mice. NK cells 
were gated as viable (LD-) CD19- CD3- NK1.1+ DX5+. Among NK1.1+ DX5+ NK cells expression 
of CD27 and CD11b defines different stages of NK cell maturation. Expression profile of the key 
transcription factors Eomes and T-bet in splenic NK1.1+ DX5+ NK cells is shown on the right.  
 
Figure 2. Identification of human circulating PB-NK cells. Representative gating strategy to 
identify human CD3- CD56bright, CD56dim CD57-, and CD56dim CD57+ NK cell populations after 
pre-gating on viable CD14- CD19- human PBMCs. Expression profile of the key transcription 
factors Eomes and T-bet in these NK cell subsets is shown on the right.  
 
Figure 3. Identification of murine SI LP ILCs. Representative gating strategy of ILCs derived 
from the small intestinal (SI) lamina propria LP of 6-week-old C57BL/6 mice. Mononuclear cells 
(MCs) were prepared as previously described [44]. Cells were gated as viable (LD-), B220- 
CD11c- Gr-1- F4/80- FcR1- (Lin-) CD45+ TCR- TCRδ- and either as NKp46+ (grey gate, A) T-
bet+ Eomes- ILC1, Eomes+ T-bet+ NK cells or as CD127+ (black gate, B) GATA3+ RORt- ILC2 
and RORt+ GATA3lo ILC3 which can be further separated according to NKp46 and CD4 
expression (B). 
 
Figure 4. Identification of human tonsil ILCs. Representative gating strategy (upper panel) 
and expression of transcription factors (lower panel) of human ILCs derived from tonsillectomy.  
After magnetic depletion of CD3+ cells, cells were gated as viable (LD-), CD3- CD14− CD19− 
FcεRIα− CD123− CD11c- BDCA3- (Lin-) and either CD94+/lo CD127-/lo CD56+ NK cells; CD94− 
CD127hi CD117+ CRTH2- ILC3; CD94− CD127hi CD117+/lo CRTH2+ ILC2; or CD94− CD127hi 
CD117- CRTH2- NKp44- CD56- ILC1. 
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Table 1: Selection of important markers for flow cytometry analysis of mouse and human ILC 
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Section 5 – Natural killer (NK) cells 
Natural killer (NK) cells were described over 40 years ago as cells capable of killing tumor cells 
without prior sensitization. They are lymphoid cells derived from hemopoietic stem cells (HSCs) 
[1] and belong to the innate immunity cell family. In contrast to T and B cells, NK cells do not 
express receptors encoded by rearranging genes and they play a major role in innate immunity 
as both effector and regulatory cells, participating in the first line of defence against pathogens 
and tumors. Notably, NK-cell-susceptible tumors are primarily those lacking or expressing 
insufficient amounts of MHC class I molecules (missing-self hypothesis) [2]. Another requirement 
for NK-cell-mediated tumor cell killing is the surface expression of a series of different stress-
induced structures [3]. The NK cell function appears to complement the cytolytic T cell-mediated 
MHC-I-dependent activity [4]. 
The recognition of MHC class-I is mediated by a family of receptors termed Killer Ig-like 
receptors (KIRs), by the NKG2A/CD94 heterodimer and by LIR-1 (CD85j). In particular, 
NKG2A/CD94, expressed early during the process of NK cell maturation, recognizes the non-
classical HLA-E molecule [5-6] while KIRs, expressed a later stages of NK cell maturation, 
recognize allelic determinants of HLA-A -B or -C [7,8]. Other non-HLA-related inhibitory 
receptors including Siglec7 (CD328), PD1 (CD279) and IRP60 (CD300a) may be expressed at 
the surface of NK cells (see Table 1). In most instances, the NK receptors that mediate their 
activation upon binding to target cells are non-HLA-specific and recognize cell stress-induced 
molecules. These receptors include NKp30, NKp44 and NKp46 (which constitute the natural 
cytotoxicity (NCR) family), NKp80, 2B4 (CD244) and NKG2D [9-11]. Of note, activating isoforms 
of KIRs also exist [12]. While inhibitory KIRs are characterized by immune-receptor tyrosine-
based inhibition motif (ITIM) domains in their long intracytoplasmic tail, the various activating 
receptors bear a short intracytoplasmic tail and are associated with signalling polypeptides 
containing immune-receptor tyrosine-based activating motifs (ITAM) domains [13]. 
Among peripheral NK cells, two major subsets have been identified on the basis of the cell 
surface density of CD56 molecules (neural cell adhesion molecule, N-CAM). CD56bright (CD3-
CD56++CD16-/+) represent approximately 10% of the circulating PB NK cells while they prevail in 
secondary lymphoid organs (liver, synovial fluid and decidua). CD56dim (CD3-CD56+/- CD16++) 
cells are largely predominant (~90%) in PB NK cells. They derive from CD56bright NK cells, as 
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revealed by different studies in vitro (differentiation from HSC) and in vivo after HSC 
transplantation [14,15]. 
5.1 CD56bright NK cells 
All CD56bright, in contrast to CD56dim, NK cells express both high (CD25) and intermediate 
(CD122/CD132) affinity IL-2 receptors and c-Kit (CD117), rendering them highly susceptible to 
IL-2–induced cell proliferation [16,17]. Moreover, CD56bright NK cells express high levels of both 
CD62L [18] and CXCR3 which, together with the surface expression of CCR7, dictates their 
preferential homing into secondary lymphoid organs [19-21]. Notably, although under resting 
conditions, CD56bright NK cells are poorly cytotoxic, they may acquire cytolytic activity 
comparable to that of CD56dim cells upon stimulation with cytokines, such as IL-2, IL-12, IL-15. 
While CD56bright NK cells express CD94/NKG2A (i.e. the receptor for HLA-E) they lack KIRs. 
Regarding activating NK receptors, CD56bright cells express higher levels of NKp46 and NKp30 
than CD56dim cells, while CD56bright cells lack or express low amounts of CD16. 
5.2 CD56dim NK cells 
CD56dim NK cells under resting conditions express granules containing perforin and granzymes, 
and display cytolytic activity. Until recently, CD56dim NK cells were mainly associated with 
cytotoxicity while cytokine production was thought to be confined to the CD56bright subset. 
However, more recently, it has been shown that, upon stimulation via activating receptors, 
CD56dim NK cells rapidly release cytokines such as IFN-- and TNF- (even more efficiently than 
CD56bright cells) and chemokines such as MIP-1β and MIP-1α [22,23]. 
In contrast to CD56bright NK cells, the CD56dim population is phenotypically heterogeneous. Thus, 
as shown in Fig.1, NKG2A vs KIR expression allows three distinct subsets that recapitulate the 
consecutive steps of PB NK cell maturation to be distinguished. The “maturing” population 
(NKG2A+KIR-) is characterized by the NKG2A+/KIR- phenotype, similar to that of CD56bright cells, 
while the “mature” population expresses the NKG2A-KIR+ phenotype. An intermediate step of 
maturation is identified by the “double positive” NKG2A+KIR+ cells [24,25]. The unidirectional 
nature of NK cell differentiation is further supported by the presence of CD57 on the surface of 
the “terminally differentiated” NK subset. When compared with the CD57-negative counterpart, 
the NKG2A-KIR+CD57+ population shows a decreased surface expression of NKp30 and NKp46, 
and a reduced proliferative potential, possibly as the result of downmodulation of IL-2Rβ 
(CD122) and IL-18Rα (CD218a) [25,26]. 
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In CMV-positive healthy donors it is possible to find an additional subset of mature cells that 
expresses CD57 and the activating HLA-E-specific receptor NKG2C dimerizing with CD94 [27]. 
This subset appears to contain cells endowed with an adaptive/memory-like capability (i.e. clonal 
expansion, prompt response to restimulation and epigenetic modification including that of the 
intracytoplasmic FcεRγ chain) [28-30]. Recent data have shown that, in CMV positive 
individuals, a fraction of CD57 positive cells may also express PD-1 [31]. 
The recruitment of CD56dim NK cells to inflamed peripheral tissues is driven by several 
chemokines and homing receptors including, for example, CXCR1, CX3CR1 and in certain 
subsets CD62L and CXCR3low also [19]. 
5.3 NK cells present in decidua 
During the first trimester of pregnancy, NK cells represent the main lymphoid population (50-
70%) in human decidua where they bear a unique phenotypic and functional profile. Their 
phenotypic features resemble to an extent those of CD56bright PB NK cells; however, in addition 
to the NKG2AhighNKp30highNKp46high surface phenotype, they also display characteristics of 
CD56dim NK cells including high expression of KIR and lytic granules. Of note, in contrast to PB 
NK cells, the 2B4 (CD244) receptor on decidual NK cells displays a strong inhibitory (and not 
activating) activity, similar to that seen in NK cell precursors [32], that renders this population 
poorly cytolytic [33,34]. Moreover, in contrast to PB NK cells, decidual NK cells release a unique 
set of cytokines, including IL-8 (CXCL8), VEGF, CXCL12 (stromal-derived factor–1 (SDF-1)), 
and IFN-–inducing protein 10 (IP-10, CXCL10), that play a pivotal role in tissue remodelling (i.e. 
placenta development processes) and neo-angiogenesis [35]. 
5.4 NK cells present in lymph nodes 
In normal conditions, NK cells are present in lymph nodes where they occupy the T cell areas 
[35]. They are consistently CD56brightCD16negKIRneg and lack perforin and granzymes. In contrast 
to PB CD56bright NK cells, lymph node NK cells do not express CCR7 nor CD62L. Concerning 
the NCR family, lymph node NK cells express low levels of NKp46 and may lack NKp30. 
Remarkably, however, upon IL-2 activation, lymph node NK cells may express KIRs and CD16, 
and upregulate NCR [36,37]. 
5.5 Protocols and Stainings 
All the protocols described in Chapter VIII – Section 1 for T cells can be applied to the analysis 
of NK cells and NK cell characterization is also described in Chapter VIII – Section 4 Innate 
Lymphoid Cells. Regarding the effector function and expression of chemokine receptors, that 
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which is already described for T cells is also true for NK cells. Here we will suggest a series of 
conjugated monoclonal antibodies that are commonly used for the surface staining of NK cells. 
Beckman Coulter: CD3 APC-Alexa750 (UCHT1, IgG1) CD158a PE (EB6B, IgG1), CD158b PE 
(GL183), CD158e PE (Z27, IgG2a), CD159a PE-Cy7 (Z199 IgG2b), NKp30 (Z25, IgG1), NKp44 
(Z231, IgG1) NKp46 (BAB281, IgG1), NKp80 (MA152, IgG1) NKG2D (ON72, IgG1) 
Becton Dickinson: CD16 BV510 (3G8, IgG1), CD56 BV650 (NCAM16.2, IgG2b), CD57 BV421 
(NK-1, IgM), CD158b (CH-L, IgG2b) 
Miltenyi: PD1 PE (PD1.3.1.3, IgG1), NKG2C VioBright FITC (REA205, Ig1) 
R&D System: NKG2C Alexa700 (134591, IgG2a) 
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FIGURE 1 
NK cells can be first gated on the basis of their surface level of CD56 expression and lack of 
CD3. The CD56bright NK subpopulation is positive for NKG2A, negative for KIRs while CD16 can 
be either negative or dimly expressed (as shown). NKG2A and KIR surface expression allows 
three subpopulations of CD56dim NK cells, namely “maturing” (NKG2A+KIR-), “double positive” 
(NKG2A+KIR+) and “mature” (NKG2A-KIR+), to be identified. Among the mature population, 
CD57 molecule is expressed on the, so called, “terminally differentiated” NK cells. In CMV 
positive donors, a percentage of this latter population can also express NKG2C representing the 
so called “memory NK cells”. Recently it has been demonstrated that in CMV positive individuals 
a fraction of the NKG2C subset can also express PD1. 
 
Table 1 NK cell phenotypes 
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 Section 6 – Mononuclear Phagocytes 
 
6.1 Introduction 
Mononuclear phagocytes belong to the myeloid immune cell lineage and comprise 
monocytes, macrophages and dendritic cells (DCs), which collectively play critical, but 
distinct roles in tissue homeostasis and immunity. The 'mononuclear phagocyte concept' [1] 
was originally based on the assumption that the maintenance of tissue-resident 
macrophages and DCs relies on constant replenishment by blood monocytes. However, 
short-lived classical DCs (cDCs) are now known to originate from distinct DC-committed 
precursors that arise in the bone marrow (BM) [2],[3]. Adult tissue macrophage 
compartments, on the other hand, are established before birth and, with few notable 
exceptions, these cells subsequently maintain themselves through longevity and self-renewal 
[4],[5] - independent from monocytic input, as shown by fate mapping studies. According to 
their distinct ontogeny, monocytes, macrophages and cDCs can therefore be regarded as 
distinct cellular entities [6], despite the fact that these cells display considerable overlap with 
respect to phenotype and function (Figure 1). 
Monocytes are circulating in the blood and comprise in mammals two main subsets, which 
in mice have been defined as CX3CR1int CCR2+ CD62L+ CD43lo  Ly6Chi  and CXCR1high 
CCR2- CD62L- CD43hi Ly6Clo cells [7]. Monocytes develop in the BM from common monocyte 
precursors (cMOP) [8] that themselves derive from the monocyte/macrophage-DC 
precursors (MDP) [9],[10]. Murine Ly6Chi monocytes, and their human counterpart, classical 
CD14+ monocytes, are short-lived, and poised to home to sites of inflammation [11], where 
they can give rise to monocyte-derived DC (MoDC, also called 'inflammatory DC') or 
macrophages (Table 1). Murine Ly6Clo cells are in steady state progeny of Ly6Chi 
monocytes, display more extended half-lives [12] and are as 'patrolling' cells specialized in 
surveillance of vascular integrity [13]. 
Macrophages are strategically positioned throughout the body tissues, where they ingest 
and degrade dead cells, debris and foreign material, and orchestrate inflammatory processes 
[14]. Recent studies show that tissue macrophages form, aside from being immune sentinels, 
also integral components of their respective host tissue [5]. Distinct tissue macrophage 
compartments, such as brain microglia and liver Kupffer cells, develop locally and 
independently from each other. This entails their specialization in response to local 
environmental cues to contribute to the development and specific function of their tissue of 
residence. Factors that govern tissue macrophage specialization are emerging [5]. Moreover, 
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tissue specialization is prominently reflected in discrete gene expression profiles of 
macrophages, including selected surface markers (Table 1), as well as epigenetic signatures 
reporting actual and potential enhancer usage [15]. 
Dendritic cells have unrivaled potential to stimulate T cells and form a critical interface 
between innate and adaptive immunity [3]. As immune cell sentinels, cDCs are specialized in 
the sensing of pathogen challenges and cancer, translating the latter into peptide form for T 
cells. In addition, cDCs provide critical information on the original antigen context to trigger a 
diverse spectrum of appropriate protective responses and T-cell polarization. cDCs generally 
display a short half-life and are constantly replenished from dedicated BM precursors in a 
strictly Flt3L-dependent manner [2]. cDCs can be divided into functionally distinct subsets, 
including cells specialized for cross-presentation, which are characterized by expression of 
surface markers, such as XCR1 and the E7 integrin CD103, and a less well-defined 
population negative for these markers. Both sub-populations can be found in lymphoid 
tissue, including spleen, lymph nodes and BM, as well as most non-lymphoid tissue (Table 
1). 
 Given the limited availability of known robust surface markers and considerable 
overlap of their expression among mononuclear phagocytes, the phenotypic discrimination of 
these cells is challenging. The integrin CD11c for instance, was long considered specific for 
mouse DCs, but its expression is shared by macrophages in lung and gut, as well as Ly6Clo 
monocytes, and even certain lymphocytes [16]. Emerging unbiased approaches to the study 
of mononuclear phagocytes, including massive parallel single-cell RNA-seq (MARS-seq) 
[17], might help to molecularly define subsets and provide new markers that can be used in 
flow cytometry to allow future better definition of functional entities within this cellular 
compartment.  
 Below we provide guidelines for the flow cytometric analysis of mononuclear 
phagocyte populations of selected lymphoid and non-lymphoid tissues (i.e. spleen, gut, 
brain), as well as the blood. Collectively, these protocols highlight the fact that analysis of 
tissue resident mononuclear phagocytes requires protocols, which have been adjusted to the 
respective tissues, including extended digests, or cell fractionations prior to the flow 
cytometric analysis. Of note, classical fluorescence-based flow cytometric analysis of 
mononuclear phagocytes can be complemented by mass spectometry-based CyTOF 
analysis, (see Chapter I, Section 5, Mass cytometry), which allows for a considerable 
extension of simultaneously used parameters [18],[19].  
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For additional information on the ever-growing number of sub-populations of mononuclear 
phagocytes in specific we refer to http://www.immgen.org, [32] and  [33] (skin) and [34] 
(lung). For markers of the respective corresponding human cells we refer to the following 
recent review articles: [3],[33] 
 
6.2. Materials 
General reagents 
- Dulbecco's Phosphate Buffered Saline without calcium and magnesium (PBS -/-)  
- Dulbecco's Phosphate Buffered Saline with calcium and magnesium (PBS+/+) 
- Staining medium: PBS -/- with 2% heat-inactivated Fetal Calf/Bovine Serum (FCS/FBS) and 
1mM EDTA. 
- Delicate cell-strainer (80μm). 
- Flow cytometry tubes suitable for reading in the flow cytometry cell sorting machine of use 
(for example "Polystyrene Round Bottom Test Tube" 5ml, Cat# 352052, by BD Falcon). 
- All antibodies described in these protocols are available at Biolegend. 
 
General comments 
- Adult mice, such as C57BL/6, typically 6-10 weeks old are commonly used. 
- Antibodies should be tested and titrated to determine ideal conditions for staining.  
- Staining volume for the samples should be 20μl for up to 2 x 106 cells, 50μl for up to 5 x 106  
cells, etc. 
- Incubation with antibodies should be performed on 4oC (or on ice) in dark. In the majority of 
cases 10-20 minutes should be sufficient. 
- The volume of staining buffer, in which to suspend the cells before reading in the flow 
cytometry cell sorting machine varies according to cell numbers. Initially suspend 1 x 106 
cells 100μl of staining buffer and dilute if necessary. 
  
6.2.1. Staining of mouse blood monocytes 
1. Anti-coagulant such as Heparin (for example "Heparin sodium salt from porcine intestinal 
mucosa", Cat# H3393 by Sigma-Aldrich).  
2. Ficoll for isolation of lymphocytes and removal of erythrocytes by gradient (for example 
"Ficoll-Paque PLUS", Cat# 17-1440-03 by GE healthcare); alternatively, erythrocytes 
can be lysed using ACK buffer ( a solution of 0.15M NH4C, 0.01M KHC03 is made by 
dissolving of 8 g of NH4Cl and 1 g of KHC03 (Merck, Germany) in 1 liter of DDW. The 
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solution is then divided into 50 ml aliquots and stored at -20C). ACK treatment retains 
neutrophils, which are largely depleted using the Ficoll gradient. 
3. Staining antibodies (clones indicated within brackets): CD45 mAb (30-F11), CD11b mAb 
(M1/70), CD115/CSF-1R mAb (AF598), anti-Ly-6C (HK1.4). 
    
6.2.2. Staining of mouse intestinal macrophages and DCs 
1. [Recommended] Repeater pipette/dispenser (for example "Repeater M4" Cat# 
4982000322 by Eppendorf) and suitable tips (for example "Combitips Advanced" Cat# 
depends on pipette, by Eppendorf).  
2. Solution 1: 5ml/sample (up to 300gr of tissue) of Hanks' Balanced Salt Solution (HBSS) 
with 10% heat-inactivated FCS/FBS, 2.5mM EDTA and 1mM DTT (for example "DL-
Dithiothreitol (DTT)", Cat# D9779 by Sigma-Aldrich). Divide 5ml per 50ml tube. 
3. Solution 2: 5ml/sample of PBS +/+ with 5% heat-inactivated FCS/FBS, 1 mg/ml 
Collagenase VIII (for example "Collagenase type VIII", Cat# C2139 by Sigma) and 0.1 
mg/ml DNase I (for example "DNase I" Cat# 10104159001 by Roche). Divide 5ml per 
50ml tube. 
4. Cell strainers: crude (<100 μm) and delicate (80μm). 
5. Staining antibodies (clones indicated within brackets): CD45 mAb (30-F11), CD64/FcγRI 
mAb (X54-5/7.1), CD11c mAb (N418), CD103 mAb (2E7), CD11b mAb (M1/70), anti-Ly-
6C (HK1.4). Additional markers, which can be used: anti-F4/80 (BM8), ant-XCR1 (ZET), 
anti-Sirpα/CD172a (p84). 
 
6.2.3. Staining of mouse splenic DCs 
1. 1ml syringes. 
2. Collagenase D (for example "Collagenase D", Cat# 11088858001 by Roche)  
3. Red blood cell lysis buffer (for example "Red Blood Cells Lysis Buffer", Cat# 
11814389001 by Roche).  
4.  Staining antibodies (clones indicated within brackets): CD45 mAb (30-F11), CD11b mAb 
(M1/70), CD11c mAb (N418), anti-I-Ab / MHC-II (AF6-120.1), anti-SIRPα (P84), anti-
XCR1 (ZET).  
 
6.2.4 Staining of mouse brain macrophages  
1.  24-well plate for incubation of homogenized brains.  
2. Collagenase D solution: 1ml/brain of Hanks’ Balanced Salt Solution (HBSS) with Bovine 
Serum Albumins (BSA), 1mg/mL of collagenase D (for example "Collagenase D", Cat# 
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11088858001 by Roche) and DNase I (for example "DNase I" Cat# 10104159001 by 
Roche).  
3. Percoll for isolation of mononuclear cells (for example "Percoll", Cat# 1644 by Sigma) 
4. Staining antibodies (clones indicated within brackets): CD45 mAb (30-F11), CD11b mAb 
(M1/70), anti-Ly-6G (1A8), anti-Ly-6C (HK1.4). 
 
6.3 Sample preparation 
6.3.1 Sample preparation of murine blood monocytes 
1. Extract blood (for techniques see [35]) and immediately transfer to a tube containing the 
company-recommended amount of anti-coagulant. Note: if more than 300μl of blood are 
extracted, consider dividing the sample. 
2. Carefully load the blood-anti-coagulant mixture onto 1ml room-temperature Ficoll in a 
flow cytometry tube. 
3. Centrifuge at room temperature, 925 g without breaks for 15 minutes. 
4. Collect the ring between the phases, transfer to a new, clean tube and wash with staining 
buffer.  
   (Alternatively perform ACK lysis by incubation with 1ml of hypotonic ACK buffer for 2 
minutes at room temperature (RT). Lysis is stopped by dilution of the ACK buffer with 
PBS-/- (10 fold volume at least). 
5. Centrifuge in 4oC, 375 g for 6 minutes. Collect and discard supernatant. 
6. Re-suspend the pellet in staining buffer with the antibodies. Incubate in dark in 4oC. 
7. Wash with staining buffer, centrifuge in 4oC, 375 g for 6 minutes. Collect and discard 
supernatant. 
8. Re-suspend in staining buffer, filter with delicate cell strainer into a new, clean flow 
cytometry tube and read sample in flow cytometry cell sorting machine. 
# Gating: Blood monocytes are defined by gating on CD45+/CD11b+/CD115+ cells. The 
monocytes subsets are revealed as Ly-6C positive and negative cells (Figure 2). 
 
6.3.2 Sample preparation of mouse intestinal macrophages/DCs 
1. Remove desired part of the intestine, i.e. colon, ileum etc.  
2. Flush out fecal content by washing the lumen of the intestine with PBS -/-, either with a 
regular pipette or a repeater pipette/dispenser with suitable tip. 
3. Open the intestine longitudinally and cut into short pieces of 0.5 cm into 5ml/sample of 
Solution 1. 
4. Incubate in 37oC shaker at 300rpm for 30 minutes to remove mucus and epithelial cells. 
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5. Vortex hard for 10 seconds and filter suspension through a crude cell strainer. Collect the 
pieces and transfer to 5ml/sample of solution 2. 
6. Incubate in 37oC shaker at 300rpm for 20 minutes (small intestine) or 40 minutes (large 
intestine) to extract cells from lamina propria, i.e. the connective tissue underlying the 
epithelium.  
7. Vortex hard for 30 seconds until tissue is dissolved (incubate again for 5-10 minutes if 
tissue did not dissolve well) and filter through crude cell strainer. Wash with PBS -/- and 
centrifuge in 4oC, 375 g for 6 minutes. 
8. Re-suspend the pellet in staining buffer with the antibodies. Incubate in the dark in 4oC. 
10. Wash with staining buffer, centrifuge in 4oC, 375 g for 6 minutes. Collect and discard 
supernatant 
11. Re-suspend in staining buffer, filter with delicate cell strainer into a new, clean flow 
cytometry tube and read sample in flow cytometry cell sortingmachine. 
# Gating: intestinal DCs are defined as CD45+ CD64- CD11c+ CD103+/- CD11b+/- cells. 
Intestinal macrophages are CD45+ CD64+ CD11b+ Ly-6C- cells.  
   Infiltrating monocytes (under conditions of gut inflammation) are CD45+ CD64+ CD11b+ 
Ly-6C+ cells. For further details please see [18] (Figure 3). 
 
6.3.3. Sample preparation of mouse splenic DCs 
1. Isolate spleen and inject it with 1 mL of PBS+/+ containing 1mg/mL of collagenase D 
using 1 mL syringe. 
2. Incubate in 37oC for 30 minutes.  
3.  Filter cell suspension using an 80 μm cell-strainer and centrifuge at 4 oC, 375 g for 5 
minutes.  
4. Remove erythrocytes using red blood cell lysis buffer according to manufacturer's 
protocol. If not indicated in protocol, centrifuge in 4oC, 375 g for 6 minutes and discard 
the supernatant. 
5.  Re-suspend the pellet in staining buffer with the antibodies. Incubate in dark in 4oC. 
6. Wash with staining buffer, centrifuge in 4oC, 375 g for 6 minutes. Collect and discard 
supernatant. 
7. Re-suspend in staining buffer, filter with delicate cell strainer into a new, clean flow 
cytometry tube and read sample in flow cytometry cell sorting machine. 
# Gating: splenic classical DCs are defined as CD45+ CD11c+ MHC-II+ cells. BATF3-
dependent CD8α-expressing classical DCs are XCR1+ (blue) and the other populations 
are CD11b+ (red) (Figure 4). 
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6.3.4. Sample preparation of mouse brain macrophages 
1. For the analysis of non-parenchymal and parenchymal CNS macrophages, as well as 
monocyte-derived macrophages that arise during neuro-inflammation from monocyte 
infiltrates, perfuse mice with ice-cold PBS -/- and isolate brains.  
2. Homogenize brains and incubate with 1 ml/brain of collagenase D solution in 37oc for 30 
minutes.  
3.  Filter cell suspensions using an 80 μm cell-strainer and centrifuge at 4oC, 975 g for 5 
minutes.  
4. Resuspend the pellet in 3ml/brain 40% Percoll and centrifuge in room temperature, 
975G without breaks for 15 minutes. Collect and discard supernatant. 
5. Wash in staining buffer, centrifuge in 4oC, 375 g for 6 minutes. Collect and discard 
supernatant. 
6.  Re-suspend the pellet in staining buffer with the antibodies. Incubate in dark in 4oC. 
7. Wash with staining buffer, centrifuge in 4oC, 375 g for 6 minutes. Collect and discard 
supernatant 
8. Re-suspend in staining buffer, filter with delicate cell strainer into a new, clean flow 
cytometry tube and read sample in flow cytometry cell sorting machine. 
# Gating: microglia are defined as Ly-6G-/CD11b+/CD45low cells. Monocytes are Ly-6G-
/CD11b+/CD45high/Ly-6Chigh. Other brain macrophages are Ly-6G-/CD11b+/CD45high/Ly-
6Clow (Figure 5). 
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Figure 1. Schematic illustrating the tripartite organization of the mononuclear 
phagocyte system 
Classical tissue macrophages are established before birth and with few exceptions, self-
maintain throughout adulthood. Classical DCs are short-lived and continuously replaced from 
dedicated BM-derived precursor cells. Monocytes reside in the blood circulation and are 
recruited to tissues on demand where they give rise to cells with macrophage or DC features.  
(for further details see [11]). 
 
Figure 2. Flow cytometric analysis of murine myeloid blood cells. Neutrophils are 
defined by high sideward scatter (not shown) and expression of Ly6G. Monocytes are 
defined as CD115hi cells and can be further subdivided into classical (Ly6Chi; red) and 
patrolling monocytes (Ly6Clo; blue) (for further details see [18]). 
 
Figure 3. Flow cytometric analysis of colonic mononuclear phagocytes. Classical DCs 
are defined as CD11chi cells (Red), which can be further subdivided into three subsets 
according to their CD103 and CD11b expression.  Monocyte-derived intestinal macrophages 
are defined as CD64+ CD11c low-int CD11b+ cells (Blue) (for further details see [18]). 
 
Figure 4. Flow cytometric analysis of splenic DCs. Classical CD11chi MHCII+ DCs can be 
further subdivided into two main subsets according to CD11b and XCR1 expression (for 
further details see [18]). 
 
Figure 5. Flow cytometric analysis of CNS macrophages. Neutrophils are excluded 
according to their Ly6G expression. Microglia are defined as CD45int CD11b+ cells (red). 
Monocytes (blue) and monocyte-derived macrophages (green) are defined as CD45hi 
CD11b+ Ly6C+ and Ly6C- cells, respectively. 
 
Table 1: Selected commonly used surface markers for murine mononuclear phagocytes  
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7.1 Sample preparation 
Successful flow cytometry analysis requires viable single cell suspensions. Granulocytes are 
sensitive cells which can rapidly die or aggregate upon inappropriate treatment (extended 
incubation on density gradients, harsh physical treatment). Therefore, it is necessary to use 
optimized protocols for the dissociation of different tissues to prepare cell suspensions for flow 
cytometry. The easiest way to obtain granulocytes for analysis is to use whole blood and 
perform lysis of erythrocytes. This can be achieved by several methods (e.g. short hypotonic 
water lysis, ammonium chloride treatment or commercially available RBC lysis buffers). 
 
7.2 Discrimination by FSC/SSC 
Differential light scattering of cells depending on the size and morphology is useful to 
discriminate subsets of cells. The side scatter (SSC) is considered to be an indicator for the 
internal structure of the cell (e.g. nuclear morphology) and the forward scatter (FSc) reflects 
cellular size. Since neutrophils and eosinophils have a multilobulated nucleus, they exhibit a 
high SSC signal. However, eosinophils show a slightly higher signal in this parameter. The 
nuclear morphology of basophils is less complex and therefore they are found among the 
lymphocyte population and cannot be distinguished in such a manner (Fig. 1A). 
Changes in SSC and FSC may also represent other morphological features of various cellular 
processes (e.g. phagocytosis, cell death). These changes can also be detected in this fashion 
as described below in this section.  
 
7.3 Discrimination using specific antibodies 
To detect either human or murine granulocytes it is useful to start with a staining for CD45 to 
define white blood cells, accompanied by simultaneous staining for CD11b. These two
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markers, together with FSC and SSC features, are enough to roughly identify granulocytes from 
whole blood preparations. 
Human neutrophils are the most abundant cell type within the granulocyte family. They can be 
easily distinguished from other granulocytes by their positivity for both CD15 and CD16. 
Eosinophils are positive for CD15, but do not express CD16. Additional staining for CCR3 and 
Siglec-8 allows a specific detection of eosinophils. Basophils neither express CD15 nor CD16, 
therefore staining with anti-FcεRIα identifies them in the CD15neg/CD16neg population (Fig. 1B). 
Murine neutrophils and eosinophils are CD11b positive and exhibit an intermediate to low 
expression of Ly6C. Neutrophils are detected as Ly6G positive cells, whereas eosinophils are 
identified by their expression of CCR3 and Siglec-F. Basophils also show positivity for CD11b, 
but have only a low expression of Ly6C. They can be further identified by the expression of 
CD200R3 and CD49d (Fig. 1C). For details see Table 1. 
 
 
7.4 LIVE/DEAD analysis of granulocytes 
Especially in the context of studying inflammatory infiltrates, it is sometimes necessary to 
determine whether neutrophils are viable. During the resolution of inflammation, neutrophils 
undergo apoptosis, mediate anti-inflammatory and immunosuppressive effects, and secrete 
factors that prevent the additional influx of neutrophils.  
Granulocyte apoptosis can be detected by a combination of propidium iodide (PI) and 
fluorophore-conjugated annexin A5 (AxA5). PI is a DNA-intercalating substance that only enters 
cells that have lost their membrane integrity (necrotic cells and NETotic cells). AxA5 binds to 
phosphatidylserine (PS) exposed by cells undergoing apoptosis (Fig. 2A). Please refer to 
Chapter VII, Section 8: Cell death for further information.  
1) If granulocytes have been purified prior to the live/dead analysis, no antibody staining is 
needed. However, if more than one cell type is present, the cell death staining should be 
supplemented with an antibody combination, allowing the identification of granulocytes 
as mentioned above.  
2) Minimal manipulation of the cells is essential for the quality of the cell death staining. 
The initial cell suspension, i.e. a peritoneal lavage or whole blood, should be depleted of 
erythrocytes, centrifuged at 300g for 10min and then resuspended in a small volume of 
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HBSS including calcium and magnesium and supplemented with 2% FCS. Usually, cell 
suspensions of 1x106 cells per milliliter are required for antibody and apoptosis staining. 
Optimal results are achieved using a staining solution containing PI (100ng/ml) and 
AxA5 (1µg/ml). Homogenous staining can be assured by gentle tapping of the tube. 
3) The cells should be stained for 30 minutes at room temperature in the dark. 
4) After incubation, the sample is immediately subjected to analysis by flow cytometry. No 
additional washing steps are recommended, since they can lead to the loss of 
subcellular apoptotic particles and to the degeneration of apoptotic cells. 
Modern flow cytometers allow the simultaneous use of multiple fluorophores. If such an 
instrument is available, the classical apoptosis staining, deploying AxA5-conjugates and PI, can 
be supplemented with two additional dyes (e.g. Hoechst33342 and 1,1′,3,3,3′,3′-
hexamethylindodicarbo-cyanine iodide (DilC1(5)), which would allow a more detailed 
characterization of cell death. This staining takes into account the condition of the nucleus and 
the mitochondrial membrane potential for the nucleus and the mitochondrial membrane, 
respectively and can also deployed for live-cell imaging [1, 2]. 
 
7.5 Measuring phagocytic uptake of microparticles by granulocytes 
Neutrophils show a strong capacity to take up particulate matter. When confronted with 
nanoparticles or small-sized monosodium urate crystals, neutrophils engulf these particles. 
Since such materials cannot be easily conjugated with fluorophores, one has to rely on other 
methods to monitor their uptake. Soluble dyes, such as Lucifer Yellow, can be added together 
with the “prey particle” and will be co-ingested during phagocytosis. In addition, the uptake of 
particulate matter tends to increase the complexity of the phagocyte. As shown in figure 2B, the 
increase in SSC and in Lucifer Yellow strongly correlates. Observation of either one represents 
a feasible method for addressing such questions.  
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7.6 Pitfalls of flow cytometry analysis of granulocytes 
 Neutrophil release from the bone marrow follows a circadian rhythm [3]. To ensure the 
highest comparability, neutrophils from different donors should be isolated roughly at the 
same time after awakening. 
 When flow cytometric analysis is performed, proper arrangements are necessary to 
prevent neutrophil adhesion. Neutrophils show a tendency to adhere under serum free 
conditions, to glass or adhesive plastic surfaces and especially fast in response to 
stimulation. Supplementation of culture media with 10% fetal calf serum or 1% bovine 
serum albumin counteracts neutrophil adhesion to surfaces..  
 Neutrophils have a very limited life time. They undergo full blown apoptosis in less than 
24 h. In addition, several stimuli induce the formation of neutrophil extracellular traps. 
Although it is possible to detect NETs as material with very high SSC, flow cytometry is 
not robust enough to quantify NETs.  
 Furthermore, NETs tend to aggregate and form material which cannot be collected by 
standard needles.  
 Phagocytic uptake of particles alters the morphology of a variety of cell types. It is 
therefore not advisable to identify granulocyte populations only by SSC. 
 Activation of leukocytes is usually accompanied by shedding or membrane renewal 
consequently changing their phenotype (e.g. CD16 downregulation). 
 Live/dead stainings deploying AxA5 must be performed in the presence of at least 2 mM 
calcium, since binding of AxA5 to phosphatidylserine in the membrane is calcium-
dependent. 
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Figure 1. Discrimination of granulocyte subpopulations. Human or murine whole blood was 
subjected to hypotonic water lysis to remove erythrocytes prior to antibody staining. Cells were 
incubated with antibodies for 30 min at 4°C (human) or on ice (murine) in the dark. Cell 
stainings were measured using a Beckman Coulter Gallios™ Flow Cytometer and analyzed by 
Beckman Coulter Kaluza® Flow Analysis Software 1.3. (A) Human cells are displayed in a SSc 
versus (vs) FSC dot plot to show the location of eosinophils (green, high SSC), neutrophils 
(blue, high SSC), and basophils (red, low SSC). (B) Human cells were stained with antibodies 
against CD45, CD11b, CD15, CD16, CCR3, Siglec-F and FcεRIα. CD45+/CD11b+ cells were 
gated on CD15 vs CD16 to distinguish granulocyte subpopulations. CD15+/CD16+ cells were 
determined as neutrophils, CD15+CD16- were further designated as eosinophils by their 
expression of Siglec-8 and CCR3, and the CD15-/CD16- population was depicted in a FcεRIα 
vs. CCR3 plot to identify the double positive basophil fraction. (C) CD45+ murine cells were 
gated on CD11b/Ly6C to display the CD11b+/Ly6int population which was further analyzed using 
Ly6G to identify neutrophils (blue). CD11b+/LyCneg-low cells were gated on Siglec-F vs. CD200R3 
and were subsequently analyzed for expression of additional cell subset markers. CD200R3- 
cells expressing Siglec-F and CCR3 were designated as eosinophils (green) and Siglec-F- cells 
were marked as basophils (red) supported by their expression of CD200R3 and CD49b. 
 
Figure 2. Apoptosis detection and uptake of nanoparticles in purified human 
granulocytes. Human granulocytes were purified by density gradient centrifugation with 
Lymphoflot. Erythrocyte contaminations were depleted by hypotonic water lysis. Human 
granulocytes were resuspended in RPMI-1640 supplemented with 50 U/ml 
penicillin/streptomycin, 2 mM glutamine and 10% heat-inactivated fetal calf serum and 25 mM 
HEPES at a concentration of 2 x 106 cells/ml. (A) Granulocytes were cultivated at 37°C/CO2 for 
indicated time points and stained according to the protocol included in this article. Subsequently, 
they were subjected to analysis on a Beckman Coulter CytoFLEXTM Flow Cytometer. Evaluation 
of data was performed with the Beckman Coulter software CytExpert 1.2. During apoptosis, 
granulocytes shrink and increase in granularity, as indicated by a decrease in FSC and an 
increase in SSC. Viable cells (V) first start to expose AxA5-FITC and become apoptotic (A), 
before they lose their plasma membrane integrity and become necrotic as indicated by PI-
positivity (N). Note that in the N-gate the population high in PI reflects cells without the loss of 
nuclear content. In contrast, the population low in PI reflects cells with a subG1 DNA content, 
which is considered a hallmark of apoptosis. (B) 20 µg/ml micro monosodium urate crystals and 
250 µg/ml Lucifer Yellow were added to the granulocytes and the suspension was incubated at 
37°C/CO2 for the time points indicated. Subsequently, analysis was performed on a Beckman 
Coulter GalliosTM flow cytometer. Evaluation of data was performed with the Beckman Coulter 
Kaluza® Flow Analysis Software 1.3. The increase in Lucifer Yellow (see arrow; in red) is 
restricted to the population of cells which increase in granularity. Therefore, the simultaneous 
increase in Lucifer Yellow and SSc can be used to monitor the uptake of nanoparticles by 
granulocytes. 
 
Table 1. Selection of most important markers for flow cytometry analysis of granulocyte
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Section 8 – Bone marrow stromal cells 
8.1 Introduction 
The bone marrow microenvironment is composed of multiple stromal cell populations 
involved in the formation and regeneration of the skeleton and in the regulation of 
hematopoiesis. Bone marrow stromal cells are thought to originate from mesenchymal stem 
and progenitor cells (MSPCs) [1, 2] and have been shown to support hematopoietic stem cell 
(HSC) functions through their expression of adhesion molecules and their secretion of HSC 
maintenance factors [3]. Recent technological advances allowed the identification of distinct 
perivascular stromal cell populations that constitute the HSC niche and are responsible for 
maintaining either quiescent or proliferative HSCs at the steady state or after stress [4-7]. 
Cell surface markers have been suggested to label bone marrow stromal cells but many of 
these markers are based on the expression of cultured stromal cells [8] as opposed to freshly 
isolated stroma [9-11]. Therefore, the identification and isolation of bone marrow stromal 
cells by flow cytometry using standardized cell preparation criteria are critical for their 
application in regenerative medicine and the understanding of their role in the HSC niche.  
8.2 Materials 
8.2.1 Animals 
 - Adult mice such as C57BL/6 (8-12 weeks old)  
8.2.2 Reagents 
 - Collagenase type IV (Gibco, Cat #17104019) 
 - Dispase (Gibco, Cat #17105-041) 
 - PBS 10X (Fisher Scientific, Cat #BP665-1) 
- EDTA (Sigma, Cat #E5134) 
- Ammonium chloride (Sigma, Cat #A4514) 
- Potassium bicarbonate (Fisher Scientific, Cat #P235) 
- BSA (Sigma, Cat #BP1600-100)  
- DAPI (Sigma, Cat #D9542) 
- Anti-Mouse CD45 antibody (30-F11, Biolegend) 
- Anti-Mouse Ter119 antibody (Ter-119, Biolegend) 
- Anti-Mouse CD31 antibody (390, Biolegend) 
- Anti-Mouse CD51 antibody (RMV-7, eBioscience) 
- Anti-Mouse PDGFRα antibody (APA5, eBioscience) 
8.2.3 Solutions 
 - HBSS (Corning, Cat #21-023-CV) 
 - Flow cytometry buffer (PBS 1X, EDTA 2 mM, BSA 0.1%) 
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  - RBC lysis buffer (NH4Cl 0.17M, KHCO3 0.01 M, EDTA 0.1 mM) 
 - Digestion buffer (Collagenase IV 2 mg/mL, Dipase II 1 mg/mL in HBSS) 
 - DAPI (0.05 μg/mL in flow cytometry buffer) 
8.2.4 Equipment 
 - 1 mL syringe with 21G x 1 needle (for femurs) or 25 G x 5/8 needle (for tibias) 
 - 100 uM cell strainer (Falcon, Cat #08-771-19) 
 - CD45 microbeads, mouse (Miltenyi Biotec, Cat #130-052-301) 
 - MACS LS column (Miltenyi Biotec, Cat #130-042-401) 
 - QuadroMACS separator (Miltenyi Biotec, Cat #130-090-976) 
 - Flow cytometry cell sorter (at least 5 colors and equipped with UV laser) 
 
8.3 Procedure 
 
The stromal fraction of the bone marrow is highly heterogeneous and includes MSPCs that 
possess tri-lineage differentiation into osteoblasts, adipocytes and chondroblasts [2].  In 
order to isolate MSPCs and stromal cells from the bone marrow, extraction of an intact bone 
marrow plug is necessary as opposed to the standard crushing or flushing technique used for 
hematopoietic cells [12]. Sequential digestion of the bone marrow plug allows the recovery of 
MSPCs that can be measured by colony-forming units-fibroblasts (CFU-F) activity, which is 
mostly absent in crushed or flushed bone marrow. Femurs or tibias from mice are cut below 
the metaphysis and the intact bone marrow plug is gently flushed out with digestion buffer 
containing collagenase type IV and dispase. Bone marrow plugs are sequentially digested 3 
times for 10 min at 37C and the supernatant is collected between digestions and pooled into 
a tube containing ice-cold flow cytometry buffer to stop further digestion, which may result in 
a loss of cell viability or detection of cell surface markers. The single-cell suspension 
containing bone marrow stromal cells can then be pelleted, subjected to red blood cell lysis 
and filtered using 100 m cell strainer. For cell sorting, enrichment for stromal cells can also 
be obtained by incubating bone marrow digested cells with CD45 mAb-conjugated 
microbeads (see Chapter II section 1.2.1 for further details on magnetic beads coupled to 
antibodies). After 10 min incubation at 4C, the cell suspension is washed and applied onto a 
MACS LS column, resulting in the elution of an enriched fraction in bone marrow stromal 
cells. In order to analyze stromal cells by flow cytometry, antibody staining is performed 
using antibodies (Table 1) that allow exclusion of hematopoietic cells (CD45, Ter119), as well 
as the identification of endothelial cells (CD31). Finally, stained cells are washed and 
resuspended in a buffer containing a viability dye such as DAPI to exclude dead cells. 
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8.4 Gating strategy 
 
In adult mice (8-12 weeks old), the bone marrow stromal fraction is commonly defined as 
CD45− Ter119−  CD31−  cells (Figure 1) and represents 0.3-1.0% of total digested live cells, 
using the above-mentioned digestion conditions. Therefore it is important that antibody 
titration is performed prior to staining in order to exclude any hematopoietic (CD45+ or 
Ter119+) or endothelial cells (CD45− Ter119− CD31+). To analyze MSPCs, the first gate is 
drawn around the stromal fraction and then MSPCs can be identified by their expression of 
both CD51 and PDGFR (CD45− Ter119− CD31− PDGFR+ CD51+) [10]. Under these 
conditions, the frequency of MSPCs is typically around 5-15% of the stromal compartment 
(Fig. 1), however depending on the gating for the stromal fraction, the efficiency of the 
digestion as well as the method used in isolating bone marrow cells the MSPC frequency can 
vary. Indeed, previous studies showed that MSPCs can also be isolated by digesting crushed 
bones which includes bone stromal cells that are probably phenotypically and functionally 
distinct [6, 9, 10].  
 
Genetic models can also be used in order to label stromal cells, for example mice expressing 
GFP under the Nestin promoter have been shown to label MSPCs [13] where 60% of Nestin-
GFP stromal cells overlap with the CD45− CD31− Ter119− PDGFR+ CD51+ and leptin 
receptor expressing cells [10].  MSPCs defined as CD45− CD31− Ter119− PDGFR+ Sca1+ 
can be harvested from digested crushed bones although they exhibit little overlap (~5%) with 
bone marrow Nestin-GFP cells, suggesting that bone marrow MSPC activity, unlike that of 
bone, may not be contained in the bone marrow CD45− CD31− Ter119− PDGFR+ Sca1+ cell 
fraction [10]. Expression of fluorescent proteins in stromal cells can also be achieved through 
the use of reporter mice, which can be useful for labeling stromal cell populations or 
performing lineage-tracing studies that can be analyzed by flow cytometry cell sorting [5-7, 
13-17]. 
 
Figure 1. Gating strategy for bone marrow stromal cells. Live single cells are separated 
using CD45, Ter119 and CD31 markers. Cells were then gated for the stromal fraction 
(CD45- Ter119- CD31- ) and analyzed using CD51 and PDGFR, which allow the analysis of 
MSPCs (CD45- Ter119- CD31- PDGFR+ CD51+). 
 
Table 1: Antibodies for bone marrow stromal cells 
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Section 9 – Hematopoietic stem cells 
 
9.1 Introduction 
Hematopoietic stem cells (HSCs) are rare, self-renewing progenitors giving rise to all 
lineages of blood cells. Moreover, HSCs are capable of long-term production of all blood cell 
types in primary irradiated recipients in transplantations, as well as self-renewal, such that 
the cells can be transplanted to secondary hosts to give rise to long-term multilineage 
repopulation [1-3].  
The balance of HSC quiescence, self-renewal and differentiation strongly depends on 
interaction of HSCs with their niche [4-6]. In the developing embryo HSCs reside in fetal liver 
that do yet not form a niche allowing longevity of the cells [7]. From E 17.5 the bone marrow 
(BM) is colonized by HSCs, the BM remains the main hematopoietic niche throughout adult 
life [8-9]. In adults, the most primitive HSCs are thought to localize to the most hypoxic 
microenvironments in the BM, the hypoxic stem cell niche, resulting in the maintenance of 
the primitive phenotype and cell cycle quiescence to avoid HSC senescence [10-11]. 
Mouse HSCs can be isolated by flow cytometry, based on surface-marker expression. The 
first step in the isolation of mouse HSCs from BM usually consists of removing mature cells 
that express “lineage” (Lin) antigens specific to terminally differentiated blood cells, including 
F4/80+/Mac1+ monocytes and macrophages, Gr1+ granulocytes, CD11c+ dendritic cells, 
CD4+/CD8+/CD3+ T cells, CD5+CD19+B220+ B cells, NK1.1+ NK cells and Ter119+ 
erythrocytes. These antigens are absent on HSCs. HSCs are then further enriched as 
lineage-negative (Lin-) cells that express combinations of cell surface markers. Commonly 
used markers include Thy1.1, c-Kit and Sca1. Thus, multipotent hematopoietic progenitors 
have been purified as Lin-Thy1.1loc-Kit+Sca-1+ cells that make up <0.1% of nucleated BM 
cells [12-15]. Although this population contains all multipotent progenitors in mice, it is still 
heterogeneous, containing transiently reconstituting multipotent progenitors in addition to 
long-term reconstituting HSCs. 
Fortunately, there are differences in surface-marker expression between long-term self-
renewing HSCs and transiently reconstituting multipotent progenitors, which permit the 
independent isolation of these progenitor populations. One strategy involves sorting of so-
called “SLAM” cells [16-18] as a Lin–c-Kit+Sca-1+Thy1.1loCD150+CD48– population containing 
mainly long-term self-renewing HSCs, the Lin–c-Kit+Sca-1+Thy1.1loCD150+CD48+ population 
containing mainly transiently self-renewing multipotent progenitors, and the Lin–c-Kit+Sca-
1+Thy1.1loCD150-CD48+ population containing mainly non-self-renewing multipotent 
progenitors, followed by transplantation analyses. These three distinct populations vary with 
each stage in the progression toward lineage commitment in their frequency, engraftment-
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kinetics, self-renewal potential, cell-cycle status, gene expression, and lineage distribution of 
the mature cells they can generate in vivo.  
However, SLAM-defined cells themselves are still heterogeneous populations in which HSCs 
represent, at most, 20% of all cells. Further enrichment of HSCs can be achieved by the 
purification of SLAM-defined cells that express high levels of CD201 (EPCR) and low levels 
of CD34 and Flk2 [19-20]. Thus, long-term self-renewing pluripotent HSCs (LT-pHSCs) are 
enriched as Lin–c-Kit+Sca-1+Thy1.1loFlk2-CD34-CD201highCD150+CD48– bone marrow cells 
(Fig. 1A; Table 1). Although transiently reconstituting multipotent progenitors are enriched in 
the CD34+ fraction, no evidence indicates that they can be purified based on CD34 
expression.  
In addition, other markers such as AA4.1 or Aldehyde dehydrogenase permit the purification 
of HSCs, but they have not been shown to permit the simultaneous purification of transiently 
reconstituting multipotent progenitors [21]. 
Finally, HSCs can be isolated due to their hypoxia-induced high expression of the multidrug 
transporter proteins MDR1 and ABCG2, thus, cells that retain only low levels of DNA dyes, 
such as Rhodamine-123 (Rho123) and Hoechst 33342. Rho123lo or Hoechstlo cells (“side 
population”, SP cells), and that are Lin–c-Kit+Sca-1+ are nearly pure populations of long-term 
reconstituting HSCs [22-23] (Fig. 1B; Table 1). 
Nevertheless, all of these purified HSCs are still heterogeneous population of cells regarding 
their functionality. It is believed that myeloid-biased HSCs express higher levels of CD150 
and efflux Hoechst 33342 more efficiently than lymphoid-biased HSCs. They also exhibit 
higher self-renewal ability as demonstrated by serial transplantation of BM cells from primary 
recipients into secondary hosts. 
In contrast, the most important marker of primitive human hematopoietic cells is the cell 
surface protein CD34. Most human HSCs are CD34+, as demonstrated by 
xenotransplantation assays and clinical transplants performed with purified CD34+ cells from 
different hematopoietic tissues. However, CD34 expression alone does not provide an 
accurate measure of HSCs and immature progenitors, and additional markers are required to 
identify and isolate the most primitive hematopoietic cells [24]. 
As described for mouse cells, human HSCs do not express Lin antigens and Lin-CD34+ cells 
can then be separated by sub-fractionating using markers that are differentially expressed on 
primitive and more differentiated cells. The most common markers include CD38 and 
CD45RA, which are absent or only weakly expressed on primitive cells, and CD90, which is 
expressed at higher levels on primitive cells than on differentiated cells (Fig. 2; Table 1). As 
few as 10 Lin-CD34+CD38-CD45RA-CD90+ peripheral blood cells have been shown to engraft 
the BM of immunodeficient mice and generate human lymphoid and myeloid cells for at least 
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12 weeks after transplantation, thus, are identified as LT-pHSCs [25]. Purified Lin-
CD34+CD38-CD45RA- cells that lack CD90 expression can also contribute to long-term 
repopulation in immunodeficient mice, but more cells are required to achieve engraftment 
and the cellular output per transplanted stem cell is lower. This suggests that HSCs in the 
CD90- subset represent a less primitive cell subset than their CD90+ counterparts. 
 
 
9.2 Materials 
9.2.1 Staining of mouse BM 
5. Adult mice such as C57BL/6, typically, 6–10-wk-old mice are used for the isolation of 
HSCs. 
2.  Staining medium: Phosphate Balanced Salt Solution (1xPBS) with 2% heat-
inactivated 
     calf serum. 
3.  Nylon screen (40 μm nylon mesh) to filter the cells after isolation. 
4.  10-mL syringes with 25-gauge needles to flush marrow out of femurs and tibias. 
5.  Use 15-mL tubes to stain BM cells. Note that cells must be transferred to 6-mL Falcon 
tubes for fluorescence-activated cell-sorting 
 
Antibodies described in this protocol are available from eBioscience and BioLegend. 
6. Lineage-marker antibodies: anti-Mac1 (M1/70), anti-Gr1 (RB6-8C5), anti-Ter119 
(TER-119), CD19 mAb (1D3), anti-B220 (RA3-6B2), CD5 mAb (53-7.3), CD3ε mAb 
(145-2C11), CD11c mAb (N418), CD4 mAb (GK1.5), CD8 mAb (53-6.7), anti-NK1.1 
(PK136). Note that all antibodies should be titrated before use, and used at dilutions 
that brightly stain antigen-positive cells without nonspecifically staining antigen-
negative cells. 
7. anti-Thy-1.1 (19XE5), anti-Flk2 (A2F10), CD201 mAb (RCR-16), anti-Sca-1 (D7), anti-
c-kit (2B8), CD150 mAb (TC15-12F12.2), CD34 mAb (RAM34), CD48 mAb (HM48-1), 
8. SP buffer (PBS, 2% FCS, 2mM HEPES buffer; GIBCO, Life Technologies), Hoechst 
33342 (5 µg/ml, Molecular Probes, Life Technologies), 
9. a viability dye such as propidium iodide (PI) or 7-aminoactinomycin D (7-AAD). 
 
 
9.2.2 Staining of human peripheral blood 
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1. For the purification of 2–40 × 103 circulating human hematopoietic precursor cells 
from 90 ml of peripheral blood, PBMCs were obtained by Ficoll-Paque density 
gradient centrifugation. 
2. Lineage-marker antibodies: CD1c mAb (AD5-8E7, Miltenyi Biotec), CD3 mAb 
(UCHT1, Beckman Coulter), CD11c mAb (Bu15, Beckman Coulter), CD14 mAb 
(RMO52, Beckman Coulter), CD15 mAb (HI98, BioLegend),  mAb CD16 (3G8, 
Beckman Coulter), CD20 mAb (2H7, BioLegend), CD41 mAb (SZ22, Beckman 
Coulter), CD56 mAb (C218, Beckman Coulter), CD203c mAb (NP4D6, BioLegend), 
CD235a mAb (KC16, Beckman Coulter), anti-BDCA2 (AC144, Miltenyi Biotec), 
3. CD34 mAb (8G12, BD Biosciences), CD38 mAb (HIT2, Biolegend) and CD90 mAb 
(5E10, Biolegend), 
4. a viability dye such as propidium iodide (PI) or 7-aminoactinomycin D (7-AAD). 
 
A flow cytometry cell sorter with at least four-color capability, for example a FACS ARIA (BD 
Biosciences) should be used.  
 
Figure 1. Phenotypic characterization of mouse HSCs in BM in vivo. (A) LT-pHSCs were 
identified as Lin–c-Kit+Sca-1+Thy1.1loFlk2-CD34-CD201highCD150+CD48– cells [26]. (B) 
Alternatively, LT-pHSCs that are endowed with Hoechst dye efflux properties were identified 
as SP cells and further purified as Lin–c-Kit+Sca-1+ cells.  
 
Figure 2.Phenotypic characterization of human pHSCs in the peripheral blood in vivo. 
LT-pHSCs were identified as Lin–CD34+CD38–CD90+ cells, and MPPs as Lin–
CD34+CD38+CD90- cells [26].  
 
Table 1. Selection of most important markers for flow cytometry analysis of mouse BM 
hematopoietic stem cells.  
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Section 10 – Tumor cells 
 
 
10.1 Introduction 
Tumor, also called cancer, cells are derived from healthy, non-transformed cells of either 
hematopoietic, epithelial, endothelial, neuroectdermal or mesenchymal origin, resulting from a 
sophisticated process of malignant transformation. Therefore, the respective origin of a tumor cell 
implicates the markers suitable for its flow cytometric characterization. The hematopoietic marker 
pan-CD45, which was originally defined as leukocyte common antigen (LCA), can be used for the 
discrimination of hematopoietic tumor cells such as leukemias and lymphomaswith CD45 epitopes 
being present in all splice variants that can be utilized to stain all cells of hematopoietic origin 
including hematopoietic progenitor cells (HCS, see Chapter VIII Section 9: Hematopoietic stem 
cells [1]). As a consequence, pan-CD45 represents a useful marker for the discrimination of 
hematopoietic malignancies from solid tumor cells.  
The classification of leukemias and lymphomas is guided by flow cytometry that has been 
harmonized, standardized and successfully integrated into clinical routine for immunophenotying 
[2]. The EuroFlow (www.euroflow.org) consortium, represented and headed by Jacques M. van 
Dongen, has designed panels for n-dimensional flow cytometric immunophenotyping of normal, 
reactive and malignant leukocytes, and developed novel computerized evaluation procedures for 
the characterization and quantification of human hematopoietic malignancies. The EuroFlow 
guidelines represent the gold standard of immunophenotyping of hematopoietic malignancies 
(http://euroflow.org/usr/pub/pub.php). For research laboratories working on leukemias or 
lymphomas in rodents or man, it is important to mention that virtually all hematopoietic 
malignancies are accompanied by a disturbed distribution of the lymphocyte subsets in peripheral 
blood. Therefore, detailed knowledge of the “normal” distribution of leukocytes in healthy donors, 
human or mouse, is instrumental for the analysis of the influence of malignant cells on 
hematopoiesis and immune function. “The ONE Study” group guided by Birgit Sawitzki has 
established an advanced flow cytometry panel for humans in order to define the distribution of the 
most important T-cell, B-cell, NK-cell and monocyte, dendritic cell subsets in healthy individuals in 
order to be able to compare these in the future with the distribution of patients undergoing solid 
organ transplantation accompanied by cellular therapy using suppressor cell populations [3]. The 
International Society for Advancement of Cytometry (Cytoconference, 
http://cytoconference.org/2016/Home.aspx), the CIP consortium (CIMT immunoguiding program) 
of the Cancer Immunotherapy Consortium (CIMT, http://www.cimt.eu/ workgroups/cip/proficiency), 
the International Clinical Cytometry Society (ICCS, http:// www.cytometry.org/web/index.php), the 
Federation of Clinical Immunology Societies (FOCIS, http://www.focisnet.org/index.php) represent 
other initiatives with the aim to  harmonize and standardize protocols for immunophenotyping 
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primarily of human peripheral blood, but also tissue-derived immune cells as well as parenchymal 
cells such as tumor cells. The tremendous efforts of these consortia to establish guidelines, 
protocols and tools for the quantification of leukocytes, tumor cells and immune responses will be 
instrumental not only for research projects but also for future clinical studies, in particular with 
immunological endpoints. 
10.2 Material, solutions, antibodies;  
Solid tumor cell lines are available in collaboration with research groups, by several vendors and 
the ATCC (american type tissue collection, https://www.lgcstandards-atcc.org/). Recommended 
antigens for staining of human solid tumor cells for flow cytometry cell sorting are listed in Table 
10.2.1. The staining procedures are identical to the general recommendations for indirect surface 
marker staining, direct surface marker staining and intracellular staining protocols, respectively, 
summarized in Chapter VII, section 2: “Surface parameters” and section 3: “Intracellular 
parameters”  
 
10.3 Preparation of tissue, staining of samples and gating strategy  
The staining protocols for human or murine tumor cell lines or tumor cells derived from fresh tumor 
tissue after enzymatic digestion follow the general recommendations summarized in Chapter VII, 
section 2: “Surface parameters” and section 3: “Intracellular parameters” of this guideline. With 
respect to human or murine tumor tissue digestion, the same protocols can be applied as 
summarized in Chapter IV, Section 3 “Preparation of Single Cell Suspensions” , using collagenase, 
hyaluronidase and DNAse. These three enzymes are known not to affect surface expression of the 
molecules listed in Tables 10.2.1  and 10.2.2, respectively. After digestion and Ficoll density 
centrifugation, single cell suspensions can be frozen as living cells or analyzed immediately using 
the flow cytometry cell sorting staining protocols presented in Section 3 – Preparation of Single 
Cell Suspensions. 
 
10.3.1. Direct and indirect staining of surface molecules expressed by adherent tumor cells 
1. Cultured adherent tumor cells are detached and singularized by washing with 5 ml PBS followed 
by treatment with 0.05% trypsin/ 0.02% EDTA solution (1 ml per T25 culture flask) for 2-5 
minutes, gentle shaking and detachment by adding 5 ml medium (RPMI1640 + 5% heat-
inactivated FBS).  
2. cell count of the single cell suspension is determined using trypan blue solution for 
discrimination of dead cells  
3. 1-2 x 105 cells for each antibody are pelleted by centrifugation (800 g, 5 min) in flow cytometry 
tubes and resuspended (15 sec vortex).  
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4a. For indirect staining, unlabeled monoclonal antibody or isotype control mab solutions (50 µl, 5 
µg/ml) are added to the single cell suspensions for 30 min at 4°C. After washing twice with 500 
µl flow cytometry buffer (PBS, 1 % FBS, 0.1 % Na-azide), and vortexing, FITC-, PE-, APC- or 
pacific blue-labeled goat-anti mouse antibody solutions (100 µl of dilutions between 1:100 and 
1:200) are added for 30 min at 4°C in the dark.  
4b. for direct staining, cells are resuspended in 50 µl flow cytometry buffer and 1-5 µl of directly 
labeled (titrated) mab are added for 30 min at 4°C in the dark. 
5.  after two washing steps, cells are resuspended in 150 µl flow cytometry buffer if measured 
immediately or in flow cytometry fixation buffer (PBS, 1 % FCS, 1 % paraformaldehyde) and 
stored at 4°C until measurement.  
6. for live/dead exclusion, 1-2 µl propidium iodide (PE chanel) or 7AAD (PerCP chanel) solutions 
are added directly before measurement which is only suitable without prior fixation.  
 
10.3.2. Detection of circulating tumor cells in peripheral blood and bone marrow 
The detection of circulating tumor cells in peripheral blood and bone marrow, respectively, has 
clinical relevance for several forms of carcinomas and sarcomas in terms of disease staging and 
treatment response [4]. Although molecular methods such as real-time PCR of tumor-specific 
mRNA expressed by carcinoma, sarcoma or melanoma tumor cells etc., recently called “real time 
liquid biopsy”, have a higher sensitivity compared to flow cytometry, this technique is still valid for 
the quantification and characterization of circulating cancer cells. Under non-malignant conditions, 
cells of epithelial, mesenchymal or neuroectodermal origin cannot be detected in blood or bone 
marrow aspirates. However, the process of metastasis formation is associated with dissemination 
of malignant cells through the blood stream and bone marrow. Therefore, disseminating cancer 
cells are detectable in these compartments but at very low frequencies close to the detection limit. 
Hence, enrichment techniques such as antibody-based magnetic positive or negative selection are 
used to increase sensitivity of detection. For the quantification of tumor cells, the direct or indirect 
staining protocol outlined in 9.3.1 is combined with the marker pan-CD45 for the exclusion of 
leukocytes. As discussed in more detail in the following paragraphs, the epithelial markers Ep-
CAM (CD326) or CK18 are suitable markers for the detection of carcinoma cells. For sarcomas, 
the mesenchymal marker (CD99) is recommended and growth factor receptors like c-Met or 
PDGFR are appropriate for melanoma cell detection.       
 
Addition to the protocol: 
5. at step 5, stained tumor cells are resuspended in 50 µl flow cytometry buffer and directly labeled 
pan-CD45 antibody (2-5  µl) is added for 30 min at 4°C in the dark.  
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6. after two washing steps, cells are resuspended in 150 µl flow cytometry buffer if measured 
immediately or in flow cytometry fixation buffer (PBS, 1 % FCS, 1 % paraformaldehyde) and 
stored at 4°C until measurement.  
 
10.4 Specific recommendations for human and murine solid tumors  
10.4.1. Characterization of solid tumors 
In contrast to leukemias and lymphomas, solid tumor cells are classified according to their 
originating cell type, i.e. tumor cells derived from i) epithelial cells are defined as carcinoma cells, 
from ii) mesenchymal cells are defined as sarcoma cells and from iii) neuroendocrine tumors are 
defined by originating from endocrine glands and iv) neuroectodermal tumors are defined by 
originating from neuroectodermal cells of the skin or brain. This classification is identical for all 
species, e.g. humans, non-human primates, dogs, cats, and rodents. Although many solid tumor 
cells can express a variety of tumor-associates antigens (TAA) including cancer-testis (CT), 
carcinoembryonal (CEA) and neo-antigens, most of these antigens are not suitable for flow 
cytometric characterization of tumor cells, either due to their poor expression, intracellular 
localization or simply the lack of specific antibodies [5,6]. Therefore, the characterization of solid 
tumor cells relies on surface markers associated with their tissue origin, in combination with 
exclusion markers for hematopoietic cells such as pan-CD45. Of note, loss or downregulation of 
major histocompatibility (MHC) or human leukocyte antigen (HLA) class I molecules due to the 
mutation or deletion of beta-2-microglobulin (ß2m) represents one of the major tumor escape 
strategies in vivo by human tumors as well as murine tumor models. Thus, class I (mouse H-2) or 
HLA class I (human) surface staining by flow cytometry is highly recommended for all 
immunological experiments with solid tumor cells [7]. In addition to HLA class I molecules, ligands 
for NK-cell receptors, NKG2D ligands (NKG2DL) are important for the definition of the sensitivity of 
tumor cells towards NK-cell recognition and elimination [8]. The expression of MHC class I 
molecules by tumor cells determines the recognition by CD8+ cytotoxic T cells with specificity for 
MHC/peptide complexes derived from tumor-associated antigens. In contrast, MHC class I 
molecules, human HLA-C in particular, serve as inhibitory ligands for NK cells by specific binding 
to inhibitory receptors of the killer-immunoglobuline–like (KIR) and C-type lectin (CD94/NKG2A) 
receptors, respectively. This negative signaling is balanced by positive signals of activating NK cell 
receptors that recognize expression of particular ligands on the surface of tumor cells. For 
example, NKG2D (CD314) belongs to the receptors expressed by NK and T cells that are 
conserved between humans, non-human primates and rodents. In order to investigate the 
immunogenicity of tumor cells, it is therefore, recommended to determine the surface expression of 
NKG2D ligands on human or mouse tumor cells. Details of ligands and monoclonal antibodies are 
given in Table 10.2.1 (human) and 10.2.2 (mouse). Moreover, these ligands for T-cell and NK-cell 
receptors can also be targeted by oncogenic signaling of mutated MAP kinase signaling [9]. 
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Surface expression of adhesion molecules such as ICAM-1, and VCAM should also be included in 
the flow cytometric characterization of solid tumor cells due to their increased expression upon 
development of metastases in human tumors and mouse models and, thus, their relevance for T-
cell and NK-cell activation, as well as formation of metastases. Besides these surface molecules, 
which are commonly expressed by non-malignant as well as malignant cells of both hematopoietic 
and parenchymal origin, solid tumor cells should be also characterized by markers of their tissue 
origin. Splice variants of CD44, especially CD44v6, have a long-standing and controversial history 
as potential “tumor stem cell” markers, together with the hematopoietic stem cell markers CD34, 
CD133 with a recent revival of CD24 as potential prognostic marker for some carcinomas [10,11]. 
A selection of the most relevant human cancers, grouped into carcinomas, sarcomas, 
neuroectodermal tumors and their tumor biology, “the hallmarks of cancer”, is given in this short 
chapter with the respective recommendation for their flow cytometric characterization.  
 
10.4.2. Solid tumors – human carcinomas 
Carcinomas, i.e. epithelial tumors, represent the most frequent human cancers [12] and their 
malignant transformation is often based on “driver mutations” in growth factor receptors, receptor 
tyrosine kinases, in particular, as well as their downstream signaling pathways. For the 
identification of carcinoma cells, epithelial markers such as cytokeratin (CK) 18 and 8 are useful 
although they have to be detected by intracellular staining procedures [13]. In addition, epithelial 
cells express selectively growth factors like epidermal growth factor receptor (EGFR), platelet-
derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), Her-2, c-Met 
and others [14]. These surface receptors often directly contribute to tumorigenesis by carrying 
“tumor-driving mutations” in their signaling domains; providing constitutive proliferative signals 
independently from the availability of growth factors. Therefore, these receptors can be useful for 
the identification and characterization of tumor cells in terms of their growth factor receptor 
repertoire. Importantly, the intracellular protein vimentin serves as specific marker for the 
discrimination from fibroblasts.    
Some of the most frequent human carcinomas are listed here with their originating epithelial cell 
type (Table 10.4.2). 
 
10.4.3 Solid tumors – human sarcomas 
Mesenchymal tumors, i.e. sarcomas [21], develop from tissue cells originating from 
mesenchymal progenitors and manifest primarily in soft tissue like fat, muscle, tendons, nerve or 
connective tissue cells, blood and lymph vessels or fibroblasts (Table 10.4.3). The family of Ewing 
osteosarcomas comprises a severe form of juvenile sarcoma with manifestations preferentially in 
bone, bone marrow and organs like lung or rarely kidney. For the flow cytometric detection of 
Ewing sarcoma cells in peripheral blood of patients, CD99, the MIC2 gene product, normally 
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expressed by osteoclasts and leukocytes, has been proposed in the absence of the pan-leukocyte 
marker CD45 [22]. Kaposi’s sarcoma represents a virally induced form of sarcoma mediated by the 
human herpesvirus 8 (HHV8) also called Kaposi’s sarcoma-associated herpesvirus (KSHV). The 
viral HHV8 genome contributes to the pathophysiology and tumorigenesis by its manipulation of 
mechanisms regulating viral latency and lytic replication [23]. For bone and soft tissue sarcomas, 
dysregulation of the Hippo signaling pathway has been shown to affect several surface receptors 
including EGFR, E-cadherin, CD44 and tight junctions indicating that oncogenic signaling can 
impinge on the stability of these surface receptors as markers for sarcoma cells [24].  
 
10.4.4 Solid tumors – human neuroectodermal tumors 
Neuroectodermal tumors, i.e. malignant cells derived from neuroectodermal cells, belong to less 
prevalent but life-threatening cancers such as melanoma (black skin cancer) and several forms of 
brain cancer (Table 10.4.4). In malignant melanoma, melanocytes originating from 
neuroectodermal cells acquire “driver” mutations in components of the MAK kinase signaling, most 
frequently in the BRaf kinase with the highest prevalence of the BRafV600E mutation or the upstream 
NRas GTPase [25]. Although these mutations cannot directly be utilized for the flow cytometry of 
melanoma cells, their mutation status may have an impact on the recognition by T cells and NK-
cells [26, 27]. Several forms of brain cancers are derived from neuroectodermal cells including 
some the most aggressive brain tumors like glioblastoma with malignant cells derived from glial 
cells [28]. Besides their poor MHC expression, glioblastoma cells utilize a broad selection of 
immune evasion strategies that are in part responsible for their aggressive nature and the resulting 
poor survival of glioma patients [29]. Other forms of brain tumors are represented by astrocytomas, 
a group of differentially graded variants, i.e. diffuse, polycystic and anaplastic astrocytoma with 
different degrees of aggressiveness. Due to the lack of reliable surface markers, molecular 
characterization, i.e. expression profiling, is currently used for a more detailed classification at the 
level of gene profiles, signaling pathways, and regulatory networks. Despite these molecular 
analyses, the cellular origin is still controversially discussed ranging from stem cell-like precursors 
to neuronal stem cells [30].  
 
10.5. Characterization of murine tumor cells  
For the flow cytometric characterization of murine tumor cells, both hematopoietic tumors like 
mouse leukemias and lymphomas, and solid tumors like carcinomas of the mouse breast, liver or 
colon, melanomas or sarcomas, the same recommendations can be applied as outlined for human 
tumor cells. Since the numerous mouse tumor models cannot be discussed here comprehensively, 
only general remarks are provided regarding flow cytometry of murine tumor cells. Mouse solid 
tumor cells are also classified into carcinomas, sarcomas and neuroectodermal tumors, 
respectively, depending from their originating tissue. Therefore, the same surface molecules can 
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be utilized for their characterization by flow cytometry, which are listed on Table 10.2.2. showing a 
selection of known monoclonal antibodies for mouse antigens and the protocols do not differ from 
the general protocols of direct, indirect surface and intracellular staining (Chapter VII, section 2: 
“Surface parameters” and section 3: “Intracellular parameters” of this guideline). The recent clinical 
advances in immunotherapy of human solid tumors could only be achieved using sophisticated 
preclinical mouse models. Since the early days of transplanted tumor cells into immunodeficient 
mice, numerous elegant mouse models with spontaneously developing tumors based on germline 
or inducible mutations have been developed in the past decade [31]. More recently, humanized 
mouse models with severely immunodeficient mice, reconstituted with human peripheral or even 
hematopoietic stem cells, have gained tremendous insight into immune recognition of human 
tumor cells, escape mechanisms and opened the door for new therapeutic approaches that finally 
made their way into clinical application [32]. 
 
10.6. Solid tumors – general hallmarks of cancer 
The various alterations involved in this process of malignant transformation are elegantly 
summarized in “Hallmarks of cancer – the next generation” by Hanahan and Weinberg 2011 [33]. 
In order to become a tumor cell, the basic cellular mechanisms regulating contact inhibition, 
proliferation (e.g. Hayflick limit), sensitivity towards cell death like apoptosis, necrosis, necroptosis, 
ferroptosis etc. as well as cellular senescence, energy metabolism, have to be targeted and 
dysregulated to favor an unlimited survival strategy of the malignant cell. With respect to the 
cancer microenvironment, in particular for solid tumors, angiogenesis and immunity have to be 
high-jacked in order to guarantee supplementation of nutrition simultaneously to independence 
from the availability of exogenous growth factors on one hand, and to allow evasion of immune 
recognition on the other hand.  A lot of these mechanisms can be detected using flow cytometry 
and the most relevant examples are summarized in Chapter VI, starting with surface expression of 
hematopoietic, epithelial, endothelial and neuroectodermal markers for the classification of tumor 
cells according to their cellular origin. The malignant transformation can be studied using low 
cytometry by the quantification of cell cycle, proliferation, signaling pathways, apoptosis, necrosis 
and other cell death pathways such as autophagy. As mentioned before, immune evasion 
strategies such as downregulation or loss of MHC class I molecules and simultaneous expression 
of ligands for inhibitory receptors like the PD-1 ligand PD-L1 (B7-H1) or B7-H4 undermines  tumor-
specific immune responses by an induction of T-cell unresponsiveness, anergy and, eventually, T-
cell death. Therefore, flow cytometric analysis of the surface receptor expression of these ligands 
is important for the determination of the immunogenicity of tumor cells, ideally assessed in parallel 
to non-transformed “healthy” tissue cells. Taken together, the detailed knowledge regarding the 
repertoire of growth factor receptors as well as ligands for immune receptors, primarily provided by 
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flow cytometry, is instrumental for the improvement of existing and the development of novel 
therapeutic strategies against all types of cancers [34].    
 
 
Table headlines: 
Table 10.2.1 Collection of surface molecules for flow cytometry cell sorting staining of human solid 
tumor cells 
Table 10.2.2 Collection of surface molecules for flow cytometry cell sorting staining of murine solid 
tumor cells 
Table 10.4.2: Overview of the most frequent human carcinomas 
Table 10.4.3: Overview of the most frequent human sarcomas 
Table 10.4.4: Overview of the most frequent human neuroectoderma tumors 
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New table numbers given, with old numbers in brackets. 
 
Ch II S1 Table 1 (1): Example of sort performance metrics. 
Purity Yield Orig -log(Y-) log(Fe) 
% % %     
95 100 50 1.28 1.28 
95 90 50 1.32 1.28 
95 10 50 2.28 1.28 
99 90 1 4.04 3.99 
95.6 90 0.1 4.38 4.34 
 
Ch II S2.2 Table 2 (1): Expected purities, yields and processing times for different 
starting cell concentrations 
Total cells/mL 106 107 108 
 
Purity in Yield Sort[%] 
Yield in Purity Sort[%] 
Time to process cells  
 
96 
96 
309 
 
69 
64 
31 
 
18 
11 
3:05 
 
Ch III S1 Table 3 (1): The consequences of using positive and negative populations 
with differing autofluoresence.  
  
       Fluorescence (MFI) 
 
 
 
FITC 
 
PE 
 
SOV 
Cells (+) 3,135 903 n/a 
Cells (-) 95 78 27% 
Beads (-) 107 228 22% 
 Ch III S2 Table 4 (1): Suggested maintenance intervals for different instrument components. 
System Component Observation/ Read out Reason/  
Maintenance 
Frequency 
of checking 
Optics 
Laser/ LED/  
Light source 
measured decline of power output exchange light 
source 
upon request 
high %CVs (performance test 
failed) 
Realign Optic upon request 
Weak or shifting signals Laser Delay routinously 
Filter/ Beam 
Splitter 
Performance fail Ageing seldom 
Impaired Scatter or Fluorescence 
signals  
Dust frequently 
PMT/ Diode/ 
Detector 
When loss of sensitivity is observed Sensitivity routinously 
Define Min. Volt and Max. Volt to 
know the linear detection range for 
each detector 
Linearity (3) after initial 
installation or 
changing 
components 
Fluidics 
Saline-Filter 
Weak or no signals Venting routinously 
unexpected scatter signals / high 
background 
Replacement every 6 
month 
Tubing 
High carry over between samples Cleaning after usage 
Unwanted dead cell staining for the 
sample 
Bleaching after usage 
of DNA-Dyes 
No signals/ Clog Sonicate or 
exchange 
upon request 
Flow cell/ 
Cuvette 
unexpected scatter signals / high 
background 
Cleaning inside upon request 
 Storage over night after usage 
Pressure 
system 
Unstable flow Cleaning or replace 
sealing, if leaky 
upon request 
Ball Seal 
No signals / Sample tube is filling 
up 
Replacement every 6 
month 
Pump tubing 
e.g. wrong volumetric counting Exchange every 6 
month 
Sheath Tank 
 Refill routinously 
 Cleaning 2-3 times/ 
year 
Waste tank  Empty routinously 
HTS 
Carry over between samples Cleaning after usage 
Stop during operation Alignment upon request 
Volumetric 
Pump 
Wrong cell counting Replace tubing Upon 
request/ bi-
monthly 
Computer/ 
Software 
Database 
System is slowing down Backup / Size 
control 
usage 
dependent 
Hard drive System is slowing down Defragmentation monthly 
Cell Sorting 
Deflection 
plates 
Spray in drop deflection Cleaning routinously 
Camera optics Additional scattering signals Cleaning routinously 
ACDU 
Poor plating efficiency  Adjustment in front of 
sort 
Drop delay 
Poor Yield, lower purity Adjustment In front of 
sort 
Nozzle 
Unstable droplet break off Cleaning or 
degas Sheath tank 
upon request 
Leakage Exchange upon failure 
Unsterile sorting Cleaning  
Cuvette/ Flow 
cell 
Additional background/ lower 
sensitivity 
Remove dust and 
salt 
Upon request 
Cooling 
System 
Bacterial growth in water bath Cleaning and 
replacing cooling 
water 
1-2 times/ 
year 
 Ch III S2 Table 5 (2): Summary of critical parameters defining the optical performance 
of a flow cytometer. 
Parameter A measure for … Recommended Value 
SDEN … electronical noise as low as possible 
%rCV … Laser alignment as low as possible 
Qr … Detector efficiency as high as possible 
Br … the channel background as low as possible 
Signal to Noise ratio … sensitivity of Detector as high as possible 
 
Ch V S3 Table 6 (1). The number of acquired events, for a cell population with final 
frequency 0.01%. 
Acquired events (N) 100,000 1,000,000 4,010,000 10,000,000 
Positive (R) 10 100 401 1,000 
Proportion (P) 0.0001  0.0001  0.0001  0.0001  
Variance (Var) 10.0 100.0 400.6 999.9 
Standard deviation (SD) 3.16 10.0 20.1 31.62 
Coefficient of Variation (CV) 31.62 10.00 4.99 3.16 
 
Ch VI S3Table 7 (1): Comparison of two data sets X and Y in a rank analysisa).  
Y-group   y1   y2  y3 y4 
X-group x1 x2  x3 x4  x5   
values 3 7 9 15 23 31 36 44 51 
Rank 1 2 3 4 5 6 7 8 9 
 
  
 Ch VI S3 Table 8 (2): Part of the Mann-Whitney probability table example for the X-
group size of Table 7 (N=5).  
U N1 = 1 N1 = 2 N1 = 3 N1 = 4 N1 = 5 
0 .167 .047 .018 .008 .004 
1 .323 .095 .036 .016 .008 
2 .500 .190 .071 .032 .016 
3 .667 .286 .125 .056 .023 
4  .429 .196 .095 .048 
5  .571 .286 .143 .075 
6   .393 .206 .111 
7   .500 .278 .155 
8   .607 .365 .210 
9    .452 .271 
 
Ch VI S3 Table 9 (3): Kolmogorov-Smirnoff (K-S) statistic critical values, Dc, with their 
associated P-values (probabilities) 
Dc 1.0727 1.2238 1.3581 1.5174 1.6276 1.7317 1.8585 1.9525 
p 0.200 0.100 0.050 0.020 0.010 0.005 0.002 0.001 
 
 
 
Ch VI S3 Table 10 (4): Hypothetical results of the same determinations from two 
different laboratories. 
Sample 1 2 3 4 5 6 7 8 9 10 
Lab A .61 .23 .31 .11 .41 .19 .10 .03 .07 .17 
Lab B .54 .38 .42 .20 .36 .27 .21 .11 .14 .12 
 
Ch VI S3 Table 11 (5): Ranking of the data from Table 10 with rank differences, d, and 
d2 
Sample 1 2 3 4 5 6 7 8 9 10 
Lab A 10 7 8 4 9 6 3 1 2 5 
Lab B 10 8 9 4 7 6 5 1 3 2 
Rank difference, 
d 
0 -1 -1 0 2 0 -2 0 -1 3 
d2 0 1 1 0 4 0 4 0 1 9 
 
Ch VI S3 Table 12 (6): Differences between values from Table 4 by subtracting Lab B 
results from those of Lab A. 
Sample 1 2 3 4 5 6 7 8 9 10 
Lab A .61 .23 .31 .11 .41 .19 .10 .03 .07 .17 
Lab B .54 .38 .42 .20 .36 .27 .21 .11 .14 .12 
Sample difference, d .07 -.15 -.11 -.09 .05 -.08 .-11 -.08 -.07 .05 
d2 .0049 .0225 .0121 .0081 .0025 .0064 .0121 .0064 .00
29 
.0025 
 
Ch VI S3 Table 13 (7): Results of the immunofluorescence analysis example, taken 
from Watson (2001) [17] 
Sample 1 2 3 4 5 6 7 8 9 10 
Lab A .61 .23 .31 .11 .41 .19 .10 .03 .07 .17 
Lab B .54 .38 .42 .20 .36 .27 .21 .11 .14 .12 
Sample difference, d .07 -.15 -.11 -.09 .05 -.08 .-11 -.08 -.07 .05 
d2 .0049 .0225 .0121 .0081 .0025 .0064 .0121 .0064 .0029 .0025 
 
Ch VI S3 Table 14 (8): Illustration of potential interpretation problems when counting 
extremely rare cellsa).  
Sample 1 2 3 4 
   
  6 2 6 8 
   
  3 7 1 6 
   
  1 3 5 3 
   
  1 4 5 6 
   
  1 4 6 3 
   
Mean 2.4 4 4.6 5.2 
   
St.Dev 2.2 1.9 2.1 2.2 
    
Overall mean:  4.1 
 
Overall St.Dev: 2.2 
 
 
  
 Ch VI S4 Table 15 (1): Important provided data for cytometric publications. (*part of 
MiFlowCyte). 
Data set Details 
 
Sample/Specimen 
 
Type*, source*, source treatment*, taxonomy, age*, gender*, 
phenotype*, genotype*, location* 
Sample Treatment 
 
Analytes*, Ab clone*,  names/numbers*, manufacturer*, catalogue 
numbers* 
Reagents 
 
Concentration, purity 
Controls Quality Control Measures*, FMOs*, 
Positive/negative control* 
 
Instrument 
 
Manufacturer*, model*, configuration*, settings*, detector voltages*, 
optical filters* 
 
Data Analysis 
 
List-mode data file*, compensation*, gating* 
  
Ch VI S5 Table 16 (1): Overview of repositories for flow cytometry data. 
Name URLs and References Technical Notes and Highlighted Features 
Cytobank http://www.cytobank.org/ 
PMID: 24590675 
PMID: 20578106 
Free community version, requires registration 
Web access 
Advanced online data analysis options in paid versions 
Extended CyTOF data support 
FlowRepository https://flowrepository.org/ 
PMID: 22887982 
PMID: 22752950 
 
Free and open source, no registration required to download 
data 
Web access, R library, FlowJo plugin 
Full MIFlowCyt support 
Basic online data analysis options 
Integrated FCS de-identification (optional) 
Included in Thomson Reuters Data Citation Index 
Recommended by Nature, Cytometry Part A and PLOS 
journals 
ImmPort https://immport.niaid.nih.gov/ 
PMID: 24791905 
Free, requires registration and approval 
Web access 
Data from dozens of assay types including cytometry 
Online data analysis tools 
Templates for data deposition, management and 
dissemination 
Used mainly for NIAID/DAIT funded studies 
ImmuneSpace https://www.immunespace.org/ 
PMID: 24441472 
Free, requires registration 
Web access, R library 
Database and analysis engine that leverages ImmPort 
infrastructure 
Exploring, integration and analyses of data across assays 
Ontology support through standards-aware data templates 
Used mainly for HIPC data 
 Ch VII S4 Table 17 (1). Cytokine assay reagents.  
Target Bead ID 
IL-10 A4 
IFN-g A5 
IL-5 A6 
IL-2 A7 
TNF-a A8 
CM-CSF A10 
IL-4 B2 
IL-17F B3 
IL-9 B4 
IL-17A B5 
IL-13 B6 
IL-22 B7 
IL-6 B9 
 Ch VII S6.2 Table 18 (1): Methods for the detection of antigen-specific T cells. 
Detection 
Method 
Duration Commonly used markers Cell Type Disadvantages 
Proliferation 3-5 days  CD4+ and CD8+ 
Bystander proliferation may occur 
Selective outgrowth of single clones 
No direct quantification of specific cells 
Phenotypical and functional changes during long-
term in vitro culture 
Cytokine 
secretion 
5-12 hours (different 
cytokines may have 
different kinetics) 
TNF-α CD4+ and CD8+ 
Restricted to preselected cytokine producers;  
Non-cytokine producing Tcells (e.g. naive, Treg) are 
neglected 
IFN-γ CD4+ and CD8+ 
IL-2 CD4+ and CD8+ 
IL-4, IL-5, IL-9, IL-10, IL-13, IL-17A, 
IL-17F, IL-21, IL-22, GM-CSF, ... 
mainly CD4+ 
GARP/LAP/TGF-β Treg 
Activation 
marker 
5 hours - several 
days (different 
activation markers 
have different 
kinetics) 
CD69 (3 till 24 hours) CD4+ and CD8+ Sensitive to bystander activation 
CD25 (24 till <72 hours) CD4+ and CD8+ 
Sensitive to bystander activation; late up-regulation; 
constitutively expressed by Treg 
HLA-DR (24 till <72 hours) CD4+ and CD8+ Late up-regulation  
CD134 (OX-40)  (48 till 72h) CD4+ and CD8+ Late up-regulation 
CD154 (CD40L) (6 till 16 hours) mainly CD4+ Restricted to CD4+ T cells; not expressed on Treg 
CD137 (4-1BB) (6 till 24 hours) 
Treg (6h), later also on 
CD4+Tcon and CD8+ 
Detection Treg requires co-staining with CD154; On 
CD4+ and CD8+ Tcon sensitive to bystander 
activation 
Cytotoxicity 1-6 hours 
Perforin mainly CD8+ 
Restricted to preselected cytotoxic marker; non-
cytotoxic T cells are neglected 
Granzyme A mainly CD8+ 
Granzyme B mainly CD8+ 
CD107a mainly CD8+ 
 Ch VII S7 Table 19 (7.1 or 1): Approaches for determining cell proliferation. 
Nucleotide incorporation/dye dilution Determination of cell divisions 
5-bromo-2'-deoxyuridine (BrdU) 1-2 
BrdU / Hoechst / PI (quenching) technique 3-4 
Dye dilution > 4 
 
Ch VII S8.6 Table 20 (1): Main fluorescent probes used to stain mitochondria in intact, 
living cells. 
Full name Short name Abs (nm) Em 
(nm) 
Fixable 
   
Mitochondrial membrane potential  
3,3’-dihexyloxacarbocyanine iodide DiOC6 484 501 No 
Rhodamine 123 Rh123 507 529 No 
5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl-benzimidazolcarbocyanine JC-1 514 529/590 No 
3,3’-dimethyl-lpha-naphthox-acarbocyanine iodide JC-9 522 535/635 No 
Tetramethylrhodamine ethyl ester TMRE 549 574 No 
Tetramethylrhodamine methyl ester TMRM 548 573 No 
Mitotracker Red CMXRos   578 599 Yes 
  
Mitochondrial mass  
Nonyl Acridine Orange NAO 495 519 No 
Mito ID Red  558 690 Yes 
Mitotraker Green FM  489 517 No 
Mitotraker Deep Red 633  644 665 Yes 
Mitotracker Red 580  581 644 No 
  
Mitochondrial reactive oxygen species  
MitoSOX Red mitochondrial superoxide indicator MitoSOX 510 580  
Mitochondria Peroxy Yellow-1 MitoPY-1 510 528/540  
 
Ch VII S10 Table 21 (1): Autophagy inducers for primary immune cells.  
Primary Cell Type Autophagy Inducer 
T cells CD3/CD28 (highest after 4 days) 
B cells IgM, megaCD40L (CD40L construct, Enzo life sciences) 
Monocytes LPS, IFN- 
Macrophages LPS, IFN- 
 Ch VII S15 Table 22 (1): Most common transcription factors measured by flow 
cytometry.  
Transcription 
Factors 
Cell type Cellular location 
AHR Liver, Treg and Th17 cells cytoplasm 
Aiolos B, T and NK cells nucleus 
AIRE 
dendritic cells, lymph node, lymphoid stromal cells, and 
monocytes 
perinuclear region 
(??) 
BATF B and T cells nucleus 
Bcl-6 
B cells and CD4+ T follicular helper cells and memory T 
cells 
nucleus 
β Catenin 
several non-immune tissues, B, T, and hematopoietic stem 
cells 
cytoplasm / 
nucleus 
Blimp1 B, T, dendritic and some NK cells cytoplasm 
c-Maf neural, ocular and hematopoietic systems nucleus 
c-Rel Treg, mature T cells 
cytoplasm / 
nucleus 
E4BP4 NK, NKT, and dendritic cells nucleus 
Egr1 B, T and myeloid cells. 
cytoplasm / 
nucleus 
Egr2 (B),  T and NKT cells 
cytoplasm / 
nucleus 
Eomesodermin / 
TBR2 
NK and T cells nucleus 
Eos T cells and nervous system transmembrane 
FoxJ1 ciliated epithelial cells, naive B and T cells nucleus 
FoxP3 
CD4+CD25+ regulatory T cells (Treg cells), and 
CD4+CD25- cells 
cytoplasm / 
nucleus 
Gata-3 
central nervous system, kidney, mammary glands, skin,  
and T cells 
nucleus 
Helios / IKZF2 T and hematopoietic stem cells nucleus 
IkB-zeta macrophages, monocytes, B and T cells nucleus 
IRF4 macrophages, B  and T cells 
cytoplasm / 
nucleus 
Nanog 
 blastocyst, embryonic stem (ES) cells, and embryonic 
germ (EG) cells. 
nucleus 
NFkB almost all cell types 
cytoplasm / 
nucleus 
NFTA T cells 
cytoplasm / 
nucleus / 
transmembrane 
Notch1 
 thymocytes, bone marrow hematopoietic stem cells, T and 
NK cells 
cytoplasm / Golgi/ 
nucleus / 
transmembrane 
Notch2 activated peripheral T cells, bone marrow and thymocytes,  
cytoplasm / Golgi/ 
nucleus / 
transmembrane 
Notch3 
CNS, some thymocyte subsets,  vascular smooth muscle, 
and T cells 
cytoplasm / Golgi/ 
nucleus / 
transmembrane 
Notch4 
CD8+ splenic dendritic cells, endothelial cells, and 
macrophages 
cytoplasm / Golgi/ 
nucleus / 
transmembrane 
Nurr77  thymocytes and T cell  
cytoplasm / 
nucleus 
OCT3/4 
embryonic stem (ES) and induced pluripotent stem (iPS) 
cells 
nucleus 
Pax5 hematopoietic cells, B cells nucleus 
PLZF CD4 and CD8+ T cells, gamma delta T cells and NK. 
cytoplasm / 
nucleus 
RORγ 
heart, kidney, liver, lung, muscle, and  CD4+CD8+ 
thymoycte cells 
nucleus 
Runx1 / AML1 hematopoietic, myeloid, B and T cells 
cytoplasm / 
nucleus 
Sox2 embryonic stem (ES) cells and neural cells 
cytoplasm / 
nucleus 
T-bet B cells and CD4+ T cell lineage nucleus 
ThPOK 
hematopoietic cells, skin, heart, smooth muscle, and liver, 
invariant natural killer T (iNKT) cells and gamma delta T 
cells 
nucleus 
TOX 
thymocytes, T lymphocytes, NK cells, and lymphoid tissue-
inducer (LTi) cells 
nucleus 
 
Ch VII S16 Table 23 (1): Worksheet for timed addition of reagents for 15 minute (max) 
LPS activation of whole blood. 
Work Sheet for Kinetics of LPS Activation Experiment (Figure 4) 
 
     
    Time of Addition Time of Addition 
Time of 
Addition 
Tube 
No. Tube Label  LPS Formaldehyde Triton X-100 
1 LPS 15' 0:00 15:00 25:00 
2 LPS 10' 5:10 15:10 25:10 
3 LPS 8' 7:20 15:20 25:20 
4 LPS 6' 9:30 15:30 25:30 
5 LPS 4' 11:40 15:40 25:40 
6 LPS 2' 13:50 15:50 25:50 
7 Unstimulated control   16:00 26:00 
8 CD14-PC7/CD45-KrO only   16:10 26:10 
     
 
Unstimulated control:   
Vortex and put into 37C water bath at 
14:00 
 
 
CD14-PC7/CD45-KrO only:   
Vortex and put into 37C water bath at 
14:10 
 
     
 
Blood samples:   100uL 
  
 
Addition of LPS:   
2uL of 50ug/mL PBS; final concentration 100ng per 100uL 
blood 
 
Addition of Formaldehyde:   65uL of 10% solution: final concentration 4% 
 
Additon of 0.1% Triton X-
100:   1mL of 0.1% Triton X-100/PBS 
 
 
Ch VII S17 Table 24 (1): List of cell permeable dyes described in this chapter, along 
with solvents, working concentrations and storage conditions. 
Solution 
 
Suppliera) Solvent (Stock) Working concentration Storage  
6-NBGD (Life Technologies, 
#N23106) 
dH2O (100 mM) 300 µM -20°C  
DCFDA Therno Fisher 
(#D399) 
DMSO (100 mM) 1 µM -20°C  
DIOC6 Sigma-Adrich 
(#318426) 
EtOH (40µM) 1nM- 40nM -20°C 
MitoTracker 
Green FM 
Cell signalling 
(#9074S) 
DMSO (1mM) 5-10 nM -20°C 
MitoTracker Red 
FM 
Thermo Fisher  
(#M22425) 
DMSO (1mM) 50-100 nM -20°C 
TMRE Life Technologies 
(#T668) 
MeOH or 
DMSO 
(20 M) 20nM -20°C 
 
Ch VIII S2 Table 25 (1): Phenotypic differentiation of B lineage cell subsets based on 
their characteristic expression of surface markers*. 
B cell population (CD19+) Phenotype/Subphenotype 
Transitional  
T1+T2 CD24++CD38++CD10+CD27-IgM++ 
Naive  
Resting CD24+/-CD38+/-CD27-IgM++/+IgD++CD21+CD95- 
Activated CD24-CD38-CD27-IgM++IgD++CD21-CD95+MTG+ 
Memory (Ki-67-)  
Pre-switched IgM+IgD+/-CD27+CD1c+ 
Switched IgG/IgA+CD27+CD21+ 
 
Atypical memory 
a) Double negative IgD-CD27- 
b) activated double negative IgD-CD27-CD95+ 
c) Syk++ IgD+/-CD27-CD95+/-CD21+/-CD38-MTO-Syk++ 
d) tissue-resident IgM/IgG/IgA+CD27-FcRL4+ 
Marginal Zone  
Spleen IgD+IgM+CD27++CD21++CD1c+ 
Circulating IgD+IgM+CD27+CD1c+ 
Antibody secreting cells  
Circulating 
PB CD38++CD27++CD138-Ki-67+ 
PC CD38++CD27++CD138-Ki-67+ 
Bone marrow 
a) CD19+ PC CD19+CD38++CD27++CD138+Ki-67- 
b) CD19- PC CD19-CD38++CD27++CD138+Ki-67- 
 
  
 Ch VIII S4 Table 26 (1): Selection of important markers for flow cytometry analysis of 
mouse and human ILC. 
 Mouse Human 
 
NK 
cells 
CD127+ 
ILC1 
ILC2 NCR- 
ILC3 
NCR+ 
ILC3 
NK 
cells 
CD127+ 
ILC1 
ILC2 NCR- 
ILC3 
NCR+ 
ILC3 
Marker 
CD127 - + + + + lo/- + + + + 
CD117 lo/- - +/- - lo lo/- - +/- + + 
CD25 - lo + + ND +/- lo + +/- lo 
IL-23R - lo/- - + + lo +/- lo + + 
IL-17RB - - + - - - lo/- + ND - 
ST2 - - + - - - ND + ND - 
IL-1R1 - lo ND + + +/- lo/- lo + + 
CCR6 - - - +/- - - + + + + 
RANKL lo/- ND ND + + - ND ND + + 
CRTH2 ND ND ND ND ND - - + - - 
ICOS - ND + + + - + + + + 
NK1.1/CD161 + + - - lo/- +/lo + + + + 
CD56 NA NA NA NA NA + - - +/- +/- 
CD94 +/- ND +/- - +/- +/- - - - - 
CD16 +/- ND - - - +/- - - - - 
NKp30 NA NA NA NA NA + ND +/lo +/- + 
NKp44 NA NA NA NA NA +a - - - + 
NKp46 + + - - + + - - - + 
Ly49/KIR +/- lo - - - +/- - - - - 
CD57 NA NA NA NA NA +/- ND ND ND ND 
CD27 +/- + - - - +/- + - - - 
CD11b +/- - - ND ND +/- ND ND ND ND 
Perforin + lo - - - + - - - - 
Transcription factors 
T-bet + + - +/- + + + - - - 
Eomes + - - - + + - - - - 
RORt - - - + + - - -/lo + + 
GATA3 lo lo + lo lo lo lo + lo lo 
Cytokines 
IFN + + -/lo -/lo -/lo + + - - - 
IL-22 - - lo + + - - lo lo/- + 
IL-17 - - - +/- - - - - + - 
IL-13 - - + - - lo - + - lo 
IL-5 - - + - - - - + - - 
 
  
 Ch VIII S5 Table 27 (1): NK cell phenotypes. 
(A) Receptor Ligand CD56bright CD56dim 
          
A
ct
iv
at
io
n
 
NKG2C (CD159a) HLA-E  - subsets 
NKG2D (CD314) 
MIC-A - MIC-B - 
ULPBs 
 - Subsets 
KIR2DS1 (CD158h) HLA-C2  - subsets 
KIR2DS2/3 (CD158j)  ???  - subsets 
KIR2DL4 (CD158d) HLA-G  - subsets 
KIR2DS4 (CD158i) HLA-A*11 and HLA-C  - subsets 
KIR2DS5 (CD158f) ???  - subsets 
KIR3DS1 (CD158e1) HLA-Bw4  - subsets 
NKp30 (CD337) B7-H6 - BAG6/BAT3  ++  + 
NKp44 (CD336) 21spe-MLL5 only on activated cells 
NKp46 (CD335) 
CFP (properdin), 
haemagglutinin, 
PfEMP1 
 ++  + 
NKp80 AICL  +  + 
DNAM1 (CD226) 
Nectin-2 (CD112), 
PVR (CD155) 
 +  + 
2B4 (CD244) CD48 All mature NK cells 
NTB-A (CD352) NTB-A (CD352) All mature NK cells 
CRACC/CS1 (CD319) CRACC/CS1 (CD319) All mature NK cells 
Tactile (CD96) PVR (CD155) All mature NK cells 
FcγRIII (CD16) IgG  -/+  +/++ 
  
          
In
h
ib
it
io
n
 
NKG2A/KLRD1 
(CD159a/CD94) 
HLA-E  + subsets 
KIR2DL1 (CD158a) HLA-C2  - subsets 
KIR2DL2/3 (CD158b) HLA-C1  - subsets 
KIR2DL4 (CD158d) HLA-G  - subsets 
KIR2DL5 (CD158f) ???  - subsets 
KIR3DL1 (CD158e1) HLA-Bw4  - subsets 
KIR3DL2 (CD158k) HLA-A*03 and *11  - subsets 
ILT2/LIR-1 (CD85J) Different MHC-I alles  - subsets 
PD-1 (CD279) 
PDL1 (CD274) 
PDL2 (CD273) 
 - subsets 
Siglec-7 (CD328) Ganglioside DSGb5  +  + 
IRP60 (CD300a) 
α-herpes virus 
Pseudorabide virus 
Phosphatidylserine 
Phosphatidylethnola
mine 
 +  + 
TIGIT PVR (CD155) All mature NK cells 
          
(B)  Receptor Ligand CD56bright CD56dim 
          
A
d
h
es
io
n
 
LFA-1 (CD11a/CD18) 
ICAM-1, ICAM-2, 
ICAM-3 
 -/+  ++ 
LFA-2 (CD2) CD15, CD58, CD59 Most of mature NK cells 
LFA-3 (CD58) CD2, CD48, CD58 Most of mature NK cells 
MAC-1 (CD11b/CD18) 
iC3b, C4b, ICAM-1, 
fibrinogen 
most of circulating NK, up-
regulated upon activation 
ICAM-1 (CD54) LFA-1, MAC-1  ++  +/- 
N-CAM (CD56) ???, FGFR  ++  + 
HNK-1 (CD57) ???  - subsets 
L-Selectin (CD62L) 
GLyCAM-1 MadCAM-
1 
 ++ subsets 
  
          
C
yt
o
ki
n
e
 /
C
h
em
o
ki
n
e
 r
ec
ep
to
rs
 IL-2Rα (CD25) IL-2  +  - 
IL-2Rβ/IL-2Rγ 
(CD122/CD132) 
IL-2 AND IL.15 Almost all PB NK cells 
c-Kit (CD117) SCF (KL)  +  - 
IL7Rα (CD127) IL-7  +  - 
CXCR1 (CD181) CXCL8 (IL-8)  -  ++ 
CXCR3 (CD183) 
CXCL9, CXCL10, 
CXCL11 
 ++ Subsets 
CXCR4 (CD184) CXCL2 Subsets of PB NK cells 
CCR5 (CD195) 
RANTES, CCL3 
(MIP1α) and CCL4 
(MIP1β) 
Subsets of PB NK cells 
CCR7 (CD197) CCL19, CCL21  +  - 
IL-18R (CD218a) IL-18  ++  + 
ChemR23 Chemerin  -  + 
CX3CR1 Fraktaline  -  + 
          
D
e
at
h
 
R
e
ce
p
to
rs
 Fas/APO-1 (CD95) Fas ligand (CD95L) Activated NK cells 
Fas ligand (CD95L) Fas/APO-1 (CD95) 
Activated NK cells 
They induce target apoptosis 
CD40L (CD154) CD40 
TRAIL (CD253) 
DR4 (TRAIL-R1), DR5 
(TRAIL-R2) 
          
O
th
er
 
su
rf
ac
e
 
m
o
le
cu
le
s LAMP1 (CD107a)  --- 
Briefly expressed on NK cell 
surface after degranulation 
LAMP2 (CD107b)  --- 
LAMP3 (CD63)  --- 
TNFRSF7 (CD27) CD70  +  - 
 
  
 Ch VIII S6 Table 28 (1): Selected commonly used surface markers for murine 
mononuclear phagocytes.  
 
phenotype selected references 
Monocytes  
  
classical 
CD115+ CX3CR1int CCR2+ 
CD62L+ CD43lo  Ly6Chi   
[4],[7],[20]  
non-classical CX3CR1hi CCR2+ CD62L+ 
CD43hi   
[4],[7],[20]  
Macrophages    
Kupffer cells (liver) CD11b+ F4/80+ CD68+/-, 
Clec4F+ 
[5],[21],[22] 
microglia (brain) CX3CR1hi CD45int CD11b+ 
F4/80+  Siglec+   
[23],[24] 
intestinal lamina 
propria macrophages  
CD64+ CX3CR1+ CD11c+/- 
F4/80+ CD11b+ (lamina propria)  
 
 
[25]-[29] 
 
Dendritic cells   
 
  
lymphoid organ  CD11c+ MHCII+ CD24+/- 
XCR1+/- 
[2],[3] 
non-lymphoid organ 
(intestine) 
CD11c+ CD103+/- MHCII+ 
CD24+/- CD11b+/- 
 
[3],[30],[31] 
 
  
 Ch VIII S7 Table 29 (1): Selection of most important markers for flow cytometry 
analysis of granulocytes. 
Cell type 
 
Mouse Human 
 
Basophil 
 
CD45pos, CD11bpos, Ly6Clow, 
CD200R3pos, CD49bpos, 
FcεRIαpos 
 
 
CD45pos, CD11bpos, CD15neg, 
CD16neg, CCR3pos, FcεRIαpos, 
CD203pos, CD117neg 
 
Eosinophil CD45pos, CD11bpos, Ly6Clow/int, 
Siglec-Fpos, CCR3pos, FcεRIαpos 
 
CD45pos, CD11bpos, CD15pos, 
CD16neg, Siglec-8pos, CCR3pos, 
FcεRIαpos 
 
Neutrophil CD45pos, CD11bpos, Ly6Cint, 
Ly6Gpos 
 
CD45pos, CD11bpos, CD15pos, 
CD16pos, CD66bpos 
 
 
Ch VIII S8 Table 30 (1): Antibodies for bone marrow stromal cells. 
Antibody Clone Company 
CD45 30-F11 Biolegend 
Ter119 Ter-119 Biolegend 
CD31 390 Biolegend 
CD51 RMV-7 eBioscience 
PDGFRα APA5 eBioscience 
   
 
 
Ch VIII S9 Table 31 Table 1. Selection of most important markers for flow cytometry 
analysis of mouse BM hematopoietic stem cells.  
Cell type Mouse Human 
 
Long-term 
self-renewing 
pluripotent 
hematopoietic 
stem cells 
(LT-pHSC) 
 
Negative: 
F4/80, Mac1, Gr1, CD11c, CD4, CD8, 
CD3, CD5, CD19, B220, NK1.1, 
Ter119 
Thy1.1low, Flk2, CD34, CD48 
Rho123low / Hoechstlow 
Positive: 
c-Kit, Sca1, CD201high, CD150 
 
Negative: 
CD1c, CD14, CD15, CD16, CD20, 
CD41, CD11c, CD56, CD203c, 
CD235a, BDCA2, Ter119 
CD38, CD45RA 
Rho123low / Hoechstlow 
Positive: 
CD34, CD90 
 
Ch VIII S10 Table 32 (10.2.1): Collection of surface molecules for flow cytometry cell 
sorting staining of human solid tumor cells 
Antigen molecules / synonyms antibody / clone (selection) 
MHC class I complex  HLA class I, all HLA-A, -B, -C 
alleles 
W6/32, HC10 
 beta2- microglobuline, 2m HB28, B2M-01, 2M2 
MHC class II HLA-DR; HLA-DQ; HLA-DP L243; TÜ169,  SK10; B7/21 
NKG2D ligands MICA; MICB; ULBP1; ULBP2; 
ULBP3  
MAB1300; MAb1599; MAB1380; 
MAB1289; MAB1517 
ICAM-1 CD54 9H21L19; LB-2  
VCAM CD106 51-10C9 
Ep-CAM CD326 EBA-1, 9C4, 22HCLC 
VE-cadherin CD144 BV13, 55-7H1, BV9 
E-cadherin CD234 36/E-cadherin, 5HCLC, 67A4 
EGFR HER1 EGFR.1, H11, 199.12,  
PDGFR CD140a (alpha chain) 
CD140b (beta chain) 
AlphaR1, 16A1, 
28D4, 18A2, Y92,  
c-Met HGFR 3D6, ebioclone97 
pan-cytokeratin  pan-cytokeratin  C-11, PAN-CK 
cytokeratin 18 CK18 CK2, C-04, DC10, AE1, E431-1 
cytokeratin 8 CK8 K8.8, 5D3, C-43, M20 
CD99  TÜ12, 3B2/TA8, EPR3096,  
 
Ch VIII S10 Table 33 (10.2.2): Collection of surface molecules for flow cytometry cell 
sorting staining of murine solid tumor cells 
Antigen molecules / synonyms antibody / clone (selection) 
MHC class I complex  MHC class I all H-2 molecules  M1/42  
 H-2K; H-2D; H-2L Kd+Dd (ab131404); Dd (ab25590); Kb 
(ab93364);  
 beta2-microglobuline, 2m S19.8 
MHC class II I-A, I-E M5/114.15.2 
NKG2D ligands Rae-1, H60, MULT1 (Rae-1g (CX1); H60 (MAB1155); MULT1 (5D0)  
ICAM-1 CD54 
YN1/1.7.4 
VCAM CD106 429 
Ep-CAM CD326 G8.8 
VE-cadherin CD144 ab33168, MC13.3 
E-cadherin CD234 DECMA-1, M168 
EGFR HER1 EP38Y,  
PDGFR CD140a (alpha chain) 
CD140b (beta chain) 
APA-5 
APB-5 
c-Met HGFR ebioclone7, EP1454Y 
pan-cytokeratin  pan-cytokeratin  C-11, ab9377, AE1/AE3 
cytokeratin 18 CK18 6-19 
cytokeratin 8 CK8+CK18 EP1628Y 
CD24  J11d, M1/69, 30-F1 
CD34  RAM34, MEC14.7, MAB6518 
CD44  IM7,  
CD133  13A4, 315-2C11,  
 
  
 Ch VIII S10 Table 34 (10.4.2): Overview of the most frequent human carcinomas 
carcinoma tissue  most frequent form of 
carcinoma 
originating cell Re
f 
lung cancer non-small cell lung cancer 
(NSCLC) 
type I / II alveolar epithelial cells [12] 
breast cancer mammary carcinoma epithelial cells of the milk duct [15] 
colon cancer colorectal carcinoma (CRC) epithelial cells of inner mucosal layer  [12] 
prostate cancer prostate carcinoma  epithelial basal cells of the prostate [16] 
liver cancer  hepatocellular carcinoma (HCC) Hepatocytes [12] 
stomach cancer  stomach carcinoma epithelial cells transformed by H. pylori [12] 
cervical cancer cervical carcinoma cervical epithelial cells after HPV 
infection 
[17] 
oesophagus cancer oesophagus carcinoma Epithelial cells lining the oesophagus [18] 
bladder cancer  bladder carcinoma transitional epithelium of the bladder 
wall 
[19] 
pancreatic cancer pancreatic carcinoma endocrine ductal epithelial cells  [20] 
kidney cancer  renal cell carcinoma (RCC) proximal tubular epithelial cells [12] 
ovarian cancer ovarian carcinoma ovarian tubal-type epithelium [12] 
squamous cancer squamous cell carcinoma epithelial cells of skin or glands [12] 
 
Ch VIII S10 Table 35 (10.4.3): Overview of the most frequent human sarcomas 
sarcoma tissue  mesenchymal tumor  originating cell Ref. 
Ewing sarcoma Ewing’s sarcomas (bone, bone 
marrow, lung, kidney) 
soft tissue cell of the respective organ [22, 
24] 
Kaposi’s sarcoma soft tissue sarcoma Induced after infection with HHV-8  [23] 
 
Ch VIII S10 Table 36 (10.4.4): Overview of the most frequent human neuroectoderma 
tumors 
tumor tissue  neuroectodermal tumor  originating cell Ref. 
black skin cancer malignant melanoma melanocytes of the skin [25-27] 
brain cancer gioblastoma, glioma glial cells of the brain [28-29] 
brain cancer Astrocytoma Astrocytes of the brain [30] 
 
New figure numbers given, with old figure numbers in brackets 
 
Ch I S1 Figure 1 (1): Sample core after hydrodynamic focussing by lam inar sheath flow in 
a flow   cham ber  
 
 
Ch I S1 Figure 2 (2): Intensity profile of a  focus spot of a Gaussian laser beam.  
 
 Ch I S1 Figure 3 (3): Liquid stream of a jet in air sensing cell sorter.  
 
 
Ch I S1 Figure 4 (4): Schem atics of fluidics of a jet in air sensing cell sorter 
  
Ch I S2 Figure 5 (1): Typical electronic signal processing of a flow cytometer.  
 
 
Ch I S3 Figure 6 (1): Principle of a spectral flow cytometer.  
 
 Ch I S4 Figure 7 (1): Amnis® Im ageStream assays on im m une cells. 
 
 
Ch I S5 Figure 8 (1). Schem atic overview of a mass cytom etric m easurem ent. 
  
Ch I S5 Figure 9 (2). Typical gating strategy for PBMC analyzed by m ass cytometry 
 
 
Ch II S1 Figure 10 (1): Check-list: param eters for selecting a sorting m ethod 
 
 
Ch II S1 Figure 11 (2): Im provement of population discrimination after pre-enrichment.  
 
 Ch II S2.1 Figure 12 (1): PBMC Sort. 
 
 
Ch II S2.2 Figure 13 (1): Staining pattern and gating strategy for a CD34+ enrichment. 
 
 Ch II S2.2 Figure 14 (2): Result of a sequential sorting process. 
 
 
Ch III S1 Figure 15 (1): Spillover and com pensation.  
 
 
Ch III S1 Figure 16 (2): Brightness of positive population. 
  
Ch III S1 Figure 17 (3): Accuracy for SOV.  
 
 
Ch III S2 Figure 18 (1): Examples for performance tracking w ith and without a CS&T 
m odule, perform ed according to [1]. 
 
 
Ch III S2 Figure 19 (2): How  one can detect suboptim al alignment of lasers. 
  
Ch IV S2 Figure 20 (1): Titration of a CD4 m Ab (clone GK1.5) conjugated to FITC and 
titrated on m urine splenocytes.  
 
 
Ch IV S4 Figure 21 (1): Schemata of density gradient centrifugation with Ficoll® as pre-
enrichm ent. 
 
 
Ch IV S4 Figure 22 (2): Title needed (talks about elutriation chambers) 
  
 
Ch IV S4 Figure 23 (3): Title needed (talks about mesh size) 
 
 
Ch IV S4 Figure 24 (4): Exam ples for MACS®-enriched cell populations.  
 
 Ch IV S4 Figure 25 (5):Title needed (talks about Tregs) 
 
 
Ch IV S6 Figure 26 (1): Hum an whole blood fixed w ith formaldehyde and permeabilized 
w ith TX-100.  
  
Ch IV S6 Figure 27 (2): Impact of m ethanol concentration on P-STAT5 im munoreactivity in 
peripheral blood monocytes activated in vitro using GM-CSF.  
 
 
Ch IV S6 Figure 28 (3): Effect of m ethanol treatment on CD14 staining of hum an 
peripheral blood monocytes.  
  
Ch IV S6 Figure 29 (4). Effect of form aldehyde concentration on P-STAT5 
im munoreactivity in K562 cells (from  reference 5, used with permission).  
 
 
Ch IV S7 Figure 30 (1). Workflow of cell sam ple barcoding for flow and mass cytom etry.  
 
 Ch IV S7 Figure 31 (2). Barcoding schem es.  
 
 
Ch IV S8 Figure 32 (1): Spreading error and loss of detection sensitivity.  
 
 Ch IV S9 Figure 33 (1): Structural characteristics of imm unoglobulins.  
 
 
 Ch IV S9 Figure 34 (2): Structural characteristics of VLR antibodies.  
 
 
Ch V S2 Figure 35 (1): The threshold value defines a signal intensity, in one or m ore 
param eters, above w hich the cytometer starts to recognize an event. All other events will 
be invisible to the instrument's electronics. 
 
 
Ch V S3 Figure 36 (1). An exam ple of a gating stategy for rare cells. 
  
Ch VI S1 Figure 37 (1). Quality control analysis to detect batch effects.   
 
 
Ch VI S1 Figure 38 (2).  Model data illustrating the very different interpretations of tw o 
samples with similar proportions of cells in a positive gate.  
 
 Ch VI S2 Figure 39 (1): Typical autom ated analysis w orkflow s in flow  cytom etry.  
 
 
Ch VI S3 Figure 40 (1): Measurements of central tendencies for cytometric intensity 
histograms.   
 
 
Ch VI S3 Figure 41 (2): The histogram representation of fluorescence from a w eak 
staining of a sm all (rare) population.  
  
Ch VI S3 Figure 42 (3): Cum ulative frequencies from the two histograms in Fig. 2 and 
difference.  
 
 
Ch VI S3 Figure 43 (4): Result of the histogram analysis.  
 
 Ch VI S4 Figure 44 (1). Uni-, bi- and m ulti-param eter presentation of flow  data.  
 
 
Ch VI S4 Figure 45 (2). Sem i-autom ated analysis of flow  cytom etric data by SPADE.  
  
Ch VII S3 Figure 46 (1). An example of intracellular cytokine detection.  
 
 
Ch VII S3 Figure 47 (2). An example of intranuclear transcription factor detection.  
  
Ch VII S4 Figure 48 (1): An exam ple of how a traditional flow  cytometry assay m ight be 
designed using test tubes or even a 96 w ell plate assay.  
 
 
Ch VII S4 Figure 49 (2): Com binatorial cytometry integrates the ideas of screening 
biological responses.  
  
Ch VII S4 Figure 50 (3): Autom ated processing of bead-based cytokine assay.  
 
 
Ch VII S4 Figure 51 (4): Response curves automatically produced from data extracted 
from m ultiple FCS files.  
  
Ch VII S4 Figure 52 (5): The pipeline design canvas of the PlateAnalyzer.  
 
 
Ch VII S5 Figure 53 (1): An exam ple of a combinatorial staircase giving 28 unique dual 
color codes to 28 different peptides. 
 
 Ch VII S5 Figure 54 (2): Dot plots showing an antigen specific T cell population detected 
in T cells isolated from  a tum or lesion.  
 
 
Ch VII S6.1 Figure 55 (1): Principle of MHC multim er staining by increasing the binding 
avidity of MHC-TCR interactions.  
 
 Ch VII S6.1 Figure 56 (2): MHC multim er staining of hum an PBMCs for CMV peptide pp65 
w ith BV421 and APC.  
 
 
Ch VII S6.2 Figure 57 (1). Principle of antigen-specific stimulation assays.  
 
 Ch VII S6.2 Figure 58 (2). Enrichm ent of antigen-specific T cells increases sensitivity for 
the detection of rare cells.  
 
 
Ch VII S7 Figure 59 (7.1). Representative DNA fluorescence histogram of PI-stained cells. 
 
 Ch VII S7 Figure 60 (7.2): Identification of single cell populations for analysis using flow  
cytom etry.  
 
 
Ch VII S7 Figure 61 (7.3): Schematic representation of fluorescent dot plot for the flow  
cytom etric analysis of cell proliferation on the basis of BrDU incorporation.  
 
 Ch VII S7 Figure 62 (7.4): Schem atic fluorescence histogram  depicting a progressive 
decline in the fluorescent intensity of proliferating cells stained w ith CFSE.  
 
 
Ch VII S8.4 Figure 63 (1): Identifying healthy and apoptotic cells on the basis of Annexin V 
staining.  
 
 Ch VII S8.5 Figure 64 (1): Identifying healthy and apoptotic cells on the basis of activated 
caspase-3 expression.  
 
 
Ch VII S8.6 Figure 65 (1). TMRM and JC-1 staining of CD4+ T cells.  
 
 Ch VII S8.6 Figure 66 (2): Mitotracker Green staining of different subsets of CD8+ T cells.  
 
 
Ch VII S8.6 Figure 67 (3): MitoSOX Mitochondrial Red superoxide indicator and 
Mitochondria Peroxy Yellow -1 staining of different subsets of CD8+ T cells.  
 
 Ch VII S9 Figure 68 (1): Representative examples of strategies to differentiate betw een 
attached and internalized fluorescent bacteria in w hole-blood phagocytosis assays by 
conventional flow  cytom etry (A–C) and imaging flow  cytometry (D–F).  
 
 
Ch VII S10 Figure 69 (1): Autophagy pathway showing key m odulators used in detection 
of autophagy.  
 Ch VII S10 Figure 70 (2): Autophagy induction and flux m easured w ith the FlowCellect 
LC3 kit.  
 
 
Ch VII S11 Figure 71 (1): Quantification of ex vivo cytotoxicity by influenza-specific CTLs.  
 
 
Ch VII S11 Figure 72 (2): Quantification of in vivo cytotoxicity by influenza-specific CTLs.  
 Ch VII S12 Figure 73 (1): Identification of leukocytes in hum an whole blood using violet 
laser and Vybrant DyeCycle Violet stain on the Attune NxT Flow  Cytom eter.  
 
 
Ch VII S12 Figure 74 (2): Identification of leukocytes in hum an whole blood using violet 
side scatter on the flow cytometer. 
 
  
Ch VII S12 Figure 75 (3): Use of the Attune NxT No-Wash No-Lyse Filter Kit.  
 Ch VII S12 Figure 76 (4): Reactive oxygen species production.  
 
 
Ch VII S13 Figure 77 (1): Measuring intracellular Ca2+ mobilization in hum an B cells in 
response to anti-IgM stimulation after labeling with Indo-1 AM by flow  cytometry. 
 
 Ch VII S14 Figure 78 (1): PrimeFlow™ RNA Assay procedure 
 
 
 
Ch VII S15 Figure 79 (1):  Typical sequential gating analysis perform ed on samples of 
cycling cells stained for DNA content and intra-nuclear histone modifications.   
 
 
 Ch VII S15 Figure 80 (2). FoxP3 staining to detect T-regulatory cells.   
 
 Ch VII S16 Figure 81 (1): “Canonical” pathw ays for LPS activation of m ultiple signaling 
pathw ays in peripheral blood monocytes via TLR-4 (adapted from Guha and Mackm an, 
2001).  
 
 Ch VII S16 Figure 82 (2): LPS activation of the ERK pathway in hum an peripheral blood 
m onocytes.  
 
 
Ch VII S16 Figure 83 (3): Sim ultaneous m easurement of four different signaling targets.  
 
 Ch VII S16 Figure 84 (4): Kinetics of LPS activation of the AKT and ERK pathw ays in 
peripheral blood monocytes.  
 
 
Ch VII S17 Figure 85 (1): Analysis of the sensitivity of m tmP tow ards CCCP in real time.  
 
 Ch VII S17 Figure 86 (2): Testing the specificity of DCFDA.  
 
 
 
Ch VIII S1.1 Figure 87 (1). Gating of CD4+ and CD8+ T cells in peripheral blood.   
 
 
Ch VIII S1.1 Figure 88 (2). A four-dim ensional m odel to address T-cell differentiation 
stages.  
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